Query 048517
Match_columns 453
No_of_seqs 396 out of 2403
Neff 8.5
Searched_HMMs 46136
Date Fri Mar 29 10:12:54 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/048517.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/048517hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 KOG1187 Serine/threonine prote 100.0 3.7E-53 8.1E-58 422.4 23.8 269 150-426 62-355 (361)
2 KOG0192 Tyrosine kinase specif 100.0 3.7E-44 8.1E-49 355.8 22.0 244 165-428 45-308 (362)
3 KOG0197 Tyrosine kinases [Sign 100.0 1.3E-44 2.7E-49 359.3 15.8 247 157-425 202-463 (468)
4 KOG0581 Mitogen-activated prot 100.0 1.7E-41 3.6E-46 323.4 16.3 233 166-418 84-334 (364)
5 KOG0615 Serine/threonine prote 100.0 6.3E-42 1.4E-46 328.6 12.6 245 154-418 165-436 (475)
6 KOG0575 Polo-like serine/threo 100.0 5.6E-41 1.2E-45 336.7 17.9 232 161-418 18-268 (592)
7 KOG0591 NIMA (never in mitosis 100.0 5.1E-41 1.1E-45 308.1 12.3 248 160-425 18-287 (375)
8 KOG0595 Serine/threonine-prote 100.0 4.8E-40 1E-44 316.0 18.1 232 163-418 12-267 (429)
9 cd05102 PTKc_VEGFR3 Catalytic 100.0 8.3E-40 1.8E-44 325.8 17.4 249 160-426 6-337 (338)
10 KOG1026 Nerve growth factor re 100.0 6.5E-41 1.4E-45 348.0 9.5 246 161-425 486-764 (774)
11 KOG0193 Serine/threonine prote 100.0 1.6E-39 3.5E-44 325.0 14.6 250 158-426 389-656 (678)
12 KOG0196 Tyrosine kinase, EPH ( 100.0 6E-40 1.3E-44 335.0 10.2 248 157-426 625-894 (996)
13 KOG1095 Protein tyrosine kinas 100.0 4E-39 8.6E-44 345.7 14.5 251 157-426 688-964 (1025)
14 KOG0598 Ribosomal protein S6 k 100.0 8.7E-39 1.9E-43 304.7 15.1 224 163-411 27-269 (357)
15 KOG0578 p21-activated serine/t 100.0 3.1E-38 6.7E-43 314.7 18.4 229 166-418 278-522 (550)
16 cd05104 PTKc_Kit Catalytic dom 100.0 1.3E-37 2.8E-42 314.7 20.5 246 160-423 34-374 (375)
17 cd05096 PTKc_DDR1 Catalytic do 100.0 1E-37 2.2E-42 306.0 18.7 250 160-422 4-304 (304)
18 KOG0661 MAPK related serine/th 100.0 7E-38 1.5E-42 305.5 15.3 249 159-419 8-291 (538)
19 KOG3653 Transforming growth fa 100.0 5E-37 1.1E-41 299.3 20.2 255 164-425 213-505 (534)
20 PHA02988 hypothetical protein; 100.0 3.9E-37 8.5E-42 299.3 19.2 230 167-422 26-278 (283)
21 cd05631 STKc_GRK4 Catalytic do 100.0 1.7E-37 3.7E-42 301.9 16.6 235 163-418 2-260 (285)
22 PF07714 Pkinase_Tyr: Protein 100.0 2.2E-37 4.7E-42 297.0 17.0 235 165-420 3-259 (259)
23 cd05106 PTKc_CSF-1R Catalytic 100.0 2.2E-37 4.8E-42 312.9 17.5 247 160-424 37-373 (374)
24 cd05064 PTKc_EphR_A10 Catalyti 100.0 3.2E-37 7E-42 296.7 17.6 241 160-423 4-265 (266)
25 cd05072 PTKc_Lyn Catalytic dom 100.0 5.9E-37 1.3E-41 293.4 18.5 240 161-422 6-260 (261)
26 cd05068 PTKc_Frk_like Catalyti 100.0 8.1E-37 1.8E-41 292.6 18.9 242 159-422 4-260 (261)
27 KOG4278 Protein tyrosine kinas 100.0 1E-37 2.3E-42 311.1 12.9 244 158-423 264-523 (1157)
28 KOG0582 Ste20-like serine/thre 100.0 7.3E-37 1.6E-41 296.4 18.3 246 161-418 26-292 (516)
29 cd05049 PTKc_Trk Catalytic dom 100.0 1.1E-36 2.4E-41 294.5 19.6 244 160-422 4-280 (280)
30 cd05114 PTKc_Tec_Rlk Catalytic 100.0 8.5E-37 1.8E-41 291.6 18.7 236 162-420 5-255 (256)
31 KOG0593 Predicted protein kina 100.0 2.1E-37 4.6E-42 286.9 13.9 244 164-418 5-283 (396)
32 KOG0198 MEKK and related serin 100.0 3.4E-37 7.4E-42 297.7 15.7 241 162-421 18-278 (313)
33 cd05052 PTKc_Abl Catalytic dom 100.0 1.4E-36 3.1E-41 291.4 19.6 240 162-423 7-262 (263)
34 cd05048 PTKc_Ror Catalytic Dom 100.0 9.8E-37 2.1E-41 295.4 18.6 242 162-422 6-282 (283)
35 KOG4721 Serine/threonine prote 100.0 5.2E-38 1.1E-42 310.9 9.8 242 168-435 131-381 (904)
36 KOG0592 3-phosphoinositide-dep 100.0 2.7E-37 6E-42 305.7 14.1 233 163-419 75-338 (604)
37 KOG0597 Serine-threonine prote 100.0 3.8E-37 8.2E-42 305.0 15.0 251 162-439 3-273 (808)
38 cd05054 PTKc_VEGFR Catalytic d 100.0 1.2E-36 2.6E-41 303.4 18.7 248 160-425 6-335 (337)
39 PTZ00283 serine/threonine prot 100.0 1.4E-36 2.9E-41 317.4 19.3 240 161-419 32-297 (496)
40 cd05108 PTKc_EGFR Catalytic do 100.0 2.1E-36 4.6E-41 298.5 19.5 244 160-426 6-271 (316)
41 cd05033 PTKc_EphR Catalytic do 100.0 2.1E-36 4.5E-41 290.6 18.5 241 161-423 4-265 (266)
42 cd05062 PTKc_IGF-1R Catalytic 100.0 2.8E-36 6E-41 291.6 19.2 245 159-422 4-277 (277)
43 cd05105 PTKc_PDGFR_alpha Catal 100.0 2.5E-36 5.3E-41 307.4 19.4 247 161-425 37-399 (400)
44 KOG0194 Protein tyrosine kinas 100.0 3.7E-37 8.1E-42 310.3 13.1 240 164-428 160-425 (474)
45 cd05067 PTKc_Lck_Blk Catalytic 100.0 7.4E-36 1.6E-40 285.8 21.4 242 158-422 3-259 (260)
46 cd05148 PTKc_Srm_Brk Catalytic 100.0 4.8E-36 1E-40 287.0 20.0 239 161-422 6-260 (261)
47 PLN00113 leucine-rich repeat r 100.0 1.1E-35 2.5E-40 335.0 26.4 243 165-425 694-953 (968)
48 cd05071 PTKc_Src Catalytic dom 100.0 5.1E-36 1.1E-40 287.7 20.0 241 160-423 5-260 (262)
49 cd05113 PTKc_Btk_Bmx Catalytic 100.0 6.1E-36 1.3E-40 286.2 20.2 237 162-421 5-256 (256)
50 cd05571 STKc_PKB Catalytic dom 100.0 1.5E-36 3.3E-41 300.7 16.6 226 167-418 1-250 (323)
51 cd05059 PTKc_Tec_like Catalyti 100.0 3.8E-36 8.2E-41 287.3 18.6 236 162-420 5-255 (256)
52 cd05091 PTKc_Ror2 Catalytic do 100.0 4E-36 8.6E-41 291.3 18.8 243 161-422 5-282 (283)
53 cd05612 STKc_PRKX_like Catalyt 100.0 4.5E-36 9.7E-41 292.9 19.2 228 163-419 3-254 (291)
54 KOG0583 Serine/threonine prote 100.0 3E-36 6.6E-41 301.5 18.3 233 160-418 16-274 (370)
55 cd05070 PTKc_Fyn_Yrk Catalytic 100.0 6.8E-36 1.5E-40 286.1 20.0 240 160-422 5-259 (260)
56 KOG2345 Serine/threonine prote 100.0 1.4E-36 3E-41 274.6 13.9 252 160-423 20-300 (302)
57 cd05585 STKc_YPK1_like Catalyt 100.0 3.6E-36 7.7E-41 296.6 17.6 226 169-420 1-245 (312)
58 cd05093 PTKc_TrkB Catalytic do 100.0 8.4E-36 1.8E-40 290.2 19.9 245 162-425 6-281 (288)
59 KOG1094 Discoidin domain recep 100.0 2.2E-36 4.7E-41 300.5 15.8 252 157-422 534-803 (807)
60 cd05094 PTKc_TrkC Catalytic do 100.0 5.1E-36 1.1E-40 292.1 18.0 245 162-425 6-284 (291)
61 cd05616 STKc_cPKC_beta Catalyt 100.0 3.7E-36 8E-41 297.9 17.2 225 163-413 2-246 (323)
62 cd05075 PTKc_Axl Catalytic dom 100.0 7.9E-36 1.7E-40 287.2 19.0 240 165-423 3-271 (272)
63 cd05032 PTKc_InsR_like Catalyt 100.0 8.2E-36 1.8E-40 287.8 18.9 244 160-422 5-277 (277)
64 cd05590 STKc_nPKC_eta Catalyti 100.0 6.9E-36 1.5E-40 295.7 18.8 221 167-413 1-241 (320)
65 KOG0201 Serine/threonine prote 100.0 2.9E-37 6.2E-42 299.0 8.5 231 163-418 15-262 (467)
66 cd05035 PTKc_Axl_like Catalyti 100.0 1.5E-35 3.3E-40 285.0 20.5 241 164-423 2-272 (273)
67 PTZ00267 NIMA-related protein 100.0 5.2E-36 1.1E-40 312.3 18.3 237 163-418 69-322 (478)
68 cd05587 STKc_cPKC Catalytic do 100.0 6.5E-36 1.4E-40 296.2 18.2 225 163-413 2-246 (324)
69 cd05053 PTKc_FGFR Catalytic do 100.0 5.8E-36 1.3E-40 291.6 17.5 245 161-424 12-292 (293)
70 cd05608 STKc_GRK1 Catalytic do 100.0 4.9E-36 1.1E-40 290.9 16.6 232 169-418 1-256 (280)
71 cd05591 STKc_nPKC_epsilon Cata 100.0 6E-36 1.3E-40 296.1 17.5 227 167-419 1-254 (321)
72 cd05600 STKc_Sid2p_Dbf2p Catal 100.0 2.2E-36 4.8E-41 300.7 14.4 235 163-419 3-257 (333)
73 cd05116 PTKc_Syk Catalytic dom 100.0 2.8E-35 6.1E-40 281.5 21.5 231 168-422 2-254 (257)
74 KOG0600 Cdc2-related protein k 100.0 3.9E-36 8.5E-41 295.3 15.7 248 162-418 118-399 (560)
75 KOG0616 cAMP-dependent protein 100.0 3.3E-36 7.2E-41 278.4 14.4 219 163-410 46-283 (355)
76 cd05043 PTK_Ryk Pseudokinase d 100.0 8E-36 1.7E-40 288.7 17.8 248 159-425 4-278 (280)
77 cd05069 PTKc_Yes Catalytic dom 100.0 2E-35 4.3E-40 283.0 20.3 239 161-422 6-259 (260)
78 cd05090 PTKc_Ror1 Catalytic do 100.0 1.1E-35 2.4E-40 288.3 18.6 242 162-422 6-282 (283)
79 cd05592 STKc_nPKC_theta_delta 100.0 8.3E-36 1.8E-40 294.6 18.0 225 167-417 1-246 (316)
80 KOG0659 Cdk activating kinase 100.0 5.5E-35 1.2E-39 266.7 21.8 244 162-419 3-281 (318)
81 cd05618 STKc_aPKC_iota Catalyt 100.0 6.2E-36 1.3E-40 297.2 17.1 229 167-413 1-250 (329)
82 cd07862 STKc_CDK6 Catalytic do 100.0 1.2E-35 2.6E-40 289.0 18.7 242 162-418 2-286 (290)
83 cd05620 STKc_nPKC_delta Cataly 100.0 2.4E-35 5.2E-40 291.3 21.1 225 167-417 1-246 (316)
84 cd05109 PTKc_HER2 Catalytic do 100.0 1.1E-35 2.3E-40 287.8 18.3 240 162-424 8-269 (279)
85 cd05111 PTK_HER3 Pseudokinase 100.0 1.7E-35 3.7E-40 286.8 19.6 241 162-425 8-270 (279)
86 PTZ00263 protein kinase A cata 100.0 6.7E-36 1.4E-40 296.9 17.0 228 162-418 19-270 (329)
87 cd06649 PKc_MEK2 Catalytic dom 100.0 8.5E-36 1.8E-40 296.4 17.7 242 161-419 5-301 (331)
88 cd05061 PTKc_InsR Catalytic do 100.0 1.4E-35 3E-40 288.6 18.9 248 159-425 4-280 (288)
89 cd05593 STKc_PKB_gamma Catalyt 100.0 9.3E-36 2E-40 295.8 17.9 227 167-419 1-251 (328)
90 cd05614 STKc_MSK2_N N-terminal 100.0 2.5E-36 5.4E-41 300.1 13.7 236 163-418 2-266 (332)
91 cd05034 PTKc_Src_like Catalyti 100.0 3.2E-35 6.9E-40 281.3 20.8 243 158-422 3-260 (261)
92 cd05615 STKc_cPKC_alpha Cataly 100.0 1.4E-35 2.9E-40 294.0 18.9 225 163-413 2-246 (323)
93 KOG0588 Serine/threonine prote 100.0 3.8E-36 8.3E-41 303.2 15.0 231 163-419 14-263 (786)
94 cd05589 STKc_PKN Catalytic dom 100.0 1.7E-35 3.8E-40 293.2 19.5 228 164-418 2-256 (324)
95 cd05595 STKc_PKB_beta Catalyti 100.0 8.3E-36 1.8E-40 295.5 17.2 226 167-418 1-250 (323)
96 cd07848 STKc_CDKL5 Catalytic d 100.0 1.3E-35 2.7E-40 288.4 18.1 246 163-418 3-283 (287)
97 cd07859 STKc_TDY_MAPK_plant Ca 100.0 8.9E-36 1.9E-40 296.2 17.3 248 163-418 2-289 (338)
98 cd00192 PTKc Catalytic domain 100.0 5.2E-35 1.1E-39 278.6 21.9 236 167-421 1-262 (262)
99 cd05098 PTKc_FGFR1 Catalytic d 100.0 8.2E-36 1.8E-40 293.0 16.7 250 157-425 14-301 (307)
100 cd05045 PTKc_RET Catalytic dom 100.0 1.2E-35 2.7E-40 289.2 17.8 243 164-425 3-288 (290)
101 cd05103 PTKc_VEGFR2 Catalytic 100.0 3.2E-35 7E-40 293.7 21.1 248 160-425 6-341 (343)
102 cd05619 STKc_nPKC_theta Cataly 100.0 1.7E-35 3.7E-40 292.4 18.9 225 167-417 1-246 (316)
103 cd05084 PTKc_Fes Catalytic dom 100.0 1.6E-35 3.5E-40 282.0 18.0 233 167-421 1-251 (252)
104 cd05588 STKc_aPKC Catalytic do 100.0 1.7E-35 3.6E-40 294.1 18.9 234 167-418 1-261 (329)
105 cd05100 PTKc_FGFR3 Catalytic d 100.0 2.1E-35 4.6E-40 293.7 19.3 249 157-424 8-294 (334)
106 cd05101 PTKc_FGFR2 Catalytic d 100.0 1.3E-35 2.8E-40 291.1 17.4 249 158-425 12-298 (304)
107 KOG0605 NDR and related serine 100.0 5E-36 1.1E-40 296.8 14.5 225 166-412 146-435 (550)
108 cd05036 PTKc_ALK_LTK Catalytic 100.0 1.7E-35 3.8E-40 286.2 18.1 243 160-421 5-276 (277)
109 PTZ00426 cAMP-dependent protei 100.0 1.4E-35 3E-40 296.0 17.9 234 157-419 26-284 (340)
110 cd08228 STKc_Nek6 Catalytic do 100.0 4.8E-35 1E-39 280.9 21.0 244 162-423 3-265 (267)
111 cd08229 STKc_Nek7 Catalytic do 100.0 3.9E-35 8.6E-40 281.6 20.2 244 162-423 3-265 (267)
112 cd05042 PTKc_Aatyk Catalytic d 100.0 3.3E-35 7.2E-40 282.7 19.5 242 167-421 1-268 (269)
113 PLN00034 mitogen-activated pro 100.0 5.4E-35 1.2E-39 293.2 21.6 232 164-419 77-328 (353)
114 cd05097 PTKc_DDR_like Catalyti 100.0 1.1E-35 2.4E-40 290.3 16.2 250 159-421 3-294 (295)
115 KOG0694 Serine/threonine prote 100.0 1.4E-35 3.1E-40 301.1 17.4 223 164-413 371-613 (694)
116 cd05107 PTKc_PDGFR_beta Cataly 100.0 2.8E-35 6E-40 299.6 19.5 250 157-424 33-400 (401)
117 cd08224 STKc_Nek6_Nek7 Catalyt 100.0 1.1E-34 2.3E-39 278.1 22.5 244 162-423 3-265 (267)
118 cd05594 STKc_PKB_alpha Catalyt 100.0 8.3E-36 1.8E-40 295.6 15.1 226 167-418 1-251 (325)
119 cd05573 STKc_ROCK_NDR_like Cat 100.0 9.2E-36 2E-40 297.9 15.4 236 162-419 2-285 (350)
120 cd05617 STKc_aPKC_zeta Catalyt 100.0 3.3E-35 7.1E-40 291.7 19.0 228 167-413 1-248 (327)
121 cd05060 PTKc_Syk_like Catalyti 100.0 5.3E-35 1.1E-39 279.4 19.7 233 167-423 1-255 (257)
122 cd07869 STKc_PFTAIRE1 Catalyti 100.0 1.4E-35 3E-40 290.9 16.0 244 162-418 6-287 (303)
123 cd05092 PTKc_TrkA Catalytic do 100.0 2.9E-35 6.3E-40 285.2 18.0 242 162-422 6-280 (280)
124 cd05570 STKc_PKC Catalytic dom 100.0 2.2E-35 4.9E-40 291.7 17.5 226 167-418 1-251 (318)
125 cd05605 STKc_GRK4_like Catalyt 100.0 3.1E-35 6.7E-40 286.0 18.2 236 162-418 1-260 (285)
126 cd06650 PKc_MEK1 Catalytic dom 100.0 4.3E-35 9.2E-40 291.7 19.5 187 158-356 2-205 (333)
127 cd05073 PTKc_Hck Catalytic dom 100.0 3.8E-35 8.2E-40 281.1 18.4 242 158-422 3-259 (260)
128 cd05087 PTKc_Aatyk1_Aatyk3 Cat 100.0 7.1E-35 1.5E-39 280.6 20.2 242 167-421 1-268 (269)
129 cd05575 STKc_SGK Catalytic dom 100.0 1.6E-35 3.4E-40 293.4 16.0 222 167-414 1-242 (323)
130 cd05051 PTKc_DDR Catalytic dom 100.0 3E-35 6.6E-40 286.8 17.5 248 161-421 5-295 (296)
131 cd05112 PTKc_Itk Catalytic dom 100.0 9.5E-35 2.1E-39 277.1 20.5 236 162-420 5-255 (256)
132 cd07871 STKc_PCTAIRE3 Catalyti 100.0 2.8E-35 6E-40 286.7 17.1 243 162-418 6-284 (288)
133 cd05085 PTKc_Fer Catalytic dom 100.0 6.2E-35 1.3E-39 277.5 18.8 232 167-421 1-249 (250)
134 cd05050 PTKc_Musk Catalytic do 100.0 4.1E-35 8.8E-40 285.1 17.8 242 162-422 6-288 (288)
135 cd05055 PTKc_PDGFR Catalytic d 100.0 8.9E-35 1.9E-39 285.3 19.9 246 158-423 32-301 (302)
136 PHA03212 serine/threonine kina 100.0 8.5E-35 1.8E-39 295.6 20.4 247 161-418 92-375 (391)
137 cd05063 PTKc_EphR_A2 Catalytic 100.0 5.1E-35 1.1E-39 281.1 17.8 240 162-423 6-267 (268)
138 cd05604 STKc_SGK3 Catalytic do 100.0 3.4E-35 7.3E-40 291.3 17.0 225 167-417 1-245 (325)
139 cd05095 PTKc_DDR2 Catalytic do 100.0 7.6E-35 1.7E-39 284.6 18.9 248 161-421 5-295 (296)
140 cd08528 STKc_Nek10 Catalytic d 100.0 1.4E-34 3.1E-39 278.2 20.3 239 163-421 2-268 (269)
141 cd05602 STKc_SGK1 Catalytic do 100.0 3.1E-35 6.8E-40 291.5 16.1 226 167-418 1-246 (325)
142 cd05099 PTKc_FGFR4 Catalytic d 100.0 1.3E-34 2.9E-39 285.4 20.5 247 161-426 12-296 (314)
143 cd05584 STKc_p70S6K Catalytic 100.0 8.3E-35 1.8E-39 288.3 18.9 226 167-418 2-255 (323)
144 cd05115 PTKc_Zap-70 Catalytic 100.0 2.2E-34 4.8E-39 275.6 21.3 232 168-422 2-254 (257)
145 cd05080 PTKc_Tyk2_rpt2 Catalyt 100.0 3.6E-35 7.8E-40 284.8 15.8 244 164-423 7-281 (283)
146 cd05628 STKc_NDR1 Catalytic do 100.0 4.9E-35 1.1E-39 294.6 17.3 236 163-419 3-293 (363)
147 cd05039 PTKc_Csk_like Catalyti 100.0 1.1E-34 2.4E-39 276.8 18.9 235 161-422 6-255 (256)
148 cd05047 PTKc_Tie Catalytic dom 100.0 1.1E-34 2.4E-39 279.6 18.9 236 167-424 1-269 (270)
149 cd06637 STKc_TNIK Catalytic do 100.0 1.7E-34 3.6E-39 278.0 20.2 238 161-418 6-268 (272)
150 cd05603 STKc_SGK2 Catalytic do 100.0 6.7E-35 1.5E-39 288.5 17.8 222 167-414 1-242 (321)
151 cd05088 PTKc_Tie2 Catalytic do 100.0 3.8E-35 8.1E-40 288.0 15.8 247 158-426 4-283 (303)
152 cd05082 PTKc_Csk Catalytic dom 100.0 1.4E-34 2.9E-39 276.4 19.2 233 162-422 7-255 (256)
153 cd08529 STKc_FA2-like Catalyti 100.0 1.9E-34 4.2E-39 274.7 20.1 233 163-418 2-252 (256)
154 cd05086 PTKc_Aatyk2 Catalytic 100.0 1.6E-34 3.5E-39 278.3 19.7 242 167-421 1-267 (268)
155 cd05044 PTKc_c-ros Catalytic d 100.0 1E-34 2.2E-39 279.1 18.2 236 167-421 1-268 (269)
156 cd05089 PTKc_Tie1 Catalytic do 100.0 6.4E-35 1.4E-39 285.4 17.1 245 163-429 4-281 (297)
157 cd05065 PTKc_EphR_B Catalytic 100.0 6.7E-35 1.5E-39 280.6 16.9 241 161-423 4-268 (269)
158 cd05601 STKc_CRIK Catalytic do 100.0 1E-35 2.2E-40 295.4 11.5 236 163-418 3-262 (330)
159 cd05586 STKc_Sck1_like Catalyt 100.0 1.8E-35 3.9E-40 293.7 13.2 226 169-418 1-252 (330)
160 cd05596 STKc_ROCK Catalytic do 100.0 5E-35 1.1E-39 295.4 16.0 238 161-419 43-304 (370)
161 cd05626 STKc_LATS2 Catalytic d 100.0 4.7E-35 1E-39 296.7 15.7 237 163-419 3-305 (381)
162 PTZ00284 protein kinase; Provi 100.0 1.9E-34 4E-39 300.0 20.6 248 161-422 129-443 (467)
163 cd06646 STKc_MAP4K5 Catalytic 100.0 9.5E-35 2.1E-39 279.1 16.9 242 160-420 8-266 (267)
164 PHA03211 serine/threonine kina 100.0 2.6E-34 5.6E-39 296.6 20.9 249 162-419 170-455 (461)
165 KOG4257 Focal adhesion tyrosin 100.0 1.6E-35 3.4E-40 296.0 11.3 241 161-425 389-651 (974)
166 cd05607 STKc_GRK7 Catalytic do 100.0 2.2E-34 4.7E-39 278.9 19.1 232 169-420 1-251 (277)
167 PTZ00036 glycogen synthase kin 100.0 1.4E-34 3.1E-39 298.4 18.8 245 162-418 67-350 (440)
168 cd05079 PTKc_Jak1_rpt2 Catalyt 100.0 2.3E-34 5E-39 279.4 19.1 248 161-423 4-283 (284)
169 PF00069 Pkinase: Protein kina 100.0 3.4E-35 7.5E-40 280.2 13.0 238 163-418 1-256 (260)
170 cd05599 STKc_NDR_like Catalyti 100.0 3.4E-35 7.5E-40 295.6 13.6 234 163-418 3-295 (364)
171 cd05038 PTKc_Jak_rpt2 Catalyti 100.0 4.9E-34 1.1E-38 276.1 21.2 248 162-423 5-283 (284)
172 cd05582 STKc_RSK_N N-terminal 100.0 4.2E-35 9.1E-40 289.6 13.7 223 167-415 2-245 (318)
173 cd05041 PTKc_Fes_like Catalyti 100.0 3.9E-34 8.5E-39 272.1 19.8 234 167-422 1-251 (251)
174 KOG1025 Epidermal growth facto 100.0 1.1E-34 2.4E-39 297.6 16.6 240 166-428 701-962 (1177)
175 cd05066 PTKc_EphR_A Catalytic 100.0 2E-34 4.4E-39 277.1 17.6 241 161-423 4-266 (267)
176 cd05630 STKc_GRK6 Catalytic do 100.0 1.6E-34 3.4E-39 281.1 17.0 235 163-418 2-260 (285)
177 cd05040 PTKc_Ack_like Catalyti 100.0 3.7E-34 7.9E-39 273.3 19.2 233 167-421 1-256 (257)
178 cd05081 PTKc_Jak2_Jak3_rpt2 Ca 100.0 4.7E-34 1E-38 276.9 19.9 247 163-423 6-283 (284)
179 cd05621 STKc_ROCK2 Catalytic d 100.0 8.5E-35 1.9E-39 293.6 15.2 238 161-419 43-304 (370)
180 cd05058 PTKc_Met_Ron Catalytic 100.0 2.7E-34 5.9E-39 275.0 17.9 236 167-424 1-260 (262)
181 cd05110 PTKc_HER4 Catalytic do 100.0 4E-34 8.7E-39 280.6 19.5 241 163-426 9-271 (303)
182 cd05057 PTKc_EGFR_like Catalyt 100.0 5.5E-34 1.2E-38 275.9 20.1 243 160-425 6-270 (279)
183 cd06638 STKc_myosinIIIA Cataly 100.0 3.8E-34 8.3E-39 277.7 18.9 241 162-419 19-283 (286)
184 cd06620 PKc_MAPKK_Byr1_like Ca 100.0 3.5E-34 7.6E-39 278.1 18.6 247 160-420 4-267 (284)
185 cd05632 STKc_GRK5 Catalytic do 100.0 4.1E-34 8.9E-39 278.1 18.9 235 163-418 2-260 (285)
186 cd06654 STKc_PAK1 Catalytic do 100.0 3.6E-34 7.8E-39 280.1 18.5 233 162-418 21-269 (296)
187 KOG0594 Protein kinase PCTAIRE 100.0 2.5E-34 5.3E-39 273.9 16.7 247 162-419 12-302 (323)
188 cd05629 STKc_NDR_like_fungal C 100.0 6.7E-35 1.5E-39 295.1 13.8 235 163-419 3-305 (377)
189 cd07853 STKc_NLK Catalytic dom 100.0 3E-34 6.4E-39 289.8 18.4 246 164-419 3-288 (372)
190 cd05037 PTK_Jak_rpt1 Pseudokin 100.0 8.1E-34 1.8E-38 270.8 20.4 226 167-421 1-259 (259)
191 cd07863 STKc_CDK4 Catalytic do 100.0 3.2E-34 7E-39 278.5 17.8 241 163-418 2-284 (288)
192 cd07872 STKc_PCTAIRE2 Catalyti 100.0 4.2E-34 9E-39 281.2 18.7 247 162-418 7-285 (309)
193 cd05056 PTKc_FAK Catalytic dom 100.0 2.8E-34 6.1E-39 276.4 17.1 242 160-425 5-267 (270)
194 cd08219 STKc_Nek3 Catalytic do 100.0 3.4E-34 7.3E-39 273.4 16.8 234 163-419 2-252 (255)
195 cd05077 PTK_Jak1_rpt1 Pseudoki 100.0 1.1E-33 2.4E-38 271.7 20.2 226 167-421 1-262 (262)
196 KOG0611 Predicted serine/threo 100.0 2E-34 4.4E-39 275.8 14.7 235 159-420 51-304 (668)
197 cd06619 PKc_MKK5 Catalytic dom 100.0 6.6E-34 1.4E-38 275.6 18.6 234 163-419 3-253 (279)
198 cd06642 STKc_STK25-YSK1 Cataly 100.0 1.3E-33 2.7E-38 273.1 20.5 233 161-419 4-253 (277)
199 cd06612 STKc_MST1_2 Catalytic 100.0 1.3E-33 2.9E-38 268.8 20.2 234 162-418 4-252 (256)
200 cd05598 STKc_LATS Catalytic do 100.0 1E-34 2.2E-39 293.6 13.1 236 163-419 3-301 (376)
201 PHA03207 serine/threonine kina 100.0 7.8E-34 1.7E-38 288.9 19.6 249 160-419 91-375 (392)
202 cd05625 STKc_LATS1 Catalytic d 100.0 1.7E-34 3.6E-39 292.7 14.4 235 163-418 3-304 (382)
203 cd07861 STKc_CDK1_euk Catalyti 100.0 1.1E-33 2.5E-38 274.0 19.3 248 163-418 2-281 (285)
204 PHA03209 serine/threonine kina 100.0 8.5E-34 1.8E-38 285.0 18.7 180 162-353 67-256 (357)
205 cd05622 STKc_ROCK1 Catalytic d 100.0 3E-34 6.5E-39 289.8 15.5 240 159-419 41-304 (371)
206 cd05597 STKc_DMPK_like Catalyt 100.0 8E-34 1.7E-38 282.2 18.3 239 163-419 3-266 (331)
207 smart00219 TyrKc Tyrosine kina 100.0 2.3E-33 5E-38 267.1 20.3 234 165-420 3-258 (258)
208 cd06645 STKc_MAP4K3 Catalytic 100.0 1.5E-33 3.2E-38 270.8 18.9 239 161-418 9-264 (267)
209 cd07846 STKc_CDKL2_3 Catalytic 100.0 8.4E-34 1.8E-38 275.1 17.4 247 162-418 2-282 (286)
210 cd08223 STKc_Nek4 Catalytic do 100.0 2.1E-33 4.6E-38 267.8 19.8 233 163-418 2-253 (257)
211 cd05076 PTK_Tyk2_rpt1 Pseudoki 100.0 1.2E-33 2.6E-38 273.4 18.3 225 168-421 2-274 (274)
212 PRK13184 pknD serine/threonine 100.0 7.2E-34 1.6E-38 307.0 18.6 247 162-425 3-292 (932)
213 cd06624 STKc_ASK Catalytic dom 100.0 1.2E-33 2.6E-38 271.8 18.2 239 160-418 5-264 (268)
214 cd07868 STKc_CDK8 Catalytic do 100.0 5.5E-33 1.2E-37 274.0 23.3 186 166-357 6-220 (317)
215 cd07876 STKc_JNK2 Catalytic do 100.0 1.5E-33 3.2E-38 283.3 19.5 244 161-419 21-315 (359)
216 cd06643 STKc_SLK Catalytic dom 100.0 1.8E-33 4E-38 272.6 19.5 236 163-418 7-261 (282)
217 cd05083 PTKc_Chk Catalytic dom 100.0 1.3E-33 2.8E-38 269.3 17.9 232 162-422 7-253 (254)
218 cd05633 STKc_GRK3 Catalytic do 100.0 1.3E-33 2.9E-38 273.7 18.1 228 168-419 1-255 (279)
219 KOG0585 Ca2+/calmodulin-depend 100.0 3.9E-34 8.5E-39 279.1 14.3 241 160-420 96-373 (576)
220 cd06625 STKc_MEKK3_like Cataly 100.0 1.5E-33 3.3E-38 269.7 18.1 235 163-419 4-260 (263)
221 cd06656 STKc_PAK3 Catalytic do 100.0 1.3E-33 2.8E-38 276.3 18.0 234 161-418 19-268 (297)
222 cd06639 STKc_myosinIIIB Cataly 100.0 2.1E-33 4.5E-38 273.5 19.3 240 162-418 23-286 (291)
223 cd06608 STKc_myosinIII_like Ca 100.0 2.1E-33 4.5E-38 269.9 19.0 241 161-418 6-271 (275)
224 cd06655 STKc_PAK2 Catalytic do 100.0 1.3E-33 2.9E-38 276.1 17.9 232 163-418 21-268 (296)
225 KOG0580 Serine/threonine prote 100.0 7.8E-34 1.7E-38 255.7 14.8 230 164-419 25-273 (281)
226 cd05074 PTKc_Tyro3 Catalytic d 100.0 1.5E-33 3.3E-38 271.4 17.9 241 164-423 2-272 (273)
227 cd05078 PTK_Jak2_Jak3_rpt1 Pse 100.0 8.9E-34 1.9E-38 271.4 15.9 226 167-421 1-258 (258)
228 cd06622 PKc_MAPKK_PBS2_like Ca 100.0 5.9E-33 1.3E-37 269.5 21.7 239 162-418 2-261 (286)
229 cd06629 STKc_MAPKKK_Bck1_like 100.0 2.6E-33 5.6E-38 269.8 19.0 240 163-418 3-268 (272)
230 cd08227 PK_STRAD_alpha Pseudok 100.0 2.5E-33 5.5E-38 278.0 19.4 249 165-418 2-306 (327)
231 PTZ00266 NIMA-related protein 100.0 1.1E-33 2.4E-38 306.7 18.3 244 158-418 10-294 (1021)
232 cd08217 STKc_Nek2 Catalytic do 100.0 3.2E-33 7E-38 266.9 19.4 239 163-419 2-262 (265)
233 KOG0589 Serine/threonine prote 100.0 4.1E-34 9E-39 283.3 13.5 235 162-419 5-258 (426)
234 cd07878 STKc_p38beta_MAPK11 Ca 100.0 2.3E-33 5E-38 280.1 19.1 244 161-419 15-298 (343)
235 PHA02882 putative serine/threo 100.0 8.6E-34 1.9E-38 277.2 15.7 247 157-421 8-294 (294)
236 cd06617 PKc_MKK3_6 Catalytic d 100.0 2.4E-33 5.1E-38 271.5 18.5 238 163-418 3-260 (283)
237 cd07875 STKc_JNK1 Catalytic do 100.0 3.4E-33 7.4E-38 281.2 20.3 244 161-419 24-318 (364)
238 cd07841 STKc_CDK7 Catalytic do 100.0 4.7E-33 1E-37 271.8 20.7 243 163-419 2-282 (298)
239 cd06615 PKc_MEK Catalytic doma 100.0 1.2E-33 2.7E-38 277.9 16.5 240 163-419 3-287 (308)
240 cd05623 STKc_MRCK_alpha Cataly 100.0 1.4E-33 3.1E-38 280.5 17.1 239 163-419 3-266 (332)
241 cd05627 STKc_NDR2 Catalytic do 100.0 2.5E-34 5.4E-39 289.1 11.6 234 163-418 3-292 (360)
242 cd08221 STKc_Nek9 Catalytic do 100.0 3.3E-33 7.2E-38 266.5 18.8 235 163-420 2-254 (256)
243 cd06609 STKc_MST3_like Catalyt 100.0 4.3E-33 9.2E-38 268.8 19.7 232 162-418 2-250 (274)
244 cd06621 PKc_MAPKK_Pek1_like Ca 100.0 6.6E-33 1.4E-37 269.7 21.0 244 163-418 3-265 (287)
245 cd06644 STKc_STK10_LOK Catalyt 100.0 3.6E-33 7.7E-38 272.1 19.1 238 161-418 12-268 (292)
246 cd06658 STKc_PAK5 Catalytic do 100.0 4.3E-33 9.3E-38 272.1 19.6 229 167-419 28-272 (292)
247 cd06636 STKc_MAP4K4_6 Catalyti 100.0 3.1E-33 6.8E-38 270.9 18.5 238 161-418 16-278 (282)
248 cd06659 STKc_PAK6 Catalytic do 100.0 4.5E-33 9.7E-38 272.6 19.7 230 166-419 26-271 (297)
249 cd06640 STKc_MST4 Catalytic do 100.0 6.1E-33 1.3E-37 268.4 20.3 233 161-419 4-253 (277)
250 cd06631 STKc_YSK4 Catalytic do 100.0 2.8E-33 6.1E-38 268.5 17.8 235 163-418 2-261 (265)
251 cd07847 STKc_CDKL1_4 Catalytic 100.0 2.9E-33 6.2E-38 271.2 17.8 246 163-418 3-282 (286)
252 cd08218 STKc_Nek1 Catalytic do 100.0 3E-33 6.6E-38 266.8 17.7 233 163-418 2-252 (256)
253 cd07839 STKc_CDK5 Catalytic do 100.0 4.1E-33 8.8E-38 270.2 18.6 244 163-418 2-280 (284)
254 cd07867 STKc_CDC2L6 Catalytic 100.0 1.1E-32 2.4E-37 271.5 22.0 185 167-357 7-220 (317)
255 cd05624 STKc_MRCK_beta Catalyt 100.0 1.3E-33 2.8E-38 280.7 15.4 239 163-419 3-266 (331)
256 cd07873 STKc_PCTAIRE1 Catalyti 100.0 2.8E-33 6E-38 274.2 17.5 252 162-423 7-292 (301)
257 cd06628 STKc_MAPKKK_Byr2_like 100.0 4.4E-33 9.5E-38 267.3 18.3 233 163-418 2-263 (267)
258 cd07874 STKc_JNK3 Catalytic do 100.0 4.5E-33 9.8E-38 279.3 19.1 243 162-419 18-311 (355)
259 KOG0660 Mitogen-activated prot 100.0 8.3E-34 1.8E-38 269.7 12.8 244 166-418 27-309 (359)
260 cd05046 PTK_CCK4 Pseudokinase 100.0 7.9E-33 1.7E-37 266.9 20.0 241 163-422 7-275 (275)
261 KOG4279 Serine/threonine prote 100.0 1.7E-33 3.7E-38 284.1 15.7 231 168-418 582-831 (1226)
262 cd05611 STKc_Rim15_like Cataly 100.0 3.9E-33 8.6E-38 266.8 17.0 229 167-421 2-250 (260)
263 KOG0200 Fibroblast/platelet-de 100.0 4.4E-33 9.5E-38 296.7 19.1 244 164-425 299-581 (609)
264 cd06611 STKc_SLK_like Catalyti 100.0 4.6E-33 1E-37 269.4 17.5 238 161-418 5-261 (280)
265 cd06632 STKc_MEKK1_plant Catal 100.0 6.7E-33 1.4E-37 264.1 18.4 232 163-418 2-254 (258)
266 cd06647 STKc_PAK_I Catalytic d 100.0 1.4E-32 3.1E-37 268.4 20.5 247 161-431 19-283 (293)
267 cd06613 STKc_MAP4K3_like Catal 100.0 1.1E-32 2.3E-37 263.6 19.2 239 162-418 4-259 (262)
268 cd06917 STKc_NAK1_like Catalyt 100.0 1.2E-32 2.5E-37 266.0 19.4 232 163-418 3-254 (277)
269 cd07832 STKc_CCRK Catalytic do 100.0 7.2E-33 1.6E-37 268.4 18.0 244 163-419 2-282 (286)
270 cd06610 STKc_OSR1_SPAK Catalyt 100.0 1.2E-32 2.7E-37 263.6 19.4 242 163-418 3-263 (267)
271 cd07835 STKc_CDK1_like Catalyt 100.0 1.1E-32 2.4E-37 266.9 19.2 246 164-418 2-279 (283)
272 cd07837 STKc_CdkB_plant Cataly 100.0 1.2E-32 2.5E-37 268.4 19.4 245 163-418 3-290 (295)
273 cd08220 STKc_Nek8 Catalytic do 100.0 1.2E-32 2.6E-37 262.3 18.4 232 163-418 2-252 (256)
274 cd06605 PKc_MAPKK Catalytic do 100.0 2.1E-32 4.6E-37 262.1 20.2 236 163-418 3-256 (265)
275 KOG2052 Activin A type IB rece 100.0 9.3E-33 2E-37 267.7 17.7 250 164-425 214-505 (513)
276 KOG0667 Dual-specificity tyros 100.0 3E-33 6.5E-38 283.9 14.8 188 157-357 182-392 (586)
277 KOG0599 Phosphorylase kinase g 100.0 9.4E-34 2E-38 259.2 10.0 232 166-418 22-282 (411)
278 KOG0199 ACK and related non-re 100.0 1.7E-33 3.6E-38 284.6 12.6 234 164-419 113-368 (1039)
279 cd07831 STKc_MOK Catalytic dom 100.0 7.9E-33 1.7E-37 267.5 16.9 243 163-418 1-278 (282)
280 cd07860 STKc_CDK2_3 Catalytic 100.0 1.7E-32 3.8E-37 265.8 19.1 240 163-418 2-280 (284)
281 cd06626 STKc_MEKK4 Catalytic d 100.0 2E-32 4.4E-37 261.9 19.4 238 163-418 2-260 (264)
282 cd07849 STKc_ERK1_2_like Catal 100.0 1.6E-32 3.4E-37 273.3 19.3 251 162-426 6-301 (336)
283 cd05609 STKc_MAST Catalytic do 100.0 7.2E-33 1.6E-37 271.9 16.6 239 163-422 3-273 (305)
284 KOG0577 Serine/threonine prote 100.0 5.7E-34 1.2E-38 283.4 8.7 226 167-418 32-277 (948)
285 cd07842 STKc_CDK8_like Catalyt 100.0 1.4E-32 3.1E-37 270.3 18.7 251 163-418 2-312 (316)
286 cd05606 STKc_beta_ARK Catalyti 100.0 1.1E-32 2.5E-37 267.0 17.5 227 168-418 1-254 (278)
287 cd06641 STKc_MST3 Catalytic do 100.0 2.5E-32 5.4E-37 264.1 19.8 233 161-419 4-253 (277)
288 cd05574 STKc_phototropin_like 100.0 3.1E-32 6.6E-37 268.5 20.7 236 163-418 3-288 (316)
289 PHA03390 pk1 serine/threonine- 100.0 2.3E-32 4.9E-37 263.4 19.2 224 169-418 24-261 (267)
290 KOG1989 ARK protein kinase fam 100.0 5.1E-33 1.1E-37 290.4 15.4 242 164-425 40-313 (738)
291 cd08225 STKc_Nek5 Catalytic do 100.0 4.9E-32 1.1E-36 258.2 20.7 233 163-418 2-253 (257)
292 cd06618 PKc_MKK7 Catalytic dom 100.0 3.4E-32 7.4E-37 265.8 19.6 238 162-419 16-273 (296)
293 cd06651 STKc_MEKK3 Catalytic d 100.0 2.3E-32 5E-37 262.7 18.1 233 163-418 4-260 (266)
294 cd07833 STKc_CDKL Catalytic do 100.0 1.5E-32 3.2E-37 266.5 16.8 248 162-418 2-284 (288)
295 cd07830 STKc_MAK_like Catalyti 100.0 4.1E-32 8.8E-37 262.9 19.9 246 163-418 1-279 (283)
296 PLN03225 Serine/threonine-prot 100.0 3E-32 6.5E-37 287.7 20.4 252 161-418 132-449 (566)
297 KOG0032 Ca2+/calmodulin-depend 100.0 4.3E-32 9.3E-37 271.7 20.3 238 157-418 31-292 (382)
298 KOG0658 Glycogen synthase kina 100.0 1.2E-33 2.7E-38 269.0 8.6 242 165-418 28-305 (364)
299 cd06635 STKc_TAO1 Catalytic do 100.0 7.6E-32 1.6E-36 266.2 21.7 235 162-422 26-280 (317)
300 cd06648 STKc_PAK_II Catalytic 100.0 4.7E-32 1E-36 263.6 19.9 229 166-418 24-268 (285)
301 cd08530 STKc_CNK2-like Catalyt 100.0 5.5E-32 1.2E-36 257.5 19.8 233 163-418 2-252 (256)
302 cd05583 STKc_MSK_N N-terminal 100.0 2E-32 4.4E-37 266.1 17.0 241 163-422 2-266 (288)
303 cd06607 STKc_TAO Catalytic dom 100.0 4.2E-32 9.1E-37 266.7 19.3 233 161-419 15-267 (307)
304 cd07844 STKc_PCTAIRE_like Cata 100.0 1.9E-32 4.2E-37 266.5 16.6 244 162-418 6-287 (291)
305 cd07840 STKc_CDK9_like Catalyt 100.0 3.5E-32 7.6E-37 263.3 18.3 242 164-418 2-283 (287)
306 KOG0663 Protein kinase PITSLRE 100.0 1.3E-32 2.7E-37 258.3 14.4 238 166-418 81-360 (419)
307 cd06630 STKc_MEKK1 Catalytic d 100.0 8.6E-32 1.9E-36 258.3 20.7 237 163-418 2-263 (268)
308 KOG0574 STE20-like serine/thre 100.0 8.4E-34 1.8E-38 262.5 6.4 235 162-419 34-283 (502)
309 cd05579 STKc_MAST_like Catalyt 100.0 5.6E-32 1.2E-36 258.3 19.2 231 169-421 1-256 (265)
310 cd05118 STKc_CMGC Catalytic do 100.0 1E-31 2.2E-36 259.7 21.2 241 164-418 2-279 (283)
311 cd06623 PKc_MAPKK_plant_like C 100.0 7.3E-32 1.6E-36 257.9 20.0 235 163-419 3-256 (264)
312 cd06614 STKc_PAK Catalytic dom 100.0 5.9E-32 1.3E-36 262.6 19.5 235 162-418 20-269 (286)
313 cd05122 PKc_STE Catalytic doma 100.0 9.5E-32 2E-36 254.3 20.3 233 163-418 2-250 (253)
314 cd06652 STKc_MEKK2 Catalytic d 100.0 7.2E-32 1.6E-36 258.9 19.4 233 163-418 4-260 (265)
315 cd07858 STKc_TEY_MAPK_plant Ca 100.0 7.6E-32 1.7E-36 268.6 20.2 252 162-424 6-298 (337)
316 cd05578 STKc_Yank1 Catalytic d 100.0 4.1E-32 8.9E-37 259.4 17.3 231 163-417 2-253 (258)
317 cd06616 PKc_MKK4 Catalytic dom 100.0 5E-32 1.1E-36 263.2 18.0 237 164-418 7-266 (288)
318 cd05580 STKc_PKA Catalytic dom 100.0 6.9E-32 1.5E-36 262.9 18.9 227 163-418 3-253 (290)
319 cd08215 STKc_Nek Catalytic dom 100.0 1E-31 2.2E-36 255.3 19.4 235 163-418 2-254 (258)
320 cd07870 STKc_PFTAIRE2 Catalyti 100.0 3.4E-32 7.5E-37 264.9 16.3 245 163-418 7-287 (291)
321 cd08216 PK_STRAD Pseudokinase 100.0 2E-31 4.4E-36 262.3 21.4 248 165-418 6-294 (314)
322 cd07836 STKc_Pho85 Catalytic d 100.0 8.6E-32 1.9E-36 260.7 18.3 248 163-418 2-280 (284)
323 cd07852 STKc_MAPK15 Catalytic 100.0 3.6E-32 7.8E-37 270.8 16.1 250 160-419 6-295 (337)
324 cd07843 STKc_CDC2L1 Catalytic 100.0 9.8E-32 2.1E-36 262.0 18.6 247 162-418 6-289 (293)
325 cd06606 STKc_MAPKKK Catalytic 100.0 2E-31 4.4E-36 253.0 20.3 235 163-418 2-256 (260)
326 cd05613 STKc_MSK1_N N-terminal 100.0 4.6E-32 9.9E-37 263.9 16.0 237 163-418 2-267 (290)
327 PLN00009 cyclin-dependent kina 100.0 1E-31 2.2E-36 262.0 18.4 240 163-418 4-283 (294)
328 cd05572 STKc_cGK_PKG Catalytic 100.0 2.2E-31 4.7E-36 255.0 20.1 226 169-418 1-251 (262)
329 cd05577 STKc_GRK Catalytic dom 100.0 6.7E-32 1.4E-36 261.1 16.6 229 169-418 1-253 (277)
330 KOG0596 Dual specificity; seri 100.0 2.8E-32 6E-37 270.3 14.0 234 162-418 362-626 (677)
331 cd07855 STKc_ERK5 Catalytic do 100.0 1.7E-31 3.6E-36 265.7 19.6 248 162-418 6-293 (334)
332 cd07838 STKc_CDK4_6_like Catal 100.0 2.1E-31 4.5E-36 258.1 19.5 240 164-418 2-283 (287)
333 cd07864 STKc_CDK12 Catalytic d 100.0 1.8E-31 3.9E-36 260.9 19.2 246 160-418 6-298 (302)
334 cd08222 STKc_Nek11 Catalytic d 100.0 2.6E-31 5.5E-36 254.2 19.7 234 163-418 2-256 (260)
335 KOG0033 Ca2+/calmodulin-depend 100.0 2.6E-33 5.7E-38 252.8 5.4 235 161-418 11-266 (355)
336 cd06657 STKc_PAK4 Catalytic do 100.0 2.7E-31 5.8E-36 259.4 20.0 228 167-418 26-269 (292)
337 KOG0579 Ste20-like serine/thre 100.0 1.8E-32 3.9E-37 274.2 11.6 236 163-418 34-288 (1187)
338 cd06634 STKc_TAO2 Catalytic do 100.0 2.7E-31 5.8E-36 261.3 19.4 236 159-420 13-268 (308)
339 cd08226 PK_STRAD_beta Pseudoki 100.0 4.6E-31 9.9E-36 261.9 20.5 247 167-418 4-307 (328)
340 cd07850 STKc_JNK Catalytic dom 100.0 2.9E-31 6.2E-36 266.1 19.2 244 161-419 16-311 (353)
341 cd07845 STKc_CDK10 Catalytic d 100.0 3.7E-31 8.1E-36 260.1 19.4 247 162-418 8-289 (309)
342 cd07865 STKc_CDK9 Catalytic do 100.0 3.5E-31 7.6E-36 259.5 18.9 249 162-418 13-306 (310)
343 cd06627 STKc_Cdc7_like Catalyt 100.0 5.1E-31 1.1E-35 250.4 18.9 231 163-418 2-250 (254)
344 KOG0986 G protein-coupled rece 100.0 1.5E-32 3.3E-37 266.4 8.4 227 165-412 189-434 (591)
345 cd05581 STKc_PDK1 Catalytic do 100.0 5.1E-31 1.1E-35 254.2 18.7 232 163-418 3-276 (280)
346 cd06633 STKc_TAO3 Catalytic do 100.0 1.3E-30 2.9E-35 257.0 21.2 228 165-418 25-272 (313)
347 KOG0610 Putative serine/threon 100.0 1E-30 2.2E-35 251.9 19.7 240 164-423 80-398 (459)
348 cd07834 STKc_MAPK Catalytic do 100.0 5.6E-31 1.2E-35 261.1 18.2 251 163-422 2-294 (330)
349 cd07829 STKc_CDK_like Catalyti 100.0 1.2E-30 2.6E-35 252.1 20.1 245 164-418 2-278 (282)
350 cd07854 STKc_MAPK4_6 Catalytic 100.0 9.6E-31 2.1E-35 261.2 19.6 248 161-418 5-299 (342)
351 PHA03210 serine/threonine kina 100.0 1.9E-31 4.2E-36 279.2 14.6 253 160-419 147-454 (501)
352 PTZ00024 cyclin-dependent prot 100.0 5.9E-31 1.3E-35 261.7 17.0 241 165-418 13-312 (335)
353 KOG0690 Serine/threonine prote 100.0 2.4E-31 5.2E-36 248.6 13.2 222 164-411 171-411 (516)
354 cd07857 STKc_MPK1 Catalytic do 100.0 1E-30 2.2E-35 259.9 18.7 247 163-418 2-291 (332)
355 KOG0983 Mitogen-activated prot 100.0 4.6E-32 1E-36 248.3 8.1 234 165-418 96-348 (391)
356 cd07880 STKc_p38gamma_MAPK12 C 100.0 1.6E-30 3.4E-35 259.8 19.2 247 162-423 16-304 (343)
357 cd07879 STKc_p38delta_MAPK13 C 100.0 1.5E-30 3.2E-35 259.9 18.8 244 163-423 17-303 (342)
358 cd07866 STKc_BUR1 Catalytic do 100.0 1.7E-30 3.7E-35 254.8 18.8 249 162-418 9-307 (311)
359 cd05123 STKc_AGC Catalytic dom 100.0 3.9E-30 8.6E-35 244.0 20.6 221 169-415 1-240 (250)
360 cd05576 STKc_RPK118_like Catal 100.0 8E-31 1.7E-35 248.0 15.5 211 172-415 4-225 (237)
361 KOG0584 Serine/threonine prote 100.0 1.9E-31 4.1E-36 268.8 11.0 230 164-418 43-295 (632)
362 cd06653 STKc_MEKK3_like_1 Cata 100.0 2.4E-30 5.3E-35 248.3 17.9 233 163-418 4-260 (264)
363 cd07851 STKc_p38 Catalytic dom 100.0 2.4E-30 5.3E-35 258.4 18.3 242 162-418 16-297 (343)
364 KOG0612 Rho-associated, coiled 100.0 1.1E-30 2.3E-35 276.7 14.7 237 161-418 75-337 (1317)
365 KOG0696 Serine/threonine prote 100.0 6.1E-31 1.3E-35 252.4 11.7 229 157-411 345-593 (683)
366 cd07856 STKc_Sty1_Hog1 Catalyt 100.0 2.6E-30 5.7E-35 256.7 16.6 242 162-419 11-288 (328)
367 KOG1006 Mitogen-activated prot 100.0 2.4E-32 5.1E-37 249.3 1.6 237 167-419 70-327 (361)
368 KOG4645 MAPKKK (MAP kinase kin 100.0 5.9E-32 1.3E-36 289.5 4.5 234 166-420 1240-1495(1509)
369 cd07877 STKc_p38alpha_MAPK14 C 100.0 5.1E-30 1.1E-34 256.3 18.1 249 156-419 10-300 (345)
370 PLN03224 probable serine/threo 100.0 9.9E-30 2.1E-34 263.0 19.3 246 162-418 146-499 (507)
371 KOG0603 Ribosomal protein S6 k 100.0 2.5E-30 5.5E-35 261.6 13.9 226 162-418 323-562 (612)
372 KOG4250 TANK binding protein k 100.0 4E-30 8.6E-35 262.2 15.1 249 164-423 16-310 (732)
373 KOG1035 eIF-2alpha kinase GCN2 100.0 3.4E-30 7.4E-35 274.9 13.6 182 217-418 671-870 (1351)
374 KOG4717 Serine/threonine prote 100.0 7.8E-30 1.7E-34 250.5 15.1 235 159-418 16-269 (864)
375 KOG0671 LAMMER dual specificit 100.0 4.8E-31 1E-35 251.9 6.3 249 156-418 84-405 (415)
376 cd05610 STKc_MASTL Catalytic d 100.0 1.3E-29 2.7E-34 273.8 18.2 129 162-297 5-152 (669)
377 KOG0604 MAP kinase-activated p 100.0 6.3E-30 1.4E-34 236.9 12.0 235 167-418 68-321 (400)
378 KOG0587 Traf2- and Nck-interac 100.0 2.7E-29 5.9E-34 260.6 16.4 238 162-418 20-281 (953)
379 KOG0607 MAP kinase-interacting 100.0 8.8E-29 1.9E-33 231.0 17.8 259 167-435 84-379 (463)
380 KOG0666 Cyclin C-dependent kin 100.0 1.1E-29 2.5E-34 236.3 11.8 254 162-420 25-338 (438)
381 smart00220 S_TKc Serine/Threon 100.0 2.1E-28 4.5E-33 229.6 20.5 223 173-418 1-240 (244)
382 KOG1151 Tousled-like protein k 100.0 7.7E-30 1.7E-34 246.7 10.4 239 164-417 466-739 (775)
383 KOG0586 Serine/threonine prote 100.0 4.6E-29 9.9E-34 251.3 13.2 230 163-418 58-305 (596)
384 KOG1024 Receptor-like protein 100.0 5.1E-29 1.1E-33 238.1 10.8 238 165-422 288-554 (563)
385 KOG4236 Serine/threonine prote 100.0 6.4E-29 1.4E-33 244.6 8.7 227 167-417 570-817 (888)
386 KOG0984 Mitogen-activated prot 100.0 9.3E-29 2E-33 218.4 8.1 185 167-357 52-256 (282)
387 KOG0695 Serine/threonine prote 100.0 4.2E-28 9.2E-33 227.6 11.1 229 165-411 254-502 (593)
388 KOG1027 Serine/threonine prote 99.9 3.4E-28 7.3E-33 251.5 7.5 230 167-417 515-765 (903)
389 KOG0614 cGMP-dependent protein 99.9 7.2E-28 1.6E-32 236.6 7.8 221 167-412 426-665 (732)
390 KOG0662 Cyclin-dependent kinas 99.9 4.7E-27 1E-31 203.4 11.3 240 166-418 7-282 (292)
391 KOG0608 Warts/lats-like serine 99.9 4.5E-27 9.7E-32 235.9 12.2 193 167-368 635-886 (1034)
392 smart00750 KIND kinase non-cat 99.9 1.9E-26 4.2E-31 207.7 14.7 166 227-422 1-168 (176)
393 KOG0669 Cyclin T-dependent kin 99.9 9.6E-28 2.1E-32 217.6 4.8 248 162-418 18-314 (376)
394 KOG1290 Serine/threonine prote 99.9 2.7E-26 5.8E-31 225.0 14.9 117 161-282 78-221 (590)
395 cd00180 PKc Catalytic domain o 99.9 1.8E-25 3.8E-30 204.2 19.5 196 169-419 1-214 (215)
396 KOG0664 Nemo-like MAPK-related 99.9 1.2E-27 2.6E-32 219.2 3.2 246 166-421 58-345 (449)
397 PLN00181 protein SPA1-RELATED; 99.9 8.8E-26 1.9E-30 249.1 13.8 209 185-418 15-264 (793)
398 KOG1345 Serine/threonine kinas 99.9 8.2E-25 1.8E-29 200.6 13.9 240 161-420 24-285 (378)
399 KOG0670 U4/U6-associated splic 99.9 2.6E-25 5.6E-30 219.2 9.3 254 154-418 425-745 (752)
400 KOG0668 Casein kinase II, alph 99.9 3.7E-25 7.9E-30 198.4 9.4 244 161-418 38-321 (338)
401 smart00221 STYKc Protein kinas 99.9 6.2E-24 1.3E-28 197.5 17.4 184 164-355 2-202 (225)
402 KOG1167 Serine/threonine prote 99.9 4.2E-24 9.2E-29 206.9 11.7 183 163-356 38-281 (418)
403 KOG1152 Signal transduction se 99.9 2.3E-24 5E-29 214.9 9.6 177 166-354 566-770 (772)
404 KOG0576 Mitogen-activated prot 99.9 3.4E-24 7.3E-29 216.9 8.4 236 163-417 17-269 (829)
405 KOG0665 Jun-N-terminal kinase 99.9 8.2E-23 1.8E-27 191.6 10.2 231 167-419 23-310 (369)
406 KOG0195 Integrin-linked kinase 99.9 3.5E-22 7.5E-27 183.4 7.2 237 162-424 191-447 (448)
407 KOG1164 Casein kinase (serine/ 99.8 5.7E-20 1.2E-24 182.1 18.0 251 162-430 19-304 (322)
408 KOG0590 Checkpoint kinase and 99.8 1.2E-20 2.5E-25 199.6 9.2 238 165-418 322-584 (601)
409 PRK09188 serine/threonine prot 99.8 3.8E-20 8.1E-25 184.2 11.8 151 160-325 17-194 (365)
410 KOG1023 Natriuretic peptide re 99.8 7.6E-20 1.6E-24 185.5 13.4 216 200-425 5-226 (484)
411 COG0515 SPS1 Serine/threonine 99.8 1.3E-18 2.8E-23 168.5 20.3 247 163-419 2-275 (384)
412 cd05147 RIO1_euk RIO kinase fa 99.8 2.6E-19 5.6E-24 163.6 13.2 126 166-299 2-167 (190)
413 KOG1165 Casein kinase (serine/ 99.8 7.9E-19 1.7E-23 165.6 16.3 249 162-426 29-302 (449)
414 KOG1163 Casein kinase (serine/ 99.8 3.9E-19 8.4E-24 161.0 10.4 260 158-433 12-294 (341)
415 cd05145 RIO1_like RIO kinase f 99.8 1.8E-18 3.9E-23 158.2 13.3 128 166-301 2-169 (190)
416 PF14531 Kinase-like: Kinase-l 99.8 2.8E-18 6E-23 164.2 11.6 218 165-410 16-288 (288)
417 KOG1166 Mitotic checkpoint ser 99.7 2.7E-17 5.8E-22 178.0 16.1 182 157-350 694-900 (974)
418 KOG1240 Protein kinase contain 99.7 6.6E-18 1.4E-22 179.8 6.8 237 162-422 24-294 (1431)
419 PRK10359 lipopolysaccharide co 99.7 3.1E-17 6.6E-22 152.6 9.4 160 155-347 25-216 (232)
420 smart00090 RIO RIO-like kinase 99.7 1.8E-16 3.9E-21 149.8 12.8 129 163-299 30-198 (237)
421 KOG1033 eIF-2alpha kinase PEK/ 99.7 2.5E-17 5.3E-22 164.7 4.8 175 216-416 330-509 (516)
422 cd05144 RIO2_C RIO kinase fami 99.7 4.1E-16 8.8E-21 143.6 12.4 126 162-300 16-176 (198)
423 PRK12274 serine/threonine prot 99.7 1.8E-16 3.9E-21 144.7 9.7 177 166-358 7-212 (218)
424 KOG0603 Ribosomal protein S6 k 99.7 1.9E-17 4.2E-22 168.4 3.6 216 169-420 2-241 (612)
425 cd05119 RIO RIO kinase family, 99.6 1.2E-15 2.7E-20 138.7 11.5 125 166-299 2-164 (187)
426 KOG4158 BRPK/PTEN-induced prot 99.6 2E-15 4.3E-20 145.8 10.7 185 214-420 315-511 (598)
427 PRK14879 serine/threonine prot 99.6 5.8E-15 1.3E-19 136.9 12.0 119 167-298 2-143 (211)
428 TIGR03724 arch_bud32 Kae1-asso 99.6 1.5E-14 3.3E-19 132.9 11.6 115 168-298 1-138 (199)
429 KOG0606 Microtubule-associated 99.5 4.7E-15 1E-19 158.2 6.2 204 166-412 88-305 (1205)
430 PRK09605 bifunctional UGMP fam 99.5 2.9E-14 6.4E-19 150.8 11.7 118 165-299 337-477 (535)
431 PRK10345 hypothetical protein; 99.5 8.9E-14 1.9E-18 128.7 10.8 118 167-296 8-156 (210)
432 cd05120 APH_ChoK_like Aminogly 99.5 4.8E-13 1E-17 115.9 12.1 121 166-299 3-139 (155)
433 KOG0590 Checkpoint kinase and 99.4 5.7E-14 1.2E-18 148.9 0.5 242 161-418 20-285 (601)
434 TIGR01982 UbiB 2-polyprenylphe 99.3 7.6E-12 1.7E-16 128.6 13.2 125 167-300 123-308 (437)
435 PRK01723 3-deoxy-D-manno-octul 99.3 5.4E-12 1.2E-16 119.5 11.1 119 167-298 37-191 (239)
436 KOG1266 Protein kinase [Signal 99.3 2.2E-12 4.7E-17 122.3 7.4 185 214-418 144-330 (458)
437 cd05151 ChoK Choline Kinase (C 99.1 2.8E-10 6.1E-15 101.4 10.4 116 167-298 4-136 (170)
438 PRK04750 ubiB putative ubiquin 99.1 1.3E-10 2.7E-15 121.4 9.2 125 167-301 125-316 (537)
439 KOG0601 Cyclin-dependent kinas 99.1 3E-10 6.6E-15 116.1 8.1 236 159-418 112-378 (524)
440 cd05146 RIO3_euk RIO kinase fa 99.0 5.1E-09 1.1E-13 95.5 10.8 125 167-299 3-174 (197)
441 cd05154 ACAD10_11_like Acyl-Co 98.9 1.6E-08 3.5E-13 93.9 11.7 127 167-298 4-206 (223)
442 KOG0601 Cyclin-dependent kinas 98.8 1.8E-09 3.8E-14 110.6 2.7 227 164-421 268-516 (524)
443 COG4248 Uncharacterized protei 98.8 1.9E-07 4.2E-12 92.0 16.2 249 165-423 15-300 (637)
444 COG3642 Mn2+-dependent serine/ 98.7 1.9E-07 4.2E-12 83.0 11.6 116 168-299 3-141 (204)
445 KOG3087 Serine/threonine prote 98.6 5.1E-07 1.1E-11 80.0 11.8 127 167-299 13-166 (229)
446 KOG0606 Microtubule-associated 98.6 3.2E-08 7E-13 106.8 5.0 181 213-414 875-1084(1205)
447 PF01163 RIO1: RIO1 family; I 98.6 4.6E-07 9.9E-12 82.3 11.7 73 217-299 81-156 (188)
448 KOG2137 Protein kinase [Signal 98.5 3.3E-08 7.1E-13 102.9 1.7 152 252-418 105-264 (700)
449 PRK15123 lipopolysaccharide co 98.5 1.1E-06 2.4E-11 84.4 11.7 78 216-298 109-194 (268)
450 KOG1243 Protein kinase [Genera 98.5 7.1E-07 1.5E-11 92.8 10.9 151 182-349 34-199 (690)
451 COG0478 RIO-like serine/threon 98.4 1.3E-06 2.7E-11 82.3 10.1 122 164-297 94-250 (304)
452 COG0661 AarF Predicted unusual 98.3 4E-06 8.7E-11 87.3 10.2 135 158-301 121-317 (517)
453 KOG3741 Poly(A) ribonuclease s 98.2 0.00013 2.9E-09 74.2 18.9 155 175-353 290-476 (655)
454 KOG1235 Predicted unusual prot 98.1 2.8E-05 6.2E-10 80.9 12.1 130 163-300 162-356 (538)
455 PF06293 Kdo: Lipopolysacchari 98.1 8.2E-06 1.8E-10 75.5 7.4 77 216-299 91-171 (206)
456 COG1718 RIO1 Serine/threonine 98.1 5.8E-05 1.3E-09 70.5 12.1 126 167-299 54-216 (268)
457 PRK09902 hypothetical protein; 97.9 0.00017 3.6E-09 66.4 12.6 124 169-298 26-179 (216)
458 PF06176 WaaY: Lipopolysacchar 97.9 8.7E-05 1.9E-09 68.5 10.2 124 157-297 27-182 (229)
459 TIGR02172 Fb_sc_TIGR02172 Fibr 97.6 0.00057 1.2E-08 64.1 11.5 30 268-298 153-182 (226)
460 PF01636 APH: Phosphotransfera 97.3 0.0012 2.6E-08 61.3 9.6 129 167-297 3-196 (239)
461 cd05150 APH Aminoglycoside 3'- 97.3 0.0023 5E-08 60.5 11.0 30 268-297 163-192 (244)
462 PF12260 PIP49_C: Protein-kina 97.3 0.00078 1.7E-08 61.3 7.2 91 204-299 22-112 (188)
463 PRK10593 hypothetical protein; 96.9 0.0098 2.1E-07 58.3 11.7 61 167-229 20-100 (297)
464 cd05155 APH_ChoK_like_1 Unchar 96.9 0.012 2.7E-07 55.3 11.5 31 268-298 164-194 (235)
465 cd05157 ETNK_euk Ethanolamine 96.8 0.01 2.3E-07 55.6 10.5 31 267-297 169-200 (235)
466 PLN02876 acyl-CoA dehydrogenas 96.8 0.016 3.4E-07 65.0 13.1 44 256-299 205-258 (822)
467 COG2112 Predicted Ser/Thr prot 96.7 0.013 2.9E-07 52.2 9.8 119 165-299 26-156 (201)
468 PRK09550 mtnK methylthioribose 96.4 0.046 1E-06 55.6 12.6 32 267-299 222-253 (401)
469 KOG0576 Mitogen-activated prot 96.4 0.00078 1.7E-08 70.4 -0.3 170 166-353 247-430 (829)
470 PF14380 WAK_assoc: Wall-assoc 96.3 0.015 3.3E-07 46.4 6.7 47 64-110 19-68 (94)
471 KOG2270 Serine/threonine prote 96.3 0.015 3.2E-07 57.6 7.7 126 165-297 148-312 (520)
472 PF13095 FTA2: Kinetochore Sim 96.2 0.025 5.3E-07 51.8 8.7 40 249-296 167-206 (207)
473 KOG2268 Serine/threonine prote 96.2 0.0058 1.3E-07 59.4 4.3 120 163-295 94-248 (465)
474 COG2334 Putative homoserine ki 96.1 0.1 2.2E-06 51.7 12.9 126 169-297 34-227 (331)
475 TIGR02721 ycfN_thiK thiamine k 96.0 0.058 1.3E-06 51.4 10.6 30 268-298 146-175 (256)
476 cd05156 ChoK_euk Choline Kinas 95.9 0.058 1.3E-06 52.7 10.3 32 266-297 177-212 (302)
477 cd05153 HomoserineK_II Homoser 95.9 0.066 1.4E-06 52.1 10.6 130 167-297 20-204 (296)
478 PRK05231 homoserine kinase; Pr 95.9 0.08 1.7E-06 52.1 11.3 31 267-297 186-216 (319)
479 KOG1035 eIF-2alpha kinase GCN2 95.9 0.035 7.5E-07 62.2 9.0 167 221-421 265-436 (1351)
480 PF10707 YrbL-PhoP_reg: PhoP r 95.6 0.13 2.9E-06 47.1 10.5 112 167-292 7-165 (199)
481 KOG1826 Ras GTPase activating 95.5 0.0018 3.9E-08 73.7 -2.2 134 216-353 1305-1440(2724)
482 PLN02236 choline kinase 95.4 0.11 2.4E-06 52.0 10.3 32 267-298 199-231 (344)
483 COG3173 Predicted aminoglycosi 94.8 0.37 8.1E-06 47.4 11.5 43 259-301 184-231 (321)
484 PRK06148 hypothetical protein; 93.9 0.54 1.2E-05 53.9 12.2 33 266-298 201-236 (1013)
485 PF13947 GUB_WAK_bind: Wall-as 93.7 0.14 3E-06 41.8 5.2 23 2-24 46-68 (106)
486 KOG1236 Predicted unusual prot 93.6 0.2 4.3E-06 50.6 6.9 60 217-283 320-379 (565)
487 COG5072 ALK1 Serine/threonine 93.4 0.21 4.6E-06 49.6 6.6 55 242-299 317-371 (488)
488 PRK11768 serine/threonine prot 93.1 1.6 3.6E-05 43.1 12.7 29 267-297 195-223 (325)
489 PLN02421 phosphotransferase, a 92.7 0.8 1.7E-05 45.5 9.9 31 268-298 182-213 (330)
490 TIGR00938 thrB_alt homoserine 92.6 0.18 4E-06 49.4 5.2 42 256-297 171-216 (307)
491 PHA03111 Ser/Thr kinase; Provi 92.4 0.15 3.2E-06 50.1 4.0 37 246-282 279-316 (444)
492 PLN02756 S-methyl-5-thioribose 91.5 2.8 6E-05 42.9 12.1 31 267-298 229-259 (418)
493 PF03881 Fructosamin_kin: Fruc 91.2 0.65 1.4E-05 45.2 7.1 60 167-227 23-97 (288)
494 PF05445 Pox_ser-thr_kin: Poxv 90.8 0.25 5.3E-06 48.8 3.7 51 248-300 277-348 (434)
495 PF03109 ABC1: ABC1 family; I 89.9 0.088 1.9E-06 44.1 -0.2 34 163-196 12-46 (119)
496 TIGR02906 spore_CotS spore coa 89.7 0.7 1.5E-05 45.1 6.0 30 267-297 186-215 (313)
497 PF07387 Seadorna_VP7: Seadorn 89.2 0.57 1.2E-05 43.6 4.5 76 256-351 151-226 (308)
498 PRK10271 thiK thiamine kinase; 88.2 0.42 9.1E-06 43.3 2.9 30 268-298 77-106 (188)
499 PF04655 APH_6_hur: Aminoglyco 88.0 2.6 5.5E-05 40.2 8.3 65 168-232 9-85 (253)
500 PF01633 Choline_kinase: Choli 87.8 0.57 1.2E-05 43.1 3.7 30 268-297 143-173 (211)
No 1
>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.7e-53 Score=422.40 Aligned_cols=269 Identities=43% Similarity=0.750 Sum_probs=226.4
Q ss_pred ccccchhHHHHHhhhhh--cccCccCceEEEEEEEcCCcEEEEEEecCCCCC-HHHHHHH--------------Hhcccc
Q 048517 150 VDNILLPEIIAVTNHFT--HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCS 212 (453)
Q Consensus 150 ~~~~~~~~~~~~~~~~~--~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~ 212 (453)
...+...++..+|++|. +.||+||||.||+|.+++|+.||||++...... ..+|.+| |+|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 34577889999999999 689999999999999999999999998876554 5668777 799999
Q ss_pred cCc-ceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEE
Q 048517 213 EGF-KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS 291 (453)
Q Consensus 213 ~~~-~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~ 291 (453)
+.. .++||||||+||+|.++|+..... .++|.+|++||.++|+||+|||+.|.++|+||||||+|||||+++++||+
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 998 499999999999999999875543 88999999999999999999999999999999999999999999999999
Q ss_pred ecCCccccCC-CCCceeeccc-CCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHH
Q 048517 292 DFGLAKFHPK-ENDFVSISDT-RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWV 369 (453)
Q Consensus 292 DFGla~~~~~-~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 369 (453)
|||+|+..+. .... ... .||.||+|||++.. +.++.|+|||||||+|+||+||+++.+..... .+..+..|.
T Consensus 220 DFGLa~~~~~~~~~~---~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~~-~~~~l~~w~ 293 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSV---STTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRPR-GELSLVEWA 293 (361)
T ss_pred CccCcccCCccccce---eeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCCc-ccccHHHHH
Confidence 9999987765 3221 122 89999999999976 58999999999999999999999998865522 344588898
Q ss_pred HHHhhhCCCccccchh----hhHH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517 370 YDQLNKGGDLELRNVT----EIES-MIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426 (453)
Q Consensus 370 ~~~l~~~~~~~~~~~~----~~~~-~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~ 426 (453)
...+.++...++.+.. .... ....++..++.+|++.+|++||+|.+|+++|+.....
T Consensus 294 ~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 294 KPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 8887776443333322 1221 4566799999999999999999999999999765443
No 2
>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]
Probab=100.00 E-value=3.7e-44 Score=355.75 Aligned_cols=244 Identities=32% Similarity=0.502 Sum_probs=197.3
Q ss_pred hhcccCccCceEEEEEEEcCCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCc-ceEEEEEecCC
Q 048517 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGF-KRALVYEYMPN 226 (453)
Q Consensus 165 ~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~-~~~lv~E~~~~ 226 (453)
+.+.||+|+||+||+|.++....||||++...... .++|.+| ++|.|.+.. ..++|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 44569999999999999995555999999875433 3356555 688888877 78999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCc-eeecccCCcceEEcCCC-ceEEEecCCccccCCCCC
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC-ILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivH~Dikp~NILl~~~~-~~kl~DFGla~~~~~~~~ 304 (453)
|+|.++++.. ....+++..++.++.+||+||+|||++ + ||||||||+|||++.++ ++||+|||+++......
T Consensus 125 GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 125 GSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 9999999764 357899999999999999999999998 6 99999999999999997 99999999998765432
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 384 (453)
...+...||+.|||||++.+....++.|+||||||+++|||+||+.||..... ..-+......+.+..+.
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-------~~~~~~v~~~~~Rp~~p-- 268 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-------VQVASAVVVGGLRPPIP-- 268 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcCCCCCCC--
Confidence 23355789999999999984223799999999999999999999999976543 11233333444444332
Q ss_pred hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCC
Q 048517 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ 428 (453)
Q Consensus 385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~ 428 (453)
......+..++.+||+.||+.||++.+++.+|+.....+.
T Consensus 269 ----~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 269 ----KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred ----ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 2255678999999999999999999999999997665443
No 3
>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.3e-44 Score=359.30 Aligned_cols=247 Identities=30% Similarity=0.487 Sum_probs=210.1
Q ss_pred HHHHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEE
Q 048517 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYE 222 (453)
Q Consensus 157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E 222 (453)
++......+.++||+|-||.||.|.++....||||.++......++|+.| ++|+|..+...+||||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence 44555566789999999999999999988899999999887788888766 7899999889999999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 302 (453)
||++|+|.++|.. ..+..+...+.+.++.|||+|++||+++ ++|||||.++|||++++..+||+|||||+....
T Consensus 282 ~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d- 355 (468)
T KOG0197|consen 282 YMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD- 355 (468)
T ss_pred ecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC-
Confidence 9999999999954 3457899999999999999999999998 999999999999999999999999999995444
Q ss_pred CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517 303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381 (453)
Q Consensus 303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 381 (453)
+.+.......-++.|.|||++.. +.+|.||||||||++||||+| |+.|+...... -+.+.+++|.+..-
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~--------ev~~~le~GyRlp~ 425 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE--------EVLELLERGYRLPR 425 (468)
T ss_pred CceeecCCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCHH--------HHHHHHhccCcCCC
Confidence 44444455667889999999975 589999999999999999999 77776654432 27788888887654
Q ss_pred cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517 382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID 425 (453)
Q Consensus 382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~ 425 (453)
+ ...+..+.+++..||+.+|++|||++.+...|+....
T Consensus 426 P------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 426 P------EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred C------CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 3 3355779999999999999999999999999986443
No 4
>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-41 Score=323.36 Aligned_cols=233 Identities=27% Similarity=0.369 Sum_probs=185.1
Q ss_pred hcccCccCceEEEEEEEc-CCcEEEEEEecCC--CCCHHHHHHH--------------HhcccccCc-ceEEEEEecCCC
Q 048517 166 THKLGQGGFGSVYKGQLH-TGRLIAVKMMENS--KFSAEEFINE--------------LLGLCSEGF-KRALVYEYMPNG 227 (453)
Q Consensus 166 ~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~--~~~~~~~i~e--------------l~g~~~~~~-~~~lv~E~~~~g 227 (453)
.+.||+|.-|+|||++++ +++.+|+|.+... .....+.++| .+|.|.... ...++||||++|
T Consensus 84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgG 163 (364)
T KOG0581|consen 84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGG 163 (364)
T ss_pred hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCC
Confidence 467999999999999965 7899999999543 3334455555 456666666 499999999999
Q ss_pred ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517 228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 307 (453)
Q Consensus 228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 307 (453)
||++.+.. .+.+++..+-.|+.++++||.|||+. ..||||||||+|||++..|.+||+|||.++..... .
T Consensus 164 SLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~ 233 (364)
T KOG0581|consen 164 SLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----I 233 (364)
T ss_pred CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----h
Confidence 99998842 25689999999999999999999963 39999999999999999999999999999876543 2
Q ss_pred ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhh
Q 048517 308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEI 387 (453)
Q Consensus 308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 387 (453)
..+..||..|||||.+.+. .|+.++||||||++++|+.+|+-|+....... ... ...+..+..+....++.
T Consensus 234 a~tfvGT~~YMsPERi~g~--~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~--~~~-~~Ll~~Iv~~ppP~lP~---- 304 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGE--SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY--LDI-FELLCAIVDEPPPRLPE---- 304 (364)
T ss_pred cccccccccccChhhhcCC--cCCcccceecccHHHHHHhhCCCCCCCcCCCC--CCH-HHHHHHHhcCCCCCCCc----
Confidence 3567899999999999975 89999999999999999999999987652111 111 11233444333322211
Q ss_pred HHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 388 ESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 388 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
...+++++.++..||+.||.+|||+.|+++
T Consensus 305 -~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 305 -GEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred -ccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 146788999999999999999999999987
No 5
>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=6.3e-42 Score=328.62 Aligned_cols=245 Identities=25% Similarity=0.346 Sum_probs=196.9
Q ss_pred chhHHHHHhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCH-------HHH-HHH--------------Hhcc
Q 048517 154 LLPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA-------EEF-INE--------------LLGL 210 (453)
Q Consensus 154 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~-------~~~-i~e--------------l~g~ 210 (453)
..|+.....|-+.+.||+|+||.|-+|. .++|+.||||++++.+... ... .+| +.++
T Consensus 165 ~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~ 244 (475)
T KOG0615|consen 165 VPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF 244 (475)
T ss_pred CccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee
Confidence 3455566677788999999999999998 5689999999998632211 111 122 6788
Q ss_pred cccCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC---Cc
Q 048517 211 CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN---FI 287 (453)
Q Consensus 211 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~---~~ 287 (453)
+......|+|||||+||.|.+.+.. ...+....-..+++|++.|+.|||++ +|+||||||+|||+..+ ..
T Consensus 245 f~~~ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~l 317 (475)
T KOG0615|consen 245 FEVPDSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCL 317 (475)
T ss_pred eecCCceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceE
Confidence 8888888999999999999998853 35677778899999999999999998 99999999999999765 88
Q ss_pred eEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCC-CccchHHHHHHHHHHHHcCCCCCCCCccccccccch
Q 048517 288 PKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTV-SCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP 366 (453)
Q Consensus 288 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 366 (453)
+||+|||+|+...... -+.+.+||+.|.|||++.+....+ ..|.|+||+||+||-+++|.+||.......
T Consensus 318 lKItDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~------ 388 (475)
T KOG0615|consen 318 LKITDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP------ 388 (475)
T ss_pred EEecccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc------
Confidence 9999999999876433 356789999999999998753333 348999999999999999999997544322
Q ss_pred HHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 367 SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 367 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
-..+++.++....- ......++++...++.|||+.||++|||+.|+++
T Consensus 389 -sl~eQI~~G~y~f~---p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 389 -SLKEQILKGRYAFG---PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -cHHHHHhcCccccc---ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 15566766654322 2356678889999999999999999999999986
No 6
>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=5.6e-41 Score=336.71 Aligned_cols=232 Identities=24% Similarity=0.377 Sum_probs=194.5
Q ss_pred HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecC----CCCCHHHHHHH--------------HhcccccCcceEEEE
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMEN----SKFSAEEFINE--------------LLGLCSEGFKRALVY 221 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~----~~~~~~~~i~e--------------l~g~~~~~~~~~lv~ 221 (453)
.+|...+.||+|||..||+++. .+|..||+|++.+ .....+...+| +++++++....|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4567778899999999999995 8999999999976 22233333333 789999999999999
Q ss_pred EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517 222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 301 (453)
Q Consensus 222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 301 (453)
|+|++|+|..++. ....++++++..+..||+.||.|||+. +|+|||||..|+||+++.++||+|||||.....
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999998873 347899999999999999999999998 999999999999999999999999999998875
Q ss_pred CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517 302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381 (453)
Q Consensus 302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 381 (453)
++.. ..+.+|||.|+|||++.+. ..+..+||||+||++|-|+.|++||+...-. ..++.+....-.
T Consensus 171 ~~Er--k~TlCGTPNYIAPEVl~k~--gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk--------ety~~Ik~~~Y~-- 236 (592)
T KOG0575|consen 171 DGER--KKTLCGTPNYIAPEVLNKS--GHSFEVDIWSLGCVMYTLLVGRPPFETKTVK--------ETYNKIKLNEYS-- 236 (592)
T ss_pred cccc--cceecCCCcccChhHhccC--CCCCchhhhhhhhHHHhhhhCCCCcccchHH--------HHHHHHHhcCcc--
Confidence 5432 2567899999999999865 7899999999999999999999999765422 255555554332
Q ss_pred cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.+..++....+|+..+|+.+|.+|||+++|+.
T Consensus 237 -----~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 237 -----MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -----cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 23345567788999999999999999999997
No 7
>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=5.1e-41 Score=308.12 Aligned_cols=248 Identities=25% Similarity=0.386 Sum_probs=198.0
Q ss_pred HHhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCH---HHHHHH--------------Hhc-ccccCcc-eEE
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA---EEFINE--------------LLG-LCSEGFK-RAL 219 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g-~~~~~~~-~~l 219 (453)
...+.+.++||+|.||+||++. +.+|..||.|.++....+. .+.+.| .++ .+.+... .+|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 3456778899999999999998 7799999999887643332 233333 233 2223333 789
Q ss_pred EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCc--eeecccCCcceEEcCCCceEEEecCCcc
Q 048517 220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC--ILHFDIKPHNILLDHNFIPKVSDFGLAK 297 (453)
Q Consensus 220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dikp~NILl~~~~~~kl~DFGla~ 297 (453)
||||+..|+|...+......++.++++.+|+++.|+++||..+|++- ++ |+||||||.||+|++++.+||+||||++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHh
Confidence 99999999999999877777889999999999999999999999942 24 9999999999999999999999999999
Q ss_pred ccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC
Q 048517 298 FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG 377 (453)
Q Consensus 298 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 377 (453)
++..+..+ .....|||.||+||.+... +++.||||||+||++|||+.-++||...+- .+ ..+.+.++.
T Consensus 177 ~l~s~~tf--A~S~VGTPyYMSPE~i~~~--~Y~~kSDiWslGCllyEMcaL~~PF~g~n~-------~~-L~~KI~qgd 244 (375)
T KOG0591|consen 177 FLSSKTTF--AHSLVGTPYYMSPERIHES--GYNFKSDIWSLGCLLYEMCALQSPFYGDNL-------LS-LCKKIEQGD 244 (375)
T ss_pred HhcchhHH--HHhhcCCCcccCHHHHhcC--CCCcchhHHHHHHHHHHHHhcCCCcccccH-------HH-HHHHHHcCC
Confidence 98766543 2567899999999999876 899999999999999999999999975421 11 344556654
Q ss_pred CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517 378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID 425 (453)
Q Consensus 378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~ 425 (453)
...+ ...-++..+.+++..|+..||+.||+...+++.+...++
T Consensus 245 ~~~~-----p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~l~ 287 (375)
T KOG0591|consen 245 YPPL-----PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSELD 287 (375)
T ss_pred CCCC-----cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHHhc
Confidence 3222 224578899999999999999999997666666665443
No 8
>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=4.8e-40 Score=316.00 Aligned_cols=232 Identities=25% Similarity=0.428 Sum_probs=181.2
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH---HHHHHH--------------HhcccccCcceEEEEEec
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA---EEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
|.+.++||+|+||+||+|++. ++..||||.+.+.+... +-.+.| |+.++...+..+||||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 456678999999999999954 78999999987754322 211222 677888889999999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC------CceEEEecCCccc
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN------FIPKVSDFGLAKF 298 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~------~~~kl~DFGla~~ 298 (453)
.+|+|.+||... ..+++.....++.|+|.||++||++ +||||||||+||||+.+ -.+||+|||+|+.
T Consensus 92 ~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 92 NGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred CCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 999999999543 4799999999999999999999998 99999999999999764 5789999999998
Q ss_pred cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517 299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD 378 (453)
Q Consensus 299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~ 378 (453)
...... ..+.+|++-|||||++... +|+.|+|+||+|++||+|++|+.||+.....+ ....++++..
T Consensus 165 L~~~~~---a~tlcGSplYMAPEV~~~~--~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e--------L~~~~~k~~~ 231 (429)
T KOG0595|consen 165 LQPGSM---AETLCGSPLYMAPEVIMSQ--QYDAKADLWSIGTILYQCLTGKPPFDAETPKE--------LLLYIKKGNE 231 (429)
T ss_pred CCchhH---HHHhhCCccccCHHHHHhc--cccchhhHHHHHHHHHHHHhCCCCccccCHHH--------HHHHHhcccc
Confidence 875432 3567899999999999754 89999999999999999999999997544221 2224444433
Q ss_pred ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
... ..+...+..+.++....++.+|.+|-+..+-..
T Consensus 232 ~~~----~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 232 IVP----VLPAELSNPLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred ccC----chhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence 221 133344445567777778888888877766543
No 9
>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V
Probab=100.00 E-value=8.3e-40 Score=325.79 Aligned_cols=249 Identities=26% Similarity=0.420 Sum_probs=186.5
Q ss_pred HHhhhhhcccCccCceEEEEEEE------cCCcEEEEEEecCCCCC--HHHHHHH---------------Hhccccc-Cc
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSE-GF 215 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~~------~~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~-~~ 215 (453)
...+.+.++||+|+||.||+|.. .+++.||||++...... ...+..| +++.|.. +.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 34567789999999999999974 23578999998753321 2234444 3344443 34
Q ss_pred ceEEEEEecCCCChhhhhhhccCC--------------------------------------------------------
Q 048517 216 KRALVYEYMPNGSLDRHIFSKENK-------------------------------------------------------- 239 (453)
Q Consensus 216 ~~~lv~E~~~~gsL~~~l~~~~~~-------------------------------------------------------- 239 (453)
..+++|||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 578999999999999988642210
Q ss_pred --CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCc
Q 048517 240 --GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGY 317 (453)
Q Consensus 240 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 317 (453)
...+++.++..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++...............+|+.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 13588889999999999999999998 9999999999999999999999999999865443332233345567899
Q ss_pred cChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHH
Q 048517 318 LAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLC 396 (453)
Q Consensus 318 ~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~ 396 (453)
+|||++.+. .++.++||||||+++|||++ |+.||...... ......+..+..... +...+..+.
T Consensus 243 ~aPE~~~~~--~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~------~~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-------EEFCQRLKDGTRMRA------PENATPEIY 307 (338)
T ss_pred cCcHHhhcC--CCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-------HHHHHHHhcCCCCCC------CCCCCHHHH
Confidence 999998764 78999999999999999997 99998653321 112233333322211 122345688
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517 397 MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426 (453)
Q Consensus 397 ~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~ 426 (453)
+++.+||+.||++|||+.+++++|+..+.+
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999976553
No 10
>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]
Probab=100.00 E-value=6.5e-41 Score=347.96 Aligned_cols=246 Identities=28% Similarity=0.453 Sum_probs=205.0
Q ss_pred HhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceE
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRA 218 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~ 218 (453)
..-.+.++||+|.||.||+|+.. +...||||.|+.... ...+|.+| |+|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 33446688999999999999853 345799999998544 35667666 799999999999
Q ss_pred EEEEecCCCChhhhhhhccCC----------CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCce
Q 048517 219 LVYEYMPNGSLDRHIFSKENK----------GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIP 288 (453)
Q Consensus 219 lv~E~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~ 288 (453)
+|+|||..|+|.++|...... ...|+..+.+.||.|||.|++||-++ .+|||||..+|+|+.++..+
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence 999999999999999643221 23388899999999999999999998 99999999999999999999
Q ss_pred EEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchH
Q 048517 289 KVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPS 367 (453)
Q Consensus 289 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 367 (453)
||+||||+|-.-..+.+.......-.++||+||.|.. +.+|.+||||||||+|||+++ |+.|+.....++
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E------- 713 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE------- 713 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccchHH-------
Confidence 9999999997766666554445567889999999974 699999999999999999998 888887654432
Q ss_pred HHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517 368 WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID 425 (453)
Q Consensus 368 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~ 425 (453)
+.+.+.+++.+. -++..+.++..|+..||+.+|++||+++||-..|+...+
T Consensus 714 -VIe~i~~g~lL~------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 714 -VIECIRAGQLLS------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred -HHHHHHcCCccc------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 777788877654 344456789999999999999999999999999987544
No 11
>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-39 Score=324.96 Aligned_cols=250 Identities=27% Similarity=0.491 Sum_probs=193.8
Q ss_pred HHHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCH---HHHHHH--------------HhcccccCcceEEE
Q 048517 158 IIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA---EEFINE--------------LLGLCSEGFKRALV 220 (453)
Q Consensus 158 ~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~~~~~~~lv 220 (453)
|......+...||+|.||+||+|++.. .||||+++...... +.|-+| +.|+|..... ++|
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi 465 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII 465 (678)
T ss_pred cCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence 333344456889999999999999883 59999998855443 445555 5688877665 999
Q ss_pred EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517 221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 300 (453)
..||++.+|+.+|+-.+ ..|...+.+.||.|||+|+.|||.+ +|||||||..||+|.++++|||+||||+....
T Consensus 466 TqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeee
Confidence 99999999999997654 5688999999999999999999999 99999999999999999999999999997544
Q ss_pred CCCCceeecccCCCCCccChhhhcc-cCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517 301 KENDFVSISDTRGTIGYLAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL 379 (453)
Q Consensus 301 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~ 379 (453)
.-..........|...|||||++.. ...++++.+||||||+|+|||++|..|+.....++ ..| .+.+|..
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq--Iif------mVGrG~l- 610 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ--IIF------MVGRGYL- 610 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh--eEE------Eeccccc-
Confidence 3222223455668899999999863 23488999999999999999999999998443322 111 1112210
Q ss_pred cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517 380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426 (453)
Q Consensus 380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~ 426 (453)
..+.........+.|.+|+..||..++++||.+.+++.+|+..+..
T Consensus 611 -~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 611 -MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred -CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 1111223445567899999999999999999999999999876553
No 12
>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]
Probab=100.00 E-value=6e-40 Score=335.04 Aligned_cols=248 Identities=27% Similarity=0.430 Sum_probs=199.0
Q ss_pred HHHHHhhhhhcccCccCceEEEEEEEc-C---CcEEEEEEecCC--CCCHHHHHHH--------------HhcccccCcc
Q 048517 157 EIIAVTNHFTHKLGQGGFGSVYKGQLH-T---GRLIAVKMMENS--KFSAEEFINE--------------LLGLCSEGFK 216 (453)
Q Consensus 157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~-~---g~~VAVK~l~~~--~~~~~~~i~e--------------l~g~~~~~~~ 216 (453)
||....-.+.+.||.|.||.|++|+++ . ...||||.|+.. .....+|+.| |.|+......
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 333333345577999999999999975 2 347999999873 4456788887 5666677778
Q ss_pred eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517 217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA 296 (453)
Q Consensus 217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 296 (453)
.++|.|||+||+|+.+|... ...|+|.++..++.+||.|+.||-+. ++|||||..+|||++.|..+||+||||+
T Consensus 705 vMIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccce
Confidence 89999999999999999433 35699999999999999999999986 9999999999999999999999999999
Q ss_pred cccCCCCCc-eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhh
Q 048517 297 KFHPKENDF-VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLN 374 (453)
Q Consensus 297 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~ 374 (453)
|....+... .......-+++|.|||.+.- ..+|.+|||||||+++||.++ |.+|+......+ +.+.++
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd--------VIkaIe 848 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------VIKAIE 848 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCcccccchHH--------HHHHHH
Confidence 977554421 11122223578999999974 489999999999999999886 888886554322 677788
Q ss_pred hCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517 375 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426 (453)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~ 426 (453)
++-++.. +.+.+..|.+|+++|||+|..+||++.+++.+|++.+..
T Consensus 849 ~gyRLPp------PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 849 QGYRLPP------PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred hccCCCC------CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 8777653 334557799999999999999999999999999987654
No 13
>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4e-39 Score=345.67 Aligned_cols=251 Identities=27% Similarity=0.462 Sum_probs=202.0
Q ss_pred HHHHHhhhhhcccCccCceEEEEEEEc--CCc----EEEEEEecCC--CCCHHHHHHH--------------HhcccccC
Q 048517 157 EIIAVTNHFTHKLGQGGFGSVYKGQLH--TGR----LIAVKMMENS--KFSAEEFINE--------------LLGLCSEG 214 (453)
Q Consensus 157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~--~g~----~VAVK~l~~~--~~~~~~~i~e--------------l~g~~~~~ 214 (453)
++...+-.+.+.||+|.||.||+|... +|. .||||.+... ....++|++| ++|.|-+.
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 344455556678999999999999854 343 4999999874 3345677777 88999999
Q ss_pred cceEEEEEecCCCChhhhhhhccC---CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEE
Q 048517 215 FKRALVYEYMPNGSLDRHIFSKEN---KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS 291 (453)
Q Consensus 215 ~~~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~ 291 (453)
...++++|||++|+|..+|...+. ....|+...++.++.+||+|+.||+++ .+|||||..+|+||++...+||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEc
Confidence 999999999999999999965421 246789999999999999999999998 99999999999999999999999
Q ss_pred ecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHH
Q 048517 292 DFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVY 370 (453)
Q Consensus 292 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 370 (453)
|||||+-....+.+.......-...|||||.+.. +.++.|+|||||||+|||++| |..|+...+... +.
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--------v~ 914 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--------VL 914 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHH--------HH
Confidence 9999996555555444334456789999999986 589999999999999999999 778886544322 34
Q ss_pred HHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517 371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426 (453)
Q Consensus 371 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~ 426 (453)
....++.+++ .+.....++.+++..||+.+|++||++..+++.++.+...
T Consensus 915 ~~~~~ggRL~------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 915 LDVLEGGRLD------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred HHHHhCCccC------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 4333344443 3344567889999999999999999999999998876554
No 14
>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]
Probab=100.00 E-value=8.7e-39 Score=304.70 Aligned_cols=224 Identities=26% Similarity=0.378 Sum_probs=180.8
Q ss_pred hhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCHH----H--------------HHHHHhcccccCcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAE----E--------------FINELLGLCSEGFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~~----~--------------~i~el~g~~~~~~~~~lv~E~ 223 (453)
..+.+.||+|+||.||..+ .++++.+|+|++++.+.... . |+..|.-.+++..+++||+||
T Consensus 27 F~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~ 106 (357)
T KOG0598|consen 27 FEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDY 106 (357)
T ss_pred eeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEec
Confidence 3456889999999999998 55799999999987433221 1 112255567788899999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+.||.|..+|. ....+++..+.-++.+|+.||.|||+. +||||||||+|||||.+|+++|+||||++..-..+
T Consensus 107 ~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 107 LNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred cCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 99999999983 346799999999999999999999998 99999999999999999999999999999655443
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
. .+...+||+.|||||++.+. .++..+|.||+|+++|||++|.+||...+.. ..++.+.++.....
T Consensus 180 ~--~t~tfcGT~eYmAPEil~~~--gy~~~vDWWsLGillYeML~G~pPF~~~~~~--------~~~~~I~~~k~~~~-- 245 (357)
T KOG0598|consen 180 D--ATRTFCGTPEYMAPEILLGK--GYDKAVDWWSLGILLYEMLTGKPPFYAEDVK--------KMYDKILKGKLPLP-- 245 (357)
T ss_pred C--ccccccCCccccChHHHhcC--CCCcccchHhHHHHHHHHhhCCCCCcCccHH--------HHHHHHhcCcCCCC--
Confidence 3 23457899999999999875 8999999999999999999999999765432 24455555442222
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCC
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRP 411 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 411 (453)
+.-++....+++...|+.+|++|-
T Consensus 246 ----p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 246 ----PGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ----CccCCHHHHHHHHHHhccCHHHhc
Confidence 122345688899999999999995
No 15
>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.1e-38 Score=314.68 Aligned_cols=229 Identities=28% Similarity=0.393 Sum_probs=187.5
Q ss_pred hcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCHHHH-HHH--------------HhcccccCcceEEEEEecCCCCh
Q 048517 166 THKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEF-INE--------------LLGLCSEGFKRALVYEYMPNGSL 229 (453)
Q Consensus 166 ~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~~~~-i~e--------------l~g~~~~~~~~~lv~E~~~~gsL 229 (453)
-.+||+|+-|.||.+. ..+++.||||++...+...++. ++| .+.-+..+...++|||||++|+|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 4689999999999998 6689999999998866655543 233 34444455789999999999999
Q ss_pred hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeec
Q 048517 230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 309 (453)
Q Consensus 230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 309 (453)
.+.+ ....+++.++..|+.++++||+|||.+ +|+|||||.+|||++.++.+||+|||++......... -.
T Consensus 358 TDvV-----t~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K--R~ 427 (550)
T KOG0578|consen 358 TDVV-----TKTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK--RS 427 (550)
T ss_pred hhhh-----hcccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCc--cc
Confidence 8887 234589999999999999999999998 9999999999999999999999999999887665542 25
Q ss_pred ccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHH
Q 048517 310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 389 (453)
Q Consensus 310 ~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 389 (453)
...||+.|||||++.+. .|.+|.||||||++++||+-|.+||-..... -....+......++. .+.
T Consensus 428 TmVGTPYWMAPEVvtrk--~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl--------rAlyLIa~ng~P~lk----~~~ 493 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRK--PYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALYLIATNGTPKLK----NPE 493 (550)
T ss_pred cccCCCCccchhhhhhc--ccCccccchhhhhHHHHHhcCCCCccCCChH--------HHHHHHhhcCCCCcC----Ccc
Confidence 67899999999999886 8999999999999999999999999653221 122233333443332 344
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 390 MIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 390 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.++..+.+++.+||+.|+++|||++|+|+
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 56778999999999999999999999987
No 16
>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit. Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce
Probab=100.00 E-value=1.3e-37 Score=314.74 Aligned_cols=246 Identities=26% Similarity=0.427 Sum_probs=186.2
Q ss_pred HHhhhhhcccCccCceEEEEEEE------cCCcEEEEEEecCCCC--CHHHHHHH---------------HhcccccCcc
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMMENSKF--SAEEFINE---------------LLGLCSEGFK 216 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~~------~~g~~VAVK~l~~~~~--~~~~~i~e---------------l~g~~~~~~~ 216 (453)
...+.+.++||+|+||.||+|+. .++..||||+++.... ..+.+.+| +++.|..+..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 44567789999999999999963 2466899999975332 12233333 5667778888
Q ss_pred eEEEEEecCCCChhhhhhhccC----------------------------------------------------------
Q 048517 217 RALVYEYMPNGSLDRHIFSKEN---------------------------------------------------------- 238 (453)
Q Consensus 217 ~~lv~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 238 (453)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999998854221
Q ss_pred -------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517 239 -------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 239 -------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 305 (453)
....++|..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 112578899999999999999999998 9999999999999999999999999999876544332
Q ss_pred eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517 306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384 (453)
Q Consensus 306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 384 (453)
.......++..|+|||.+.+. .++.++||||||+++|||++ |..||...... ....+.+..+.....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~--~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-------~~~~~~~~~~~~~~~--- 338 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-------SKFYKMIKEGYRMLS--- 338 (375)
T ss_pred cccCCCCCCcceeChhHhcCC--CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-------HHHHHHHHhCccCCC---
Confidence 222334567789999999764 78999999999999999998 78887543211 112233333222111
Q ss_pred hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 423 (453)
Q Consensus 385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~ 423 (453)
+...+..+.+++.+||+.||++|||+.+|+++|++.
T Consensus 339 ---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 339 ---PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111235688999999999999999999999999864
No 17
>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k
Probab=100.00 E-value=1e-37 Score=305.99 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=181.8
Q ss_pred HHhhhhhcccCccCceEEEEEEEcC-----------------CcEEEEEEecCCCC--CHHHHHHH--------------
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQLHT-----------------GRLIAVKMMENSKF--SAEEFINE-------------- 206 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~~~~-----------------g~~VAVK~l~~~~~--~~~~~i~e-------------- 206 (453)
+..+.+.++||+|+||.||++..++ +..||||.+..... ...++..|
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4456778999999999999997532 34799999876422 22344444
Q ss_pred HhcccccCcceEEEEEecCCCChhhhhhhcc---------------CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCcee
Q 048517 207 LLGLCSEGFKRALVYEYMPNGSLDRHIFSKE---------------NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCIL 271 (453)
Q Consensus 207 l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 271 (453)
+++++......++||||+++|+|.+++.... .....++|..++.++.|++.||.|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 4566667778899999999999999885421 1123578899999999999999999998 999
Q ss_pred ecccCCcceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcC--
Q 048517 272 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG-- 349 (453)
Q Consensus 272 H~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg-- 349 (453)
||||||+|||++.++.+||+|||+++...............++..|+|||++.. +.++.++||||||+++|||+++
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM--GKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc--CCCCchhhhHHHHHHHHHHHHccC
Confidence 999999999999999999999999986544333222334456889999999875 3789999999999999999874
Q ss_pred CCCCCCCccccccccchHHHHHHhhhCC-CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 350 RRNSNMNATRSSKAYFPSWVYDQLNKGG-DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 350 ~~p~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
..|+...... . ....+...+.... ..... .+...+..+.+++.+||+.+|++|||+.+|.+.|+.
T Consensus 239 ~~p~~~~~~~---~-~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 239 EQPYGELTDE---Q-VIENAGEFFRDQGRQVYLF----RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCCcCCHH---H-HHHHHHHHhhhcccccccc----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 4555432211 1 1111111111111 00000 111234568899999999999999999999999873
No 18
>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=7e-38 Score=305.54 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=189.1
Q ss_pred HHHhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCHHHH-----------------HHHHhcccccCc-ceEE
Q 048517 159 IAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEF-----------------INELLGLCSEGF-KRAL 219 (453)
Q Consensus 159 ~~~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~~~~-----------------i~el~g~~~~~~-~~~l 219 (453)
...+|...++||.|.||+||+|+ ..+|..||||.++..-..-++. +..|..+..+.. .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 34578888999999999999999 6689999999988754444432 222555555555 8899
Q ss_pred EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517 220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 299 (453)
||||| ..+|.+.+..+ ...|+...+..|+.||.+||+|+|.+ ++.|||+||+|||+..+..+||+|||+||-.
T Consensus 88 VfE~M-d~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhh-hhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 99999 56888877443 57899999999999999999999998 9999999999999999999999999999976
Q ss_pred CCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccccc----------chHHH
Q 048517 300 PKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY----------FPSWV 369 (453)
Q Consensus 300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~----------~~~~~ 369 (453)
.... ..+.-..|..|+|||++.+. +.|+.+.|+|++||+++|+.+-++-|...++.. +.+ ...|.
T Consensus 161 ~Skp---PYTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D-qi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 161 RSKP---PYTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEID-QIYKICEVLGTPDKDSWP 235 (538)
T ss_pred ccCC---CcchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHH-HHHHHHHHhCCCccccch
Confidence 5544 34667789999999999876 789999999999999999999998887655421 110 00111
Q ss_pred H-HHhhhCCCcccc--c---hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 370 Y-DQLNKGGDLELR--N---VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 370 ~-~~l~~~~~~~~~--~---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
. ..+......... . ........+.+..+++.+|+++||++|||+++.+++
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1 111110000000 0 011112256788999999999999999999999985
No 19
>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=5e-37 Score=299.33 Aligned_cols=255 Identities=25% Similarity=0.328 Sum_probs=189.0
Q ss_pred hhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCC--------------HHHHHHHHhcccccC----cceEEEEEecC
Q 048517 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS--------------AEEFINELLGLCSEG----FKRALVYEYMP 225 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~--------------~~~~i~el~g~~~~~----~~~~lv~E~~~ 225 (453)
++.+.||+|.||.||||+++ ++.||||++...... .++.|.++++.-..+ ...+||+||.+
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~ 291 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP 291 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence 35678999999999999998 599999999752211 123344455544433 37899999999
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcC------CCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG------CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 299 (453)
+|+|.+||. ...++|....+|+..+++||+|||+. +.++|+|||||++|||+.+|++..|+|||+|..+
T Consensus 292 kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 292 KGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred CCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 999999993 35789999999999999999999975 3468999999999999999999999999999987
Q ss_pred CCCCCceeecccCCCCCccChhhhcccCC----CCCccchHHHHHHHHHHHHcCCCCCCCCcccccc----------ccc
Q 048517 300 PKENDFVSISDTRGTIGYLAPELISRNFG----TVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK----------AYF 365 (453)
Q Consensus 300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~----------~~~ 365 (453)
.............||.+|||||++.+... ..-.+.||||+|.|||||+++-..+........+ ..+
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~ 446 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL 446 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence 65544333445789999999999986421 1123789999999999999976554322111111 112
Q ss_pred hHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517 366 PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID 425 (453)
Q Consensus 366 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~ 425 (453)
...-.-.+.+..+..+++.. ........+++.+..||..||+-|.|+.-|-+++.....
T Consensus 447 e~mq~~VV~kK~RP~~p~~W-~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 447 EEMQELVVRKKQRPKIPDAW-RKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred HHHHHHHHhhccCCCChhhh-hcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 22222233444454444433 222445678999999999999999999999998876443
No 20
>PHA02988 hypothetical protein; Provisional
Probab=100.00 E-value=3.9e-37 Score=299.33 Aligned_cols=230 Identities=19% Similarity=0.294 Sum_probs=180.0
Q ss_pred cccCccCceEEEEEEEcCCcEEEEEEecCCCCCH----HHHHHH--------------Hhccccc----CcceEEEEEec
Q 048517 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA----EEFINE--------------LLGLCSE----GFKRALVYEYM 224 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~----~~~i~e--------------l~g~~~~----~~~~~lv~E~~ 224 (453)
..||+|++|.||+|.. +|+.||||.+....... +.+.+| ++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 4699999999999998 48999999998754433 334344 4565544 34678999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
++|+|.+++.. ...++|.....++.+++.||.|||+. .+++||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999843 24689999999999999999999973 278899999999999999999999999998654322
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHh-hhCCCccccc
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL-NKGGDLELRN 383 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~ 383 (453)
....||..|+|||++.+....++.++|||||||++|||++|+.||...... . +...+ ..+.....
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-------~-~~~~i~~~~~~~~~-- 243 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-------E-IYDLIINKNNSLKL-- 243 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-------H-HHHHHHhcCCCCCC--
Confidence 234588999999999764457899999999999999999999999754321 1 22222 22222221
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
+...+..+.+++.+||+.||++|||++++++.|+.
T Consensus 244 ----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 244 ----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred ----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 11234568899999999999999999999999974
No 21
>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i
Probab=100.00 E-value=1.7e-37 Score=301.88 Aligned_cols=235 Identities=27% Similarity=0.369 Sum_probs=179.2
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
+...+.||+|+||.||++.. .+|+.||||.+..... ....+.+| +.+.+......++|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 45568899999999999984 5899999999875321 12233333 34455667788999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++|+|..++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999998877532 234689999999999999999999998 99999999999999999999999999998754332
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
. .....||..|+|||++.+. .++.++|||||||++|||++|+.||........ ...+...+.... .
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~-~---- 222 (285)
T cd05631 157 T---VRGRVGTVGYMAPEVINNE--KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK----REEVDRRVKEDQ-E---- 222 (285)
T ss_pred e---ecCCCCCCCccCHhhhcCC--CCCcccCchhHHHHHHHHHhCCCCCCCCCcchh----HHHHHHHhhccc-c----
Confidence 2 2345689999999999764 789999999999999999999999975433211 011111111111 1
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE 418 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 418 (453)
......+..+.+++.+||+.||++||+ ++++++
T Consensus 223 --~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 --EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred --cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 122234567889999999999999997 788876
No 22
>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity. Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....
Probab=100.00 E-value=2.2e-37 Score=297.05 Aligned_cols=235 Identities=33% Similarity=0.549 Sum_probs=180.1
Q ss_pred hhcccCccCceEEEEEEEc-----CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 165 FTHKLGQGGFGSVYKGQLH-----TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 165 ~~~~LG~G~fG~Vy~g~~~-----~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
+.+.||+|.||.||+|.+. .+..|+||+++..... .+++++| ++|+|......++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999976 3678999999663322 4556555 67888877789999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++|+|.++|... ....+++.++..|+.|+++||.|||+. +++|+||+++||+++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999654 235789999999999999999999998 99999999999999999999999999998774433
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 382 (453)
.........+...|+|||.+... .++.++||||||+++|||++ |+.|+..... .-+...+.++.....
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~--~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--------~~~~~~~~~~~~~~~- 226 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDG--EYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--------EEIIEKLKQGQRLPI- 226 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHS--EESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--------HHHHHHHHTTEETTS-
T ss_pred ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccc--------cccccccccccccee-
Confidence 33333445678899999999764 68999999999999999999 6777654321 113344444433222
Q ss_pred chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517 383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 420 (453)
Q Consensus 383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 420 (453)
+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 227 -----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 -----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112345688999999999999999999999986
No 23
>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti
Probab=100.00 E-value=2.2e-37 Score=312.88 Aligned_cols=247 Identities=24% Similarity=0.437 Sum_probs=184.8
Q ss_pred HHhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC--HHHHHHH---------------HhcccccCcc
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSEGFK 216 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~~~~ 216 (453)
...+.+.+.||+|+||.||+|+.. +++.||||++...... .+.+..| +++.|.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 445667899999999999998732 3458999999764322 2233333 4566777788
Q ss_pred eEEEEEecCCCChhhhhhhccC----------------------------------------------------------
Q 048517 217 RALVYEYMPNGSLDRHIFSKEN---------------------------------------------------------- 238 (453)
Q Consensus 217 ~~lv~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 238 (453)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 8999999999999998853210
Q ss_pred --------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecc
Q 048517 239 --------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISD 310 (453)
Q Consensus 239 --------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 310 (453)
....+++.+++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 113578889999999999999999998 999999999999999999999999999986544333222233
Q ss_pred cCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHH
Q 048517 311 TRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 389 (453)
Q Consensus 311 ~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 389 (453)
..++..|+|||++.+. .++.++||||||+++|||++ |+.||....... .....+..+..... +.
T Consensus 274 ~~~~~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-------~~~~~~~~~~~~~~------~~ 338 (374)
T cd05106 274 ARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-------KFYKMVKRGYQMSR------PD 338 (374)
T ss_pred CCCccceeCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccccccH-------HHHHHHHcccCccC------CC
Confidence 4567789999998753 78999999999999999997 999986533211 11222222211111 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517 390 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI 424 (453)
Q Consensus 390 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~ 424 (453)
..+..+.+++.+||+.+|++|||+.+|+++|++++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 12457889999999999999999999999998753
No 24
>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor
Probab=100.00 E-value=3.2e-37 Score=296.70 Aligned_cols=241 Identities=24% Similarity=0.361 Sum_probs=184.9
Q ss_pred HHhhhhhcccCccCceEEEEEEEc----CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEE
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRAL 219 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~~~----~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~l 219 (453)
...+.+.+.||+|+||.||+|+++ .+..||+|+++..... .+.++.| +++++..+...++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 445677899999999999999853 3678999998864322 2344444 4566677788999
Q ss_pred EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517 220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 299 (453)
||||+++|+|.+++... ...++|.+++.++.|++.||+|||+. +++||||||+|||++.++.+|++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999988532 24689999999999999999999998 9999999999999999999999999987654
Q ss_pred CCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517 300 PKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGD 378 (453)
Q Consensus 300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~ 378 (453)
...... ......++..|+|||.+.+ +.++.++||||||+++||+++ |+.||...... ...+.+.++..
T Consensus 158 ~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--------~~~~~~~~~~~ 226 (266)
T cd05064 158 KSEAIY-TTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--------DVIKAVEDGFR 226 (266)
T ss_pred cccchh-cccCCCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCCCC
Confidence 222111 1122345678999999876 378999999999999999775 99998644321 12333333322
Q ss_pred ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517 379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 423 (453)
Q Consensus 379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~ 423 (453)
.. .+...+..+.+++.+||+.+|++|||+.++++.|++.
T Consensus 227 ~~------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 LP------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CC------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 21 1223456788999999999999999999999999764
No 25
>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn. Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa
Probab=100.00 E-value=5.9e-37 Score=293.43 Aligned_cols=240 Identities=27% Similarity=0.425 Sum_probs=187.6
Q ss_pred HhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
..+.+.++||+|+||.||+|..++++.||+|.+.......+.+..| +++.+......+++|||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 3456678999999999999998888899999987655555555544 34566677778999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|+|.+++... ....+++.++..++.+++.||+|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 86 ~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05072 86 GSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT- 159 (261)
T ss_pred CcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee-
Confidence 9999988543 235689999999999999999999998 9999999999999999999999999999876443221
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 385 (453)
......++..|+|||++.. +.++.++||||||+++|||++ |+.||...... .....+........
T Consensus 160 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~---- 225 (261)
T cd05072 160 AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--------DVMSALQRGYRMPR---- 225 (261)
T ss_pred ccCCCccceecCCHHHhcc--CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--------HHHHHHHcCCCCCC----
Confidence 1223446778999999875 378889999999999999998 88888643211 12222332222111
Q ss_pred hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
....+..+.+++.+|++.+|++|||++++.++|+.
T Consensus 226 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 --MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11234568899999999999999999999999985
No 26
>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a
Probab=100.00 E-value=8.1e-37 Score=292.63 Aligned_cols=242 Identities=29% Similarity=0.406 Sum_probs=188.9
Q ss_pred HHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 159 IAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 159 ~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
...++++.+.||+|+||.||+|..++++.||||.+.......+++..| +++++......+++|||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 345667789999999999999998888899999998765555566555 345667777889999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
++++|.+++.... ...+++..+..++.+++.||.|||+. +|+|+||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999999885432 35689999999999999999999998 999999999999999999999999999987653221
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
........+..|+|||++... .++.++||||||++++||++ |+.|+...... -....+.......
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~--- 224 (261)
T cd05068 159 -EAREGAKFPIKWTAPEAALYN--RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--------EVLQQVDQGYRMP--- 224 (261)
T ss_pred -cccCCCcCceeccCccccccC--CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCC---
Confidence 111222334689999988753 78999999999999999999 88888643211 1222332222111
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
.+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 225 ---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 225 ---CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ---CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 112234678999999999999999999999999985
No 27
>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1e-37 Score=311.08 Aligned_cols=244 Identities=28% Similarity=0.408 Sum_probs=205.0
Q ss_pred HHHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEE
Q 048517 158 IIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYE 222 (453)
Q Consensus 158 ~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E 222 (453)
+......+.++||-|-||.||.|.++ -.-.||||.|+.+....++|+.| |+|+|......|||.|
T Consensus 264 meRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 264 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred ccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 33333446789999999999999976 46789999999999999999877 8999999999999999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 302 (453)
||.+|+|.+||.. -....++--.++.+|.||+.|++||..+ ++|||||..+|+|+.++-.+||+||||++++..+
T Consensus 344 fM~yGNLLdYLRe--cnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRE--CNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred cccCccHHHHHHH--hchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 9999999999943 3345677778899999999999999998 9999999999999999999999999999998776
Q ss_pred CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517 303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381 (453)
Q Consensus 303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 381 (453)
... ......-.+.|.|||.+.- ..++.|+|||+|||+|||+.| |..|+....- ..++..++++.+.+
T Consensus 419 TYT-AHAGAKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLLWEIATYGMsPYPGidl--------SqVY~LLEkgyRM~- 486 (1157)
T KOG4278|consen 419 TYT-AHAGAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYGLLEKGYRMD- 486 (1157)
T ss_pred cee-cccCccCcccccCcccccc--cccccchhhHHHHHHHHHHHhcCCCCCCCccH--------HHHHHHHhcccccc-
Confidence 432 2233445778999998864 589999999999999999998 7777754331 23888888887654
Q ss_pred cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517 382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 423 (453)
Q Consensus 382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~ 423 (453)
.+..+..++.+|+++||++.|.+||++.|+-+.+|.+
T Consensus 487 -----~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 487 -----GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred -----CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 4445668899999999999999999999999888754
No 28
>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=7.3e-37 Score=296.38 Aligned_cols=246 Identities=21% Similarity=0.296 Sum_probs=189.7
Q ss_pred HhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCHH-HHHH-H--------------HhcccccCcceEEEEEe
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAE-EFIN-E--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~~-~~i~-e--------------l~g~~~~~~~~~lv~E~ 223 (453)
..|.+.+.||.|.-++||+|+ .+.+..||||+++.++.+.+ +.+. | .+..+..++.+++||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 356778899999999999999 66889999999998766554 3333 3 23334567789999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
|.+||+.+.+...- ...+.+..+..|++++++||.|||++ +.||||||+.||||+.+|.+||+|||.+...-...
T Consensus 106 Ma~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999986532 35589999999999999999999998 99999999999999999999999999876543332
Q ss_pred Cc-eee-cccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC-cc
Q 048517 304 DF-VSI-SDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD-LE 380 (453)
Q Consensus 304 ~~-~~~-~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~-~~ 380 (453)
.. ... ....||+.|||||++.+....|+.|+||||||++..||.+|..||...-.. +.....+..... ..
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-------kvLl~tLqn~pp~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-------KVLLLTLQNDPPTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-------HHHHHHhcCCCCCcc
Confidence 22 111 456899999999997776678999999999999999999999999532211 112222222211 01
Q ss_pred c-cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 381 L-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 381 ~-~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
. ....+....+...+.+++..||+.||.+|||++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0 0112244556678999999999999999999999886
No 29
>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt
Probab=100.00 E-value=1.1e-36 Score=294.45 Aligned_cols=244 Identities=26% Similarity=0.424 Sum_probs=187.2
Q ss_pred HHhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcce
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKR 217 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~ 217 (453)
..++.+.+.||+|+||.||+|+.. +++.||||.+...... .+++.+| +++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 456778899999999999999863 3578999998764333 2334333 45666777889
Q ss_pred EEEEEecCCCChhhhhhhcc----------CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc
Q 048517 218 ALVYEYMPNGSLDRHIFSKE----------NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI 287 (453)
Q Consensus 218 ~lv~E~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~ 287 (453)
+++|||+++|+|.+++.... .....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 99999999999999986432 1234588999999999999999999998 9999999999999999999
Q ss_pred eEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccch
Q 048517 288 PKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFP 366 (453)
Q Consensus 288 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 366 (453)
+||+|||+++...............+++.|+|||++... .++.++||||||+++|||++ |+.||.......
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~------ 232 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------ 232 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccC--CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------
Confidence 999999999865433222222334567889999998763 78999999999999999998 999986433211
Q ss_pred HHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 367 SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 367 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
..+.+..+.... .+...+..+.+++.+||+.+|++||++.||++.|++
T Consensus 233 --~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 233 --VIECITQGRLLQ------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred --HHHHHHcCCcCC------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 222222222211 112244678999999999999999999999999863
No 30
>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h
Probab=100.00 E-value=8.5e-37 Score=291.65 Aligned_cols=236 Identities=25% Similarity=0.442 Sum_probs=185.2
Q ss_pred hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNG 227 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g 227 (453)
.+.+.++||+|+||.||+++.+++..+|+|.+.......+++..| +++++......+++|||+++|
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENG 84 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCC
Confidence 455678899999999999998888899999987765555666555 456777788899999999999
Q ss_pred ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517 228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 307 (453)
Q Consensus 228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 307 (453)
+|.+++.... ..++|..+..++.+++.||+|||+. +|+|+||||+||+++.++.+||+|||+++....... ..
T Consensus 85 ~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05114 85 CLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TS 157 (256)
T ss_pred cHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce-ec
Confidence 9999885322 3589999999999999999999998 999999999999999999999999999986543222 11
Q ss_pred ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
.....++..|+|||.+... .++.++||||||+++|||++ |+.|+...... . ....+.++.....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-------~-~~~~i~~~~~~~~----- 222 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFS--KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-------E-VVEMISRGFRLYR----- 222 (256)
T ss_pred cCCCCCchhhCChhhcccC--ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-------H-HHHHHHCCCCCCC-----
Confidence 2233456789999998753 68899999999999999999 88888643321 1 2223333222111
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 420 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 420 (453)
+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 223 -~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 223 -PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 111235689999999999999999999999987
No 31
>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]
Probab=100.00 E-value=2.1e-37 Score=286.94 Aligned_cols=244 Identities=25% Similarity=0.332 Sum_probs=182.5
Q ss_pred hhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH-----------------HHHHHHHhcccccCcceEEEEEecC
Q 048517 164 HFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA-----------------EEFINELLGLCSEGFKRALVYEYMP 225 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~-----------------~~~i~el~g~~~~~~~~~lv~E~~~ 225 (453)
+-..++|+|+||.||+++. ++|+.||||++..+..+. ++.+..|+..|....+.+||+||++
T Consensus 5 E~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~d 84 (396)
T KOG0593|consen 5 EKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCD 84 (396)
T ss_pred hhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecc
Confidence 3446899999999999995 479999999998754432 1234448889999999999999997
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 305 (453)
.--|+ .| +.....++.+.+.+++.|+++|+.|+|++ +++||||||+|||++.++.+||+|||.|+.......
T Consensus 85 hTvL~-eL---e~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd- 156 (396)
T KOG0593|consen 85 HTVLH-EL---ERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD- 156 (396)
T ss_pred hHHHH-HH---HhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCcc-
Confidence 65443 33 33446788999999999999999999998 999999999999999999999999999998764332
Q ss_pred eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHH--------HHhhhCC
Q 048517 306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY--------DQLNKGG 377 (453)
Q Consensus 306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~--------~~l~~~~ 377 (453)
..+.-..|..|.|||.+.+. .+|....|||++||++.||++|.+-|...++- .+.+...... +.+....
T Consensus 157 -~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi-DQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 157 -NYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI-DQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred -hhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchH-HHHHHHHHHHcccCHHHHHHhccCC
Confidence 23566789999999999875 48899999999999999999999877654432 1222111111 1111111
Q ss_pred ------CccccchhhhHH---HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 378 ------DLELRNVTEIES---MIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 378 ------~~~~~~~~~~~~---~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
..++......+. .++.-+.+++..||++||++|+|-++++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111111111222 23456889999999999999999998874
No 32
>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=3.4e-37 Score=297.74 Aligned_cols=241 Identities=29% Similarity=0.346 Sum_probs=180.2
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH-HHHHHH--------------HhcccccCc--ceEEEEEe
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA-EEFINE--------------LLGLCSEGF--KRALVYEY 223 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~-~~~i~e--------------l~g~~~~~~--~~~lv~E~ 223 (453)
.+...+.||+|+||+||++... +|...|||......... +....| .+|...... ...+.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 3556688999999999999954 59999999887652111 112222 234322222 57899999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-CCceEEEecCCccccCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~ 302 (453)
+++|+|.+++... .+ .|+.+.+..+..||++||+|||++ +|+|+||||+|||++. ++.+||+|||+++.....
T Consensus 98 ~~~GsL~~~~~~~--g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 98 APGGSLSDLIKRY--GG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred cCCCcHHHHHHHc--CC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999998432 22 699999999999999999999998 9999999999999999 799999999999866531
Q ss_pred CC-ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517 303 ND-FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381 (453)
Q Consensus 303 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 381 (453)
.. .......+||+.|||||++... .....++||||+||++.||+||++|+... .....+...........
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~~~~~P-- 242 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGREDSLP-- 242 (313)
T ss_pred cccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhccCCCC--
Confidence 11 1122456899999999999851 13345999999999999999999998642 11122222222222111
Q ss_pred cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517 382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421 (453)
Q Consensus 382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le 421 (453)
..+..++....+++..|++.+|++|||++++++..-
T Consensus 243 ----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 243 ----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 244456778899999999999999999999998554
No 33
>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase. Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays
Probab=100.00 E-value=1.4e-36 Score=291.40 Aligned_cols=240 Identities=29% Similarity=0.436 Sum_probs=186.4
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
.+.+.++||+|+||.||+|... +++.||+|.+..+....+++..| +++++......+++|||+++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 86 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence 4566789999999999999954 68899999988765544555444 45677777888999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
++|.+++... ....+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++....... .
T Consensus 87 ~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~ 160 (263)
T cd05052 87 GNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-T 160 (263)
T ss_pred CcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee-e
Confidence 9999988432 235689999999999999999999998 999999999999999999999999999986644321 1
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 385 (453)
......++.+|+|||.+... .++.++||||||+++|||++ |..|+...... -..+.+......+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~----- 225 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEKGYRME----- 225 (263)
T ss_pred ccCCCCCccccCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCCCCC-----
Confidence 11223346789999988754 78899999999999999998 88887643211 1222333221111
Q ss_pred hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 423 (453)
Q Consensus 386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~ 423 (453)
.+...+..+.+++.+||+.+|++|||+.+++++|+..
T Consensus 226 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 -RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1122346788999999999999999999999999863
No 34
>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer
Probab=100.00 E-value=9.8e-37 Score=295.40 Aligned_cols=242 Identities=25% Similarity=0.430 Sum_probs=185.7
Q ss_pred hhhhhcccCccCceEEEEEEEcC-C-----cEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLHT-G-----RLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRAL 219 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~~-g-----~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~l 219 (453)
.+.+.+.||+|+||.||+|.... + +.||+|.+..... ...++.+| +++++......++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 45677899999999999998542 2 5799999875332 12334333 3456666777899
Q ss_pred EEEecCCCChhhhhhhccC------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc
Q 048517 220 VYEYMPNGSLDRHIFSKEN------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI 287 (453)
Q Consensus 220 v~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~ 287 (453)
+|||+++|+|.+++..... ....+++.+++.++.|++.||.|||+. +++|+||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCc
Confidence 9999999999999864321 114688899999999999999999998 9999999999999999999
Q ss_pred eEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccch
Q 048517 288 PKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFP 366 (453)
Q Consensus 288 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 366 (453)
+||+|||+++...............+++.|+|||.+... .++.++|||||||++|||++ |+.||......
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDv~slG~il~el~~~g~~p~~~~~~~------- 233 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ------- 233 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccC--cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-------
Confidence 999999999865443322223344578899999998753 78999999999999999998 99898643321
Q ss_pred HHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 367 SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 367 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
-+...+..+.... .+...+..+.+++.+||+.+|++||++++|++.|++
T Consensus 234 -~~~~~i~~~~~~~------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 -EVIEMIRSRQLLP------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHHHcCCcCC------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1333333332221 223455779999999999999999999999999985
No 35
>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]
Probab=100.00 E-value=5.2e-38 Score=310.93 Aligned_cols=242 Identities=27% Similarity=0.418 Sum_probs=193.4
Q ss_pred ccCccCceEEEEEEEcCCcEEEEEEecCCCCCH--------HHHHHHHhcccccCcceEEEEEecCCCChhhhhhhccCC
Q 048517 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA--------EEFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENK 239 (453)
Q Consensus 168 ~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~--------~~~i~el~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~ 239 (453)
=||.|+.|.||+|+++ ++.||||+++.-+... ++.|.++.|+|....-.+||||||..|-|...|. .
T Consensus 131 WlGSGaQGAVF~Grl~-netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLk----a 205 (904)
T KOG4721|consen 131 WLGSGAQGAVFLGRLH-NETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLK----A 205 (904)
T ss_pred hhccCcccceeeeecc-CceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHh----c
Confidence 4999999999999998 7899999887644333 3345568899999999999999999999999984 3
Q ss_pred CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccC
Q 048517 240 GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLA 319 (453)
Q Consensus 240 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 319 (453)
+..++......+.++||.|+.|||.+ .|||||||.-||||..+..+||+|||-++......+ .....||..|||
T Consensus 206 ~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST---kMSFaGTVaWMA 279 (904)
T KOG4721|consen 206 GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST---KMSFAGTVAWMA 279 (904)
T ss_pred cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhh---hhhhhhhHhhhC
Confidence 46788888999999999999999998 999999999999999999999999999986655432 245679999999
Q ss_pred hhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHH
Q 048517 320 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIG 399 (453)
Q Consensus 320 PE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~ 399 (453)
||++... +.+.|+||||||||||||+||..|+..-+... .+.......+. ...+...++-+..|+
T Consensus 280 PEvIrne--PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----------IIwGVGsNsL~--LpvPstcP~GfklL~ 344 (904)
T KOG4721|consen 280 PEVIRNE--PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----------IIWGVGSNSLH--LPVPSTCPDGFKLLL 344 (904)
T ss_pred HHHhhcC--CcccccceehhHHHHHHHHhcCCCccccchhe-----------eEEeccCCccc--ccCcccCchHHHHHH
Confidence 9999875 89999999999999999999999986443211 11111111111 124455667788899
Q ss_pred HHhcccCCCCCCCHHHHHHHHhCCCCC-CCCCCCCCC
Q 048517 400 LWCIQVKAADRPSMTKVLEMLEGSIDD-LQMPPKPFF 435 (453)
Q Consensus 400 ~~Cl~~~p~~RPs~~evl~~Le~~~~~-~~~p~~p~~ 435 (453)
++||+.+|..|||+.+++..|+-.-.+ +.++.+.+|
T Consensus 345 Kqcw~sKpRNRPSFrqil~HldIa~pell~~tee~yf 381 (904)
T KOG4721|consen 345 KQCWNSKPRNRPSFRQILLHLDIASPELLSTTEETYF 381 (904)
T ss_pred HHHHhcCCCCCccHHHHHHHHhhcCHHHhcccHHHHH
Confidence 999999999999999999999865443 355544433
No 36
>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]
Probab=100.00 E-value=2.7e-37 Score=305.65 Aligned_cols=233 Identities=26% Similarity=0.369 Sum_probs=184.4
Q ss_pred hhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCC---------HH-HHHHH---------HhcccccCcceEEEEE
Q 048517 163 NHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS---------AE-EFINE---------LLGLCSEGFKRALVYE 222 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~---------~~-~~i~e---------l~g~~~~~~~~~lv~E 222 (453)
+.|.+.||+|+|++|++|+ ..+++.+|||++.+.... .| +.+.. |+-.+++...+|+|+|
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe 154 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE 154 (604)
T ss_pred cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence 4578999999999999999 568999999998763211 11 11222 5566788889999999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 302 (453)
|.+||+|.++|. +-+.|+......++.+|+.||+|||+. +||||||||+|||||.|+++||+|||.|+.+...
T Consensus 155 ~A~nGdll~~i~----K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 155 YAPNGDLLDLIK----KYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred ecCCCcHHHHHH----HhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 999999999994 336799999999999999999999998 9999999999999999999999999999987543
Q ss_pred CCc---------ee--ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHH
Q 048517 303 NDF---------VS--ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD 371 (453)
Q Consensus 303 ~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 371 (453)
... .. .....||..|.+||++... ..+..+|+|+|||+||.|+.|++||...++ | .+.+
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~--~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-----y---liFq 297 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS--PAGPSSDLWALGCILYQMLAGQPPFRAANE-----Y---LIFQ 297 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCC--CCCcccchHHHHHHHHHHhcCCCCCccccH-----H---HHHH
Confidence 221 11 1346799999999999864 889999999999999999999999976542 1 1233
Q ss_pred HhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 372 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 372 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
.+.+- +. +.+...++...+|+.+.|..||.+|+|.+++-+.
T Consensus 298 kI~~l---~y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 298 KIQAL---DY----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHh---cc----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 33221 11 1222333667889999999999999999998774
No 37
>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]
Probab=100.00 E-value=3.8e-37 Score=304.97 Aligned_cols=251 Identities=27% Similarity=0.377 Sum_probs=205.3
Q ss_pred hhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCHHH-----------------HHHHHhcccccCcceEEEEEe
Q 048517 162 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEE-----------------FINELLGLCSEGFKRALVYEY 223 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~~~-----------------~i~el~g~~~~~~~~~lv~E~ 223 (453)
.|.+.+.||+|+||.||||+ ..+.+.||+|.+.+.....++ .+.+++..++...+.++|.||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 46677899999999999998 557999999999876554422 244578888999999999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+.+ +|..+|. ....++++.+..|+.++..||.|||+. +|+|||+||+|||++.++++|++|||+|+.+..+.
T Consensus 83 a~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 83 AVG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 976 9999883 446799999999999999999999998 99999999999999999999999999999876543
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
. ..+...|||-|||||...+ ..++..+|.||+||++||+.+|++||.... +...+. .+...
T Consensus 155 ~--vltsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~s-------i~~Lv~-~I~~d------- 215 (808)
T KOG0597|consen 155 S--VLTSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARS-------ITQLVK-SILKD------- 215 (808)
T ss_pred e--eeeeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHH-------HHHHHH-HHhcC-------
Confidence 3 4467789999999999986 489999999999999999999999996432 111111 22211
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhCCCCCCCCCCCCCCCCCC
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEGSIDDLQMPPKPFFSSSR 439 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~~~~~~~~p~~p~~~~~~ 439 (453)
....+.+.+..+..++.-.|+.||..|.|-.+++. +.++....++.|..+.+.+.-
T Consensus 216 ~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~spf 273 (808)
T KOG0597|consen 216 PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDSPF 273 (808)
T ss_pred CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccCcc
Confidence 11233356678899999999999999999999987 678888888888888776553
No 38
>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto
Probab=100.00 E-value=1.2e-36 Score=303.37 Aligned_cols=248 Identities=28% Similarity=0.450 Sum_probs=184.7
Q ss_pred HHhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC--HHHHHHH---------------Hhcccc-cCc
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS--AEEFINE---------------LLGLCS-EGF 215 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~-~~~ 215 (453)
..++++.+.||+|+||.||+|... +++.||+|++...... .+.+..| +++.|. .+.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 346778899999999999999632 3578999998753321 1222222 334343 345
Q ss_pred ceEEEEEecCCCChhhhhhhccCC--------------------------------------------------------
Q 048517 216 KRALVYEYMPNGSLDRHIFSKENK-------------------------------------------------------- 239 (453)
Q Consensus 216 ~~~lv~E~~~~gsL~~~l~~~~~~-------------------------------------------------------- 239 (453)
..++++||+++|+|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 678999999999999988543210
Q ss_pred -CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCcc
Q 048517 240 -GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYL 318 (453)
Q Consensus 240 -~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 318 (453)
...++|..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 13689999999999999999999998 99999999999999999999999999998764433322334456678899
Q ss_pred ChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHH
Q 048517 319 APELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCM 397 (453)
Q Consensus 319 aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~ 397 (453)
|||++.+. .++.++|||||||+++||++ |+.||....... .....+..+.... .+......+.+
T Consensus 243 aPE~~~~~--~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~------~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-------EFCRRLKEGTRMR------APEYATPEIYS 307 (337)
T ss_pred CcHHhcCC--CCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-------HHHHHHhccCCCC------CCccCCHHHHH
Confidence 99998764 78999999999999999997 998886432111 1222232222211 11223456889
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517 398 IGLWCIQVKAADRPSMTKVLEMLEGSID 425 (453)
Q Consensus 398 l~~~Cl~~~p~~RPs~~evl~~Le~~~~ 425 (453)
++.+||+.+|++||++.|++++|+..++
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999997654
No 39
>PTZ00283 serine/threonine protein kinase; Provisional
Probab=100.00 E-value=1.4e-36 Score=317.43 Aligned_cols=240 Identities=25% Similarity=0.316 Sum_probs=182.2
Q ss_pred HhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCH---HHHHHHHh--------------cccccC--------
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA---EEFINELL--------------GLCSEG-------- 214 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~---~~~i~el~--------------g~~~~~-------- 214 (453)
..|.+.+.||+|+||+||+++ ..+|+.||||++....... ..+..|+. ..+...
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 467788999999999999998 5579999999987644332 23333321 111100
Q ss_pred cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecC
Q 048517 215 FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG 294 (453)
Q Consensus 215 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 294 (453)
...++||||+++|+|.+++.........+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecc
Confidence 125799999999999999866544456789999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh
Q 048517 295 LAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN 374 (453)
Q Consensus 295 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~ 374 (453)
+++...............||+.|+|||++.+. .++.++||||||+++|||++|+.||..... .. +.....
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------~~-~~~~~~ 258 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK--PYSKKADMFSLGVLLYELLTLKRPFDGENM-------EE-VMHKTL 258 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------HH-HHHHHh
Confidence 99876433222222345799999999999764 789999999999999999999999964321 11 222222
Q ss_pred hCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 375 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
.+.... .+..++..+..++.+||+.+|++||++.++++.
T Consensus 259 ~~~~~~------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGRYDP------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCCCCC------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 222111 122344678899999999999999999999864
No 40
>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor
Probab=100.00 E-value=2.1e-36 Score=298.53 Aligned_cols=244 Identities=25% Similarity=0.406 Sum_probs=183.4
Q ss_pred HHhhhhhcccCccCceEEEEEEEc-CCc----EEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceE
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQLH-TGR----LIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRA 218 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~~~-~g~----~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~ 218 (453)
...++..+.||+|+||.||+|++. +|+ .||||+++.... ..+++..| ++|+|... ...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 344566789999999999999853 444 489999875322 23344443 45555543 467
Q ss_pred EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298 (453)
Q Consensus 219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 298 (453)
+++||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 999999999999988532 24688999999999999999999998 999999999999999999999999999997
Q ss_pred cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCC
Q 048517 299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGG 377 (453)
Q Consensus 299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 377 (453)
..............++..|+|||++.+. .++.++||||||+++|||++ |+.|+...... -....+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~ 228 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------EISSILEKGE 228 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHhCCC
Confidence 7544332222334457789999998764 78999999999999999998 99988643211 1222333332
Q ss_pred CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517 378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426 (453)
Q Consensus 378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~ 426 (453)
..... ......+..++.+||+.+|++|||+.++++.|.....+
T Consensus 229 ~~~~~------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 229 RLPQP------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CCCCC------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 22111 11234678899999999999999999999999876543
No 41
>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment
Probab=100.00 E-value=2.1e-36 Score=290.64 Aligned_cols=241 Identities=27% Similarity=0.420 Sum_probs=185.1
Q ss_pred HhhhhhcccCccCceEEEEEEEc----CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEE
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALV 220 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~----~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv 220 (453)
..+.+.+.||+|+||.||+|+.. +...||||.+...... ..++..| +++++..+...+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 34567789999999999999864 2457999998764332 2345444 45556677788999
Q ss_pred EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517 221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 300 (453)
|||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+|+||||+|||+++++.+||+|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999998532 24789999999999999999999997 99999999999999999999999999999775
Q ss_pred CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517 301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDL 379 (453)
Q Consensus 301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~ 379 (453)
............++..|+|||.+... .++.++||||||++++||++ |+.|+...... ...+.+.+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~ 227 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--------DVIKAVEDGYRL 227 (266)
T ss_pred ccccceeccCCCCCccccChhhhccC--CCccccchHHHHHHHHHHHccCCCCCCCCCHH--------HHHHHHHcCCCC
Confidence 32222222234456789999998764 78899999999999999998 88887543211 122333332221
Q ss_pred cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517 380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 423 (453)
Q Consensus 380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~ 423 (453)
.. +...+..+.+++.+||+.+|++||++++++++|++.
T Consensus 228 ~~------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 PP------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 122345688999999999999999999999999864
No 42
>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh
Probab=100.00 E-value=2.8e-36 Score=291.63 Aligned_cols=245 Identities=25% Similarity=0.394 Sum_probs=183.6
Q ss_pred HHHhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcc
Q 048517 159 IAVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFK 216 (453)
Q Consensus 159 ~~~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~ 216 (453)
....+.+.++||+|+||.||+|... ++..||||.+..... ...++..| +++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3455677899999999999999753 356799999865322 22234443 4566777788
Q ss_pred eEEEEEecCCCChhhhhhhccCC------CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEE
Q 048517 217 RALVYEYMPNGSLDRHIFSKENK------GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV 290 (453)
Q Consensus 217 ~~lv~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl 290 (453)
.++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 99999999999999988543211 23568889999999999999999998 9999999999999999999999
Q ss_pred EecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHH
Q 048517 291 SDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWV 369 (453)
Q Consensus 291 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 369 (453)
+|||+++...............+++.|+|||.+.+ +.++.++||||||+++|||++ |..|+...... -.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--------~~ 230 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--------QV 230 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HH
Confidence 99999986544333222223356788999999875 378999999999999999999 67777543211 12
Q ss_pred HHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 370 YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 370 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
.+.......... +...+..+.+++.+||+.+|++|||+.|++++|++
T Consensus 231 ~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 231 LRFVMEGGLLDK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHHHcCCcCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 222222221111 11233568899999999999999999999999873
No 43
>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-
Probab=100.00 E-value=2.5e-36 Score=307.39 Aligned_cols=247 Identities=25% Similarity=0.377 Sum_probs=187.2
Q ss_pred HhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCC--CHHHHHHH---------------HhcccccCcce
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKF--SAEEFINE---------------LLGLCSEGFKR 217 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~--~~~~~i~e---------------l~g~~~~~~~~ 217 (453)
..+.+.++||+|+||.||+|+.. .+..||||++..... ..+.+++| ++++|......
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI 116 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence 34566789999999999999842 234799999975332 22344444 56677778889
Q ss_pred EEEEEecCCCChhhhhhhccC-----------------------------------------------------------
Q 048517 218 ALVYEYMPNGSLDRHIFSKEN----------------------------------------------------------- 238 (453)
Q Consensus 218 ~lv~E~~~~gsL~~~l~~~~~----------------------------------------------------------- 238 (453)
++||||+++|+|.+++.....
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (400)
T cd05105 117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE 196 (400)
T ss_pred EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence 999999999999998864210
Q ss_pred ---------------------------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC
Q 048517 239 ---------------------------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN 285 (453)
Q Consensus 239 ---------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~ 285 (453)
....+++..+..++.|+++||+|||+. +|+|+||||+|||++.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~ 273 (400)
T cd05105 197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCC
Confidence 113578889999999999999999998 99999999999999999
Q ss_pred CceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcccccccc
Q 048517 286 FIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAY 364 (453)
Q Consensus 286 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~ 364 (453)
+.+||+|||+++...............++..|+|||.+.+. .++.++||||||+++|||++ |+.|+......
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~----- 346 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN--LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD----- 346 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCcccchh-----
Confidence 99999999999876443332233344577899999998763 78899999999999999997 88888643211
Q ss_pred chHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517 365 FPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID 425 (453)
Q Consensus 365 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~ 425 (453)
......+..+.... .+...+..+.+++.+||+.+|++|||+.+|+++|+..++
T Consensus 347 --~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 347 --STFYNKIKSGYRMA------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred --HHHHHHHhcCCCCC------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11222333322211 112345678899999999999999999999999997543
No 44
>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.7e-37 Score=310.33 Aligned_cols=240 Identities=29% Similarity=0.454 Sum_probs=190.2
Q ss_pred hhhcccCccCceEEEEEEEcC--C--cE-EEEEEecCCC----CCHHHHHHH--------------HhcccccCcceEEE
Q 048517 164 HFTHKLGQGGFGSVYKGQLHT--G--RL-IAVKMMENSK----FSAEEFINE--------------LLGLCSEGFKRALV 220 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~~~--g--~~-VAVK~l~~~~----~~~~~~i~e--------------l~g~~~~~~~~~lv 220 (453)
.+.++||+|+||.||+|++.. + .. ||||..+.+. ....+|++| ++|++....+.++|
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 345899999999999999653 3 23 8999988632 234566666 79999999999999
Q ss_pred EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517 221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 300 (453)
||+|+||+|+++|... +..++..+++.++.+.|+||+|||++ +++||||..+|+|++.++.+||+||||++...
T Consensus 240 mEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 9999999999999432 23699999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCceeec-ccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHh-hhCC
Q 048517 301 KENDFVSIS-DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQL-NKGG 377 (453)
Q Consensus 301 ~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l-~~~~ 377 (453)
. +.... ...-+..|+|||.+.. +.++.++|||||||++||+.+ |..|+...... .+...+ ..+.
T Consensus 314 ~---~~~~~~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------~v~~kI~~~~~ 380 (474)
T KOG0194|consen 314 Q---YVMKKFLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------EVKAKIVKNGY 380 (474)
T ss_pred c---eeeccccccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCCCHH--------HHHHHHHhcCc
Confidence 1 11112 2346789999999986 489999999999999999998 77787654322 233344 3343
Q ss_pred CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCC
Q 048517 378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ 428 (453)
Q Consensus 378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~ 428 (453)
+..... ..+..+..++.+||+.+|++||||.++.+.|+.......
T Consensus 381 r~~~~~------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 381 RMPIPS------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred cCCCCC------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 333322 234567788889999999999999999999987666544
No 45
>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk. Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr
Probab=100.00 E-value=7.4e-36 Score=285.83 Aligned_cols=242 Identities=26% Similarity=0.419 Sum_probs=190.1
Q ss_pred HHHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHHH--------------hcccccCcceEEEEEe
Q 048517 158 IIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINEL--------------LGLCSEGFKRALVYEY 223 (453)
Q Consensus 158 ~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~el--------------~g~~~~~~~~~lv~E~ 223 (453)
+...++++.++||+|+||.||+|..++++.||+|.+.......+++..|+ ++++ .....++++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~ 81 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY 81 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence 45567888999999999999999988899999999987666666766662 2333 24457899999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++|+|.+++... .+..+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 82 MENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 9999999988532 345789999999999999999999997 99999999999999999999999999998765322
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 382 (453)
. .......++..|+|||++... .++.++||||||++++||++ |+.||...... -..+.+.++.....
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~- 224 (260)
T cd05067 157 Y-TAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--------EVIQNLERGYRMPR- 224 (260)
T ss_pred c-ccccCCcccccccCHHHhccC--CcCcccchHHHHHHHHHHHhCCCCCCCCCChH--------HHHHHHHcCCCCCC-
Confidence 2 112334567889999998753 68899999999999999998 99998643321 12223333322221
Q ss_pred chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
....+..+.+++.+||+.+|++|||++++++.|+.
T Consensus 225 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 -----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11234568999999999999999999999999974
No 46
>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk. Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom
Probab=100.00 E-value=4.8e-36 Score=286.97 Aligned_cols=239 Identities=31% Similarity=0.471 Sum_probs=188.1
Q ss_pred HhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYEYMP 225 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~ 225 (453)
..|.+.++||.|+||.||+|...+++.+|+|.+..... ...++..| +++++......++||||++
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME 85 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence 44677899999999999999988899999999876543 23333333 5566777788899999999
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 305 (453)
+|+|.+++... .+..+++.++..++.+++.||+|||+. +|+|+||||+||++++++.+||+|||++........
T Consensus 86 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~- 159 (261)
T cd05148 86 KGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY- 159 (261)
T ss_pred cCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence 99999998543 345689999999999999999999998 999999999999999999999999999986643321
Q ss_pred eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517 306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384 (453)
Q Consensus 306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 384 (453)
......++..|+|||.+... .++.++||||||+++++|++ |+.|+...... .....+..+....
T Consensus 160 -~~~~~~~~~~~~~PE~~~~~--~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~---- 224 (261)
T cd05148 160 -LSSDKKIPYKWTAPEAASHG--TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--------EVYDQITAGYRMP---- 224 (261)
T ss_pred -cccCCCCceEecCHHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--------HHHHHHHhCCcCC----
Confidence 12344567889999998753 78899999999999999998 88888643311 1222232222211
Q ss_pred hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
.+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 225 --~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 225 --CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 112334568899999999999999999999999985
No 47
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=100.00 E-value=1.1e-35 Score=334.98 Aligned_cols=243 Identities=23% Similarity=0.416 Sum_probs=185.1
Q ss_pred hhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHHH-----------HHHHhcccccCcceEEEEEecCCCChhhh
Q 048517 165 FTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEF-----------INELLGLCSEGFKRALVYEYMPNGSLDRH 232 (453)
Q Consensus 165 ~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~-----------i~el~g~~~~~~~~~lv~E~~~~gsL~~~ 232 (453)
..+.||+|+||.||+|+. .+|+.||||.+.......+++ +.+++++|......++||||+++|+|.++
T Consensus 694 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~ 773 (968)
T PLN00113 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEV 773 (968)
T ss_pred cccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHH
Confidence 345799999999999996 589999999987643332222 22378888888889999999999999999
Q ss_pred hhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecccC
Q 048517 233 IFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR 312 (453)
Q Consensus 233 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 312 (453)
+. .++|.++..|+.|+++||+|||+.+.++|+||||||+||+++.++.+++. ||........ ....
T Consensus 774 l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~ 839 (968)
T PLN00113 774 LR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCF 839 (968)
T ss_pred Hh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCcc
Confidence 83 38999999999999999999998777899999999999999999988886 6665433221 2336
Q ss_pred CCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC-----Cccccchhhh
Q 048517 313 GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG-----DLELRNVTEI 387 (453)
Q Consensus 313 gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~-----~~~~~~~~~~ 387 (453)
+|++|+|||++.+. .++.|+|||||||++|||+||+.|++..... ......|......... +..+......
T Consensus 840 ~t~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 840 ISSAYVAPETRETK--DITEKSDIYGFGLILIELLTGKSPADAEFGV--HGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred ccccccCcccccCC--CCCcccchhhHHHHHHHHHhCCCCCCcccCC--CCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 88999999998753 7899999999999999999999998643321 2234444433222111 0111111112
Q ss_pred HHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517 388 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID 425 (453)
Q Consensus 388 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~ 425 (453)
......++.+++.+||+.+|++||||+||+++|++...
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 23344568899999999999999999999999997544
No 48
>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src. Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo
Probab=100.00 E-value=5.1e-36 Score=287.71 Aligned_cols=241 Identities=27% Similarity=0.409 Sum_probs=187.1
Q ss_pred HHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMP 225 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~ 225 (453)
...+.+.++||+|+||.||+|+.+++..||+|++.......+++..| +++++ .....++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~-~~~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEE-CCCCcEEEEEcCC
Confidence 34678889999999999999998777789999998765555666555 23333 2345789999999
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 305 (453)
+|+|.+++... ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 84 KGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 99999998532 234679999999999999999999998 9999999999999999999999999999866543321
Q ss_pred eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517 306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384 (453)
Q Consensus 306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 384 (453)
......++..|+|||+..+. .++.++||||||+++|||++ |+.||..... ....+.+..+....
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--------~~~~~~~~~~~~~~---- 223 (262)
T cd05071 159 -ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYRMP---- 223 (262)
T ss_pred -cccCCcccceecCHhHhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--------HHHHHHHhcCCCCC----
Confidence 12234567789999988653 78999999999999999999 7778754321 11223332222111
Q ss_pred hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 423 (453)
Q Consensus 385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~ 423 (453)
.....+..+.+++.+|++.+|++||++.+++++|+..
T Consensus 224 --~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 224 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 1223456788999999999999999999999999864
No 49
>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome. Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds
Probab=100.00 E-value=6.1e-36 Score=286.17 Aligned_cols=237 Identities=28% Similarity=0.464 Sum_probs=186.0
Q ss_pred hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNG 227 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g 227 (453)
.+.+.+.||+|+||.||+|+..++..+|||.+.......+++.+| +++++......+++|||+++|
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG 84 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence 356778999999999999998777789999988765555666555 467777777889999999999
Q ss_pred ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517 228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 307 (453)
Q Consensus 228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 307 (453)
+|.+++... ...+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++....... ..
T Consensus 85 ~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05113 85 CLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TS 157 (256)
T ss_pred cHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce-ee
Confidence 999988532 23689999999999999999999998 999999999999999999999999999986544322 11
Q ss_pred ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
.....++..|+|||.+... .++.++||||||+++|||++ |+.|+...... -..+.+.++......
T Consensus 158 ~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~---- 223 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYS--KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--------ETVEKVSQGLRLYRP---- 223 (256)
T ss_pred cCCCccChhhCCHHHHhcC--cccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHhcCCCCCCC----
Confidence 2233466789999999753 68889999999999999998 88888543221 122333333222111
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le 421 (453)
...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 224 --~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 --HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 113467899999999999999999999998874
No 50
>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be
Probab=100.00 E-value=1.5e-36 Score=300.67 Aligned_cols=226 Identities=23% Similarity=0.329 Sum_probs=174.7
Q ss_pred cccCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517 167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEYMPNG 227 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g 227 (453)
+.||+|+||.||+++. .+|+.||||++..... ...+++.| +.+.+..+...++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999985 4799999999875321 11223333 345566777889999999999
Q ss_pred ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517 228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 307 (453)
Q Consensus 228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 307 (453)
+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~ 151 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--T 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--c
Confidence 99888843 35689999999999999999999998 999999999999999999999999999975432221 1
Q ss_pred ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhh
Q 048517 308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEI 387 (453)
Q Consensus 308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 387 (453)
.....||+.|+|||.+.+. .++.++||||+||++|||++|+.||...... .....+.... .. .
T Consensus 152 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--------~~~~~~~~~~-~~------~ 214 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILMEE-IR------F 214 (323)
T ss_pred ccceecCccccChhhhcCC--CCCccccCcccchhhhhhhcCCCCCCCCCHH--------HHHHHHHcCC-CC------C
Confidence 2345699999999999764 7889999999999999999999999643211 1122222111 11 1
Q ss_pred HHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517 388 ESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE 418 (453)
Q Consensus 388 ~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 418 (453)
+..++..+.+++.+||+.||++|| ++.++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 223456788999999999999999 7888875
No 51
>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows
Probab=100.00 E-value=3.8e-36 Score=287.32 Aligned_cols=236 Identities=28% Similarity=0.457 Sum_probs=184.2
Q ss_pred hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNG 227 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g 227 (453)
.+.+.+.||+|+||.||+|..++++.+|+|++.......+++..| +++++......++|+||++++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 356778999999999999998878899999987655555555554 455666777889999999999
Q ss_pred ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517 228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 307 (453)
Q Consensus 228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 307 (453)
+|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++........ .
T Consensus 85 ~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~ 157 (256)
T cd05059 85 CLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-S 157 (256)
T ss_pred CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc-c
Confidence 999988532 23689999999999999999999998 9999999999999999999999999999865432211 1
Q ss_pred ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
.....++..|+|||.+.+. .++.++||||||+++|||++ |+.|+...... ...+.+..+.....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~----- 222 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYS--RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--------EVVESVSAGYRLYR----- 222 (256)
T ss_pred cCCCCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--------HHHHHHHcCCcCCC-----
Confidence 1223345689999998764 78899999999999999999 78888643221 12223332222111
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 420 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 420 (453)
+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 223 -~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 -PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 112456789999999999999999999999987
No 52
>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=4e-36 Score=291.31 Aligned_cols=243 Identities=23% Similarity=0.373 Sum_probs=184.8
Q ss_pred HhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceE
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRA 218 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~ 218 (453)
..+.+.++||+|+||.||+|+.. +++.||||.+...... .+.+..| +++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45677889999999999999853 2578999999764322 2333333 456666777889
Q ss_pred EEEEecCCCChhhhhhhcc------------CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC
Q 048517 219 LVYEYMPNGSLDRHIFSKE------------NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF 286 (453)
Q Consensus 219 lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~ 286 (453)
+++||+++++|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999985321 1124588889999999999999999998 999999999999999999
Q ss_pred ceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccc
Q 048517 287 IPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYF 365 (453)
Q Consensus 287 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~ 365 (453)
.+||+|||+++...............+++.|+|||.+.. +.++.++||||||+++|||++ |..|+.....
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------- 232 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------- 232 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence 999999999886644333222344556789999999865 378899999999999999998 7777753221
Q ss_pred hHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 366 PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 366 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
.-..+.+.++..... +...+..+..++.+||+.+|++||++++|++.|+.
T Consensus 233 -~~~~~~i~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 -QDVIEMIRNRQVLPC------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HHHHHHHHcCCcCCC------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 113333433332221 12244568899999999999999999999999974
No 53
>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt
Probab=100.00 E-value=4.5e-36 Score=292.87 Aligned_cols=228 Identities=24% Similarity=0.254 Sum_probs=178.6
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHH--------------HHHHhcccccCcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEF--------------INELLGLCSEGFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~--------------i~el~g~~~~~~~~~lv~E~ 223 (453)
|.+.+.||+|+||.||+|+.. +|+.||||++..... ..+.+ +.++++.+.+....++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 556789999999999999955 789999999864321 11222 22356677778889999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 83 VPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 999999998843 24689999999999999999999998 99999999999999999999999999998654321
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
....||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... ....+.+..+.. .
T Consensus 156 -----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~~-~--- 216 (291)
T cd05612 156 -----WTLCGTPEYLAPEVIQSK--GHNKAVDWWALGILIYEMLVGYPPFFDDNP--------FGIYEKILAGKL-E--- 216 (291)
T ss_pred -----ccccCChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCc-C---
Confidence 234689999999998764 678999999999999999999999865332 112333333221 1
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLEM 419 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~~ 419 (453)
.+......+.+++.+||+.||.+||+ ++++++.
T Consensus 217 ---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 ---FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11223456889999999999999995 8887764
No 54
>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3e-36 Score=301.52 Aligned_cols=233 Identities=28% Similarity=0.425 Sum_probs=183.2
Q ss_pred HHhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCC----CC-CHHHHHH-H---------------HhcccccCcce
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENS----KF-SAEEFIN-E---------------LLGLCSEGFKR 217 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~----~~-~~~~~i~-e---------------l~g~~~~~~~~ 217 (453)
...|.+.+.||+|+||+|+.|+ ..+|+.||||++... .. ...+.+. | ++.+.......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 3466778899999999999998 457899999987663 11 1122221 2 33444556668
Q ss_pred EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC-CceEEEecCCc
Q 048517 218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLA 296 (453)
Q Consensus 218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFGla 296 (453)
++||||+.+|+|.+++.. ...+.+..+..++.|++.|++|+|+. +|+||||||+|||+|.+ +++||+|||++
T Consensus 96 ~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 999999999999999953 36788899999999999999999998 99999999999999999 99999999999
Q ss_pred cccC-CCCCceeecccCCCCCccChhhhcccCCCC-CccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh
Q 048517 297 KFHP-KENDFVSISDTRGTIGYLAPELISRNFGTV-SCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN 374 (453)
Q Consensus 297 ~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~ 374 (453)
.... .+. ......||+.|+|||++.+. +.| ..++||||+||+||.|++|+.||+.... +. .+..+.
T Consensus 169 ~~~~~~~~---~l~t~cGsp~Y~aPEvl~~~-~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-------~~-l~~ki~ 236 (370)
T KOG0583|consen 169 AISPGEDG---LLKTFCGSPAYAAPEVLSGK-GTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-------PN-LYRKIR 236 (370)
T ss_pred cccCCCCC---cccCCCCCcccCCHHHhCCC-CCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-------HH-HHHHHh
Confidence 9874 222 34678899999999999975 225 5899999999999999999999986321 11 223333
Q ss_pred hCCCccccchhhhHHHH-HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 375 KGGDLELRNVTEIESMI-ARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 375 ~~~~~~~~~~~~~~~~~-~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.+... .+..+ +..+..++.+|++.+|..|+|+.++++
T Consensus 237 ~~~~~-------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 237 KGEFK-------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred cCCcc-------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 33221 22222 677899999999999999999999994
No 55
>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk. Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r
Probab=100.00 E-value=6.8e-36 Score=286.09 Aligned_cols=240 Identities=28% Similarity=0.428 Sum_probs=186.5
Q ss_pred HHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMP 225 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~ 225 (453)
...+.+.++||+|+||.||+|..+++..||+|.+.......+++..| +++++. ....+++|||++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 34567889999999999999998888899999998766666666665 233333 345789999999
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 305 (453)
+++|.+++... ....+++.++..++.+++.||+|||+. +|+|+||||+||++++++.+||+|||++.........
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 84 KGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 99999988542 234689999999999999999999998 9999999999999999999999999999876443221
Q ss_pred eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517 306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384 (453)
Q Consensus 306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 384 (453)
......++..|+|||.+... .++.++||||||++++||++ |+.||...... ...+.+..+....
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~---- 223 (260)
T cd05070 159 -ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--------EVLEQVERGYRMP---- 223 (260)
T ss_pred -cccCCCCCccccChHHHhcC--CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCC----
Confidence 11233456789999988653 78899999999999999999 88888543211 1223333222211
Q ss_pred hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
.+...+..+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 224 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 --CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 122334568999999999999999999999999975
No 56
>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-36 Score=274.63 Aligned_cols=252 Identities=27% Similarity=0.331 Sum_probs=192.5
Q ss_pred HHhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCC-CCHHHHHHH--------------Hhccc-----ccCcceE
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSK-FSAEEFINE--------------LLGLC-----SEGFKRA 218 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~-~~~~~~i~e--------------l~g~~-----~~~~~~~ 218 (453)
..+|.+.++||+|||+.||.++ +.+++.+|+|++.... ...+..++| ++..+ ...+..+
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 3467888999999999999999 7789999999987754 333433333 33333 2344589
Q ss_pred EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298 (453)
Q Consensus 219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 298 (453)
|++.|...|||.+++.....++..+++.+.+.|+.++.+||++||+. .+++.||||||.|||+.+.+.+++.|||.++.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 99999999999999977777778899999999999999999999997 34699999999999999999999999999986
Q ss_pred cCCCCC-------ceeecccCCCCCccChhhhcccC-CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHH
Q 048517 299 HPKEND-------FVSISDTRGTIGYLAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY 370 (453)
Q Consensus 299 ~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~-~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 370 (453)
.+-.-. .+.......|..|.|||.+.-.. -.++.++|||||||+||+|+.|..||+..-+......+.
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA---- 254 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA---- 254 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe----
Confidence 542211 01112345799999999986532 367999999999999999999999997543321111110
Q ss_pred HHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517 371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 423 (453)
Q Consensus 371 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~ 423 (453)
+..++. .. .....+++.+.+++.+|+|.||.+||++.+++..++..
T Consensus 255 --v~n~q~-s~----P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 255 --VQNAQI-SI----PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred --eecccc-cc----CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 000011 00 11223778999999999999999999999999998864
No 57
>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl
Probab=100.00 E-value=3.6e-36 Score=296.55 Aligned_cols=226 Identities=25% Similarity=0.315 Sum_probs=172.6
Q ss_pred cCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH--------------HhcccccCcceEEEEEecCCCCh
Q 048517 169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSL 229 (453)
Q Consensus 169 LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL 229 (453)
||+|+||.||+++.. +++.||+|++.... .....+..| +++.+......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999954 68899999987521 122233333 44566777888999999999999
Q ss_pred hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeec
Q 048517 230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 309 (453)
Q Consensus 230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 309 (453)
.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~ 151 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTN 151 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccc
Confidence 998843 34689999999999999999999998 999999999999999999999999999986433222 123
Q ss_pred ccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHH
Q 048517 310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 389 (453)
Q Consensus 310 ~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 389 (453)
...||+.|+|||.+.+. .++.++||||+||++|||++|+.||..... .. ....+.... .. .+.
T Consensus 152 ~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~~~~-------~~-~~~~~~~~~-~~------~~~ 214 (312)
T cd05585 152 TFCGTPEYLAPELLLGH--GYTKAVDWWTLGVLLYEMLTGLPPFYDENV-------NE-MYRKILQEP-LR------FPD 214 (312)
T ss_pred cccCCcccCCHHHHcCC--CCCCccceechhHHHHHHHhCCCCcCCCCH-------HH-HHHHHHcCC-CC------CCC
Confidence 45699999999999764 789999999999999999999999964321 11 222222211 11 122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517 390 MIARKLCMIGLWCIQVKAADRPSMTKVLEML 420 (453)
Q Consensus 390 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 420 (453)
.++..+.+++.+||+.||++||++..+.+.|
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 3446788999999999999998654443333
No 58
>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly
Probab=100.00 E-value=8.4e-36 Score=290.20 Aligned_cols=245 Identities=24% Similarity=0.401 Sum_probs=186.0
Q ss_pred hhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALV 220 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv 220 (453)
.+.+.+.||+|+||.||++... ++..+|+|.+..... ..+.+..| +++++......+++
T Consensus 6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (288)
T cd05093 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 85 (288)
T ss_pred HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 4456789999999999999742 356799998876432 23334444 45667777889999
Q ss_pred EEecCCCChhhhhhhcc---------CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEE
Q 048517 221 YEYMPNGSLDRHIFSKE---------NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS 291 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~ 291 (453)
|||+++++|.+++.... .....+++.+++.++.|++.||+|||+. +++||||||+|||++.++.+||+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEec
Confidence 99999999999885432 1224589999999999999999999998 99999999999999999999999
Q ss_pred ecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHH
Q 048517 292 DFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVY 370 (453)
Q Consensus 292 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 370 (453)
|||+++...............++..|+|||.+... .++.++||||||++++||++ |+.|+...... -..
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--------~~~ 232 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--------EVI 232 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHH
Confidence 99999866443322222334567889999998753 78899999999999999998 88887543321 122
Q ss_pred HHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517 371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID 425 (453)
Q Consensus 371 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~ 425 (453)
+.+..+...... ...+..+.+++.+||+.+|.+|||+.++++.|++...
T Consensus 233 ~~i~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 233 ECITQGRVLQRP------RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHHHcCCcCCCC------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 333333222111 1233568999999999999999999999999987543
No 59
>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]
Probab=100.00 E-value=2.2e-36 Score=300.49 Aligned_cols=252 Identities=24% Similarity=0.350 Sum_probs=196.4
Q ss_pred HHHHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEE
Q 048517 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALV 220 (453)
Q Consensus 157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv 220 (453)
|+....-.|.++||+|-||.|.++....+..||||+++.... ...+|..| |+|.|..++..++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 333344457789999999999999999889999999987433 23566555 89999999999999
Q ss_pred EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517 221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 300 (453)
+|||++|+|..++...+.. .+.-.....|+.|||.|++||.+- ++|||||.++|+|+|.++++||+|||+++..-
T Consensus 614 ~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence 9999999999999654332 245566788999999999999998 99999999999999999999999999999776
Q ss_pred CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc--CCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517 301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG--GRRNSNMNATRSSKAYFPSWVYDQLNKGGD 378 (453)
Q Consensus 301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~ 378 (453)
....+........+++|||||.+.. +.+|.++|||+||+++||+++ ..+|+.....++. .+..-..+..+..
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v----ven~~~~~~~~~~ 762 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV----VENAGEFFRDQGR 762 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH----HHhhhhhcCCCCc
Confidence 6666665566678899999999875 589999999999999999876 5667754432210 0111111211111
Q ss_pred ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
.. ....+......+.+++++||..+.++|||++++...|..
T Consensus 763 ~~---~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 763 QV---VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred ce---eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 11 111334455678899999999999999999999998875
No 60
>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n
Probab=100.00 E-value=5.1e-36 Score=292.15 Aligned_cols=245 Identities=25% Similarity=0.429 Sum_probs=187.0
Q ss_pred hhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC-HHHHHHH--------------HhcccccCcceEEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEGFKRALV 220 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~~~~~lv 220 (453)
.+.+.+.||+|+||.||+|+.. ++..+|+|.+...... .+.+.+| +++++......++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 3456689999999999999742 3567999998764332 2233333 45677777888999
Q ss_pred EEecCCCChhhhhhhccC------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCce
Q 048517 221 YEYMPNGSLDRHIFSKEN------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIP 288 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~ 288 (453)
|||+++++|.+++..... ....++|..++.++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 999999999999864321 224589999999999999999999998 99999999999999999999
Q ss_pred EEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchH
Q 048517 289 KVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPS 367 (453)
Q Consensus 289 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 367 (453)
||+|||+++...............++..|+|||.+... .++.++||||||+++|||++ |+.|+......
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------- 232 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-------- 232 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------
Confidence 99999999865443322222344568899999998764 78899999999999999998 99988643321
Q ss_pred HHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517 368 WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID 425 (453)
Q Consensus 368 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~ 425 (453)
...+.+..+..... ....+..+.+++.+||+.+|++|||+.+|+++|+....
T Consensus 233 ~~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 233 EVIECITQGRVLER------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHHHhCCCCCCC------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 12223333322211 11234568899999999999999999999999997654
No 61
>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and
Probab=100.00 E-value=3.7e-36 Score=297.91 Aligned_cols=225 Identities=24% Similarity=0.297 Sum_probs=173.0
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHHH---------------HhcccccCcceEEEEE
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFINE---------------LLGLCSEGFKRALVYE 222 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~e---------------l~g~~~~~~~~~lv~E 222 (453)
+++.+.||+|+||.||+|+.. +++.||||++..... ..+.+..| +.+++......++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 456788999999999999855 688999999875321 11122222 3455566777899999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 302 (453)
|+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 82 YVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999988743 24689999999999999999999998 9999999999999999999999999999754322
Q ss_pred CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517 303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382 (453)
Q Consensus 303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 382 (453)
.. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... -....+......
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--------~~~~~i~~~~~~--- 219 (323)
T cd05616 155 GV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIMEHNVA--- 219 (323)
T ss_pred CC--ccccCCCChhhcCHHHhcCC--CCCCccchhchhHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCC---
Confidence 21 12345699999999999764 7899999999999999999999999654321 122222222111
Q ss_pred chhhhHHHHHHHHHHHHHHhcccCCCCCCCH
Q 048517 383 NVTEIESMIARKLCMIGLWCIQVKAADRPSM 413 (453)
Q Consensus 383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~ 413 (453)
.+...+..+.+++.+|++.+|++|++.
T Consensus 220 ----~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 ----YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ----CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 112345678899999999999999984
No 62
>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl. Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor
Probab=100.00 E-value=7.9e-36 Score=287.19 Aligned_cols=240 Identities=27% Similarity=0.418 Sum_probs=179.1
Q ss_pred hhcccCccCceEEEEEEEcC-Cc--EEEEEEecCCCCC---HHHHHHH--------------Hhccccc------CcceE
Q 048517 165 FTHKLGQGGFGSVYKGQLHT-GR--LIAVKMMENSKFS---AEEFINE--------------LLGLCSE------GFKRA 218 (453)
Q Consensus 165 ~~~~LG~G~fG~Vy~g~~~~-g~--~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~------~~~~~ 218 (453)
+.++||+|+||.||+|+..+ ++ .||||.++..... .+.+..| ++++|.. ....+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 56789999999999999654 33 6999988764322 2334433 3343321 12468
Q ss_pred EEEEecCCCChhhhhhhcc--CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517 219 LVYEYMPNGSLDRHIFSKE--NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA 296 (453)
Q Consensus 219 lv~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 296 (453)
+++||+++|+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 9999999999998874322 2234589999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhh
Q 048517 297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNK 375 (453)
Q Consensus 297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~ 375 (453)
+...............+++.|+|||.+... .++.++||||||+++|||++ |+.||..... ....+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~~ 229 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADR--VYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--------SEIYDYLRQ 229 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCC--CcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHc
Confidence 876543322222233467789999998764 78999999999999999999 7888754321 123444444
Q ss_pred CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517 376 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 423 (453)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~ 423 (453)
+...... ......+.+++.+||+.+|++|||+.++++.|+..
T Consensus 230 ~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 GNRLKQP------PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCCC------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 4332211 12345688999999999999999999999999864
No 63
>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological
Probab=100.00 E-value=8.2e-36 Score=287.84 Aligned_cols=244 Identities=27% Similarity=0.397 Sum_probs=186.1
Q ss_pred HHhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcce
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKR 217 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~ 217 (453)
...+.+.+.||+|+||.||+|... +++.||+|.+...... ..++..| +++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 445667789999999999999854 2468999998754321 2233333 45666777889
Q ss_pred EEEEEecCCCChhhhhhhccC------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEE
Q 048517 218 ALVYEYMPNGSLDRHIFSKEN------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS 291 (453)
Q Consensus 218 ~lv~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~ 291 (453)
++||||+++|+|.+++..... ....++|..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 999999999999999865332 123578999999999999999999998 99999999999999999999999
Q ss_pred ecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHH
Q 048517 292 DFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVY 370 (453)
Q Consensus 292 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 370 (453)
|||+++...............+|..|+|||.+... .++.++||||||+++|||++ |+.|+...... -..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--------~~~ 231 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--------EVL 231 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcC--CCCcccchHHHHHHHHHhhccCCCCCccCCHH--------HHH
Confidence 99999866544332223344578899999998753 78999999999999999998 88888543221 122
Q ss_pred HHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 371 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
+.+..+...... ...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 232 ~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 232 KFVIDGGHLDLP------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHHhcCCCCCCC------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 333333222211 1225678999999999999999999999999873
No 64
>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal
Probab=100.00 E-value=6.9e-36 Score=295.67 Aligned_cols=221 Identities=24% Similarity=0.322 Sum_probs=171.1
Q ss_pred cccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHH---------------HHhcccccCcceEEEEEecCC
Q 048517 167 HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFIN---------------ELLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~---------------el~g~~~~~~~~~lv~E~~~~ 226 (453)
+.||+|+||.||+++.. +++.||||++.... ...+.++. .+++++......++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999954 68999999987521 11222222 245566677788999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-- 151 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-- 151 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--
Confidence 999988743 24689999999999999999999998 999999999999999999999999999875432221
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... .+.+.+......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------~~~~~i~~~~~~------- 214 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEM--LYGPSVDWWAMGVLLYEMLCGHAPFEAENED--------DLFEAILNDEVV------- 214 (320)
T ss_pred cccccccCccccCHHHHcCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHhcCCCC-------
Confidence 12345699999999999764 7889999999999999999999999754321 122333222211
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCCCH
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRPSM 413 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~ 413 (453)
.+..++..+.+++.+||+.||++||++
T Consensus 215 ~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 215 YPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 112234568899999999999999998
No 65
>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.9e-37 Score=299.00 Aligned_cols=231 Identities=25% Similarity=0.350 Sum_probs=183.2
Q ss_pred hhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCH--HH--------------HHHHHhcccccCcceEEEEEecC
Q 048517 163 NHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA--EE--------------FINELLGLCSEGFKRALVYEYMP 225 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~--~~--------------~i~el~g~~~~~~~~~lv~E~~~ 225 (453)
|.-.+.||+|.||.||+|. ..+++.||+|++....... ++ .+.+.+|.+..+..++++||||.
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~ 94 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG 94 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence 3444789999999999999 4579999999998643322 11 23346777788888999999999
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 305 (453)
+|++.+.+ ..+..+.+..+.-|..++..||.|||++ +.+|||||+.|||+..++.+||+|||.+-........
T Consensus 95 gGsv~~lL----~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 95 GGSVLDLL----KSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred Ccchhhhh----ccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 99999988 3344558888888999999999999998 9999999999999999999999999999877655443
Q ss_pred eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517 306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385 (453)
Q Consensus 306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 385 (453)
. .+..||+.|||||++.+. .|+.|+||||+|++.+||.+|.+|+.....-.. .-.+.+.. ..
T Consensus 168 r--~tfvGTPfwMAPEVI~~~--~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv--------lflIpk~~------PP 229 (467)
T KOG0201|consen 168 R--KTFVGTPFWMAPEVIKQS--GYDTKADIWSLGITAIELAKGEPPHSKLHPMRV--------LFLIPKSA------PP 229 (467)
T ss_pred c--ccccccccccchhhhccc--cccchhhhhhhhHHHHHHhcCCCCCcccCcceE--------EEeccCCC------CC
Confidence 2 567899999999999864 899999999999999999999999864332100 00111111 11
Q ss_pred hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
......++.+.+++..||+.+|++|||+.++++
T Consensus 230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 122356678999999999999999999998876
No 66
>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu
Probab=100.00 E-value=1.5e-35 Score=284.99 Aligned_cols=241 Identities=29% Similarity=0.452 Sum_probs=181.5
Q ss_pred hhhcccCccCceEEEEEEEc-C---CcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCc------c
Q 048517 164 HFTHKLGQGGFGSVYKGQLH-T---GRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGF------K 216 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~~-~---g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~------~ 216 (453)
++.+.||+|+||.||+|+.. + +..||||+++..... .+++..| +++++.... .
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 45688999999999999864 2 378999998764332 2334444 344443333 3
Q ss_pred eEEEEEecCCCChhhhhhhcc--CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecC
Q 048517 217 RALVYEYMPNGSLDRHIFSKE--NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG 294 (453)
Q Consensus 217 ~~lv~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 294 (453)
.++++||+++|+|..++.... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcc
Confidence 689999999999999886543 2234689999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHh
Q 048517 295 LAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQL 373 (453)
Q Consensus 295 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l 373 (453)
+++...............++..|+|||.+... .++.++||||||+++|||++ |..|+...... -..+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--------~~~~~~ 228 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--------EIYDYL 228 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHH
Confidence 99876544332222233457789999998653 78899999999999999999 88887543211 123333
Q ss_pred hhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517 374 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 423 (453)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~ 423 (453)
..+..... +......+.+++.+||+.||++|||+.|+++.|+..
T Consensus 229 ~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 RHGNRLKQ------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HcCCCCCC------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 33322221 123446789999999999999999999999999864
No 67
>PTZ00267 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=5.2e-36 Score=312.30 Aligned_cols=237 Identities=21% Similarity=0.212 Sum_probs=182.2
Q ss_pred hhhhcccCccCceEEEEEEE-cC-CcEEEEEEecCCCCCHH-HHHHH--------------HhcccccCcceEEEEEecC
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HT-GRLIAVKMMENSKFSAE-EFINE--------------LLGLCSEGFKRALVYEYMP 225 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~-g~~VAVK~l~~~~~~~~-~~i~e--------------l~g~~~~~~~~~lv~E~~~ 225 (453)
|.+.+.||+|+||.||++.. .+ ++.||+|.+........ .+..| +++.+..+...++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 66778999999999999984 34 67899997654332222 22223 4666777888999999999
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 305 (453)
+|+|.+++.........+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999998865433445788999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517 306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385 (453)
Q Consensus 306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 385 (453)
.......||++|+|||++.+. .++.++|||||||++|||++|+.||...... .+...+..+....
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--------~~~~~~~~~~~~~----- 290 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERK--RYSKKADMWSLGVILYELLTLHRPFKGPSQR--------EIMQQVLYGKYDP----- 290 (478)
T ss_pred ccccccCCCccccCHhHhCCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCC-----
Confidence 222445699999999998764 7899999999999999999999998643221 1222222222211
Q ss_pred hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.+..++..+.+++.+||+.+|++|||+.++++
T Consensus 291 -~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 -FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11223456889999999999999999999864
No 68
>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C. Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory
Probab=100.00 E-value=6.5e-36 Score=296.24 Aligned_cols=225 Identities=24% Similarity=0.302 Sum_probs=172.1
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH---------------HhcccccCcceEEEEE
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE---------------LLGLCSEGFKRALVYE 222 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e---------------l~g~~~~~~~~~lv~E 222 (453)
+.+.+.||+|+||.||+|+.. +++.||||++.... ...+.++.| +.+++......++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 456789999999999999955 67899999987532 122223332 3344556677899999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 302 (453)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 82 YVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999988843 24688999999999999999999998 9999999999999999999999999998753222
Q ss_pred CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517 303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382 (453)
Q Consensus 303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 382 (453)
.. ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... -....+..... .
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~~~~~-~-- 219 (324)
T cd05587 155 GK--TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--------ELFQSIMEHNV-S-- 219 (324)
T ss_pred CC--ceeeecCCccccChhhhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCC-C--
Confidence 11 12345699999999999764 6889999999999999999999999644321 12222222211 1
Q ss_pred chhhhHHHHHHHHHHHHHHhcccCCCCCCCH
Q 048517 383 NVTEIESMIARKLCMIGLWCIQVKAADRPSM 413 (453)
Q Consensus 383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~ 413 (453)
.+..++..+.+++.+||+.+|.+||+.
T Consensus 220 ----~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 ----YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 112244568899999999999999976
No 69
>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,
Probab=100.00 E-value=5.8e-36 Score=291.61 Aligned_cols=245 Identities=24% Similarity=0.409 Sum_probs=185.6
Q ss_pred HhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCCH--HHHHHH---------------HhcccccCcce
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFSA--EEFINE---------------LLGLCSEGFKR 217 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~~--~~~i~e---------------l~g~~~~~~~~ 217 (453)
..+.+.+.||+|+||.||++... ....+|+|.+....... .++..| +++++..+...
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL 91 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence 34556789999999999999854 23689999987643221 223333 34556677778
Q ss_pred EEEEEecCCCChhhhhhhcc------------CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC
Q 048517 218 ALVYEYMPNGSLDRHIFSKE------------NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN 285 (453)
Q Consensus 218 ~lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~ 285 (453)
+++|||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+|||++.+
T Consensus 92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTED 168 (293)
T ss_pred EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCC
Confidence 99999999999999985432 2345789999999999999999999998 99999999999999999
Q ss_pred CceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcccccccc
Q 048517 286 FIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAY 364 (453)
Q Consensus 286 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~ 364 (453)
+.+||+|||+++...............++..|+|||.+... .++.++||||||+++|||++ |..|+......
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----- 241 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----- 241 (293)
T ss_pred CeEEeCccccccccccccceeccCCCCCCccccCHHHhccC--CcCcccceeehhhHHHHHhcCCCCCCCCCCHH-----
Confidence 99999999999876544333233344567889999988653 78899999999999999997 88887533211
Q ss_pred chHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517 365 FPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI 424 (453)
Q Consensus 365 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~ 424 (453)
-..+.+..+..... +......+.+++.+||+.+|++|||+.++++.|+..+
T Consensus 242 ---~~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 ---ELFKLLKEGYRMEK------PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ---HHHHHHHcCCcCCC------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 12333333322211 1123456889999999999999999999999998754
No 70
>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g
Probab=100.00 E-value=4.9e-36 Score=290.87 Aligned_cols=232 Identities=24% Similarity=0.329 Sum_probs=175.8
Q ss_pred cCccCceEEEEEEE-cCCcEEEEEEecCCCCC----HHHHHHH--------------HhcccccCcceEEEEEecCCCCh
Q 048517 169 LGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS----AEEFINE--------------LLGLCSEGFKRALVYEYMPNGSL 229 (453)
Q Consensus 169 LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~----~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL 229 (453)
||+|+||+||++.. .+|+.||||.+...... .+.+..| +.+.+..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999985 47899999998753221 1223333 33445666778999999999999
Q ss_pred hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeec
Q 048517 230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 309 (453)
Q Consensus 230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 309 (453)
..++.........+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 988765444456799999999999999999999998 999999999999999999999999999976544322 123
Q ss_pred ccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHH
Q 048517 310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 389 (453)
Q Consensus 310 ~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 389 (453)
...||+.|+|||.+.+. .++.++||||||+++|||++|+.||......... ......+.... ...+.
T Consensus 156 ~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~----~~~~~~~~~~~-------~~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQRILNDS-------VTYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH----HHHHHhhcccC-------CCCcc
Confidence 45789999999999864 7889999999999999999999999654321110 00111111110 11223
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517 390 MIARKLCMIGLWCIQVKAADRP-----SMTKVLE 418 (453)
Q Consensus 390 ~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 418 (453)
.++..+.+++.+||+.||++|| +++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 3556788999999999999999 6777776
No 71
>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to
Probab=100.00 E-value=6e-36 Score=296.14 Aligned_cols=227 Identities=21% Similarity=0.289 Sum_probs=174.5
Q ss_pred cccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517 167 HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE---------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
+.||+|+||.||+|+.. +++.||||++.... ...+.++.| +++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999955 68899999987532 111222222 45566677788999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|+|..++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-- 151 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-- 151 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc--
Confidence 999888743 34689999999999999999999998 999999999999999999999999999875432222
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
......||+.|+|||++.+. .++.++||||||+++|||++|+.||...... ...+.+......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--------~~~~~i~~~~~~------- 214 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQEL--EYGPSVDWWALGVLMYEMMAGQPPFEADNED--------DLFESILHDDVL------- 214 (321)
T ss_pred cccccccCccccCHHHHcCC--CCCCccceechhHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCC-------
Confidence 12345689999999998764 7889999999999999999999999754321 122223222211
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRP-------SMTKVLEM 419 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RP-------s~~evl~~ 419 (453)
.+...+..+.+++..||+.+|++|| ++.++++.
T Consensus 215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1112345688999999999999999 78888653
No 72
>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.
Probab=100.00 E-value=2.2e-36 Score=300.71 Aligned_cols=235 Identities=21% Similarity=0.286 Sum_probs=180.4
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
|.+.++||+|+||.||+|+.. +|+.||||++..... ..+.+..| +++.+......++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 456789999999999999965 689999999875321 12233333 44566677789999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 83 VPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999998842 34688999999999999999999998 999999999999999999999999999986543
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC-Ccccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG-DLELR 382 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~ 382 (453)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....+.... .....
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~~~~~~~ 220 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--------TWENLKYWKETLQRP 220 (333)
T ss_pred ---ccCCcccCccccChhHhcCC--CCCCccceecchHHHhhhhhCCCCCCCCCHHH--------HHHHHHhccccccCC
Confidence 12345699999999999764 78899999999999999999999996533211 112222111 11110
Q ss_pred chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
........++..+.+++.+||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0010112345678899999999999999999999974
No 73
>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase. Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio
Probab=100.00 E-value=2.8e-35 Score=281.48 Aligned_cols=231 Identities=25% Similarity=0.429 Sum_probs=177.2
Q ss_pred ccCccCceEEEEEEE---cCCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517 168 KLGQGGFGSVYKGQL---HTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGFKRALVYEYMPNG 227 (453)
Q Consensus 168 ~LG~G~fG~Vy~g~~---~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g 227 (453)
+||+|+||.||+|.+ .+++.+|+|++...... .+++..| +++++. ....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 699999999999974 36789999998754322 2344444 344443 44568999999999
Q ss_pred ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce-
Q 048517 228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV- 306 (453)
Q Consensus 228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~- 306 (453)
+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99998843 24689999999999999999999998 99999999999999999999999999998765443221
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 385 (453)
......++..|+|||.+.. +.++.++||||||+++|||++ |+.||...... -..+.+.++......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~i~~~~~~~~~--- 220 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--------EVTQMIESGERMECP--- 220 (257)
T ss_pred ecCCCCCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHCCCCCCCC---
Confidence 1122345678999998865 378889999999999999998 99998643221 123334443332221
Q ss_pred hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 221 ---~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 221 ---QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ---CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1234568899999999999999999999999985
No 74
>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=3.9e-36 Score=295.27 Aligned_cols=248 Identities=24% Similarity=0.331 Sum_probs=182.6
Q ss_pred hhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCH--HHH-HHH--------------Hhccccc--CcceEEEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA--EEF-INE--------------LLGLCSE--GFKRALVY 221 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~--~~~-i~e--------------l~g~~~~--~~~~~lv~ 221 (453)
.++-.++||+|.||.||+++ +.+|+.||+|++..+.... -.+ ++| |.+...+ ....|||+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 34445789999999999999 7799999999987654221 111 222 4444443 36789999
Q ss_pred EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517 222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 301 (453)
Q Consensus 222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 301 (453)
|||+. +|...+. +..-.|+..++..+++|++.||+|+|+. +|+|||||.+|||||++|.+||+|||||+++..
T Consensus 198 eYMdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 198 EYMDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred ecccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 99965 5655552 3456799999999999999999999998 999999999999999999999999999998866
Q ss_pred CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccc---------cccchHHHHHH
Q 048517 302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS---------KAYFPSWVYDQ 372 (453)
Q Consensus 302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~---------~~~~~~~~~~~ 372 (453)
.... ..+...-|..|.|||.+.+. ..|+.+.|+||.||+|.||+.|++.+....+-+. ...-..|....
T Consensus 271 ~~~~-~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 271 SGSA-PYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCc-ccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 5533 35677889999999999986 5899999999999999999999988866543210 00001121111
Q ss_pred hhhCCCccc-----cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 373 LNKGGDLEL-----RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 373 l~~~~~~~~-----~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
+..-..... +...+.-...+....+|+..+|..||.+|.|+.++++
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 110000000 0111222334567788999999999999999999876
No 75
>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]
Probab=100.00 E-value=3.3e-36 Score=278.37 Aligned_cols=219 Identities=27% Similarity=0.367 Sum_probs=178.6
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH----------HH--------HHHHHhcccccCcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA----------EE--------FINELLGLCSEGFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~----------~~--------~i~el~g~~~~~~~~~lv~E~ 223 (453)
+++.+.||.|+||.|.+.+.+ +|..+|+|++++.+.-. +. |+..|.+.+.+....++||||
T Consensus 46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmey 125 (355)
T KOG0616|consen 46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEY 125 (355)
T ss_pred hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEec
Confidence 345578999999999999954 78999999998643211 11 122267778899999999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
.++|.|..++. +..+++.+.+.-+|.+|+.||+|||+. +|++||+||+|||||.+|.+||.|||.|+.....
T Consensus 126 v~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 126 VPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred cCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 99999999983 346899999999999999999999998 9999999999999999999999999999976553
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
+.+.+|||.|+|||.++.. ++..++|.|||||++|||+.|.+||...+. .-+++.+.+++..
T Consensus 198 ----T~TlCGTPeYLAPEii~sk--~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY~KI~~~~v~---- 259 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSK--GYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIYEKILEGKVK---- 259 (355)
T ss_pred ----EEEecCCccccChHHhhcC--CCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHHHHHHhCccc----
Confidence 3567899999999999875 889999999999999999999999976543 2366666665443
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCC
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADR 410 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~R 410 (453)
.+.-.+..+.+|+...||.|-.+|
T Consensus 260 ---fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 ---FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ---CCcccCHHHHHHHHHHHhhhhHhh
Confidence 233344566777777888887777
No 76
>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase). Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It
Probab=100.00 E-value=8e-36 Score=288.72 Aligned_cols=248 Identities=21% Similarity=0.316 Sum_probs=187.3
Q ss_pred HHHhhhhhcccCccCceEEEEEEEcC-----CcEEEEEEecCCCCC--HHHHHHH--------------Hhccccc-Ccc
Q 048517 159 IAVTNHFTHKLGQGGFGSVYKGQLHT-----GRLIAVKMMENSKFS--AEEFINE--------------LLGLCSE-GFK 216 (453)
Q Consensus 159 ~~~~~~~~~~LG~G~fG~Vy~g~~~~-----g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~-~~~ 216 (453)
...++.+.+.||+|+||.||+|...+ ++.||+|++...... .+.+..| +++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 34566778899999999999999765 788999998753221 2334344 3454444 466
Q ss_pred eEEEEEecCCCChhhhhhhccCC----CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEe
Q 048517 217 RALVYEYMPNGSLDRHIFSKENK----GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSD 292 (453)
Q Consensus 217 ~~lv~E~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~D 292 (453)
.++++||+++|+|.+++...... ...+++.+++.++.+++.||+|||+. +++|+||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 78999999999999998553322 25689999999999999999999998 999999999999999999999999
Q ss_pred cCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHH
Q 048517 293 FGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYD 371 (453)
Q Consensus 293 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 371 (453)
||+++...............++..|+|||++... .++.++||||||+++||+++ |+.|+....... ...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~ 230 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNK--EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE--------MAA 230 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcC--CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH--------HHH
Confidence 9999865443322222234567789999998764 68899999999999999999 999986432211 222
Q ss_pred HhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517 372 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID 425 (453)
Q Consensus 372 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~ 425 (453)
.+..+..... ....+..+.+++.+||+.+|++|||+.++++.|+...+
T Consensus 231 ~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 231 YLKDGYRLAQ------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HHHcCCCCCC------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 2333222111 11234568899999999999999999999999987554
No 77
>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes. Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an
Probab=100.00 E-value=2e-35 Score=283.02 Aligned_cols=239 Identities=27% Similarity=0.414 Sum_probs=184.5
Q ss_pred HhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
..+.+.++||+|+||.||++..+++..||+|.+.......+.+..| +++++. ....+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 4567788999999999999998877789999987655555555554 233333 3457899999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|+|.+++... ....++|..+..++.+++.||+|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 85 ~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 85 GSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 9999988543 234589999999999999999999998 9999999999999999999999999999866433211
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 385 (453)
......++..|+|||...+. ..+.++||||||+++|||++ |+.|+...... -..+.+.......
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~----- 223 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--------EVLEQVERGYRMP----- 223 (260)
T ss_pred ccCCCccchhhCCHHHhccC--CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCC-----
Confidence 12234567789999988753 78899999999999999999 88888643211 1222232221111
Q ss_pred hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
.+...+..+.+++.+||+.+|++||++++++++|+.
T Consensus 224 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 -CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 122345678899999999999999999999999974
No 78
>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=1.1e-35 Score=288.35 Aligned_cols=242 Identities=25% Similarity=0.407 Sum_probs=183.0
Q ss_pred hhhhhcccCccCceEEEEEEE-----cCCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQL-----HTGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALV 220 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~-----~~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv 220 (453)
..++.++||+|+||.||+|+. .+++.||+|.+...... ..++.+| +++++..+...+++
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 456778999999999999984 25678999998753221 1233333 34556667788999
Q ss_pred EEecCCCChhhhhhhccC-------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc
Q 048517 221 YEYMPNGSLDRHIFSKEN-------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI 287 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~ 287 (453)
|||+++|+|.+++..... ....+++.+++.++.+++.||+|||+. +|+|+||||+|||++.++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCc
Confidence 999999999999853221 123578899999999999999999998 9999999999999999999
Q ss_pred eEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccch
Q 048517 288 PKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFP 366 (453)
Q Consensus 288 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 366 (453)
+||+|||+++...............++..|+|||++.+. .++.++||||||++++||++ |..||.....
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-------- 232 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------- 232 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------
Confidence 999999999865443322222344567789999998753 68999999999999999998 8888754321
Q ss_pred HHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 367 SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 367 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
..+.+.+........ +...+..+.+++.+||+.+|++||++.++.++|++
T Consensus 233 ~~~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 QEVIEMVRKRQLLPC------SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHcCCcCCC------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 113333333322211 12234568889999999999999999999999874
No 79
>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp
Probab=100.00 E-value=8.3e-36 Score=294.59 Aligned_cols=225 Identities=24% Similarity=0.330 Sum_probs=171.3
Q ss_pred cccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517 167 HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE---------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
+.||+|+||.||+|+.. +++.||||.+.... ...+..+.| +++.+..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 68899999987532 111122111 34455667788999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~-- 151 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG-- 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--
Confidence 999988743 24689999999999999999999998 999999999999999999999999999986433221
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... .+...+..... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~~~-~------ 214 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQ--KYNESVDWWSFGVLLYEMLIGQSPFHGEDED--------ELFDSILNDRP-H------ 214 (316)
T ss_pred ccccccCCccccCHHHHcCC--CCCCcccchhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCC-C------
Confidence 22345699999999999764 6889999999999999999999999754321 12222222111 1
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRPSMT-KVL 417 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~-evl 417 (453)
.+..++..+.+++.+||+.+|++||++. +++
T Consensus 215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1122345678899999999999999875 453
No 80
>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]
Probab=100.00 E-value=5.5e-35 Score=266.68 Aligned_cols=244 Identities=23% Similarity=0.313 Sum_probs=183.9
Q ss_pred hhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCC-----------------HHHHHHHHhcccccCcceEEEEEe
Q 048517 162 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS-----------------AEEFINELLGLCSEGFKRALVYEY 223 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~-----------------~~~~i~el~g~~~~~~~~~lv~E~ 223 (453)
+|.-.++||+|.||.||+|+ ..+|+.||||+++..+.. .++.+.+|+..+.......||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 45566889999999999999 678999999998764322 123344588888888899999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
|+ -+|+..+. .+...|+..++..++.++.+||+|||++ .|+||||||.|+|++.++.+||+|||+|+.+....
T Consensus 83 m~-tdLe~vIk---d~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 83 MP-TDLEVVIK---DKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred cc-ccHHHHhc---ccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 95 57887773 3446789999999999999999999998 99999999999999999999999999999987655
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCc----
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL---- 379 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~---- 379 (453)
.. .+...-|..|.|||.+.+. ..|+...|+||.||++.||+-|.+-+...++-+ | -..+...+......
T Consensus 156 ~~--~~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDid-Q---L~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 156 RI--QTHQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID-Q---LSKIFRALGTPTPDQWPE 228 (318)
T ss_pred cc--cccceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHH-H---HHHHHHHcCCCCcccCcc
Confidence 42 2344789999999999875 588999999999999999998876665443211 0 00111111110000
Q ss_pred -------------cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 380 -------------ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 380 -------------~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
+.......-...+....+++..++.+||.+|+|++|++++
T Consensus 229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0000000111233466899999999999999999999874
No 81
>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o
Probab=100.00 E-value=6.2e-36 Score=297.19 Aligned_cols=229 Identities=21% Similarity=0.319 Sum_probs=172.3
Q ss_pred cccCccCceEEEEEEEc-CCcEEEEEEecCCCCC----HHHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517 167 HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS----AEEFINE---------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~----~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
+.||+|+||.||+++.. +++.||+|++...... .+.+..| +++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999954 6889999998763211 1112122 45566677788999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-- 151 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-- 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--
Confidence 999887732 24689999999999999999999998 999999999999999999999999999975432221
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccc-ccccchHHHHHHhhhCCCccccchh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRS-SKAYFPSWVYDQLNKGGDLELRNVT 385 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~~~ 385 (453)
......||+.|+|||++.+. .++.++||||||+++|||++|+.||....... .......++.+.+..... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~----- 223 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R----- 223 (329)
T ss_pred ccccccCCccccCHHHHcCC--CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-C-----
Confidence 12345689999999999764 78899999999999999999999996432211 111222333333333221 1
Q ss_pred hhHHHHHHHHHHHHHHhcccCCCCCCCH
Q 048517 386 EIESMIARKLCMIGLWCIQVKAADRPSM 413 (453)
Q Consensus 386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~ 413 (453)
.+...+..+.+++.+||+.||++||+.
T Consensus 224 -~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 -IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 122234568899999999999999983
No 82
>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla
Probab=100.00 E-value=1.2e-35 Score=288.96 Aligned_cols=242 Identities=22% Similarity=0.337 Sum_probs=173.6
Q ss_pred hhhhhcccCccCceEEEEEEE-c-CCcEEEEEEecCCCC---CHHHHHHH-----------------Hhcccc-----cC
Q 048517 162 TNHFTHKLGQGGFGSVYKGQL-H-TGRLIAVKMMENSKF---SAEEFINE-----------------LLGLCS-----EG 214 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~-~-~g~~VAVK~l~~~~~---~~~~~i~e-----------------l~g~~~-----~~ 214 (453)
+|.+.++||+|+||.||+|+. . +|+.||||.+..... ....+..| ++++|. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 466778999999999999985 3 478899998865321 11122222 233332 23
Q ss_pred cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecC
Q 048517 215 FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG 294 (453)
Q Consensus 215 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 294 (453)
...++|+||+. ++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 45789999996 6898887432 234589999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh
Q 048517 295 LAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN 374 (453)
Q Consensus 295 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~ 374 (453)
+++...... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ + ..+.+...
T Consensus 156 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~---~-~~i~~~~~ 226 (290)
T cd07862 156 LARIYSFQM---ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---L-GKILDVIG 226 (290)
T ss_pred ceEeccCCc---ccccccccccccChHHHhCC--CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH---H-HHHHHHhC
Confidence 998654332 22345689999999998754 788999999999999999999999975432110 0 00111000
Q ss_pred hC-------------CCc---cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 375 KG-------------GDL---ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 375 ~~-------------~~~---~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.. ... ............+..+.+++.+||+.+|++|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 000 000000111234566789999999999999999999985
No 83
>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I
Probab=100.00 E-value=2.4e-35 Score=291.28 Aligned_cols=225 Identities=24% Similarity=0.325 Sum_probs=172.0
Q ss_pred cccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517 167 HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE---------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
+.||+|+||.||+|+.. +|+.||||.++... ...+....| +++.+......++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 68999999987532 111122211 44556677788999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-- 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--
Confidence 999988743 24688999999999999999999998 999999999999999999999999999874322211
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
......||+.|+|||++.+. .++.++||||+|+++|||++|+.||...... ...+.+..... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--------~~~~~~~~~~~-~------ 214 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGL--KYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--------ELFESIRVDTP-H------ 214 (316)
T ss_pred ceeccCCCcCccCHHHHcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCC-C------
Confidence 12345699999999999764 7889999999999999999999999644321 12222222211 1
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRPSMT-KVL 417 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~-evl 417 (453)
.+...+..+.+++.+||+.||++||++. ++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 215 YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1112345688899999999999999985 554
No 84
>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2. Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve
Probab=100.00 E-value=1.1e-35 Score=287.82 Aligned_cols=240 Identities=25% Similarity=0.420 Sum_probs=180.1
Q ss_pred hhhhhcccCccCceEEEEEEE-cCCc----EEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQL-HTGR----LIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALV 220 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~----~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv 220 (453)
..++.++||+|+||+||+|+. .+|+ .||+|++..... ..+++.+| +++++.. ...+++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~ 86 (279)
T cd05109 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLV 86 (279)
T ss_pred heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEE
Confidence 445668999999999999984 4555 489999875322 22334343 3344433 346799
Q ss_pred EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517 221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 300 (453)
+||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 87 TQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999988532 24689999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517 301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDL 379 (453)
Q Consensus 301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~ 379 (453)
............++..|+|||.+.+. .++.++||||||+++|||++ |..|+...... -....+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~ 230 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHR--RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--------EIPDLLEKGERL 230 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCCcC
Confidence 43332222233457789999998753 78899999999999999998 88887543211 122233333222
Q ss_pred cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517 380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI 424 (453)
Q Consensus 380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~ 424 (453)
.. +...+..+.+++.+||+.||++||++.++++.|+...
T Consensus 231 ~~------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 231 PQ------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred CC------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 21 1123456889999999999999999999999998643
No 85
>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3. Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r
Probab=100.00 E-value=1.7e-35 Score=286.83 Aligned_cols=241 Identities=25% Similarity=0.394 Sum_probs=179.9
Q ss_pred hhhhhcccCccCceEEEEEEE-cCCc----EEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQL-HTGR----LIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALV 220 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~----~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv 220 (453)
.+++.+.||+|+||.||+|+. .+|+ .|++|.+..... ..+++..+ +++++. +...+++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEE
Confidence 345568899999999999985 3454 478887754321 12233332 344443 3456789
Q ss_pred EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517 221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 300 (453)
+||+++|+|.+++... ...++|..+..++.|++.||+|||+. +++|+||||+|||+++++.+||+|||+++...
T Consensus 87 ~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 87 TQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999998532 34689999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517 301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDL 379 (453)
Q Consensus 301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~ 379 (453)
............++..|+|||.+.. +.++.++||||||+++|||++ |+.|+...... ...+.+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~ 230 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILF--GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--------EVPDLLEKGERL 230 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCCcC
Confidence 4332222234557789999999875 378999999999999999998 99888643221 122333333322
Q ss_pred cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517 380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID 425 (453)
Q Consensus 380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~ 425 (453)
.... .....+..++.+||+.+|++|||+.|+++.|+...+
T Consensus 231 ~~~~------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 231 AQPQ------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCC------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 2111 122456788999999999999999999999987554
No 86
>PTZ00263 protein kinase A catalytic subunit; Provisional
Probab=100.00 E-value=6.7e-36 Score=296.92 Aligned_cols=228 Identities=24% Similarity=0.339 Sum_probs=178.1
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH--------------HhcccccCcceEEEEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE--------------LLGLCSEGFKRALVYE 222 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e--------------l~g~~~~~~~~~lv~E 222 (453)
.+.+.+.||+|+||.||+|+.. +|+.||||++.... ...+.+..| +++.+..+...++|||
T Consensus 19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 98 (329)
T PTZ00263 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE 98 (329)
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence 4567789999999999999965 68999999987532 122233333 4556677788999999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 302 (453)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 99 FVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred CCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999998843 24688899999999999999999998 9999999999999999999999999999866432
Q ss_pred CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517 303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382 (453)
Q Consensus 303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 382 (453)
. ....||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... ...++.+..+. ...
T Consensus 172 ~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~~-~~~- 234 (329)
T PTZ00263 172 T-----FTLCGTPEYLAPEVIQSK--GHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FRIYEKILAGR-LKF- 234 (329)
T ss_pred c-----ceecCChhhcCHHHHcCC--CCCCcceeechHHHHHHHHcCCCCCCCCCH--------HHHHHHHhcCC-cCC-
Confidence 2 234689999999999764 678999999999999999999999964321 11223333322 111
Q ss_pred chhhhHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048517 383 NVTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE 418 (453)
Q Consensus 383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 418 (453)
+..++..+.+++.+||+.||.+||+ ++++++
T Consensus 235 -----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 235 -----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred -----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1123456789999999999999997 677764
No 87
>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2. Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=8.5e-36 Score=296.35 Aligned_cols=242 Identities=24% Similarity=0.313 Sum_probs=179.5
Q ss_pred HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
..+...++||+|+||.||+++.. +|..||+|++..... ..+++..| +++++..+...++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 34566789999999999999955 788999999876422 12334444 45666677788999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++|+|.+++.. ...+++..+..++.+++.||.|||+. .+|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 85 MDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 999999998843 24588999999999999999999975 269999999999999999999999999997653321
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccch-----------------
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP----------------- 366 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~----------------- 366 (453)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.
T Consensus 159 ----~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 159 ----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ----cccCCCCcCcCCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcc
Confidence 2345689999999999764 78999999999999999999999996432211000000
Q ss_pred ---------------------HHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 367 ---------------------SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 367 ---------------------~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
....+.+........ ....+...+.+++.+||+.||++|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKL-----PNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCC-----CCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000000 011245678999999999999999999999874
No 88
>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta
Probab=100.00 E-value=1.4e-35 Score=288.62 Aligned_cols=248 Identities=25% Similarity=0.403 Sum_probs=185.0
Q ss_pred HHHhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcc
Q 048517 159 IAVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFK 216 (453)
Q Consensus 159 ~~~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~ 216 (453)
...++.+.++||+|+||.||+|... .+..||+|.+...... ..++.+| +++.+.....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3456778899999999999999743 2558999988754322 2233333 4666777778
Q ss_pred eEEEEEecCCCChhhhhhhccC------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEE
Q 048517 217 RALVYEYMPNGSLDRHIFSKEN------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV 290 (453)
Q Consensus 217 ~~lv~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl 290 (453)
.++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 8999999999999999854221 123456778899999999999999998 9999999999999999999999
Q ss_pred EecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHH
Q 048517 291 SDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWV 369 (453)
Q Consensus 291 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 369 (453)
+|||+++...............++..|+|||.+.+. .++.++||||||++++||++ |..|+...... -.
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--------~~ 230 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--------QV 230 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccC--CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HH
Confidence 999999865443322222233457789999998753 78999999999999999998 67777543211 12
Q ss_pred HHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517 370 YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID 425 (453)
Q Consensus 370 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~ 425 (453)
.+.+..+..... +...+..+.+++.+||+.+|++|||+.++++.|++.+.
T Consensus 231 ~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 231 LKFVMDGGYLDQ------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred HHHHHcCCCCCC------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 222222222211 11224578999999999999999999999999997643
No 89
>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate
Probab=100.00 E-value=9.3e-36 Score=295.79 Aligned_cols=227 Identities=22% Similarity=0.342 Sum_probs=174.4
Q ss_pred cccCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517 167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEYMPNG 227 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g 227 (453)
+.||+|+||.||+++. .+|+.||||++..... ...+++.| +.+.+......++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999985 4799999999975321 12233333 345566777889999999999
Q ss_pred ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517 228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 307 (453)
Q Consensus 228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 307 (453)
+|..++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 151 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--T 151 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--c
Confidence 99888743 34689999999999999999999998 999999999999999999999999999875432221 1
Q ss_pred ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhh
Q 048517 308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEI 387 (453)
Q Consensus 308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 387 (453)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... . ..+.+.... .. .
T Consensus 152 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~Pf~~~~~~-------~-~~~~~~~~~-~~------~ 214 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------K-LFELILMED-IK------F 214 (328)
T ss_pred cccccCCcCccChhhhcCC--CCCccCCccccchHHHHHhhCCCCCCCCCHH-------H-HHHHhccCC-cc------C
Confidence 2345699999999999764 6889999999999999999999999643211 0 111221111 11 1
Q ss_pred HHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 048517 388 ESMIARKLCMIGLWCIQVKAADRP-----SMTKVLEM 419 (453)
Q Consensus 388 ~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 419 (453)
+..++..+.+++.+||+.||++|| ++.++++.
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 223456788999999999999997 88888753
No 90
>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=2.5e-36 Score=300.10 Aligned_cols=236 Identities=25% Similarity=0.332 Sum_probs=175.9
Q ss_pred hhhhcccCccCceEEEEEEE----cCCcEEEEEEecCCCC-----CHHHHHHH---------------HhcccccCcceE
Q 048517 163 NHFTHKLGQGGFGSVYKGQL----HTGRLIAVKMMENSKF-----SAEEFINE---------------LLGLCSEGFKRA 218 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~----~~g~~VAVK~l~~~~~-----~~~~~i~e---------------l~g~~~~~~~~~ 218 (453)
|.+.++||+|+||.||+++. .+|+.||+|++..... ..+.+..| +++.+......+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 45678999999999999874 3688999999865211 11222222 234455666788
Q ss_pred EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298 (453)
Q Consensus 219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 298 (453)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 82 lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 82 LILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999998853 24689999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517 299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD 378 (453)
Q Consensus 299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~ 378 (453)
....... ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||........ ...+...+.....
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~~~~~~~~~~~ 228 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNT----QSEVSRRILKCDP 228 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCC----HHHHHHHHhcCCC
Confidence 5433221 12345699999999998753 3478899999999999999999999965432211 1112222222111
Q ss_pred ccccchhhhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517 379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE 418 (453)
Q Consensus 379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 418 (453)
. .+..++..+.+++.+||+.||++|| +++++++
T Consensus 229 -~------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 229 -P------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -C------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1 1122445688899999999999999 6777765
No 91
>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t
Probab=100.00 E-value=3.2e-35 Score=281.27 Aligned_cols=243 Identities=30% Similarity=0.468 Sum_probs=189.6
Q ss_pred HHHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 158 IIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 158 ~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
+....+.+.++||+|+||.||++..++++.||||.+.......+++..| +++++......+++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 3345567788999999999999998888999999998766666666555 45566666788999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++++|.+++... ....+++..+..++.+++.||.|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999988542 235689999999999999999999998 99999999999999999999999999998764322
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 382 (453)
. .......++..|+|||.+.+. .++.++||||+|++++||++ |+.||...... ...+.+..+.....
T Consensus 158 ~-~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~- 225 (261)
T cd05034 158 Y-TAREGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--------EVLEQVERGYRMPR- 225 (261)
T ss_pred h-hhhhccCCCccccCHHHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCC-
Confidence 1 111233456789999998754 68899999999999999998 89888543211 12222322211111
Q ss_pred chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
+...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 226 -----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 -----PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11124568899999999999999999999999974
No 92
>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a
Probab=100.00 E-value=1.4e-35 Score=293.96 Aligned_cols=225 Identities=23% Similarity=0.301 Sum_probs=173.3
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCC----CCHHHHHH---------------HHhcccccCcceEEEEE
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSK----FSAEEFIN---------------ELLGLCSEGFKRALVYE 222 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~----~~~~~~i~---------------el~g~~~~~~~~~lv~E 222 (453)
+++.+.||+|+||.||+++. .+|+.||||++.... ...+.++. .+.+++......++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 46778999999999999985 478999999987532 11122222 24455666778899999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 302 (453)
|+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 82 YVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999988843 24689999999999999999999998 9999999999999999999999999998754322
Q ss_pred CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517 303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382 (453)
Q Consensus 303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 382 (453)
.. ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... .....+..... .
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~~~~~-~-- 219 (323)
T cd05615 155 GV--TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--------ELFQSIMEHNV-S-- 219 (323)
T ss_pred Cc--cccCccCCccccCHHHHcCC--CCCCccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCC-C--
Confidence 21 12345689999999999764 7889999999999999999999999754321 12222222211 1
Q ss_pred chhhhHHHHHHHHHHHHHHhcccCCCCCCCH
Q 048517 383 NVTEIESMIARKLCMIGLWCIQVKAADRPSM 413 (453)
Q Consensus 383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~ 413 (453)
.+...+..+.+++.+||+.+|.+|++.
T Consensus 220 ----~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 ----YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 112234567889999999999999985
No 93
>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=3.8e-36 Score=303.19 Aligned_cols=231 Identities=25% Similarity=0.353 Sum_probs=190.5
Q ss_pred hhhhcccCccCceEEEEEE-EcCCcEEEEEEecCC-------CCCHHH--HHHH---------HhcccccCcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENS-------KFSAEE--FINE---------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~-------~~~~~~--~i~e---------l~g~~~~~~~~~lv~E~ 223 (453)
+.+.+.||.|+-|.|-.|+ ..+|+.+|||++.+. ....+. .|.+ |+.++.++.++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 4567889999999999998 568999999999874 112221 2222 78888999999999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++|-|.+++. .++.|+..++.+++.||+.|+.|+|+. +|+|||+||+|+|||.+.++||+|||+|.+...+.
T Consensus 94 v~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 94 VPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred cCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 99999999994 346899999999999999999999998 99999999999999999999999999999876654
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
. ..+.+|+|.|.|||++.+. ..-..++||||.||+|+.|+||+.||+..+.+. ++..+.+|..
T Consensus 167 l---LeTSCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~--------LLlKV~~G~f----- 229 (786)
T KOG0588|consen 167 L---LETSCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV--------LLLKVQRGVF----- 229 (786)
T ss_pred c---ccccCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCccHHH--------HHHHHHcCcc-----
Confidence 2 3567899999999999985 234779999999999999999999998544221 2223333322
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
+.+..++.+...|+.+|+..||+.|.|++||++.
T Consensus 230 --~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 --EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred --cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 3456677788999999999999999999999983
No 94
>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N. Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved
Probab=100.00 E-value=1.7e-35 Score=293.21 Aligned_cols=228 Identities=26% Similarity=0.356 Sum_probs=174.9
Q ss_pred hhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHH-----------------HHHHhcccccCcceEEEE
Q 048517 164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEF-----------------INELLGLCSEGFKRALVY 221 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~-----------------i~el~g~~~~~~~~~lv~ 221 (453)
.+.+.||+|+||.||+|... +|+.||||+++... ...+.+ +.++++++..+...++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 45688999999999999854 78999999987532 111122 222556667778899999
Q ss_pred EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517 222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 301 (453)
Q Consensus 222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 301 (453)
||+++|+|..++. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 82 E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 82 EYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred cCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999988773 24689999999999999999999998 999999999999999999999999999875432
Q ss_pred CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517 302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381 (453)
Q Consensus 302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 381 (453)
... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... -....+..+...
T Consensus 154 ~~~--~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~~~~-- 219 (324)
T cd05589 154 FGD--RTSTFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--------EVFDSIVNDEVR-- 219 (324)
T ss_pred CCC--cccccccCccccCHhHhcCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCC--
Confidence 221 12345699999999999764 7889999999999999999999999654321 122222222211
Q ss_pred cchhhhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517 382 RNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE 418 (453)
Q Consensus 382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 418 (453)
.+..++..+.+++.+||+.||.+|| ++.++++
T Consensus 220 -----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 -----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1122345678899999999999999 4666655
No 95
>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in
Probab=100.00 E-value=8.3e-36 Score=295.48 Aligned_cols=226 Identities=25% Similarity=0.346 Sum_probs=173.7
Q ss_pred cccCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517 167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEYMPNG 227 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g 227 (453)
+.||+|+||.||+++. .+|+.||+|++..... ....+..| +++.+......++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999995 4799999999875321 12222222 455667777889999999999
Q ss_pred ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517 228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 307 (453)
Q Consensus 228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 307 (453)
+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 151 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--T 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--c
Confidence 99887742 34689999999999999999999998 999999999999999999999999999875322221 1
Q ss_pred ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhh
Q 048517 308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEI 387 (453)
Q Consensus 308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 387 (453)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ..+.+.... .. .
T Consensus 152 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--------~~~~~~~~~-~~------~ 214 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELILMEE-IR------F 214 (323)
T ss_pred cccccCCcCcCCcccccCC--CCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcCC-CC------C
Confidence 2345699999999998753 78899999999999999999999986443211 112221111 11 1
Q ss_pred HHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517 388 ESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE 418 (453)
Q Consensus 388 ~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 418 (453)
+..++..+.+++.+||+.||++|| ++.++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 123456788999999999999998 7888765
No 96
>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes
Probab=100.00 E-value=1.3e-35 Score=288.38 Aligned_cols=246 Identities=22% Similarity=0.278 Sum_probs=178.0
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
|.+.+.||+|+||.||+++.+ +++.||||++..... ..+.+..| +++.+......++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 566789999999999999965 688999999875322 12223332 566777788899999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
+++++.... .....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 83 EKNMLELLE----EMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred CCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 988776543 1234689999999999999999999998 999999999999999999999999999987643221
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc-------ccchHHHHHHhhhCC
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-------AYFPSWVYDQLNKGG 377 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~-------~~~~~~~~~~l~~~~ 377 (453)
. ......||+.|+|||++.+. .++.++||||+||++|||++|+.||......... ..++.-.........
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 156 A-NYTEYVATRWYRSPELLLGA--PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred c-cccccccccccCCcHHHcCC--CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 1 12345689999999999764 6889999999999999999999999754321100 000000000000000
Q ss_pred ---Ccccc---ch----hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 378 ---DLELR---NV----TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 378 ---~~~~~---~~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
..... .. ......++..+.+++.+||+.||++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 00 0011224567999999999999999999999875
No 97
>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos
Probab=100.00 E-value=8.9e-36 Score=296.24 Aligned_cols=248 Identities=20% Similarity=0.252 Sum_probs=173.4
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCC---CCHHHHHHH--------------Hhccccc-----CcceEE
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSK---FSAEEFINE--------------LLGLCSE-----GFKRAL 219 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~---~~~~~~i~e--------------l~g~~~~-----~~~~~l 219 (453)
|.+.++||+|+||.||+|+. .+|+.||||++.... ....++..| +++++.. ....++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 56678999999999999995 478999999987521 122334444 2333321 124789
Q ss_pred EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517 220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 299 (453)
||||+. ++|.+.+.. ...+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 82 v~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 82 VFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 999995 688887732 34689999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCC-ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc-------cchHHHHH
Q 048517 300 PKEND-FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA-------YFPSWVYD 371 (453)
Q Consensus 300 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~-------~~~~~~~~ 371 (453)
..... ........||+.|+|||++.+....++.++|||||||++|||++|+.||.......... ..+.....
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 33221 11123456899999999987533478899999999999999999999986543211000 00000000
Q ss_pred Hhhh---------CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 372 QLNK---------GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 372 ~l~~---------~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.+.. ...................+.+++.+||+.+|++|||++|+++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000 0000000000000113356789999999999999999999997
No 98
>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan
Probab=100.00 E-value=5.2e-35 Score=278.58 Aligned_cols=236 Identities=31% Similarity=0.506 Sum_probs=186.2
Q ss_pred cccCccCceEEEEEEEcC----CcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517 167 HKLGQGGFGSVYKGQLHT----GRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~----g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
+.||+|+||.||+|.... +..||||.+...... .+++..| +++++..+...+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999653 889999999875443 2333333 45666777888999999999
Q ss_pred CChhhhhhhccCC-----CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517 227 GSLDRHIFSKENK-----GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 301 (453)
Q Consensus 227 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 301 (453)
++|.+++...... ...+++.++..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999998544211 36799999999999999999999998 999999999999999999999999999988765
Q ss_pred CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517 302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 380 (453)
Q Consensus 302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 380 (453)
...........++..|+|||.+... .++.++||||+|++++||++ |+.|+..... ....+.+..+....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~ 227 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------EEVLEYLRKGYRLP 227 (262)
T ss_pred ccccccccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCC
Confidence 5433333456688999999998764 78999999999999999999 5888865421 11233333322221
Q ss_pred ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517 381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421 (453)
Q Consensus 381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le 421 (453)
.+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 228 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 ------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 12233567899999999999999999999999874
No 99
>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=8.2e-36 Score=293.04 Aligned_cols=250 Identities=24% Similarity=0.395 Sum_probs=186.9
Q ss_pred HHHHHhhhhhcccCccCceEEEEEEEc--------CCcEEEEEEecCCCC--CHHHHHHH---------------Hhccc
Q 048517 157 EIIAVTNHFTHKLGQGGFGSVYKGQLH--------TGRLIAVKMMENSKF--SAEEFINE---------------LLGLC 211 (453)
Q Consensus 157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~--------~g~~VAVK~l~~~~~--~~~~~i~e---------------l~g~~ 211 (453)
++....+.+.++||+|+||.||+++.. +++.+|+|.+..... ...++..| +++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 334456778899999999999999742 235799999976422 22233333 34566
Q ss_pred ccCcceEEEEEecCCCChhhhhhhccC------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcc
Q 048517 212 SEGFKRALVYEYMPNGSLDRHIFSKEN------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHN 279 (453)
Q Consensus 212 ~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~N 279 (453)
......++||||+++|+|.+++..... ....++|.+++.++.|++.||+|||+. +++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence 677788999999999999999965322 123589999999999999999999987 99999999999
Q ss_pred eEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcc
Q 048517 280 ILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAT 358 (453)
Q Consensus 280 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~ 358 (453)
|+++.++.+||+|||+++...............+++.|+|||.+.+. .++.++||||||+++|||++ |+.|+.....
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC--CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 99999999999999999866433222222223456789999998753 68899999999999999998 7788753321
Q ss_pred ccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517 359 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID 425 (453)
Q Consensus 359 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~ 425 (453)
.-+.+.+......+ .+...+..+.+++.+||+.+|++|||+.+|++.|+.++.
T Consensus 249 --------~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 249 --------EELFKLLKEGHRMD------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred --------HHHHHHHHcCCCCC------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 11223333332221 112234578889999999999999999999999987554
No 100
>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein. Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi
Probab=100.00 E-value=1.2e-35 Score=289.19 Aligned_cols=243 Identities=26% Similarity=0.400 Sum_probs=184.2
Q ss_pred hhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEE
Q 048517 164 HFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVY 221 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~ 221 (453)
++.+.||+|+||.||+|+.. ....+|+|.+...... .+++..| +++.+......++++
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 45688999999999999843 2357999988754322 2334444 456667777889999
Q ss_pred EecCCCChhhhhhhccC--------------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceE
Q 048517 222 EYMPNGSLDRHIFSKEN--------------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNIL 281 (453)
Q Consensus 222 E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIL 281 (453)
||+.+|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEE
Confidence 99999999998854221 123588999999999999999999998 9999999999999
Q ss_pred EcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcccc
Q 048517 282 LDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRS 360 (453)
Q Consensus 282 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~ 360 (453)
+++++.+||+|||+++...............++..|+|||.+.+. .++.++||||||++++||++ |+.|+.....
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC--CcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 999999999999999865443332222334567789999998754 68899999999999999998 8888854321
Q ss_pred ccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517 361 SKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID 425 (453)
Q Consensus 361 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~ 425 (453)
..+.+.+........ +...+..+.+++.+||+.+|++||++.++++.|++++.
T Consensus 236 ------~~~~~~~~~~~~~~~------~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 ------ERLFNLLKTGYRMER------PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ------HHHHHHHhCCCCCCC------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 122333333222111 12234578899999999999999999999999997654
No 101
>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp
Probab=100.00 E-value=3.2e-35 Score=293.68 Aligned_cols=248 Identities=27% Similarity=0.424 Sum_probs=183.8
Q ss_pred HHhhhhhcccCccCceEEEEEEE------cCCcEEEEEEecCCCCC--HHHHHHH---------------Hhcccc-cCc
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQL------HTGRLIAVKMMENSKFS--AEEFINE---------------LLGLCS-EGF 215 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~~------~~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~-~~~ 215 (453)
...+.+.+.||+|+||.||+|+. .+++.||||++...... ...+..| ++++|. .+.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 44677889999999999999973 35789999999764322 1223233 444443 344
Q ss_pred ceEEEEEecCCCChhhhhhhccC---------------------------------------------------------
Q 048517 216 KRALVYEYMPNGSLDRHIFSKEN--------------------------------------------------------- 238 (453)
Q Consensus 216 ~~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 238 (453)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999998864321
Q ss_pred ------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecccC
Q 048517 239 ------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTR 312 (453)
Q Consensus 239 ------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 312 (453)
....++|..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++...............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 013478889999999999999999998 99999999999999999999999999998654433222223345
Q ss_pred CCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHH
Q 048517 313 GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 391 (453)
Q Consensus 313 gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 391 (453)
++..|+|||.+... .++.++||||||+++|||++ |..|+...... ......+..+...... ...
T Consensus 243 ~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~------~~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFCRRLKEGTRMRAP------DYT 307 (343)
T ss_pred CCcceECcHHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-------HHHHHHHhccCCCCCC------CCC
Confidence 67789999998753 78899999999999999996 88887543211 1122233333222211 112
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517 392 ARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID 425 (453)
Q Consensus 392 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~ 425 (453)
+..+.+++.+||+.+|++|||+.++++.|+..++
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3468899999999999999999999999987654
No 102
>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in
Probab=100.00 E-value=1.7e-35 Score=292.38 Aligned_cols=225 Identities=25% Similarity=0.341 Sum_probs=172.1
Q ss_pred cccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517 167 HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE---------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
+.||+|+||.||+|+.. +++.||||++.... ...+....| +++.+......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 68899999987532 111222211 44556667778999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|+|.+++.. ...+++.++..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-- 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--
Confidence 999988843 24689999999999999999999998 999999999999999999999999999875322221
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ...+.+......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~~~~------- 214 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQ--KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--------ELFQSIRMDNPC------- 214 (316)
T ss_pred ceeeecCCccccCHHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCC-------
Confidence 12345689999999999764 6889999999999999999999999653311 122223222111
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRPSMT-KVL 417 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~-evl 417 (453)
.+...+..+.+++.+||+.+|++||++. ++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 215 YPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 1122345678899999999999999997 554
No 103
>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes. Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular
Probab=100.00 E-value=1.6e-35 Score=281.99 Aligned_cols=233 Identities=23% Similarity=0.406 Sum_probs=176.4
Q ss_pred cccCccCceEEEEEEE-cCCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEecCCCCh
Q 048517 167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSL 229 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL 229 (453)
++||+|+||.||+|+. .+++.||+|....... ....+..| +++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4799999999999995 4799999998764321 12334444 45667777888999999999999
Q ss_pred hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeec
Q 048517 230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 309 (453)
Q Consensus 230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 309 (453)
.+++.. ....+++.+++.++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+++............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 998843 234689999999999999999999998 99999999999999999999999999987543321111111
Q ss_pred ccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhH
Q 048517 310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 388 (453)
Q Consensus 310 ~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 388 (453)
....+..|+|||.+.. +.++.++||||||+++|||++ |..|+...... .....+....... .+
T Consensus 155 ~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------~~~~~~~~~~~~~------~~ 218 (252)
T cd05084 155 MKQIPVKWTAPEALNY--GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--------QTREAIEQGVRLP------CP 218 (252)
T ss_pred CCCCceeecCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--------HHHHHHHcCCCCC------Cc
Confidence 1223567999999875 368899999999999999997 88877543211 1222332222211 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517 389 SMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421 (453)
Q Consensus 389 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le 421 (453)
...+..+.+++.+||+.+|++|||+.++.++|+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 223457889999999999999999999999986
No 104
>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl
Probab=100.00 E-value=1.7e-35 Score=294.05 Aligned_cols=234 Identities=20% Similarity=0.308 Sum_probs=176.2
Q ss_pred cccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH----HHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517 167 HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA----EEFINE---------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~----~~~i~e---------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
+.||+|+||.||+++.. +++.||||+++...... ..+..| +++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999954 78999999997632211 112222 45556677788999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-- 151 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-- 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC--
Confidence 999888742 35689999999999999999999998 999999999999999999999999999874322221
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccc-ccccchHHHHHHhhhCCCccccchh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRS-SKAYFPSWVYDQLNKGGDLELRNVT 385 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~~~ 385 (453)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||+...... .......+..+.+..... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~----- 223 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-R----- 223 (329)
T ss_pred ccccccCCccccCHHHHcCC--CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-C-----
Confidence 12345689999999999764 78899999999999999999999997432211 112222334444433221 1
Q ss_pred hhHHHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 048517 386 EIESMIARKLCMIGLWCIQVKAADRPS------MTKVLE 418 (453)
Q Consensus 386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs------~~evl~ 418 (453)
.+..++..+.+++.+||+.||.+||| +.++++
T Consensus 224 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 -IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 11223456889999999999999997 667764
No 105
>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=2.1e-35 Score=293.72 Aligned_cols=249 Identities=24% Similarity=0.406 Sum_probs=185.9
Q ss_pred HHHHHhhhhhcccCccCceEEEEEEEc--------CCcEEEEEEecCCCC--CHHHHHHH---------------Hhccc
Q 048517 157 EIIAVTNHFTHKLGQGGFGSVYKGQLH--------TGRLIAVKMMENSKF--SAEEFINE---------------LLGLC 211 (453)
Q Consensus 157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~--------~g~~VAVK~l~~~~~--~~~~~i~e---------------l~g~~ 211 (453)
++...++.+.++||+|+||.||+++.. .+..||+|.+..... ..+++..| +++.|
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 344456788899999999999999732 123799998875322 12233333 45566
Q ss_pred ccCcceEEEEEecCCCChhhhhhhccC------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcc
Q 048517 212 SEGFKRALVYEYMPNGSLDRHIFSKEN------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHN 279 (453)
Q Consensus 212 ~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~N 279 (453)
......++++||+++|+|.+++..... ....++|.++..++.|++.||+|||+. +|+||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 677788999999999999999864321 234588999999999999999999998 99999999999
Q ss_pred eEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcc
Q 048517 280 ILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAT 358 (453)
Q Consensus 280 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~ 358 (453)
||++.++.+||+|||+++...............++..|+|||.+.+. .++.++||||||+++|||++ |+.|+.....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC--CcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999999866443322222334456789999998764 78889999999999999998 7787753321
Q ss_pred ccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517 359 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI 424 (453)
Q Consensus 359 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~ 424 (453)
.-....+......+. +......+.+++.+||+.+|++|||+.++++.|+...
T Consensus 243 --------~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 243 --------EELFKLLKEGHRMDK------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred --------HHHHHHHHcCCCCCC------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 112223333222111 1123456889999999999999999999999999766
No 106
>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=1.3e-35 Score=291.14 Aligned_cols=249 Identities=22% Similarity=0.394 Sum_probs=187.0
Q ss_pred HHHHhhhhhcccCccCceEEEEEEE--------cCCcEEEEEEecCCCC--CHHHHHHH---------------Hhcccc
Q 048517 158 IIAVTNHFTHKLGQGGFGSVYKGQL--------HTGRLIAVKMMENSKF--SAEEFINE---------------LLGLCS 212 (453)
Q Consensus 158 ~~~~~~~~~~~LG~G~fG~Vy~g~~--------~~g~~VAVK~l~~~~~--~~~~~i~e---------------l~g~~~ 212 (453)
+....+.+.+.||+|+||.||+++. .++..||+|.+..... ...++..| +++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 4455666778999999999999973 1345799999875321 12233333 455666
Q ss_pred cCcceEEEEEecCCCChhhhhhhccC------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcce
Q 048517 213 EGFKRALVYEYMPNGSLDRHIFSKEN------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNI 280 (453)
Q Consensus 213 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NI 280 (453)
.....+++|||+++|+|.+++..... ....++|.++..++.|++.||+|||+. +|+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 77788999999999999999865322 124578899999999999999999998 999999999999
Q ss_pred EEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccc
Q 048517 281 LLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATR 359 (453)
Q Consensus 281 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~ 359 (453)
+++.++.+||+|||+++...............+++.|+|||++.+. .++.++||||||+++|||++ |+.|+....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~-- 244 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-- 244 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCC--
Confidence 9999999999999999876544332223334567889999998753 68899999999999999998 777764322
Q ss_pred cccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517 360 SSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID 425 (453)
Q Consensus 360 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~ 425 (453)
.....+.+..+..... +...+..+..++.+||+.+|++|||+.++++.|++++.
T Consensus 245 ------~~~~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 245 ------VEELFKLLKEGHRMDK------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred ------HHHHHHHHHcCCcCCC------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 1113333333322211 11234568889999999999999999999999987544
No 107
>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]
Probab=100.00 E-value=5e-36 Score=296.83 Aligned_cols=225 Identities=24% Similarity=0.340 Sum_probs=173.5
Q ss_pred hcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHH----------HHHH--------HHhcccccCcceEEEEEecCC
Q 048517 166 THKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAE----------EFIN--------ELLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 166 ~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~----------~~i~--------el~g~~~~~~~~~lv~E~~~~ 226 (453)
...||+|+||.||+++. .+|..+|+|+|+++..... +.+. +|+-.+++...+||||||++|
T Consensus 146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG 225 (550)
T KOG0605|consen 146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG 225 (550)
T ss_pred heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence 46799999999999994 5799999999988543221 1122 266677888999999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC-----
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK----- 301 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~----- 301 (453)
|++...|. ....|+...+..++.+++-||+-||+. ++|||||||+|+|||.+|++||+||||+.-...
T Consensus 226 GD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 226 GDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred ccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 99999883 447899999999999999999999998 999999999999999999999999999853211
Q ss_pred ----------------CCCce------e------------------ecccCCCCCccChhhhcccCCCCCccchHHHHHH
Q 048517 302 ----------------ENDFV------S------------------ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGM 341 (453)
Q Consensus 302 ----------------~~~~~------~------------------~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gv 341 (453)
..... . .....|||-|||||++.+. .++..+|.||+||
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k--gY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK--GYGKECDWWSLGC 376 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC--CCCccccHHHHHH
Confidence 00000 0 0123599999999999986 6899999999999
Q ss_pred HHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC-CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCC
Q 048517 342 VLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG-DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS 412 (453)
Q Consensus 342 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs 412 (453)
++|||+.|.+||......+ ++..+.... .+..+ .....+.+..+++.+|+. ||++|--
T Consensus 377 ImyEmLvGyPPF~s~tp~~--------T~rkI~nwr~~l~fP----~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQE--------TYRKIVNWRETLKFP----EEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHhCCCCCCCCCHHH--------HHHHHHHHhhhccCC----CcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999997655432 444443322 11111 111223567889999998 9999985
No 108
>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase. Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well
Probab=100.00 E-value=1.7e-35 Score=286.20 Aligned_cols=243 Identities=25% Similarity=0.395 Sum_probs=181.8
Q ss_pred HHhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcce
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKR 217 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~ 217 (453)
...+.+.+.||+|+||.||+|... .+..||+|.+..... ....+..| +++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 344566789999999999999864 367899998875332 23345554 45556667778
Q ss_pred EEEEEecCCCChhhhhhhccC---CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC---ceEEE
Q 048517 218 ALVYEYMPNGSLDRHIFSKEN---KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF---IPKVS 291 (453)
Q Consensus 218 ~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~---~~kl~ 291 (453)
+++|||+++|+|.+++..... ....++|..++.++.||+.||+|||+. +++|+||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 999999999999999855321 123689999999999999999999998 999999999999998654 69999
Q ss_pred ecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHH
Q 048517 292 DFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVY 370 (453)
Q Consensus 292 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 370 (453)
|||+++................+..|+|||++.+. .++.++|||||||++|||++ |+.||...... ...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--------~~~ 231 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG--IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--------EVM 231 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHH
Confidence 99999876433222222233345789999999753 78999999999999999997 88888643221 122
Q ss_pred HHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517 371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421 (453)
Q Consensus 371 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le 421 (453)
+.+........ +...+..+.+++.+|++.+|++|||+.+|++.|+
T Consensus 232 ~~~~~~~~~~~------~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 232 EFVTGGGRLDP------PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHcCCcCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 22222222111 1223457889999999999999999999999886
No 109
>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional
Probab=100.00 E-value=1.4e-35 Score=296.03 Aligned_cols=234 Identities=23% Similarity=0.278 Sum_probs=181.8
Q ss_pred HHHHHhhhhhcccCccCceEEEEEEEc-C-CcEEEEEEecCCC----CCHHHHHHH--------------HhcccccCcc
Q 048517 157 EIIAVTNHFTHKLGQGGFGSVYKGQLH-T-GRLIAVKMMENSK----FSAEEFINE--------------LLGLCSEGFK 216 (453)
Q Consensus 157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~-~-g~~VAVK~l~~~~----~~~~~~i~e--------------l~g~~~~~~~ 216 (453)
.+....+.+.+.||+|+||.||+|+.. + +..||+|.+.... ...+.+..| +++++.....
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 444556778899999999999999854 3 3689999986532 122233333 5667777888
Q ss_pred eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517 217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA 296 (453)
Q Consensus 217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 296 (453)
.++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a 178 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFA 178 (340)
T ss_pred EEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCC
Confidence 9999999999999998843 24689999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517 297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG 376 (453)
Q Consensus 297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~ 376 (453)
+...... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+..+..+
T Consensus 179 ~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--------~~~~~~i~~~ 243 (340)
T PTZ00426 179 KVVDTRT-----YTLCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPFYANEP--------LLIYQKILEG 243 (340)
T ss_pred eecCCCc-----ceecCChhhcCHHHHhCC--CCCccccccchhhHHHHHhcCCCCCCCCCH--------HHHHHHHhcC
Confidence 8654321 345699999999999764 678999999999999999999999975432 1233333332
Q ss_pred CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 048517 377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLEM 419 (453)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 419 (453)
... .+...+..+.+++.+|++.+|++|+ |++++++.
T Consensus 244 ~~~-------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 244 IIY-------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCC-------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 211 1122345678899999999999995 89988764
No 110
>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase
Probab=100.00 E-value=4.8e-35 Score=280.95 Aligned_cols=244 Identities=21% Similarity=0.318 Sum_probs=186.3
Q ss_pred hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYE 222 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E 222 (453)
.+.+.++||+|+||.||+|+. .+++.||||.+..... ...++..| +++++......++++|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 356778999999999999995 4789999998764221 12234443 4555666677899999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 302 (453)
|+++|+|.+++.........+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999988754333345688899999999999999999998 9999999999999999999999999999876443
Q ss_pred CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517 303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382 (453)
Q Consensus 303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 382 (453)
.. ......+++.|+|||.+.+. .++.++|+||||+++|||++|+.|+...... ... ....+.......
T Consensus 160 ~~--~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-----~~~-~~~~~~~~~~~~-- 227 (267)
T cd08228 160 TT--AAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LFS-LCQKIEQCDYPP-- 227 (267)
T ss_pred hH--HHhcCCCCccccChhhhccC--CCCchhhHHHHHHHHHHHhcCCCCCcccccc-----HHH-HHHHHhcCCCCC--
Confidence 22 12345688999999998764 6788999999999999999999998543211 011 122222222111
Q ss_pred chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517 383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 423 (453)
Q Consensus 383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~ 423 (453)
......+..+.+++.+||+.+|++||++++|++.|+..
T Consensus 228 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 ---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11233456789999999999999999999999999863
No 111
>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.
Probab=100.00 E-value=3.9e-35 Score=281.55 Aligned_cols=244 Identities=23% Similarity=0.336 Sum_probs=187.0
Q ss_pred hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYE 222 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E 222 (453)
.+++.+.||+|+||.||+++. .+|+.+|||.+..... ...++.+| +++++..+...+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 356778999999999999994 5899999998765322 12233333 4566667778899999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 302 (453)
|+++++|.+++.........+++..++.++.+++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999998864333446789999999999999999999998 9999999999999999999999999998866443
Q ss_pred CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517 303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382 (453)
Q Consensus 303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 382 (453)
.. ......++..|+|||++.+. .++.++||||||+++|||++|..|+....... .. ..+.+........
T Consensus 160 ~~--~~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~-~~~~~~~~~~~~~- 228 (267)
T cd08229 160 TT--AAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YS-LCKKIEQCDYPPL- 228 (267)
T ss_pred Cc--ccccccCCcCccCHHHhcCC--CccchhhHHHHHHHHHHHHhCCCCcccccchH-----HH-HhhhhhcCCCCCC-
Confidence 22 12334688999999998764 68889999999999999999999986432110 00 1112222111111
Q ss_pred chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517 383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 423 (453)
Q Consensus 383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~ 423 (453)
.....+..+.+++.+||+.+|++||||.+|++++++.
T Consensus 229 ----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 ----PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ----CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1123556788999999999999999999999999863
No 112
>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina
Probab=100.00 E-value=3.3e-35 Score=282.73 Aligned_cols=242 Identities=24% Similarity=0.378 Sum_probs=174.0
Q ss_pred cccCccCceEEEEEEEcC---CcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517 167 HKLGQGGFGSVYKGQLHT---GRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEYMPNG 227 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~---g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g 227 (453)
++||+|+||.||+|...+ ...+|+|.+...... ...+++| +++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 469999999999997543 457889987653322 2334444 456677778899999999999
Q ss_pred ChhhhhhhccC-CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 228 SLDRHIFSKEN-KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 228 sL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
+|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865432 223457888899999999999999998 99999999999999999999999999987644333222
Q ss_pred eecccCCCCCccChhhhccc-----CCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517 307 SISDTRGTIGYLAPELISRN-----FGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 380 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~-----~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 380 (453)
......++..|+|||++... ...++.++||||||+++|||++ |+.|+...... .............
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--------~~~~~~~~~~~~~ 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--------QVLKQVVREQDIK 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--------HHHHHHhhccCcc
Confidence 22334567789999987532 1256889999999999999999 67777543211 1111111112111
Q ss_pred ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517 381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421 (453)
Q Consensus 381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le 421 (453)
+... ......+..+.+++..|+ .||++|||+++|+++|.
T Consensus 230 ~~~~-~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKP-QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCC-cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111 122334556777888898 59999999999999873
No 113
>PLN00034 mitogen-activated protein kinase kinase; Provisional
Probab=100.00 E-value=5.4e-35 Score=293.18 Aligned_cols=232 Identities=25% Similarity=0.387 Sum_probs=172.9
Q ss_pred hhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517 164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
++.++||+|+||.||+|+.. +|+.||||++...... .+++.+| +++++......++||||+++
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence 45678999999999999954 7899999998653321 2233333 56677778889999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|+|.+.. ...+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 157 ~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 223 (353)
T PLN00034 157 GSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-- 223 (353)
T ss_pred Ccccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence 9986532 345677889999999999999998 999999999999999999999999999987643321
Q ss_pred eecccCCCCCccChhhhcccC---CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 307 SISDTRGTIGYLAPELISRNF---GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~---~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
......||..|+|||.+.... ...+.++|||||||++|||++|+.||....... +.... ..........
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~----~~~~~-~~~~~~~~~~--- 295 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD----WASLM-CAICMSQPPE--- 295 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc----HHHHH-HHHhccCCCC---
Confidence 123457999999999885321 134568999999999999999999997332211 11111 1111111111
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
........+.+++.+||+.||++|||+.|+++.
T Consensus 296 ---~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 296 ---APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122345678999999999999999999999883
No 114
>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including
Probab=100.00 E-value=1.1e-35 Score=290.34 Aligned_cols=250 Identities=23% Similarity=0.366 Sum_probs=180.6
Q ss_pred HHHhhhhhcccCccCceEEEEEEEcC---------------CcEEEEEEecCCCC--CHHHHHHH--------------H
Q 048517 159 IAVTNHFTHKLGQGGFGSVYKGQLHT---------------GRLIAVKMMENSKF--SAEEFINE--------------L 207 (453)
Q Consensus 159 ~~~~~~~~~~LG~G~fG~Vy~g~~~~---------------g~~VAVK~l~~~~~--~~~~~i~e--------------l 207 (453)
....+.+.++||+|+||.||+++... ...||||.+..... ..+++.+| +
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 34567788999999999999987532 23589999876422 12334444 4
Q ss_pred hcccccCcceEEEEEecCCCChhhhhhhccC--------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcc
Q 048517 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKEN--------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHN 279 (453)
Q Consensus 208 ~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~N 279 (453)
++++......++||||+++++|.+++..... ....++|..++.++.+++.||+|||+. +++|+||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence 5667777888999999999999998854321 112478899999999999999999998 99999999999
Q ss_pred eEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc--CCCCCCCCc
Q 048517 280 ILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG--GRRNSNMNA 357 (453)
Q Consensus 280 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt--g~~p~~~~~ 357 (453)
|+++.++.+||+|||+++...............++..|+|||.+.. +.++.++||||||++++||++ +..|+....
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc--CCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 9999999999999999986544332222233456778999998875 378999999999999999998 455654332
Q ss_pred cccccccchHHHHHHhhhC-CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517 358 TRSSKAYFPSWVYDQLNKG-GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421 (453)
Q Consensus 358 ~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le 421 (453)
... ......+..... ..... ..+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 238 ~~~----~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 238 DEQ----VIENTGEFFRNQGRQIYL----SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred hHH----HHHHHHHhhhhccccccC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111 000111111111 10000 011123457999999999999999999999999986
No 115
>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-35 Score=301.11 Aligned_cols=223 Identities=26% Similarity=0.399 Sum_probs=182.5
Q ss_pred hhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHH---------------HHHHHhcccccCcceEEEEEe
Q 048517 164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEE---------------FINELLGLCSEGFKRALVYEY 223 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~---------------~i~el~g~~~~~~~~~lv~E~ 223 (453)
.|.+.||+|.||+|+++.++ +++.+|||++++... ..+. |+..|+.+++...+.++||||
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey 450 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY 450 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence 35578999999999999965 788999999988432 2222 222378888999999999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
..||++..+. ....|+...+.-++.+|+.||.|||++ +||+||||.+|||||.+|++||+||||++-.-...
T Consensus 451 ~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 451 VAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred cCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCCC
Confidence 9999965444 336799999999999999999999998 99999999999999999999999999998654333
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
. .+++..|||-|||||++.+. .|+...|.|||||+||||+.|..||...++.+ +.+.+.....
T Consensus 523 ~--~TsTfCGTpey~aPEil~e~--~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee--------~FdsI~~d~~----- 585 (694)
T KOG0694|consen 523 D--RTSTFCGTPEFLAPEVLTEQ--SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE--------VFDSIVNDEV----- 585 (694)
T ss_pred C--ccccccCChhhcChhhhccC--cccchhhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHhcCCC-----
Confidence 2 34678999999999999875 89999999999999999999999998766432 3333333221
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCCH
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPSM 413 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~ 413 (453)
..+..++.+...++.++|..+|++|--+
T Consensus 586 --~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 --RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2455567788999999999999999966
No 116
>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D
Probab=100.00 E-value=2.8e-35 Score=299.63 Aligned_cols=250 Identities=24% Similarity=0.393 Sum_probs=187.1
Q ss_pred HHHHHhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC--HHHHHHH---------------Hhccccc
Q 048517 157 EIIAVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSE 213 (453)
Q Consensus 157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~ 213 (453)
++....+.+.++||+|+||.||+|+.. .++.||||+++..... .+.++.| +++.|..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 444445566789999999999999854 3468999999764322 2334444 3456667
Q ss_pred CcceEEEEEecCCCChhhhhhhccC-------------------------------------------------------
Q 048517 214 GFKRALVYEYMPNGSLDRHIFSKEN------------------------------------------------------- 238 (453)
Q Consensus 214 ~~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------- 238 (453)
....++|+||+++|+|.++++....
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 7788999999999999999864321
Q ss_pred ---------------------------------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcc
Q 048517 239 ---------------------------------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHN 279 (453)
Q Consensus 239 ---------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~N 279 (453)
....++|..+..++.|++.||+|||+. +|+||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence 112467888899999999999999997 99999999999
Q ss_pred eEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcc
Q 048517 280 ILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAT 358 (453)
Q Consensus 280 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~ 358 (453)
||++.++.+||+|||+++...............++..|+|||.+... .++.++||||||+++|||++ |+.|+.....
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN--LYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC--CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 99999999999999999865433322222334578899999998763 68899999999999999998 8888754321
Q ss_pred ccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517 359 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI 424 (453)
Q Consensus 359 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~ 424 (453)
. ......+..+..... +...+..+.+++.+||+.+|++||+++++++.|+..+
T Consensus 348 ~-------~~~~~~~~~~~~~~~------p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 N-------EQFYNAIKRGYRMAK------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred h-------HHHHHHHHcCCCCCC------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 112223333222211 1123467899999999999999999999999998754
No 117
>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a
Probab=100.00 E-value=1.1e-34 Score=278.13 Aligned_cols=244 Identities=24% Similarity=0.354 Sum_probs=187.7
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH--------------HhcccccCcceEEEEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE--------------LLGLCSEGFKRALVYE 222 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e--------------l~g~~~~~~~~~lv~E 222 (453)
.|.+.+.||+|+||.||+|... +|+.||+|.++... ...+++..| +++.+......+++||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 4567789999999999999966 89999999886421 113334443 4555666778899999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 302 (453)
|+++|+|.+++.........+++.++..++.+++.||.|||+. +|+|+||||+||+++.++.++|+|||+++.....
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999999998865444456689999999999999999999998 9999999999999999999999999998865433
Q ss_pred CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517 303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382 (453)
Q Consensus 303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 382 (453)
.. ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...... ... ..+.+..+.....
T Consensus 160 ~~--~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~-~~~~~~~~~~~~~- 228 (267)
T cd08224 160 TT--AAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYS-LCKKIEKCDYPPL- 228 (267)
T ss_pred Cc--ccceecCCccccCHHHhccC--CCCchhcHHHHHHHHHHHHHCCCCcccCCcc-----HHH-HHhhhhcCCCCCC-
Confidence 21 12334688999999998754 6889999999999999999999998543211 111 1222222222111
Q ss_pred chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517 383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 423 (453)
Q Consensus 383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~ 423 (453)
........+.+++.+||+.+|++|||+.+++++|+++
T Consensus 229 ----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 229 ----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1123456788999999999999999999999999864
No 118
>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien
Probab=100.00 E-value=8.3e-36 Score=295.64 Aligned_cols=226 Identities=23% Similarity=0.341 Sum_probs=172.9
Q ss_pred cccCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517 167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEYMPNG 227 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g 227 (453)
+.||+|+||.||+++. .+|+.||+|++..... ...++..| +.+.+......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999985 5799999999876321 12223333 344556677889999999999
Q ss_pred ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHc-CCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
+|..++.. ...+++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-- 151 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-- 151 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--
Confidence 99888742 3468999999999999999999997 5 899999999999999999999999999875433222
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... -....+.... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--------~~~~~i~~~~-~~------ 214 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILMEE-IR------ 214 (325)
T ss_pred ccccccCCcccCCHHHHccC--CCCCccccccccceeeeeccCCCCCCCCCHH--------HHHHHHhcCC-CC------
Confidence 12345699999999999764 7889999999999999999999999643221 0111221111 11
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE 418 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 418 (453)
.+..++..+.+++.+||+.||++|+ ++.++++
T Consensus 215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 1122345688899999999999996 8999875
No 119
>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the
Probab=100.00 E-value=9.2e-36 Score=297.86 Aligned_cols=236 Identities=25% Similarity=0.327 Sum_probs=181.1
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH--------------HhcccccCcceEEEEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE--------------LLGLCSEGFKRALVYE 222 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e--------------l~g~~~~~~~~~lv~E 222 (453)
.|.+.++||+|+||+||+|+.. +|+.||||++.... .....+..| +++.+.++...++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 3566789999999999999965 79999999987532 112222222 5666777888999999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 302 (453)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 82 YMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 99999999988532 5689999999999999999999997 9999999999999999999999999999865433
Q ss_pred C---------------------------CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 048517 303 N---------------------------DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM 355 (453)
Q Consensus 303 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~ 355 (453)
. .........||+.|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCceeeEecchhhhhhccCCCCCCC
Confidence 2 00112345699999999999864 789999999999999999999999975
Q ss_pred CccccccccchHHHHHHhhh-CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 048517 356 NATRSSKAYFPSWVYDQLNK-GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS-MTKVLEM 419 (453)
Q Consensus 356 ~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-~~evl~~ 419 (453)
.... .....+.. ......... ..++..+.+++.+|++ +|.+||+ ++++++.
T Consensus 233 ~~~~--------~~~~~i~~~~~~~~~p~~----~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 233 DTLQ--------ETYNKIINWKESLRFPPD----PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCHH--------HHHHHHhccCCcccCCCC----CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 4321 11222222 111111111 1145678889999998 9999999 9999874
No 120
>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways
Probab=100.00 E-value=3.3e-35 Score=291.72 Aligned_cols=228 Identities=21% Similarity=0.316 Sum_probs=172.1
Q ss_pred cccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH----HHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517 167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA----EEFINE---------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~----~~~i~e---------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
+.||+|+||.||+++. .+++.||||++....... +.+..| +++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999995 468899999997642211 112222 34555667788999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-- 151 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-- 151 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--
Confidence 999888742 24689999999999999999999998 999999999999999999999999999975322221
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
......||+.|+|||++.+. .++.++||||||+++|||++|+.||....... ......+....+.... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~-~~------ 221 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIITDNP-DMNTEDYLFQVILEKP-IR------ 221 (327)
T ss_pred ceecccCCcccCCHHHHCCC--CCCchheeehhHHHHHHHHhCCCCCCccCCCc-ccccHHHHHHHHHhCC-CC------
Confidence 12345699999999999764 78899999999999999999999996543221 1112223333333221 11
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCCCH
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRPSM 413 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~ 413 (453)
.+...+..+.+++.+||+.||++||++
T Consensus 222 ~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 222 IPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 112234567889999999999999984
No 121
>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi
Probab=100.00 E-value=5.3e-35 Score=279.44 Aligned_cols=233 Identities=28% Similarity=0.464 Sum_probs=178.3
Q ss_pred cccCccCceEEEEEEEc-C---CcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517 167 HKLGQGGFGSVYKGQLH-T---GRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~-~---g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
++||+|+||.||+|+.. . +..+|+|.+..... ..+++..| +++++. ....+++|||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999743 2 36899999886544 33445444 234443 4467899999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|+|.+++... ..+++..+..++.|++.||+|||.. +++|+||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999998532 3689999999999999999999998 99999999999999999999999999998765433221
Q ss_pred -eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517 307 -SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384 (453)
Q Consensus 307 -~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 384 (453)
......++..|+|||.+... .++.++||||||+++|||++ |+.||...... -....+.......
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--------~~~~~~~~~~~~~---- 218 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYG--KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--------EVIAMLESGERLP---- 218 (257)
T ss_pred ccccCccccccccCHHHhcCC--CCCccchHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHHcCCcCC----
Confidence 11223345789999998753 78999999999999999998 99998643321 1223333332221
Q ss_pred hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 423 (453)
Q Consensus 385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~ 423 (453)
.+...+..+.+++.+||+.+|++||++.++++.|++.
T Consensus 219 --~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 --RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred --CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1122346788999999999999999999999999874
No 122
>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an
Probab=100.00 E-value=1.4e-35 Score=290.87 Aligned_cols=244 Identities=23% Similarity=0.324 Sum_probs=175.0
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
.|.+.++||+|+||.||+|+.. +++.||||++..... ....+.+| +++++......++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 4667789999999999999965 789999999875322 12223333 456667777889999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
+ ++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 86 H-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred C-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence 5 677777643 235688999999999999999999998 999999999999999999999999999975433221
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC--------
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG-------- 376 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~-------- 376 (453)
......+|+.|+|||.+.+. ..++.++||||+||++|||++|+.||........ .+ ..+...+...
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 159 --TYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QL-ERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred --cCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HH-HHHHHHhCCCChhhccch
Confidence 12345689999999998653 3578899999999999999999999975322100 00 0000000000
Q ss_pred --------CCccccchhhhHH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 377 --------GDLELRNVTEIES-----MIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 377 --------~~~~~~~~~~~~~-----~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
............. .....+.+++.+||+.||++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000000 12245778999999999999999999986
No 123
>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory
Probab=100.00 E-value=2.9e-35 Score=285.23 Aligned_cols=242 Identities=26% Similarity=0.419 Sum_probs=181.9
Q ss_pred hhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC-HHHHHHH--------------HhcccccCcceEEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEGFKRALV 220 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~~~~~lv 220 (453)
...+.++||+|+||.||++... ++..+|+|.+...... .+++..| +++++..+...+++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 3456789999999999999742 4668999988764322 2334333 44566677778999
Q ss_pred EEecCCCChhhhhhhccC-----------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceE
Q 048517 221 YEYMPNGSLDRHIFSKEN-----------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPK 289 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~k 289 (453)
+||+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +++|+||||+|||+++++.+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEE
Confidence 999999999999864321 113589999999999999999999998 999999999999999999999
Q ss_pred EEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHH
Q 048517 290 VSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSW 368 (453)
Q Consensus 290 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 368 (453)
|+|||+++...............+++.|+|||.+.+. .++.++|||||||++|||++ |+.||.......
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------- 232 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-------- 232 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--------
Confidence 9999999865433322222333457889999998764 78999999999999999998 888875432211
Q ss_pred HHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 369 VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 369 ~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
.......+..... +...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 233 ~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 233 AIECITQGRELER------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHHHcCccCCC------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1222222222111 11234568899999999999999999999999873
No 124
>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C. Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re
Probab=100.00 E-value=2.2e-35 Score=291.70 Aligned_cols=226 Identities=24% Similarity=0.307 Sum_probs=174.2
Q ss_pred cccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHH---------------HHhcccccCcceEEEEEecCC
Q 048517 167 HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFIN---------------ELLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~---------------el~g~~~~~~~~~lv~E~~~~ 226 (453)
+.||+|+||+||+++.. +++.||||++.... ...+.+.. .+++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 68899999987532 11122222 245666777789999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|+|..++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 151 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-- 151 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--
Confidence 999888743 24689999999999999999999998 999999999999999999999999999875322221
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+......
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--------~~~~~i~~~~~~------- 214 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQ--PYGPAVDWWALGVLLYEMLAGQSPFEGDDED--------ELFQSILEDEVR------- 214 (318)
T ss_pred cccceecCccccCHHHhcCC--CCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--------HHHHHHHcCCCC-------
Confidence 12334689999999999764 7889999999999999999999999644321 122222222111
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRPSM-----TKVLE 418 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~-----~evl~ 418 (453)
.+..++..+.+++.+||+.||++|||+ .++++
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 112244678899999999999999999 88765
No 125
>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,
Probab=100.00 E-value=3.1e-35 Score=286.00 Aligned_cols=236 Identities=28% Similarity=0.363 Sum_probs=179.5
Q ss_pred hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC----HHHHHHH--------------HhcccccCcceEEEEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS----AEEFINE--------------LLGLCSEGFKRALVYE 222 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~----~~~~i~e--------------l~g~~~~~~~~~lv~E 222 (453)
||+..+.||+|+||+||++.. .+++.||||++...... ...+.+| +++.+..+...++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 355678899999999999995 47899999998753211 1223333 3455666778999999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 302 (453)
|+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++|+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999887532 234689999999999999999999998 9999999999999999999999999999875433
Q ss_pred CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517 303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382 (453)
Q Consensus 303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 382 (453)
.. .....||+.|+|||++.+. .++.++||||+|+++|||++|+.||....... ....+...+....
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~----- 221 (285)
T cd05605 156 ET---IRGRVGTVGYMAPEVVKNE--RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV----KREEVERRVKEDQ----- 221 (285)
T ss_pred Cc---cccccCCCCccCcHHhcCC--CCCccccchhHHHHHHHHHHCCCCCCCCchhh----HHHHHHHHhhhcc-----
Confidence 22 1344689999999999753 78899999999999999999999997533211 0011111221111
Q ss_pred chhhhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517 383 NVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE 418 (453)
Q Consensus 383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 418 (453)
...+..++..+.+++.+||+.||++|| ++.++++
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 --EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred --cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 112233556788999999999999999 7888855
No 126
>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1. Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=4.3e-35 Score=291.66 Aligned_cols=187 Identities=26% Similarity=0.357 Sum_probs=153.1
Q ss_pred HHHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEE
Q 048517 158 IIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALV 220 (453)
Q Consensus 158 ~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv 220 (453)
+....|++.++||+|+||.||++... +++.+|+|++..... ..+++..| +++++..+...++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 34456778899999999999999965 788999998876422 12334333 56677788889999
Q ss_pred EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517 221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 300 (453)
|||+++|+|.+++.. ...+++..+..++.+++.||.|||+. .+|+|+||||+|||++.++.+||+|||++....
T Consensus 82 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 82 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 999999999998843 24588899999999999999999974 279999999999999999999999999997653
Q ss_pred CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 048517 301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMN 356 (453)
Q Consensus 301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~ 356 (453)
... .....||..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 156 ~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 156 DSM----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hhc----cccCCCCccccCHHHhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 321 1334689999999999764 6889999999999999999999998643
No 127
>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase. Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa
Probab=100.00 E-value=3.8e-35 Score=281.07 Aligned_cols=242 Identities=26% Similarity=0.429 Sum_probs=186.8
Q ss_pred HHHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 158 IIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 158 ~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
+...++.+.++||+|+||.||++..+++..+|+|.+.......+.+.+| +.+++.. ...+++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 3455677889999999999999998888889999987655555566555 2233334 567899999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++|+|.+++... ....+++.++..++.+++.||+|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 82 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999998542 345689999999999999999999998 99999999999999999999999999998654332
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 382 (453)
. .......++..|+|||++.. +.++.++|+||||++++|+++ |+.|+...... -....+..+....
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~~~-- 223 (260)
T cd05073 157 Y-TAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--------EVIRALERGYRMP-- 223 (260)
T ss_pred c-ccccCCcccccccCHhHhcc--CCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHhCCCCCC--
Confidence 2 12223446678999999875 378889999999999999998 88888643211 1122222222211
Q ss_pred chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
.....+..+.+++.+|++.+|++||++.++.++|+.
T Consensus 224 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 ----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 112334568899999999999999999999999974
No 128
>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells
Probab=100.00 E-value=7.1e-35 Score=280.60 Aligned_cols=242 Identities=24% Similarity=0.380 Sum_probs=174.0
Q ss_pred cccCccCceEEEEEEEcC---CcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517 167 HKLGQGGFGSVYKGQLHT---GRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEYMPNG 227 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~---g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g 227 (453)
+.||+|+||.||+|...+ +..+|+|.+...... ..++.+| +++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998653 467999988764322 2234443 466777777889999999999
Q ss_pred ChhhhhhhccC-CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 228 SLDRHIFSKEN-KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 228 sL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
+|.+++..... ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999865332 223567788889999999999999998 99999999999999999999999999997654333222
Q ss_pred eecccCCCCCccChhhhcccCC-----CCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517 307 SISDTRGTIGYLAPELISRNFG-----TVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 380 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~-----~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 380 (453)
......++..|+|||++....+ .++.++||||||+++|||++ |+.||....... ............
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--------VLTYTVREQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--------HHHHHhhcccCC
Confidence 2233457888999999864211 35789999999999999996 999986433211 111111111111
Q ss_pred ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517 381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421 (453)
Q Consensus 381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le 421 (453)
..... ........+.+++..|+ .+|++|||+++|+..|+
T Consensus 230 ~~~~~-~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPR-LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCc-cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11100 11112345777889998 58999999999999875
No 129
>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr
Probab=100.00 E-value=1.6e-35 Score=293.36 Aligned_cols=222 Identities=27% Similarity=0.329 Sum_probs=169.9
Q ss_pred cccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517 167 HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFINE---------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
+.||+|+||+||+|+.. +|+.||||++..... ...+++.| +++.+......++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999964 799999999875321 12222222 33445566778999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 151 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-- 151 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--
Confidence 999988843 34688999999999999999999998 999999999999999999999999999875432221
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ...+.+..... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~~~-~~----- 215 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA--------EMYDNILNKPL-RL----- 215 (323)
T ss_pred ccccccCChhhcChhhhcCC--CCCccccccccchhhhhhhcCCCCCCCCCHH--------HHHHHHHcCCC-CC-----
Confidence 22345699999999998764 7889999999999999999999999643211 12222222211 11
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCCCHH
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRPSMT 414 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ 414 (453)
....+..+.+++.+||+.+|++||++.
T Consensus 216 -~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 -KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 112346688999999999999999984
No 130
>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke
Probab=100.00 E-value=3e-35 Score=286.82 Aligned_cols=248 Identities=23% Similarity=0.358 Sum_probs=182.4
Q ss_pred HhhhhhcccCccCceEEEEEEEcC-----------------CcEEEEEEecCCCC--CHHHHHHH--------------H
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLHT-----------------GRLIAVKMMENSKF--SAEEFINE--------------L 207 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~~-----------------g~~VAVK~l~~~~~--~~~~~i~e--------------l 207 (453)
..+.+.++||+|+||.||+++..+ +..||+|++..... ..+++..| +
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 356778999999999999987542 35689999876432 23344443 4
Q ss_pred hcccccCcceEEEEEecCCCChhhhhhhccC-------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcce
Q 048517 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKEN-------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNI 280 (453)
Q Consensus 208 ~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NI 280 (453)
++++..+...++++||+++++|.+++..... ....+++..++.++.|++.||+|||+. +|+|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence 5566667788999999999999999854331 123689999999999999999999998 999999999999
Q ss_pred EEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc--CCCCCCCCcc
Q 048517 281 LLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG--GRRNSNMNAT 358 (453)
Q Consensus 281 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt--g~~p~~~~~~ 358 (453)
+++.++.++|+|||+++...............+|..|+|||.+.+. .++.++||||||+++|||++ |..|+.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG--KFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC--CCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999999865444333233445578899999998753 78999999999999999998 5566643221
Q ss_pred ccccccchHHHHHHhhhCC-CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517 359 RSSKAYFPSWVYDQLNKGG-DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421 (453)
Q Consensus 359 ~~~~~~~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le 421 (453)
..+...+.... ..........+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 240 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 --------QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --------HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11222221110 00000000111223457899999999999999999999999986
No 131
>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase. Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ
Probab=100.00 E-value=9.5e-35 Score=277.14 Aligned_cols=236 Identities=28% Similarity=0.495 Sum_probs=183.7
Q ss_pred hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNG 227 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g 227 (453)
.+.+.+.||+|+||.||++...+++.+|+|.+........++..| +++++......++++||++++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG 84 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence 456678999999999999997778899999988765555566555 345666777889999999999
Q ss_pred ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517 228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 307 (453)
Q Consensus 228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 307 (453)
+|.+++... ...++++.+..++.+++.||+|||+. +++|+||||+||+++.++.+||+|||+++........ .
T Consensus 85 ~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~ 157 (256)
T cd05112 85 CLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-S 157 (256)
T ss_pred cHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc-c
Confidence 999988432 24588999999999999999999998 9999999999999999999999999999865433211 1
Q ss_pred ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
.....++.+|+|||.+.+. .++.++||||||+++|||++ |+.|+...... ...+.+.++.....
T Consensus 158 ~~~~~~~~~~~aPe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~----- 222 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFS--KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--------EVVETINAGFRLYK----- 222 (256)
T ss_pred cCCCccchhhcCHhHhccC--CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--------HHHHHHhCCCCCCC-----
Confidence 1233456789999998753 78899999999999999998 88888643211 12223332221111
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 420 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 420 (453)
+...+..+.+++.+||+.+|++|||+.+++++|
T Consensus 223 -~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 223 -PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 111235688999999999999999999999987
No 132
>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament
Probab=100.00 E-value=2.8e-35 Score=286.74 Aligned_cols=243 Identities=23% Similarity=0.333 Sum_probs=175.4
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
.|.+.++||+|+||.||+|+.. +++.||+|++..... ....+.+| +++++......++||||+
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 3566789999999999999854 789999999875321 22233333 455666667788999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
+ |+|.+++.. .+..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 86 D-SDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred C-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 7 588887743 234578899999999999999999998 999999999999999999999999999976533221
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh---------
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK--------- 375 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~--------- 375 (453)
......+|+.|+|||.+.+. ..++.++||||+||++|||++|+.||........ + ..+...+..
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~---~-~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE---L-HLIFRLLGTPTEETWPGI 231 (288)
T ss_pred --cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---H-HHHHHHhCCCChHHhhcc
Confidence 12345689999999998653 3678999999999999999999999865432110 0 000000000
Q ss_pred --CC---Ccccc-----chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 376 --GG---DLELR-----NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 376 --~~---~~~~~-----~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.. ..... .........+....+++.+||+.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00 00000 000011123456789999999999999999999975
No 133
>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer. Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c
Probab=100.00 E-value=6.2e-35 Score=277.45 Aligned_cols=232 Identities=26% Similarity=0.413 Sum_probs=178.8
Q ss_pred cccCccCceEEEEEEEcCCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEecCCCChh
Q 048517 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLD 230 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL~ 230 (453)
+.||+|+||.||+|...+++.||+|.+...... ...+.+| +++++......++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 369999999999999888999999998764322 2234333 456677777889999999999999
Q ss_pred hhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecc
Q 048517 231 RHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISD 310 (453)
Q Consensus 231 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 310 (453)
+++... ...+++..+..++.+++.||.|||+. +++|+||||+||+++.++.+||+|||++........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 153 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGL 153 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCC
Confidence 988432 24588999999999999999999998 999999999999999999999999999975433221 11122
Q ss_pred cCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHH
Q 048517 311 TRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 389 (453)
Q Consensus 311 ~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 389 (453)
..++..|+|||++.. +.++.++||||||+++||+++ |..||...... .....+..+..... +.
T Consensus 154 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~------~~ 217 (250)
T cd05085 154 KQIPIKWTAPEALNY--GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--------QAREQVEKGYRMSC------PQ 217 (250)
T ss_pred CCCcccccCHHHhcc--CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHcCCCCCC------CC
Confidence 345678999999875 478899999999999999998 88888643221 12223333222211 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517 390 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421 (453)
Q Consensus 390 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le 421 (453)
..+..+.+++.+|++.+|++|||+.++++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 23467899999999999999999999999886
No 134
>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase. Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M
Probab=100.00 E-value=4.1e-35 Score=285.09 Aligned_cols=242 Identities=26% Similarity=0.423 Sum_probs=182.3
Q ss_pred hhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRAL 219 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~l 219 (453)
.+.+.++||+|+||.||+++.+ ++..||+|++..... ...++..| +++++..+...++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (288)
T cd05050 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCL 85 (288)
T ss_pred hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEE
Confidence 4556789999999999999853 467899999875432 12334433 4566777778899
Q ss_pred EEEecCCCChhhhhhhcc------------------CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceE
Q 048517 220 VYEYMPNGSLDRHIFSKE------------------NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNIL 281 (453)
Q Consensus 220 v~E~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIL 281 (453)
++||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +++||||||+||+
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil 162 (288)
T cd05050 86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCL 162 (288)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheE
Confidence 999999999999985321 1123578889999999999999999998 9999999999999
Q ss_pred EcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcccc
Q 048517 282 LDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRS 360 (453)
Q Consensus 282 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~ 360 (453)
++.++.+||+|||+++................+..|+|||.+.+. .++.++|||||||++|||++ |..|+......
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 999999999999998865433222222233456789999998754 78999999999999999997 77777533211
Q ss_pred ccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 361 SKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 361 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
-....+..+..... +...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 240 -------~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 -------EVIYYVRDGNVLSC------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -------HHHHHHhcCCCCCC------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 12223333322211 11234578899999999999999999999999974
No 135
>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept
Probab=100.00 E-value=8.9e-35 Score=285.27 Aligned_cols=246 Identities=25% Similarity=0.405 Sum_probs=185.6
Q ss_pred HHHHhhhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC--HHHHHHH---------------HhcccccC
Q 048517 158 IIAVTNHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSEG 214 (453)
Q Consensus 158 ~~~~~~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~~ 214 (453)
+....+.+.+.||+|+||.||++... ++..||||++...... .+.+..| +++.+...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 44455677889999999999999741 3558999998764322 2233333 44566677
Q ss_pred cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecC
Q 048517 215 FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG 294 (453)
Q Consensus 215 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 294 (453)
...+++|||+++|+|.+++.... ...+++.++..++.+++.||+|||+. +|+|+||||+|||++.+..+|++|||
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence 78899999999999999885422 23489999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHh
Q 048517 295 LAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQL 373 (453)
Q Consensus 295 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l 373 (453)
+++...............++..|+|||.+... .++.++||||+|+++|||++ |+.|+...... ....+.+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-------~~~~~~~ 257 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-------SKFYKLI 257 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccC--CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-------HHHHHHH
Confidence 99866544332222334567889999998754 68899999999999999998 88887643221 1112222
Q ss_pred hhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517 374 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 423 (453)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~ 423 (453)
..+..... +...+..+.+++.+||+.+|++|||+.++++.|+..
T Consensus 258 ~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 258 KEGYRMAQ------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HcCCcCCC------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 22221111 112245688999999999999999999999999863
No 136
>PHA03212 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=8.5e-35 Score=295.56 Aligned_cols=247 Identities=21% Similarity=0.215 Sum_probs=176.1
Q ss_pred HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHH-HHH--------HHhcccccCcceEEEEEecCCCChh
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEE-FIN--------ELLGLCSEGFKRALVYEYMPNGSLD 230 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~-~i~--------el~g~~~~~~~~~lv~E~~~~gsL~ 230 (453)
..|.+.++||+|+||.||++.. .+++.||+|.........|. .+. ++++++..+...++|+|++. ++|.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~ 170 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLY 170 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHH
Confidence 4577788999999999999984 57899999976543222221 111 25666777778899999994 7888
Q ss_pred hhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecc
Q 048517 231 RHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISD 310 (453)
Q Consensus 231 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 310 (453)
+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 171 ~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~~~~ 242 (391)
T PHA03212 171 CYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKYYG 242 (391)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-ccccc
Confidence 87733 24689999999999999999999998 999999999999999999999999999975432211 11234
Q ss_pred cCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccc---hHHHHH----------------
Q 048517 311 TRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF---PSWVYD---------------- 371 (453)
Q Consensus 311 ~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~---~~~~~~---------------- 371 (453)
..||+.|+|||++.+. .++.++|||||||++|||++|+.|+............ ...+..
T Consensus 243 ~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~ 320 (391)
T PHA03212 243 WAGTIATNAPELLARD--PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN 320 (391)
T ss_pred ccCccCCCChhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence 5799999999999764 7899999999999999999999886533211100000 000000
Q ss_pred ------HhhhCCCccc--cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 372 ------QLNKGGDLEL--RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 372 ------~l~~~~~~~~--~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.......... ..........+..+..++.+||+.||++|||++|+++
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 0001112234567889999999999999999999986
No 137
>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored
Probab=100.00 E-value=5.1e-35 Score=281.10 Aligned_cols=240 Identities=28% Similarity=0.437 Sum_probs=181.1
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCc---EEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGR---LIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVY 221 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~---~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~ 221 (453)
.+...+.||+|+||.||+|+.. +++ .+|+|.+..... ..+++..| +.+++......++||
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT 85 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence 4456688999999999999964 333 799999875422 22334444 455566677789999
Q ss_pred EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517 222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 301 (453)
Q Consensus 222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 301 (453)
||+++++|.+++... ...+++.++..++.+++.||+|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 86 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 86 EYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999988432 25689999999999999999999998 999999999999999999999999999986643
Q ss_pred CCCcee-ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517 302 ENDFVS-ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDL 379 (453)
Q Consensus 302 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~ 379 (453)
...... ......+..|+|||++... .++.++||||||+++|||++ |+.|+...... .....+.++...
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--------~~~~~i~~~~~~ 229 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--------EVMKAINDGFRL 229 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcC--CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--------HHHHHHhcCCCC
Confidence 322111 1122335679999998753 68899999999999999997 99998643321 122333332221
Q ss_pred cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517 380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 423 (453)
Q Consensus 380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~ 423 (453)
.. .......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 230 ~~------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 PA------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 112345688999999999999999999999999875
No 138
>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,
Probab=100.00 E-value=3.4e-35 Score=291.25 Aligned_cols=225 Identities=25% Similarity=0.293 Sum_probs=170.6
Q ss_pred cccCccCceEEEEEEE-cCCcEEEEEEecCCC----CCHHHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517 167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSK----FSAEEFINE---------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~----~~~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
+.||+|+||.||+++. .+|+.||||++.... ....++..| +++.+......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999985 579999999986531 111222222 34555667788999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|+|..++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 151 (325)
T cd05604 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-- 151 (325)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--
Confidence 99988774 235689999999999999999999998 999999999999999999999999999875422221
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ...+.+..... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~~~~~~~-~~----- 215 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQ--PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA--------EMYDNILHKPL-VL----- 215 (325)
T ss_pred CcccccCChhhCCHHHHcCC--CCCCcCccccccceehhhhcCCCCCCCCCHH--------HHHHHHHcCCc-cC-----
Confidence 12345699999999999764 7889999999999999999999999653311 12222222211 11
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRPSMTKVL 417 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl 417 (453)
....+..+.+++.+|++.+|.+||++.+.+
T Consensus 216 -~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 216 -RPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred -CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 111335677899999999999999886433
No 139
>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit
Probab=100.00 E-value=7.6e-35 Score=284.56 Aligned_cols=248 Identities=24% Similarity=0.356 Sum_probs=179.1
Q ss_pred HhhhhhcccCccCceEEEEEEEc-----------------CCcEEEEEEecCCCC--CHHHHHHH--------------H
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLH-----------------TGRLIAVKMMENSKF--SAEEFINE--------------L 207 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~-----------------~g~~VAVK~l~~~~~--~~~~~i~e--------------l 207 (453)
..+.+.++||+|+||.||++... ++..||+|++..... ...++..| +
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 34677889999999999998532 245799999875422 22344444 4
Q ss_pred hcccccCcceEEEEEecCCCChhhhhhhccC-------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcce
Q 048517 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKEN-------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNI 280 (453)
Q Consensus 208 ~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NI 280 (453)
++++......+++|||+++|+|.+++..... ....+++.++..++.|++.||+|||+. +++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 5566667778999999999999998864321 123578889999999999999999998 999999999999
Q ss_pred EEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc--CCCCCCCCcc
Q 048517 281 LLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG--GRRNSNMNAT 358 (453)
Q Consensus 281 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt--g~~p~~~~~~ 358 (453)
|++.++.+||+|||+++...............+++.|+|||.... +.++.++|||||||++|||++ |..|+.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 999999999999999986544332222223345678999998765 478999999999999999998 6667653322
Q ss_pred ccccccchHHHHHHhhhC-CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517 359 RSSKAYFPSWVYDQLNKG-GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421 (453)
Q Consensus 359 ~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le 421 (453)
.. .. .......... ...... .+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 240 ~~---~~-~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 EQ---VI-ENTGEFFRDQGRQVYLP----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HH---HH-HHHHHHHhhccccccCC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11 00 0011111111 111110 11123357889999999999999999999999986
No 140
>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.
Probab=100.00 E-value=1.4e-34 Score=278.18 Aligned_cols=239 Identities=26% Similarity=0.383 Sum_probs=182.9
Q ss_pred hhhhcccCccCceEEEEEEEcC--CcEEEEEEecCCCC-----------CHHHHHHH---------------HhcccccC
Q 048517 163 NHFTHKLGQGGFGSVYKGQLHT--GRLIAVKMMENSKF-----------SAEEFINE---------------LLGLCSEG 214 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~~--g~~VAVK~l~~~~~-----------~~~~~i~e---------------l~g~~~~~ 214 (453)
|.+.+.||+|+||.||+|.... ++.+|||.+..... ...+++.| +++++..+
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 4567889999999999999654 78899998764211 11223333 44566677
Q ss_pred cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecC
Q 048517 215 FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG 294 (453)
Q Consensus 215 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 294 (453)
...+++|||+++++|.+.+.........+++..++.++.|++.||.|||+. .+++|+||||+||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEeccc
Confidence 889999999999999988855434456789999999999999999999963 279999999999999999999999999
Q ss_pred CccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh
Q 048517 295 LAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN 374 (453)
Q Consensus 295 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~ 374 (453)
++....... ......|+..|+|||.+.+ +.++.++||||||+++|||++|+.|+...... . ....+.
T Consensus 160 ~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-------~-~~~~~~ 226 (269)
T cd08528 160 LAKQKQPES---KLTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNML-------S-LATKIV 226 (269)
T ss_pred ceeeccccc---ccccccCcccCcChhhhcC--CCCchHHHHHHHHHHHHHHHhCCCcccccCHH-------H-HHHHHh
Confidence 998765433 2244568999999999975 36899999999999999999999998543211 1 111222
Q ss_pred hCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517 375 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421 (453)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le 421 (453)
+...... .....+..+.+++.+||+.||++||++.|+.++++
T Consensus 227 ~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 227 EAVYEPL-----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hccCCcC-----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 2211111 11123467889999999999999999999999986
No 141
>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt
Probab=100.00 E-value=3.1e-35 Score=291.50 Aligned_cols=226 Identities=26% Similarity=0.306 Sum_probs=171.2
Q ss_pred cccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517 167 HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE---------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
+.||+|+||.||+++.. +++.||+|++.... ....++..| +++.+......++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999955 67899999987532 111222222 34455667788999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|+|.+++.. ...++...+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-- 151 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-- 151 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--
Confidence 999988843 34578888899999999999999998 999999999999999999999999999975432221
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..++.+..... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~~~~-~------ 214 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--------EMYDNILNKPL-Q------ 214 (325)
T ss_pred CcccccCCccccCHHHHcCC--CCCCccccccccHHHHHHhcCCCCCCCCCHH--------HHHHHHHhCCc-C------
Confidence 12345699999999999764 7889999999999999999999999643321 12222222111 1
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
....++..+.+++.+||+.+|.+||++.+.+.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 11123456888999999999999999875443
No 142
>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=1.3e-34 Score=285.45 Aligned_cols=247 Identities=24% Similarity=0.415 Sum_probs=184.9
Q ss_pred HhhhhhcccCccCceEEEEEEEc--------CCcEEEEEEecCCCCC--HHHHHHH---------------HhcccccCc
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLH--------TGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSEGF 215 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~--------~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~~~ 215 (453)
..+.+.++||+|+||.||+++.. .+..||+|.+...... ..++..| +++++....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 45567889999999999999742 3457999998754322 2233333 345566677
Q ss_pred ceEEEEEecCCCChhhhhhhccC------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc
Q 048517 216 KRALVYEYMPNGSLDRHIFSKEN------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD 283 (453)
Q Consensus 216 ~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~ 283 (453)
..++++||+++|+|.+++..... ....++|.++..++.|++.||.|||+. +|+|+||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 78999999999999999865321 124589999999999999999999998 999999999999999
Q ss_pred CCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcccccc
Q 048517 284 HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSK 362 (453)
Q Consensus 284 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~ 362 (453)
.++.+||+|||+++...............++..|+|||.+.+ +.++.++||||||+++|||++ |+.|+.....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---- 242 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---- 242 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHcc--CCcCccchhhHHHHHHHHHHhCCCCCCCCCCH----
Confidence 999999999999986644322222222345568999999875 378899999999999999999 8888753321
Q ss_pred ccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517 363 AYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426 (453)
Q Consensus 363 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~ 426 (453)
....+.+..+..... +...+..+.+++.+||+.+|++|||+.++++.|++....
T Consensus 243 ----~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 243 ----EELFKLLREGHRMDK------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred ----HHHHHHHHcCCCCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 123333333322221 112334678899999999999999999999999876543
No 143
>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in
Probab=100.00 E-value=8.3e-35 Score=288.28 Aligned_cols=226 Identities=25% Similarity=0.356 Sum_probs=173.3
Q ss_pred cccCccCceEEEEEEE----cCCcEEEEEEecCCCC-----CHHHHHH--------------HHhcccccCcceEEEEEe
Q 048517 167 HKLGQGGFGSVYKGQL----HTGRLIAVKMMENSKF-----SAEEFIN--------------ELLGLCSEGFKRALVYEY 223 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~----~~g~~VAVK~l~~~~~-----~~~~~i~--------------el~g~~~~~~~~~lv~E~ 223 (453)
++||+|+||.||+++. .+++.||||++..... ....+.. ++++.+..+...++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999984 3588999999875211 1111222 245667777889999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++|+|.+++.. ...+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999988843 34678888999999999999999998 99999999999999999999999999987543322
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
. ......||+.|+|||++.+. .++.++||||||+++|||++|+.||...... .....+..+.. .
T Consensus 155 ~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~pf~~~~~~--------~~~~~~~~~~~-~--- 218 (323)
T cd05584 155 T--VTHTFCGTIEYMAPEILMRS--GHGKAVDWWSLGALMYDMLTGAPPFTAENRK--------KTIDKILKGKL-N--- 218 (323)
T ss_pred C--cccccCCCccccChhhccCC--CCCCcceecccHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCC-C---
Confidence 1 12335699999999999764 6788999999999999999999999654321 12222222211 1
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE 418 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 418 (453)
.+..++..+.+++.+||+.+|++|| ++.++++
T Consensus 219 ---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 219 ---LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ---CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1122345688999999999999999 7888766
No 144
>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa. Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho
Probab=100.00 E-value=2.2e-34 Score=275.64 Aligned_cols=232 Identities=26% Similarity=0.429 Sum_probs=176.8
Q ss_pred ccCccCceEEEEEEEc---CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEecCCCC
Q 048517 168 KLGQGGFGSVYKGQLH---TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYMPNGS 228 (453)
Q Consensus 168 ~LG~G~fG~Vy~g~~~---~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gs 228 (453)
.||+|+||.||+|.+. ++..||+|++..... ..+++..| +++++. ....++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999754 456799999876432 22344444 345554 346789999999999
Q ss_pred hhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce-e
Q 048517 229 LDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-S 307 (453)
Q Consensus 229 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~ 307 (453)
|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+|||++.++.+||+|||+++......... .
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99988532 35689999999999999999999998 99999999999999999999999999998654433221 1
Q ss_pred ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
.....++..|+|||.+... .++.++||||||+++||+++ |+.|+...... -+...+.++......
T Consensus 155 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~---- 220 (257)
T cd05115 155 RSAGKWPLKWYAPECINFR--KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--------EVMSFIEQGKRLDCP---- 220 (257)
T ss_pred cCCCCCCcccCCHHHHccC--CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCCCCCCCC----
Confidence 1223346789999998753 68889999999999999996 99998644321 123334443332221
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
......+.+++.+||+.+|++||++.+|.+.|+.
T Consensus 221 --~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 221 --AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred --CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 1234578889999999999999999999999985
No 145
>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign
Probab=100.00 E-value=3.6e-35 Score=284.75 Aligned_cols=244 Identities=26% Similarity=0.408 Sum_probs=178.1
Q ss_pred hhhcccCccCceEEEEEEE-----cCCcEEEEEEecCCCC--CHHHHHHH--------------Hhccccc--CcceEEE
Q 048517 164 HFTHKLGQGGFGSVYKGQL-----HTGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSE--GFKRALV 220 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~-----~~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~--~~~~~lv 220 (453)
.+.+.||+|+||+||++.. .+++.||+|.+..... ..+.+..| +++++.. ....+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 5678999999999988652 3688999999876432 23444444 3344433 3357899
Q ss_pred EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517 221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 300 (453)
|||+++|+|.+++.. ..+++.++..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||+++...
T Consensus 87 ~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 87 MEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred ecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999998842 3589999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCcee-ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc-------ccchHHHHHH
Q 048517 301 KENDFVS-ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-------AYFPSWVYDQ 372 (453)
Q Consensus 301 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~-------~~~~~~~~~~ 372 (453)
....... .....++..|+|||.+... .++.++||||||++++||++|+.|+......-.. ........+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhccc--CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 4332111 1223456779999998753 7889999999999999999999987543211000 0000001111
Q ss_pred hhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517 373 LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 423 (453)
Q Consensus 373 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~ 423 (453)
+....... .+......+.+++.+||+.+|++|||+++++++|+.+
T Consensus 237 ~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 237 LERGMRLP------CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhcCCCCC------CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111110 1222346789999999999999999999999999864
No 146
>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus
Probab=100.00 E-value=4.9e-35 Score=294.60 Aligned_cols=236 Identities=23% Similarity=0.285 Sum_probs=170.0
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC----HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS----AEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~----~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
+.+.+.||+|+||+||+++. .+++.||||++...... ...+..| +++.+.+....++||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 45668899999999999985 46899999999753211 1122222 35556677788999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 83 LPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999998843 35689999999999999999999998 99999999999999999999999999987543211
Q ss_pred Cc---------------------------------eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCC
Q 048517 304 DF---------------------------------VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350 (453)
Q Consensus 304 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~ 350 (453)
.. .......||+.|+|||++.+. .++.++|||||||++|||++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC--CCCCchhhhhhHHHHHHHHhCC
Confidence 00 001234699999999999764 7889999999999999999999
Q ss_pred CCCCCCccccccccchHHHHHHhhhC-CCccccchhhhHHHHHHHHHHHHHHhc--ccCCCCCCCHHHHHHH
Q 048517 351 RNSNMNATRSSKAYFPSWVYDQLNKG-GDLELRNVTEIESMIARKLCMIGLWCI--QVKAADRPSMTKVLEM 419 (453)
Q Consensus 351 ~p~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~~~~~~~~l~~l~~~Cl--~~~p~~RPs~~evl~~ 419 (453)
.||...... .....+... ......... ..+..+.+++.+++ ..++..||+++|+++.
T Consensus 234 ~Pf~~~~~~--------~~~~~i~~~~~~~~~p~~~----~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 234 PPFCSETPQ--------ETYKKVMNWKETLIFPPEV----PISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCHH--------HHHHHHHcCcCcccCCCcC----CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 999643321 122222221 111111111 12234455555533 3344567999999874
No 147
>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk
Probab=100.00 E-value=1.1e-34 Score=276.84 Aligned_cols=235 Identities=29% Similarity=0.457 Sum_probs=184.7
Q ss_pred HhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
..+++.+.||+|+||.||+|... |+.||||.+.......+++..| +++++......++||||+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 34567789999999999999876 8899999998765444455554 45566667788999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 85 ~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 85 GSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred CcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 9999988432 224689999999999999999999998 99999999999999999999999999998663322
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 385 (453)
.....+..|+|||.+.. +.++.++||||||++++||++ |+.|+..... ......+..+....
T Consensus 157 --~~~~~~~~~~ape~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~----- 219 (256)
T cd05039 157 --DSGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPHVEKGYRME----- 219 (256)
T ss_pred --ccCCCcccccCchhhcC--CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHhcCCCCC-----
Confidence 23345678999999875 378889999999999999997 8888754321 11223333322211
Q ss_pred hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
.+...+..+.+++.+||+.+|++|||+.+++++|+.
T Consensus 220 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 -APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 112234678899999999999999999999999975
No 148
>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l
Probab=100.00 E-value=1.1e-34 Score=279.59 Aligned_cols=236 Identities=27% Similarity=0.431 Sum_probs=175.0
Q ss_pred cccCccCceEEEEEEEc-CCc--EEEEEEecCCCC--CHHHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517 167 HKLGQGGFGSVYKGQLH-TGR--LIAVKMMENSKF--SAEEFINE---------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~-~g~--~VAVK~l~~~~~--~~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
+.||+|+||.||+|+.. ++. .+|+|.+..... ..+.+..| +++++......+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999965 444 578898875322 22333333 34556666778999999999
Q ss_pred CChhhhhhhccC------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecC
Q 048517 227 GSLDRHIFSKEN------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG 294 (453)
Q Consensus 227 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 294 (453)
|+|.+++..... ....+++.++..++.|++.||+|||+. +++|+||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999854321 223588999999999999999999997 99999999999999999999999999
Q ss_pred CccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHh
Q 048517 295 LAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQL 373 (453)
Q Consensus 295 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l 373 (453)
+++..... ........+..|+|||++... .++.++||||||++++||++ |+.||...... . ....+
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-------~-~~~~~ 224 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------E-LYEKL 224 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCccccCHH-------H-HHHHH
Confidence 98632211 111223346789999998653 68899999999999999997 99988543211 1 22222
Q ss_pred hhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517 374 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI 424 (453)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~ 424 (453)
..+...+. +......+.+++.+||+.+|.+|||+.++++.|+.++
T Consensus 225 ~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 225 PQGYRLEK------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred hCCCCCCC------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 22222111 1123456889999999999999999999999998764
No 149
>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase. Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ
Probab=100.00 E-value=1.7e-34 Score=277.99 Aligned_cols=238 Identities=27% Similarity=0.343 Sum_probs=177.3
Q ss_pred HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH---------------Hhccccc------CcceE
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE---------------LLGLCSE------GFKRA 218 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e---------------l~g~~~~------~~~~~ 218 (453)
..+.+.+.||+|+||.||+|... +++.||+|.+........++..| +.+.+.. ....+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 34566788999999999999854 68999999987654444444333 2233322 23578
Q ss_pred EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298 (453)
Q Consensus 219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 298 (453)
++|||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++.
T Consensus 86 iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 86 LVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 999999999999988532 235689999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCceeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh
Q 048517 299 HPKENDFVSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 375 (453)
Q Consensus 299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~ 375 (453)
...... ......|+..|+|||++... ...++.++|||||||++|||++|+.|+....... .......
T Consensus 161 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~--------~~~~~~~ 230 (272)
T cd06637 161 LDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--------ALFLIPR 230 (272)
T ss_pred cccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH--------HHHHHhc
Confidence 543221 22345689999999998632 2357889999999999999999999986432110 1111111
Q ss_pred CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 376 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
...... .....+..+.+++.+||+.+|.+|||+.++++
T Consensus 231 ~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 NPAPRL-----KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCCC-----CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 111110 11123456889999999999999999999875
No 150
>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.
Probab=100.00 E-value=6.7e-35 Score=288.55 Aligned_cols=222 Identities=26% Similarity=0.345 Sum_probs=168.6
Q ss_pred cccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517 167 HKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFINE---------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
+.||+|+||.||+|+.. +|+.||+|++..... ...+++.| +++.+......++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 689999999865321 11222222 34555667788999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|+|..++.. ...++...+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 151 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-- 151 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--
Confidence 999887732 34688889999999999999999998 999999999999999999999999999875322221
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... . ..+.+.... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~-~~~~i~~~~-~~------ 214 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKE--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-------Q-MYDNILHKP-LQ------ 214 (321)
T ss_pred ccccccCCcccCCHHHhcCC--CCCCcCcccccchhhhhhhcCCCCCCCCCHH-------H-HHHHHhcCC-CC------
Confidence 12345689999999998764 6889999999999999999999999654211 1 222222221 11
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCCCHH
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRPSMT 414 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ 414 (453)
.+......+.+++.+||+.+|.+||+..
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1112345688999999999999999764
No 151
>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2. Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A
Probab=100.00 E-value=3.8e-35 Score=288.00 Aligned_cols=247 Identities=26% Similarity=0.409 Sum_probs=181.3
Q ss_pred HHHHhhhhhcccCccCceEEEEEEEc-CCc--EEEEEEecCCC--CCHHHHHHH---------------HhcccccCcce
Q 048517 158 IIAVTNHFTHKLGQGGFGSVYKGQLH-TGR--LIAVKMMENSK--FSAEEFINE---------------LLGLCSEGFKR 217 (453)
Q Consensus 158 ~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~--~VAVK~l~~~~--~~~~~~i~e---------------l~g~~~~~~~~ 217 (453)
+.-..+.+.+.||+|+||.||+|... ++. .+|+|.+.... ...+++..| +++++..+...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 33445667789999999999999854 454 46888776422 122233333 34566677788
Q ss_pred EEEEEecCCCChhhhhhhccC------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC
Q 048517 218 ALVYEYMPNGSLDRHIFSKEN------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN 285 (453)
Q Consensus 218 ~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~ 285 (453)
++++||+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +++||||||+|||++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 160 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCC
Confidence 999999999999999864321 224688999999999999999999998 99999999999999999
Q ss_pred CceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcccccccc
Q 048517 286 FIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAY 364 (453)
Q Consensus 286 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~ 364 (453)
+.+||+|||+++...... ......++..|+|||.+... .++.++||||||++++||+| |..||.......
T Consensus 161 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---- 231 (303)
T cd05088 161 YVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---- 231 (303)
T ss_pred CcEEeCccccCcccchhh---hcccCCCcccccCHHHHhcc--CCcccccchhhhhHHHHHHhcCCCCcccCChHH----
Confidence 999999999986432111 11222346789999988654 68899999999999999998 999885432211
Q ss_pred chHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517 365 FPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426 (453)
Q Consensus 365 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~ 426 (453)
..+.+..+..... +...+..+.+++.+||+.+|++||++.+++++|+.+++.
T Consensus 232 ----~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 232 ----LYEKLPQGYRLEK------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred ----HHHHHhcCCcCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1222222211111 112345688999999999999999999999999876554
No 152
>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re
Probab=100.00 E-value=1.4e-34 Score=276.44 Aligned_cols=233 Identities=30% Similarity=0.446 Sum_probs=179.1
Q ss_pred hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------Hhccc-ccCcceEEEEEecCC
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLC-SEGFKRALVYEYMPN 226 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~-~~~~~~~lv~E~~~~ 226 (453)
.+.+.+.||+|+||.||++... |+.||+|.+.... ..+.+..| +++++ ..+...++++||+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 4567789999999999999866 7889999987543 23444444 33433 345568999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|+|.+++... ....+++..++.++.+++.||+|||++ +++||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 85 GSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999988532 234589999999999999999999998 99999999999999999999999999987543322
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 385 (453)
....++..|+|||++... .++.++||||||+++|||++ |+.|+..... . -....+.++....
T Consensus 157 --~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-------~-~~~~~~~~~~~~~----- 219 (256)
T cd05082 157 --DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------K-DVVPRVEKGYKMD----- 219 (256)
T ss_pred --CCCccceeecCHHHHccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-------H-HHHHHHhcCCCCC-----
Confidence 233456789999998753 78899999999999999997 8888753321 1 1222232222111
Q ss_pred hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
.....+..+.+++.+|++.+|++|||+.++++.|+.
T Consensus 220 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 220 -APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 112234678899999999999999999999999975
No 153
>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc
Probab=100.00 E-value=1.9e-34 Score=274.65 Aligned_cols=233 Identities=28% Similarity=0.409 Sum_probs=182.5
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
+.+.+.||+|+||.||+|+.. +|+.|++|.+..... ..+++..| +++.+......++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 356688999999999999964 789999999865322 23344333 456667777889999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
++++|.+++... ....+++..++.++.+++.||.|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 82 ENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 999999988643 235789999999999999999999997 999999999999999999999999999986654332
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 384 (453)
. .....|++.|+|||++.+. .++.++|+||||++++||++|+.|+..... .........+....
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~---- 220 (256)
T cd08529 157 F--ANTIVGTPYYLSPELCEDK--PYNEKSDVWALGVVLYECCTGKHPFDANNQ--------GALILKIIRGVFPP---- 220 (256)
T ss_pred h--hhccccCccccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCC----
Confidence 1 1334688999999998764 688999999999999999999999864431 11222222222211
Q ss_pred hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
....+...+.+++.+||+.+|++||++.++++
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 221 --VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred --CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 12235567899999999999999999999986
No 154
>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage
Probab=100.00 E-value=1.6e-34 Score=278.25 Aligned_cols=242 Identities=22% Similarity=0.347 Sum_probs=170.4
Q ss_pred cccCccCceEEEEEEEcCC---cEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517 167 HKLGQGGFGSVYKGQLHTG---RLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYMPNG 227 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~g---~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g 227 (453)
++||+|+||.||+|...++ ..+++|.+..... ..+.+++| +++.|......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999985433 3466777654322 23344443 566777778889999999999
Q ss_pred ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517 228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 307 (453)
Q Consensus 228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 307 (453)
+|.+++.........+++..+..++.|+++||+|||+. +++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999865433334567778889999999999999998 999999999999999999999999999864322221112
Q ss_pred ecccCCCCCccChhhhccc-----CCCCCccchHHHHHHHHHHHHcC-CCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517 308 ISDTRGTIGYLAPELISRN-----FGTVSCKSDVYGFGMVLLEMAGG-RRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381 (453)
Q Consensus 308 ~~~~~gt~~y~aPE~~~~~-----~~~~s~k~DV~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 381 (453)
.....++..|+|||++... ....+.++||||||+++|||+++ ..|+..... .......+.. .....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------~~~~~~~~~~-~~~~~ 229 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-------REVLNHVIKD-QQVKL 229 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhh-ccccc
Confidence 2345678899999987532 12457899999999999999974 556643221 1112222222 11111
Q ss_pred cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517 382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421 (453)
Q Consensus 382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le 421 (453)
.... ....+...+.+++..|| .+|++||++++|++.|-
T Consensus 230 ~~~~-~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQ-LELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCc-cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1110 11124456778889999 67999999999999873
No 155
>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros. Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male
Probab=100.00 E-value=1e-34 Score=279.06 Aligned_cols=236 Identities=26% Similarity=0.443 Sum_probs=179.2
Q ss_pred cccCccCceEEEEEEEcC-------CcEEEEEEecCCC--CCHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 167 HKLGQGGFGSVYKGQLHT-------GRLIAVKMMENSK--FSAEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~-------g~~VAVK~l~~~~--~~~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
+.||+|+||.||+|+..+ ++.+|||.+.... ....++.+| +++++......+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998542 2579999886533 223444444 45667777788999999
Q ss_pred cCCCChhhhhhhccC---CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC-----ceEEEecCC
Q 048517 224 MPNGSLDRHIFSKEN---KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-----IPKVSDFGL 295 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~-----~~kl~DFGl 295 (453)
+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +++|+||||+||+++.+. .+|++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999864322 224588999999999999999999997 999999999999999877 899999999
Q ss_pred ccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhh
Q 048517 296 AKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLN 374 (453)
Q Consensus 296 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~ 374 (453)
++...............++..|+|||.+.+ +.++.++||||||+++|||++ |+.|+....... ....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~ 227 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--------VLQHVT 227 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHcc--CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--------HHHHHh
Confidence 986544332222233456788999999876 478999999999999999998 998886432111 122222
Q ss_pred hCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517 375 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421 (453)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le 421 (453)
.+.... .....+..+.+++.+||+.+|++||++.++++.|+
T Consensus 228 ~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 228 AGGRLQ------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cCCccC------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 222111 12234567889999999999999999999999986
No 156
>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1. Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.
Probab=100.00 E-value=6.4e-35 Score=285.37 Aligned_cols=245 Identities=23% Similarity=0.387 Sum_probs=181.5
Q ss_pred hhhhcccCccCceEEEEEEEc-CCc--EEEEEEecCCCC--CHHHHHHH---------------HhcccccCcceEEEEE
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGR--LIAVKMMENSKF--SAEEFINE---------------LLGLCSEGFKRALVYE 222 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~--~VAVK~l~~~~~--~~~~~i~e---------------l~g~~~~~~~~~lv~E 222 (453)
+.+.+.||+|+||.||+|+.. ++. .+|+|.++.... ..+++..| +++++......++++|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 456789999999999999865 343 578988874221 22333333 4555666677899999
Q ss_pred ecCCCChhhhhhhccC------------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEE
Q 048517 223 YMPNGSLDRHIFSKEN------------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV 290 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl 290 (453)
|+++|+|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEE
Confidence 9999999999854321 123588999999999999999999998 9999999999999999999999
Q ss_pred EecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHH
Q 048517 291 SDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWV 369 (453)
Q Consensus 291 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 369 (453)
+|||++....... .......+..|+|||++... .++.++||||||++++||++ |+.||...... . .
T Consensus 161 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-------~-~ 227 (297)
T cd05089 161 ADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYS--VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-------E-L 227 (297)
T ss_pred CCcCCCcccccee---ccCCCCcCccccCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------H-H
Confidence 9999987432111 11222345679999988753 68899999999999999997 99998543211 1 2
Q ss_pred HHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCCC
Q 048517 370 YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQM 429 (453)
Q Consensus 370 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~~ 429 (453)
...+..+.... .+..++..+.+++.+||+.+|.+|||+.++++.|+.+++..+.
T Consensus 228 ~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 228 YEKLPQGYRME------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred HHHHhcCCCCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 22232222111 1122345688999999999999999999999999987765543
No 157
>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr
Probab=100.00 E-value=6.7e-35 Score=280.61 Aligned_cols=241 Identities=26% Similarity=0.427 Sum_probs=180.7
Q ss_pred HhhhhhcccCccCceEEEEEEEc-CC---cEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEE
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLH-TG---RLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALV 220 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g---~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv 220 (453)
..+++.+.||+|+||.||+|... ++ ..||||.+..... ...+|..| +.+++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 34667889999999999999854 33 3699999876322 22344444 45556677788999
Q ss_pred EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517 221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 300 (453)
|||+++|+|.+++... ...+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++...
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999988432 34689999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCceeecccC---CCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhC
Q 048517 301 KENDFVSISDTR---GTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKG 376 (453)
Q Consensus 301 ~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~ 376 (453)
............ .+..|+|||.+.. +.++.++||||||+++|||++ |+.|+...... -..+.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--------~~~~~i~~~ 227 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--------DVINAIEQD 227 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhcc--CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHcC
Confidence 332211111111 2457999999875 378899999999999999886 99888643321 122222222
Q ss_pred CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517 377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 423 (453)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~ 423 (453)
.... .+.+.+..+.+++.+||+.+|++||++.+++.+|++.
T Consensus 228 ~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 YRLP------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CcCC------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 1122345678999999999999999999999999864
No 158
>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase. Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor
Probab=100.00 E-value=1e-35 Score=295.43 Aligned_cols=236 Identities=23% Similarity=0.275 Sum_probs=178.5
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
|.+.++||+|+||+||+++. .+|+.||||+++.... ..+.+..| +++.+......++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 56678999999999999985 4789999999976322 11222222 34556667788999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 83 QPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999988532 24689999999999999999999998 99999999999999999999999999998765433
Q ss_pred CceeecccCCCCCccChhhhccc----CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC-CC
Q 048517 304 DFVSISDTRGTIGYLAPELISRN----FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG-GD 378 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~-~~ 378 (453)
.. ......||+.|+|||++... ...++.++|||||||++|||++|+.||...... . ....+... ..
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~-~~~~i~~~~~~ 227 (330)
T cd05601 157 MV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-------K-TYNNIMNFQRF 227 (330)
T ss_pred ce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-------H-HHHHHHcCCCc
Confidence 22 22345689999999998631 235788999999999999999999999643321 1 12222221 11
Q ss_pred ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
..... ...++..+.+++..|++ +|.+|||+.++++
T Consensus 228 ~~~~~----~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 228 LKFPE----DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred cCCCC----CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 11111 11234567889999998 9999999999985
No 159
>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of
Probab=100.00 E-value=1.8e-35 Score=293.73 Aligned_cols=226 Identities=25% Similarity=0.340 Sum_probs=168.9
Q ss_pred cCccCceEEEEEEE-cCCcEEEEEEecCCCCC----HHHHHHH-----------------HhcccccCcceEEEEEecCC
Q 048517 169 LGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS----AEEFINE-----------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 169 LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~----~~~~i~e-----------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
||+|+||+||+|+. .+|+.||||++...... ....+.| ++..+......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999995 46999999998653211 1111111 22334556778999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|+|.+++.. ...+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-- 151 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-- 151 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--
Confidence 999988742 35689999999999999999999998 999999999999999999999999999975433221
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
......||+.|+|||.+.+. ..++.++||||+||++|||++|+.||...... .....+..+.. .+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~~-~~~---- 217 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--------QMYRNIAFGKV-RFP---- 217 (330)
T ss_pred CccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHH--------HHHHHHHcCCC-CCC----
Confidence 12345699999999998653 35788999999999999999999998653211 12233332221 111
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRP----SMTKVLE 418 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RP----s~~evl~ 418 (453)
...++..+.+++.+||+.+|++|| ++.++++
T Consensus 218 -~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 -KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 112345678899999999999999 4566554
No 160
>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in
Probab=100.00 E-value=5e-35 Score=295.37 Aligned_cols=238 Identities=19% Similarity=0.258 Sum_probs=179.6
Q ss_pred HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC----CCHHHHHHH--------------HhcccccCcceEEEE
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK----FSAEEFINE--------------LLGLCSEGFKRALVY 221 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~----~~~~~~i~e--------------l~g~~~~~~~~~lv~ 221 (453)
..+.+.++||+|+||.||+++.. +++.||+|++.... .....+..| +++.+..+...++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 35667789999999999999954 78999999986521 111222222 455667777899999
Q ss_pred EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517 222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 301 (453)
Q Consensus 222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 301 (453)
||+++|+|.+++.. ..++...+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 123 Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 123 EYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred cCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999998742 3477888899999999999999998 999999999999999999999999999986543
Q ss_pred CCCceeecccCCCCCccChhhhccc--CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC-CC
Q 048517 302 ENDFVSISDTRGTIGYLAPELISRN--FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG-GD 378 (453)
Q Consensus 302 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~-~~ 378 (453)
.... ......||+.|+|||.+... ...++.++|||||||++|||++|+.||...... ..+..+... ..
T Consensus 195 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~~~~~~ 265 (370)
T cd05596 195 NGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKIMDHKNS 265 (370)
T ss_pred CCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--------HHHHHHHcCCCc
Confidence 3221 12345799999999998653 134789999999999999999999999754321 122233221 11
Q ss_pred ccccchhhhHHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 048517 379 LELRNVTEIESMIARKLCMIGLWCIQVKAAD--RPSMTKVLEM 419 (453)
Q Consensus 379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~~ 419 (453)
..... ...++..+.+++.+||+.+|++ |||+.++++.
T Consensus 266 ~~~~~----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 LTFPD----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCC----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11111 1124567888999999999987 9999999763
No 161
>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po
Probab=100.00 E-value=4.7e-35 Score=296.70 Aligned_cols=237 Identities=22% Similarity=0.240 Sum_probs=172.6
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC----HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS----AEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~----~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
+.+.++||+|+||+||+|+. .+++.||||++...... ...+..| +++.+.+....++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 44568899999999999984 57899999999753221 1222222 56677778889999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 83 IPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999998843 24588889999999999999999998 99999999999999999999999999986432100
Q ss_pred Cc---------------------------------------------eeecccCCCCCccChhhhcccCCCCCccchHHH
Q 048517 304 DF---------------------------------------------VSISDTRGTIGYLAPELISRNFGTVSCKSDVYG 338 (453)
Q Consensus 304 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S 338 (453)
.. .......||+.|+|||.+.+. .++.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwS 233 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC--CCCCccceee
Confidence 00 000124699999999999764 6889999999
Q ss_pred HHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHH--hcccCCCCCCCHHHH
Q 048517 339 FGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLW--CIQVKAADRPSMTKV 416 (453)
Q Consensus 339 ~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~--Cl~~~p~~RPs~~ev 416 (453)
|||++|||++|+.||....... .....+........... ..++..+.+++.+ |+..++..||++.++
T Consensus 234 lG~il~elltG~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~~----~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTE-------TQLKVINWENTLHIPPQ----VKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHH-------HHHHHHccccccCCCCC----CCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 9999999999999997543211 01111111111111111 1123456666666 556677779999999
Q ss_pred HHH
Q 048517 417 LEM 419 (453)
Q Consensus 417 l~~ 419 (453)
++.
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 874
No 162
>PTZ00284 protein kinase; Provisional
Probab=100.00 E-value=1.9e-34 Score=299.99 Aligned_cols=248 Identities=19% Similarity=0.267 Sum_probs=171.4
Q ss_pred HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHH------HHHHH--------------Hhcccc-cCcceE
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAE------EFINE--------------LLGLCS-EGFKRA 218 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~------~~i~e--------------l~g~~~-~~~~~~ 218 (453)
..|.+.++||+|+||+||+|+. .+++.||||+++....... +++.+ ++.++. .....+
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~ 208 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC 208 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence 4566778999999999999985 4688999999965322111 12222 122232 234678
Q ss_pred EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC------------
Q 048517 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF------------ 286 (453)
Q Consensus 219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~------------ 286 (453)
+|||++ +++|.+++.. ...+++..+..|+.||+.||+|||++ .+|+||||||+|||++.++
T Consensus 209 iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred EEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccC
Confidence 999988 7788888743 24689999999999999999999973 2899999999999998665
Q ss_pred ----ceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc
Q 048517 287 ----IPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK 362 (453)
Q Consensus 287 ----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~ 362 (453)
.+||+|||++...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.........
T Consensus 282 ~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 354 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGL--GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354 (467)
T ss_pred CCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 4999999988643221 2345799999999999864 7899999999999999999999999754321100
Q ss_pred -------ccch-HHHHH--------HhhhCCCccc-cch----------hhhHHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 048517 363 -------AYFP-SWVYD--------QLNKGGDLEL-RNV----------TEIESMIARKLCMIGLWCIQVKAADRPSMTK 415 (453)
Q Consensus 363 -------~~~~-~~~~~--------~l~~~~~~~~-~~~----------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e 415 (453)
..++ .|... .......... ... ..........+++|+.+||+.||++|||++|
T Consensus 355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e 434 (467)
T PTZ00284 355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ 434 (467)
T ss_pred HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence 0000 11100 0000000000 000 0000112346789999999999999999999
Q ss_pred HHH--HHhC
Q 048517 416 VLE--MLEG 422 (453)
Q Consensus 416 vl~--~Le~ 422 (453)
+++ .+.+
T Consensus 435 ~L~Hp~~~~ 443 (467)
T PTZ00284 435 MTTHPYVLK 443 (467)
T ss_pred HhcCccccc
Confidence 997 4444
No 163
>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=9.5e-35 Score=279.08 Aligned_cols=242 Identities=23% Similarity=0.266 Sum_probs=179.6
Q ss_pred HHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC-HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
...|.+.++||+|+||.||+|+. .+++.||+|++...... ...+.+| +++.+..+...++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 34567789999999999999995 57899999998754322 2222222 44566677788999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||+++......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999998842 24688999999999999999999998 99999999999999999999999999998654321
Q ss_pred CceeecccCCCCCccChhhhccc-CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 382 (453)
. ......|+..|+|||.+... ...++.++||||||++++||++|+.|+......... ..+... .....
T Consensus 161 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--------~~~~~~-~~~~~ 229 (267)
T cd06646 161 A--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--------FLMSKS-NFQPP 229 (267)
T ss_pred c--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--------eeeecC-CCCCC
Confidence 1 12334688999999987532 235788999999999999999999998533211100 000010 00000
Q ss_pred chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517 383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 420 (453)
Q Consensus 383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 420 (453)
. .......+..+.+++.+||+.+|++|||++++++.|
T Consensus 230 ~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 K-LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred C-CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 001123446788999999999999999999998753
No 164
>PHA03211 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=2.6e-34 Score=296.55 Aligned_cols=249 Identities=19% Similarity=0.211 Sum_probs=177.9
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHH-HHHH--------HHhcccccCcceEEEEEecCCCChhh
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAE-EFIN--------ELLGLCSEGFKRALVYEYMPNGSLDR 231 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~-~~i~--------el~g~~~~~~~~~lv~E~~~~gsL~~ 231 (453)
.+.+.++||+|+||.||++... +++.||||.........+ +.+. ++++++..+...++|||++ .++|.+
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~~ 248 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLYT 248 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHHH
Confidence 4566789999999999999965 688999996543221111 1222 2567777788889999999 478888
Q ss_pred hhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeeccc
Q 048517 232 HIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311 (453)
Q Consensus 232 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 311 (453)
++... ...++|.+++.|+.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++..............
T Consensus 249 ~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 322 (461)
T PHA03211 249 YLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322 (461)
T ss_pred HHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccccc
Confidence 77432 24699999999999999999999998 9999999999999999999999999999876443222122345
Q ss_pred CCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCc--cccc------
Q 048517 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL--ELRN------ 383 (453)
Q Consensus 312 ~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~--~~~~------ 383 (453)
.||+.|+|||++.+. .++.++|||||||++|||++|..++...........+...+.+.+.+.... +...
T Consensus 323 ~GT~~Y~APE~~~~~--~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 323 AGTVDTNAPEVLAGD--PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred CCCcCCcCHHHHcCC--CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 699999999999764 789999999999999999998876543222111112222222222221110 0000
Q ss_pred -------------------hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 384 -------------------VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 384 -------------------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
...........+.+++.+||+.||.+|||+.|+++.
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000001223467889999999999999999999873
No 165
>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-35 Score=296.00 Aligned_cols=241 Identities=25% Similarity=0.429 Sum_probs=195.1
Q ss_pred HhhhhhcccCccCceEEEEEEEc---CCc--EEEEEEecCC--CCCHHHHHHH--------------HhcccccCcceEE
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLH---TGR--LIAVKMMENS--KFSAEEFINE--------------LLGLCSEGFKRAL 219 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~---~g~--~VAVK~l~~~--~~~~~~~i~e--------------l~g~~~~~~~~~l 219 (453)
..-.+.++||.|-||.||+|.+. .|. .||||.-+.+ ..+.+.|+.| |+|.|.+. ..++
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence 33345678999999999999853 233 4889987763 3345667665 88999765 6899
Q ss_pred EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517 220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 299 (453)
|||.++.|.|..||.. .+..|+...+..++.||..||+|||+. +.|||||..+|||+...-++||+|||++|..
T Consensus 468 vmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence 9999999999999943 346789999999999999999999998 9999999999999999999999999999988
Q ss_pred CCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517 300 PKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGD 378 (453)
Q Consensus 300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~ 378 (453)
..+..+.. +....++.|||||.+. +.+++.++|||.|||.+||+++ |.+||..-.... +.-++++|.+
T Consensus 542 ed~~yYka-S~~kLPIKWmaPESIN--fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD--------VI~~iEnGeR 610 (974)
T KOG4257|consen 542 EDDAYYKA-SRGKLPIKWMAPESIN--FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD--------VIGHIENGER 610 (974)
T ss_pred cccchhhc-cccccceeecCccccc--hhcccchhhHHHHHHHHHHHHHhcCCccccccccc--------eEEEecCCCC
Confidence 77766544 3455678999999885 4589999999999999999886 889997543322 3335667776
Q ss_pred ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517 379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID 425 (453)
Q Consensus 379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~ 425 (453)
+.. +...+..+..++.+||..+|.+||.+.++.+.|+..+.
T Consensus 611 lP~------P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 611 LPC------PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCC------CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 653 33456778899999999999999999999988865443
No 166
>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr
Probab=100.00 E-value=2.2e-34 Score=278.89 Aligned_cols=232 Identities=25% Similarity=0.340 Sum_probs=173.1
Q ss_pred cCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEecCCCCh
Q 048517 169 LGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSL 229 (453)
Q Consensus 169 LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL 229 (453)
||+|+||.||+++. .+|+.||+|.+..... .......| +.+.+..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999985 4699999999864211 11111112 34556667788999999999999
Q ss_pred hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeec
Q 048517 230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 309 (453)
Q Consensus 230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 309 (453)
.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... ...
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~ 152 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TIT 152 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eee
Confidence 8887532 234588999999999999999999998 99999999999999999999999999998664432 123
Q ss_pred ccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHH
Q 048517 310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 389 (453)
Q Consensus 310 ~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 389 (453)
...||..|+|||++.+. .++.++||||+||++|||++|+.|+........ ...+........ ... ...
T Consensus 153 ~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~-~~~-----~~~ 220 (277)
T cd05607 153 QRAGTNGYMAPEILKEE--PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA----KEELKRRTLEDE-VKF-----EHQ 220 (277)
T ss_pred ccCCCCCccCHHHHccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh----HHHHHHHhhccc-ccc-----ccc
Confidence 45689999999999764 689999999999999999999999864332111 001111111111 000 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517 390 MIARKLCMIGLWCIQVKAADRPSMTKVLEML 420 (453)
Q Consensus 390 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 420 (453)
.++..+.+++..||+.||++||++.|+++.+
T Consensus 221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 221 NFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred cCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 2456689999999999999999997766433
No 167
>PTZ00036 glycogen synthase kinase; Provisional
Probab=100.00 E-value=1.4e-34 Score=298.36 Aligned_cols=245 Identities=19% Similarity=0.265 Sum_probs=171.7
Q ss_pred hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHH---HHHH--------Hhcccc--------cCcceEEEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEE---FINE--------LLGLCS--------EGFKRALVY 221 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~---~i~e--------l~g~~~--------~~~~~~lv~ 221 (453)
.|.+.++||+|+||.||+|.. .+++.||||++........+ .+.. +.+++. .....++||
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvm 146 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVM 146 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEE
Confidence 466778999999999999995 47899999988654322221 1111 222221 112356899
Q ss_pred EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC-ceEEEecCCccccC
Q 048517 222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHP 300 (453)
Q Consensus 222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~~ 300 (453)
||++ ++|.+++.........+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++...
T Consensus 147 E~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~ 222 (440)
T PTZ00036 147 EFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL 222 (440)
T ss_pred ecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchhcc
Confidence 9997 467776654334456789999999999999999999998 999999999999998664 79999999998664
Q ss_pred CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC----
Q 048517 301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG---- 376 (453)
Q Consensus 301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~---- 376 (453)
.... .....||+.|+|||++.+. ..++.++|||||||++|||++|++||........ +.. +...+...
T Consensus 223 ~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~---~~~-i~~~~~~p~~~~ 294 (440)
T PTZ00036 223 AGQR---SVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ---LVR-IIQVLGTPTEDQ 294 (440)
T ss_pred CCCC---cccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHH-HHHHhCCCCHHH
Confidence 4322 1235689999999998653 3688999999999999999999999965432110 000 00000000
Q ss_pred --------CCccccch--h----hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 377 --------GDLELRNV--T----EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 377 --------~~~~~~~~--~----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
........ . ..+...+..+.+++.+||+.+|.+|||+.|+++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00000000 0 011123457889999999999999999999985
No 168
>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a
Probab=100.00 E-value=2.3e-34 Score=279.36 Aligned_cols=248 Identities=22% Similarity=0.370 Sum_probs=181.4
Q ss_pred HhhhhhcccCccCceEEEEEEE-----cCCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccC--cce
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQL-----HTGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEG--FKR 217 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~-----~~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~--~~~ 217 (453)
.++...++||+|+||.||+++. .+++.||+|.+..... ..+++..| +.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3456678899999999999974 3578999999875322 12333333 34444443 457
Q ss_pred EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517 218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297 (453)
Q Consensus 218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 297 (453)
++||||+++++|.+++... ...++|..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 8999999999999988432 24589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCce-eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccc--------cccccchHH
Q 048517 298 FHPKENDFV-SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATR--------SSKAYFPSW 368 (453)
Q Consensus 298 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~--------~~~~~~~~~ 368 (453)
......... ......++..|+|||++.+. .++.++||||||++++||++++.|....... ..+... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 234 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQS--KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTV-TR 234 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccC--CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccH-HH
Confidence 765433221 11234567789999998753 6889999999999999999987664322110 001111 11
Q ss_pred HHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517 369 VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 423 (453)
Q Consensus 369 ~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~ 423 (453)
..+.+..+.... .+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 235 ~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 235 LVRVLEEGKRLP------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHcCccCC------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 122222222221 1122456799999999999999999999999999864
No 169
>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity. Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....
Probab=100.00 E-value=3.4e-35 Score=280.24 Aligned_cols=238 Identities=30% Similarity=0.451 Sum_probs=178.6
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHH---HHH--------------HhcccccCcceEEEEEec
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEF---INE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~---i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
|++.+.||+|+||+||+++.. +++.+|+|++.......... ..| +++++......+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999965 57799999998764433322 112 344555677788999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
++++|.+++. ....+++..+..++.|+++||.+||+. +|+|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~- 152 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN- 152 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT-
T ss_pred cccccccccc----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-
Confidence 9999999985 235689999999999999999999998 99999999999999999999999999998642211
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 384 (453)
.......+|..|+|||.+.. ....+.++||||+|+++++|++|+.|+.......... ...+.... .....
T Consensus 153 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~----~~~~~~~~----~~~~~ 222 (260)
T PF00069_consen 153 -ENFNPFVGTPEYMAPEVLQQ-GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLE----IIEKILKR----PLPSS 222 (260)
T ss_dssp -SEBSSSSSSGGGSCHHHHTT-TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHH----HHHHHHHT----HHHHH
T ss_pred -cccccccccccccccccccc-cccccccccccccccccccccccccccccccchhhhh----hhhhcccc----ccccc
Confidence 23456678999999999872 1478999999999999999999999987541111000 01111110 00000
Q ss_pred hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
..........+.+++.+||+.||++|||+.++++
T Consensus 223 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 223 SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001111267999999999999999999999975
No 170
>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica
Probab=100.00 E-value=3.4e-35 Score=295.60 Aligned_cols=234 Identities=24% Similarity=0.300 Sum_probs=174.6
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
|.+.+.||+|+||+||+++.. +|+.||||++..... ....+..| +++.+..+...++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 456689999999999999954 789999999875321 11122222 55667778889999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 83 LPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999998853 24689999999999999999999998 99999999999999999999999999987543211
Q ss_pred Cce------------------------------------eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHH
Q 048517 304 DFV------------------------------------SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMA 347 (453)
Q Consensus 304 ~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ell 347 (453)
... ......||+.|+|||++.+. .++.++|||||||+++||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC--CCCCeeeeecchhHHHHhh
Confidence 000 00123599999999998764 7899999999999999999
Q ss_pred cCCCCCCCCccccccccchHHHHHHhhh-CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 048517 348 GGRRNSNMNATRSSKAYFPSWVYDQLNK-GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS---MTKVLE 418 (453)
Q Consensus 348 tg~~p~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---~~evl~ 418 (453)
+|+.||....... ....+.. ......... ..++..+.+++.+|+. +|.+|++ +.++++
T Consensus 234 ~G~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~~----~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNPQE--------TYRKIINWKETLQFPDE----VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCHHH--------HHHHHHcCCCccCCCCC----CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999996543211 1112211 111111111 1234567788888986 9999998 888876
No 171
>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut
Probab=100.00 E-value=4.9e-34 Score=276.08 Aligned_cols=248 Identities=26% Similarity=0.443 Sum_probs=183.8
Q ss_pred hhhhhcccCccCceEEEEEEEc-----CCcEEEEEEecCCCCC--HHHHHHH--------------Hhccccc--CcceE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-----TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSE--GFKRA 218 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-----~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~--~~~~~ 218 (453)
.+++.++||+|+||.||++++. +++.||||.+...... .+++..| +++++.. +...+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4556789999999999999854 3789999999875543 3445444 3444444 45678
Q ss_pred EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298 (453)
Q Consensus 219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 298 (453)
++|||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 85 lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999985332 3589999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCc-eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc-------cchHHHH
Q 048517 299 HPKENDF-VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA-------YFPSWVY 370 (453)
Q Consensus 299 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~-------~~~~~~~ 370 (453)
....... .......++..|+|||.+... .++.++||||||++++||++|+.|+.......... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTS--KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccC--CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 7633322 111223456679999998764 78899999999999999999998875432211000 0011111
Q ss_pred HHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517 371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 423 (453)
Q Consensus 371 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~ 423 (453)
+.+....... .+...+..+.+++.+||+.+|++|||+.||+++|+++
T Consensus 237 ~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 237 ELLKEGERLP------RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHcCCcCC------CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 2222221111 1112335688999999999999999999999999864
No 172
>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate
Probab=100.00 E-value=4.2e-35 Score=289.63 Aligned_cols=223 Identities=24% Similarity=0.302 Sum_probs=171.7
Q ss_pred cccCccCceEEEEEEE----cCCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517 167 HKLGQGGFGSVYKGQL----HTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYMP 225 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~----~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~ 225 (453)
+.||+|+||.||+++. .+|+.||+|++..... ....+..| +++.+......++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3689999999875321 11222222 4566677788899999999
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 305 (453)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 9999998843 34689999999999999999999998 999999999999999999999999999986543321
Q ss_pred eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517 306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385 (453)
Q Consensus 306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 385 (453)
......||+.|+|||.+.+. .++.++||||||+++|||++|+.||...... .....+.+... .
T Consensus 154 -~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~--------~~~~~i~~~~~-~----- 216 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--------ETMTMILKAKL-G----- 216 (318)
T ss_pred -ceecccCChhhcCHHHHcCC--CCCCccceeccceEeeeeccCCCCCCCCCHH--------HHHHHHHcCCC-C-----
Confidence 12345689999999999764 6788999999999999999999998643211 12222222211 1
Q ss_pred hhHHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 048517 386 EIESMIARKLCMIGLWCIQVKAADRPSMTK 415 (453)
Q Consensus 386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e 415 (453)
.+..++..+.+++.+||+.||++|||+.+
T Consensus 217 -~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 -MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 12224466889999999999999999544
No 173
>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k
Probab=100.00 E-value=3.9e-34 Score=272.10 Aligned_cols=234 Identities=27% Similarity=0.445 Sum_probs=178.6
Q ss_pred cccCccCceEEEEEEEcCCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEecCCCChh
Q 048517 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLD 230 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL~ 230 (453)
++||+|+||.||++..++++.||+|.+...... .+++..| +++++......++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999777999999988764332 2344444 455667777889999999999999
Q ss_pred hhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecc
Q 048517 231 RHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISD 310 (453)
Q Consensus 231 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 310 (453)
+++... ...+++..+..++.+++.||.|||++ +++||||||+||+++.++.+||+|||+++.............
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 988432 24688999999999999999999998 999999999999999999999999999986543221111122
Q ss_pred cCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHH
Q 048517 311 TRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 389 (453)
Q Consensus 311 ~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 389 (453)
..++..|+|||.+.+ +.++.++|+||||++++||++ |..|+...... .....+....... .+.
T Consensus 155 ~~~~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--------~~~~~~~~~~~~~------~~~ 218 (251)
T cd05041 155 KQIPIKWTAPEALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--------QTRERIESGYRMP------APQ 218 (251)
T ss_pred CcceeccCChHhhcc--CCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--------HHHHHHhcCCCCC------CCc
Confidence 334667999999875 378899999999999999998 77777543211 1122222221111 112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 390 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 390 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
..+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 234578899999999999999999999999863
No 174
>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-34 Score=297.59 Aligned_cols=240 Identities=27% Similarity=0.441 Sum_probs=195.4
Q ss_pred hcccCccCceEEEEEE-EcCCc----EEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 166 THKLGQGGFGSVYKGQ-LHTGR----LIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 166 ~~~LG~G~fG~Vy~g~-~~~g~----~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
.++||+|+||+||+|. .+.|+ +||||++..... ...+++.| |+|+|.... ..||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 3679999999999998 55554 689999876432 24444444 888887665 77999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
+.|+|.+|+.. ....+.....+.+..|||+||.|||.+ +++||||..+|||+..-..+|+.|||++++...++.
T Consensus 780 P~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 780 PLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred ccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 99999999954 346788899999999999999999998 999999999999999999999999999999877665
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
........-.+.|||=|.+... .++.++|||||||++||++| |.+|++....++ +.+.++++.++.
T Consensus 854 ey~~~~gK~pikwmale~i~~~--~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e--------I~dlle~geRLs--- 920 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIR--KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE--------IPDLLEKGERLS--- 920 (1177)
T ss_pred cccccccccCcHHHHHHHhhcc--CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH--------hhHHHhccccCC---
Confidence 4444444556789999999864 89999999999999999998 888887654332 666777777643
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCC
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ 428 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~ 428 (453)
.+.....++..++.+||..|++.||+++++.+.+.....+.+
T Consensus 921 ---qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 921 ---QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred ---CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 333455678899999999999999999999998877655543
No 175
>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul
Probab=100.00 E-value=2e-34 Score=277.08 Aligned_cols=241 Identities=27% Similarity=0.433 Sum_probs=182.2
Q ss_pred HhhhhhcccCccCceEEEEEEEc-C---CcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEE
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLH-T---GRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALV 220 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~-~---g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv 220 (453)
..+++.+.||+|+||.||+|+.. + +..+|+|.++..... .+.+..| +.+++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 35567789999999999999853 2 347999998754322 2334444 45566677788999
Q ss_pred EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517 221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 300 (453)
|||+++|+|.+++... ...+++.++..++.|++.||+|||+. +++|+||||+|||++.++.+|++|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999998532 24689999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCcee-ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517 301 KENDFVS-ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGD 378 (453)
Q Consensus 301 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~ 378 (453)
....... .....++..|+|||.+... .++.++||||||++++|+++ |+.|+....... ....+.++..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--------~~~~~~~~~~ 227 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--------VIKAIEEGYR 227 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccC--ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--------HHHHHhCCCc
Confidence 4332111 1122345689999999763 78999999999999999886 999886433211 2222333221
Q ss_pred ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517 379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 423 (453)
Q Consensus 379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~ 423 (453)
.. .....+..+.+++.+|++.+|++||||.++++.|++.
T Consensus 228 ~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 LP------APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CC------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11 1112345688999999999999999999999999864
No 176
>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as
Probab=100.00 E-value=1.6e-34 Score=281.10 Aligned_cols=235 Identities=27% Similarity=0.365 Sum_probs=176.6
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC----HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS----AEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~----~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
++..+.||+|+||.||++.. .+++.||||.+...... ...+..| +.+.+..+...++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 44567899999999999985 47899999998753221 1223333 33445566778999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 9999999988543 224689999999999999999999997 99999999999999999999999999997654332
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
. .....||..|+|||++.+. .++.++||||+|+++|||++|+.||.......... ...........
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~----~~~~~~~~~~~----- 222 (285)
T cd05630 157 T---IKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE----EVERLVKEVQE----- 222 (285)
T ss_pred c---ccCCCCCccccChHHHcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH----HHHhhhhhhhh-----
Confidence 2 1334689999999999764 78899999999999999999999997543211000 01111111000
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE 418 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 418 (453)
.........+.+++.+||+.||++||| +.|+++
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 --EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred --hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 011223456889999999999999999 788876
No 177
>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase. Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and
Probab=100.00 E-value=3.7e-34 Score=273.28 Aligned_cols=233 Identities=30% Similarity=0.456 Sum_probs=177.3
Q ss_pred cccCccCceEEEEEEEcC--C--cEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517 167 HKLGQGGFGSVYKGQLHT--G--RLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~--g--~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
+.||+|++|.||+|...+ + ..||||.+..... ..+++..| +++.+.. ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3699999987544 23344444 3444445 678899999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|+|.+++..... ..++|..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999854322 5689999999999999999999998 99999999999999999999999999998775433221
Q ss_pred -eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhh-CCCccccc
Q 048517 307 -SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNK-GGDLELRN 383 (453)
Q Consensus 307 -~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~ 383 (453)
......++.+|+|||++... .++.++||||||++++||++ |+.|+...... . ....+.. .....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~-~~~~~~~~~~~~~--- 221 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTR--TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-------Q-ILKKIDKEGERLE--- 221 (257)
T ss_pred ecccCCCCCceecCHHHhccc--CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-------H-HHHHHHhcCCcCC---
Confidence 11234578899999998754 78899999999999999998 99998643221 1 1112221 11111
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le 421 (453)
.+...+..+.+++.+|++.+|++|||+.++++.|.
T Consensus 222 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 ---RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11223457889999999999999999999999885
No 178
>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th
Probab=100.00 E-value=4.7e-34 Score=276.89 Aligned_cols=247 Identities=27% Similarity=0.422 Sum_probs=177.2
Q ss_pred hhhhcccCccCceEEEEEEEc-----CCcEEEEEEecCCCCC-HHHHHHH--------------Hhccc--ccCcceEEE
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-----TGRLIAVKMMENSKFS-AEEFINE--------------LLGLC--SEGFKRALV 220 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-----~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~--~~~~~~~lv 220 (453)
+.+.+.||+|+||.||++... +++.||||.+...... .+++..| +.+++ ......++|
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 85 (284)
T cd05081 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLV 85 (284)
T ss_pred ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEE
Confidence 456688999999999999742 5889999998764322 2334344 23333 223457899
Q ss_pred EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517 221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 300 (453)
+||+++|+|.+++... ...++|..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+++...
T Consensus 86 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 86 MEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999988432 24589999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCceee-cccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccc-----c---ccchHHHHH
Q 048517 301 KENDFVSI-SDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS-----K---AYFPSWVYD 371 (453)
Q Consensus 301 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~-----~---~~~~~~~~~ 371 (453)
........ ....++..|+|||++.+. .++.++||||||++++||++|..+......... . ........+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccC--CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 44332111 122234569999998753 688999999999999999998766432211000 0 000011111
Q ss_pred HhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517 372 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 423 (453)
Q Consensus 372 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~ 423 (453)
.+....... .....+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 238 ~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 LLKNNGRLP------APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHhcCCcCC------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 222221111 1112345789999999999999999999999999864
No 179
>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found
Probab=100.00 E-value=8.5e-35 Score=293.59 Aligned_cols=238 Identities=20% Similarity=0.277 Sum_probs=177.3
Q ss_pred HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC---C-CHHHHHHH--------------HhcccccCcceEEEE
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK---F-SAEEFINE--------------LLGLCSEGFKRALVY 221 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~---~-~~~~~i~e--------------l~g~~~~~~~~~lv~ 221 (453)
..|.+.+.||+|+||.||+++.. +++.||+|++.... . ....+..| +++.+..+...++||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 45667789999999999999965 68899999986521 1 11122222 455667778899999
Q ss_pred EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517 222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 301 (453)
Q Consensus 222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 301 (453)
||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 123 Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 123 EYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred cCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 99999999998832 3478889999999999999999998 999999999999999999999999999987643
Q ss_pred CCCceeecccCCCCCccChhhhcccC--CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC-CC
Q 048517 302 ENDFVSISDTRGTIGYLAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG-GD 378 (453)
Q Consensus 302 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~-~~ 378 (453)
... .......||+.|+|||++.+.. +.++.++||||+||++|||++|+.||...... .....+... ..
T Consensus 195 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~--------~~~~~i~~~~~~ 265 (370)
T cd05621 195 TGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV--------GTYSKIMDHKNS 265 (370)
T ss_pred CCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCcc
Confidence 322 1223567999999999987532 23788999999999999999999999654321 122222221 11
Q ss_pred ccccchhhhHHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 048517 379 LELRNVTEIESMIARKLCMIGLWCIQVKAAD--RPSMTKVLEM 419 (453)
Q Consensus 379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~~ 419 (453)
.... ....++..+..++.+|++.++.+ |||+.|+++.
T Consensus 266 ~~~p----~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 LNFP----EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cCCC----CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 2211 11224556778888999755543 8899999885
No 180
>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron. Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca
Probab=100.00 E-value=2.7e-34 Score=274.96 Aligned_cols=236 Identities=27% Similarity=0.408 Sum_probs=172.4
Q ss_pred cccCccCceEEEEEEEc----CCcEEEEEEecCCCC--CHHHHHHH--------------Hhcccc-cCcceEEEEEecC
Q 048517 167 HKLGQGGFGSVYKGQLH----TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCS-EGFKRALVYEYMP 225 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~----~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~-~~~~~~lv~E~~~ 225 (453)
+.||+|+||.||+|... ++..||||.+..... ..+.+..| +++++. .+...++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 245799998864322 22344343 345443 3455789999999
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 305 (453)
+|+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999998532 23467888899999999999999998 9999999999999999999999999999865432211
Q ss_pred e--eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCC-CCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517 306 V--SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382 (453)
Q Consensus 306 ~--~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 382 (453)
. ......++..|+|||.+... .++.++||||||+++|||++|+ .|+...... . ....+..+.....
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-------~-~~~~~~~~~~~~~- 223 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF-------D-ITVYLLQGRRLLQ- 223 (262)
T ss_pred eecccccCcCCccccChhHhccC--ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------H-HHHHHhcCCCCCC-
Confidence 1 11233467789999998753 7889999999999999999965 444322111 1 2222333222211
Q ss_pred chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517 383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI 424 (453)
Q Consensus 383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~ 424 (453)
+...+..+.+++.+||+.+|++||++.++++.|+...
T Consensus 224 -----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 224 -----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 1122356889999999999999999999999998754
No 181
>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4. Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin
Probab=100.00 E-value=4e-34 Score=280.61 Aligned_cols=241 Identities=26% Similarity=0.434 Sum_probs=179.3
Q ss_pred hhhhcccCccCceEEEEEEE-cCCc----EEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEE
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGR----LIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVY 221 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~----~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~ 221 (453)
+...+.||+|+||.||+|+. .+|+ .||+|.+...... ..++.+| ++++|.. ....+++
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~v~ 87 (303)
T cd05110 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PTIQLVT 87 (303)
T ss_pred ceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-CCceeee
Confidence 34457899999999999985 3454 5799988764322 1233333 4555543 3467899
Q ss_pred EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517 222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 301 (453)
Q Consensus 222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 301 (453)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+++....
T Consensus 88 e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 88 QLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred hhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccC
Confidence 999999999988532 24688999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517 302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 380 (453)
Q Consensus 302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 380 (453)
...........++..|+|||.+.+. .++.++||||||+++|||++ |+.|+...... ...+.+..+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~ 231 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYR--KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--------EIPDLLEKGERLP 231 (303)
T ss_pred cccccccCCCccccccCCHHHhccC--CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHCCCCCC
Confidence 3322222334467789999998753 78899999999999999997 88888543211 1222333332222
Q ss_pred ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517 381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426 (453)
Q Consensus 381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~ 426 (453)
.. ......+..++..||..+|++||++.++++.|+...++
T Consensus 232 ~~------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 232 QP------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11 11234688899999999999999999999999875443
No 182
>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea
Probab=100.00 E-value=5.5e-34 Score=275.86 Aligned_cols=243 Identities=25% Similarity=0.406 Sum_probs=183.9
Q ss_pred HHhhhhhcccCccCceEEEEEEEc-CCc----EEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceE
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQLH-TGR----LIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRA 218 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~~~-~g~----~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~ 218 (453)
...+++.+.||+|+||.||+|..+ +|+ .||+|.+..... ..+++.+| ++++|.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 345667789999999999999854 343 689998876543 22344444 3445544 5778
Q ss_pred EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298 (453)
Q Consensus 219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 298 (453)
+++||+++|+|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 999999999999998543 24589999999999999999999997 999999999999999999999999999987
Q ss_pred cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCC
Q 048517 299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGG 377 (453)
Q Consensus 299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 377 (453)
..............++..|+|||.+.. ..++.++|+||||++++|+++ |+.|+...... -+...+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~ 228 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--------EIPDLLEKGE 228 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHhCCC
Confidence 654433222222334678999998865 378899999999999999998 99998654321 1223333332
Q ss_pred CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517 378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID 425 (453)
Q Consensus 378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~ 425 (453)
...... ..+..+.+++.+||..+|++||++.++++.|+....
T Consensus 229 ~~~~~~------~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 229 RLPQPP------ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCCC------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 222111 122457889999999999999999999999987644
No 183
>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin. Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear
Probab=100.00 E-value=3.8e-34 Score=277.67 Aligned_cols=241 Identities=22% Similarity=0.284 Sum_probs=177.4
Q ss_pred hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHHHHHH---------------Hhccc-----ccCcceEEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEFINE---------------LLGLC-----SEGFKRALV 220 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~i~e---------------l~g~~-----~~~~~~~lv 220 (453)
++.+.+.||+|+||.||++.. .+++.+|+|++.......+++..| +++++ ..+...++|
T Consensus 19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv 98 (286)
T cd06638 19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV 98 (286)
T ss_pred ceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence 455668999999999999985 468999999987543322333222 33333 234567999
Q ss_pred EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517 221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 300 (453)
|||+++++|.+++.........+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 999999999988754333445688999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCceeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC
Q 048517 301 KENDFVSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG 377 (453)
Q Consensus 301 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 377 (453)
.... ......|++.|+|||++... ...++.++||||+||++|||++|+.|+....... .........
T Consensus 176 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--------~~~~~~~~~ 245 (286)
T cd06638 176 STRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--------ALFKIPRNP 245 (286)
T ss_pred cCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--------HHhhccccC
Confidence 3221 12344689999999988531 1357889999999999999999999986432110 000111111
Q ss_pred CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
..... .+......+..++.+||+.+|++|||+.|+++.
T Consensus 246 ~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 246 PPTLH----QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCccc----CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 11110 111234568899999999999999999999874
No 184
>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=3.5e-34 Score=278.10 Aligned_cols=247 Identities=26% Similarity=0.304 Sum_probs=182.4
Q ss_pred HHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEE
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYE 222 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E 222 (453)
...+++.++||+|+||+||++.. .+|+.||+|++..... ..+++..| +++.+......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 34567789999999999999985 4789999998765322 23344443 3456667778899999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 302 (453)
|+++++|.+++.. ...+++..+..++.+++.||.|||+. .+++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999888732 24689999999999999999999973 27999999999999999999999999998754322
Q ss_pred CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517 303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382 (453)
Q Consensus 303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 382 (453)
. .....|+..|+|||++.+. .++.++|||||||+++||++|+.||...............+.+.+.........
T Consensus 158 ~----~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd06620 158 I----ADTFVGTSTYMSPERIQGG--KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP 231 (284)
T ss_pred c----cCccccCcccCCHHHHccC--CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC
Confidence 1 1234689999999998753 788999999999999999999999975443211111111111111111000000
Q ss_pred chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517 383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 420 (453)
Q Consensus 383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 420 (453)
. .........+.+++.+||+.||++|||+.|++++.
T Consensus 232 ~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 232 R--LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred C--CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0 01112456788999999999999999999999864
No 185
>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with
Probab=100.00 E-value=4.1e-34 Score=278.08 Aligned_cols=235 Identities=26% Similarity=0.355 Sum_probs=175.7
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC----HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS----AEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~----~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
+...+.||+|+||+||+|.. .+++.||+|.+...... ...+..| +.+.+..+...+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 34557899999999999985 57999999998753221 1223333 23455566778999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 9999999887543 234699999999999999999999998 99999999999999999999999999997654322
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
. .....|+..|+|||++.+. .++.++|+||||+++|||++|+.||........ ...+...+......
T Consensus 157 ~---~~~~~g~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~----~~~~~~~~~~~~~~---- 223 (285)
T cd05632 157 S---IRGRVGTVGYMAPEVLNNQ--RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK----REEVDRRVLETEEV---- 223 (285)
T ss_pred c---ccCCCCCcCccChHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhhhccccc----
Confidence 1 1334689999999999753 788999999999999999999999965432110 01111111111110
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE 418 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 418 (453)
.....+..+.+++..|++.+|++||+ +.++++
T Consensus 224 ---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 224 ---YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ---cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 11223456788999999999999999 566665
No 186
>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=3.6e-34 Score=280.10 Aligned_cols=233 Identities=26% Similarity=0.359 Sum_probs=179.2
Q ss_pred hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC-HHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517 162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEGFKRALVYEYMP 225 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~~~~~lv~E~~~ 225 (453)
+|.+.++||+|+||.||+|+. .+++.||+|.+...... .+.+..| +++.+..+...++||||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 455668899999999999984 57899999998764332 2333333 4455666778899999999
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 305 (453)
+++|.+++.. ..+++.++..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 101 ~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 101 GGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred CCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence 9999998732 3578999999999999999999998 999999999999999999999999999886543321
Q ss_pred eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517 306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385 (453)
Q Consensus 306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 385 (453)
......+++.|+|||.+.+. ..+.++|||||||+++||++|+.||....... ......... ....
T Consensus 172 -~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-------~~~~~~~~~-~~~~---- 236 (296)
T cd06654 172 -KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-------ALYLIATNG-TPEL---- 236 (296)
T ss_pred -ccCcccCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-------hHHHHhcCC-CCCC----
Confidence 11334688999999998763 67899999999999999999999996443211 111111111 1111
Q ss_pred hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
..+..+...+.+++.+||+.+|++|||+.++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 112334567889999999999999999999997
No 187
>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]
Probab=100.00 E-value=2.5e-34 Score=273.90 Aligned_cols=247 Identities=24% Similarity=0.316 Sum_probs=178.9
Q ss_pred hhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCC--------HHH-HHHH---------HhcccccCc------c
Q 048517 162 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS--------AEE-FINE---------LLGLCSEGF------K 216 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~--------~~~-~i~e---------l~g~~~~~~------~ 216 (453)
.+...++||+|+||+||+|+ ..+|+.||+|++..+... +|. .+++ |.+++.... .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 44556789999999999999 568999999998764331 111 1222 444444444 6
Q ss_pred eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517 217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA 296 (453)
Q Consensus 217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 296 (453)
.++|+||+ .-+|.+++.........++...+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+|
T Consensus 92 l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence 78999999 5688888855432224566688999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517 297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG 376 (453)
Q Consensus 297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~ 376 (453)
+...-... ..+...+|..|.|||++.+. ..|+...||||+||++.||++++.-|....+... -.-+.+.+...
T Consensus 168 ra~~ip~~--~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q----l~~If~~lGtP 240 (323)
T KOG0594|consen 168 RAFSIPMR--TYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ----LFRIFRLLGTP 240 (323)
T ss_pred HHhcCCcc--cccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH----HHHHHHHcCCC
Confidence 97653332 23566789999999999876 3699999999999999999999888866543110 00011111110
Q ss_pred C-----------Cc--c------ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 377 G-----------DL--E------LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 377 ~-----------~~--~------~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
. +. . ................+++.+||+.+|.+|.|++.++++
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0 00 0 000011111122468889999999999999999999885
No 188
>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of
Probab=100.00 E-value=6.7e-35 Score=295.06 Aligned_cols=235 Identities=24% Similarity=0.304 Sum_probs=172.9
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
|.+.++||+|+||.||+++. .+|+.||||++..... ...++..| +++.+.+....++||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 45678999999999999985 5799999999865321 11222222 55667777889999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 83 ~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 83 LPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999998843 34688899999999999999999998 99999999999999999999999999996432110
Q ss_pred Cc------------e---------------------------------eecccCCCCCccChhhhcccCCCCCccchHHH
Q 048517 304 DF------------V---------------------------------SISDTRGTIGYLAPELISRNFGTVSCKSDVYG 338 (453)
Q Consensus 304 ~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S 338 (453)
.. . ......||+.|+|||++.+. .++.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwS 233 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC--CCCCceeeEe
Confidence 00 0 00123599999999999764 7889999999
Q ss_pred HHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh-CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCC---CCHH
Q 048517 339 FGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK-GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADR---PSMT 414 (453)
Q Consensus 339 ~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R---Ps~~ 414 (453)
|||++|||++|+.||...... .....+.. ........ ...++..+.+++.+|++ +|.+| ||+.
T Consensus 234 lGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~~~~~~p~----~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSH--------ETYRKIINWRETLYFPD----DIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHH--------HHHHHHHccCCccCCCC----CCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 999999999999999643321 12222221 11111111 11234567889999997 66665 5999
Q ss_pred HHHHH
Q 048517 415 KVLEM 419 (453)
Q Consensus 415 evl~~ 419 (453)
++++.
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98874
No 189
>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase. Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription
Probab=100.00 E-value=3e-34 Score=289.85 Aligned_cols=246 Identities=23% Similarity=0.323 Sum_probs=174.5
Q ss_pred hhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCc-----ceEEE
Q 048517 164 HFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGF-----KRALV 220 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~-----~~~lv 220 (453)
+..++||+|+||.||++.. .+|+.||||++..... ...++.+| +++++.... ..++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 3567899999999999995 5799999999865321 22333333 455555444 67999
Q ss_pred EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517 221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 300 (453)
+||+. ++|.+.+. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 83 TELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred eeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 99996 57777663 235689999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc---------ccchH----
Q 048517 301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK---------AYFPS---- 367 (453)
Q Consensus 301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~---------~~~~~---- 367 (453)
..... ......+|+.|+|||.+.+. ..++.++||||+||+++||++|+.||......... .....
T Consensus 155 ~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 155 PDESK-HMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cCccc-cCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 33221 22344688999999998763 35788999999999999999999999654321100 00000
Q ss_pred --HHHHHhhhCCCcc--ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 368 --WVYDQLNKGGDLE--LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 368 --~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
.....+....... ...........+..+.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0001111100000 000000111224568899999999999999999999873
No 190
>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki
Probab=100.00 E-value=8.1e-34 Score=270.82 Aligned_cols=226 Identities=23% Similarity=0.365 Sum_probs=170.0
Q ss_pred cccCccCceEEEEEEEcC-C----------cEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEE
Q 048517 167 HKLGQGGFGSVYKGQLHT-G----------RLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVY 221 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~-g----------~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~ 221 (453)
+.||+|+||.||+|...+ + ..|++|.+.........+..| +++++.. ...++|+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 469999999999999653 3 258888876644333444333 5666666 6679999
Q ss_pred EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC-------ceEEEecC
Q 048517 222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-------IPKVSDFG 294 (453)
Q Consensus 222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~-------~~kl~DFG 294 (453)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+|||++.++ .+||+|||
T Consensus 80 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 80 EYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999885432 2689999999999999999999998 999999999999999887 79999999
Q ss_pred CccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcC-CCCCCCCccccccccchHHHHHHh
Q 048517 295 LAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG-RRNSNMNATRSSKAYFPSWVYDQL 373 (453)
Q Consensus 295 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~l 373 (453)
++...... ....++..|+|||++......++.++||||||+++|||++| ..|+....... +. ...
T Consensus 154 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-------~~-~~~ 219 (259)
T cd05037 154 IPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-------KE-RFY 219 (259)
T ss_pred cccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-------HH-HHH
Confidence 99865431 23346778999999876434688999999999999999994 66664432111 01 111
Q ss_pred hhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517 374 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421 (453)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le 421 (453)
......... . ...+.+++.+||+.+|.+|||+.++++.|+
T Consensus 220 ~~~~~~~~~--~------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 220 QDQHRLPMP--D------CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred hcCCCCCCC--C------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111111110 0 157889999999999999999999999874
No 191
>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou
Probab=100.00 E-value=3.2e-34 Score=278.47 Aligned_cols=241 Identities=24% Similarity=0.362 Sum_probs=171.4
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH-----------------Hhccccc-----Ccc
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE-----------------LLGLCSE-----GFK 216 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e-----------------l~g~~~~-----~~~ 216 (453)
|.+.++||+|+||.||+|+.. +|+.||+|.+..... .......| +++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 556789999999999999854 789999998875221 11111111 2233221 234
Q ss_pred eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517 217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA 296 (453)
Q Consensus 217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 296 (453)
.++++||++ ++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred EEEEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 689999997 5888877432 234589999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517 297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG 376 (453)
Q Consensus 297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~ 376 (453)
+....... .....||..|+|||++.+. .++.++||||+||+++||++|++||....... .+.. +...+...
T Consensus 156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~---~~~~-~~~~~~~~ 226 (288)
T cd07863 156 RIYSCQMA---LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGK-IFDLIGLP 226 (288)
T ss_pred ccccCccc---CCCccccccccCchHhhCC--CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH---HHHH-HHHHhCCC
Confidence 86643321 2345689999999999764 78999999999999999999999986443211 0000 11100000
Q ss_pred -------------CCc---cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 377 -------------GDL---ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 377 -------------~~~---~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
... ...........+...+.+++.+||+.||++|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 227 PEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 000001111234567889999999999999999999875
No 192
>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play
Probab=100.00 E-value=4.2e-34 Score=281.19 Aligned_cols=247 Identities=22% Similarity=0.336 Sum_probs=176.3
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
+|.+.++||+|+||.||+|+.. +++.||+|.+..... ....+.+| +++++..+...++||||+
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 4666789999999999999854 788999999875321 12223333 466677777889999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
++ +|.+++... +..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 87 DK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 75 787776432 34588999999999999999999998 999999999999999999999999999976533221
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccc-------hHHHHHHhhhC-
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------PSWVYDQLNKG- 376 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~-------~~~~~~~l~~~- 376 (453)
......+|+.|+|||.+.+. ..++.++||||+|++++||++|+.||............ ....+..+...
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred --ccccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 12334678999999998653 36788999999999999999999999654321100000 00000000000
Q ss_pred --CCcccc-----chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 377 --GDLELR-----NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 377 --~~~~~~-----~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
...... ........++..+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000 000111224556789999999999999999999987
No 193
>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase. Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions
Probab=100.00 E-value=2.8e-34 Score=276.44 Aligned_cols=242 Identities=24% Similarity=0.372 Sum_probs=183.3
Q ss_pred HHhhhhhcccCccCceEEEEEEEcC----CcEEEEEEecCCC--CCHHHHHHH--------------HhcccccCcceEE
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQLHT----GRLIAVKMMENSK--FSAEEFINE--------------LLGLCSEGFKRAL 219 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~~~~----g~~VAVK~l~~~~--~~~~~~i~e--------------l~g~~~~~~~~~l 219 (453)
..++.+.++||+|+||.||+|...+ ...||||...... ...+++.+| +++++.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4456677899999999999998543 3479999887543 223345444 3445544 45689
Q ss_pred EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517 220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 299 (453)
||||+++|+|.+++... ...+++.++..++.+++.||+|||+. +++|+||||+||+++.++.+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999998432 24589999999999999999999997 9999999999999999999999999999876
Q ss_pred CCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517 300 PKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGD 378 (453)
Q Consensus 300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~ 378 (453)
...... ......++..|+|||.+... .++.++||||||++++||++ |+.||....... ....+..+..
T Consensus 158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--------~~~~~~~~~~ 226 (270)
T cd05056 158 EDESYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--------VIGRIENGER 226 (270)
T ss_pred ccccce-ecCCCCccccccChhhhccC--CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHcCCc
Confidence 544322 12233456789999988653 68899999999999999986 999986443211 1223333332
Q ss_pred ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517 379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID 425 (453)
Q Consensus 379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~ 425 (453)
... +...+..+.+++.+|+..+|++|||+.++++.|++..+
T Consensus 227 ~~~------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 227 LPM------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 221 12234578889999999999999999999999987554
No 194
>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati
Probab=100.00 E-value=3.4e-34 Score=273.39 Aligned_cols=234 Identities=24% Similarity=0.302 Sum_probs=179.7
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC--CCHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK--FSAEEFINE--------------LLGLCSEGFKRALVYEYMP 225 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~--~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~ 225 (453)
+.+.++||+|+||.||+++.. +++.+|+|.+.... ...+++..| +.+.+..+...++++||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 456789999999999999854 78999999886432 122333333 3455667778899999999
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 305 (453)
+|+|.+++.. .....+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++++|||+++........
T Consensus 82 ~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 82 GGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 9999888743 2335688999999999999999999998 9999999999999999999999999999866443221
Q ss_pred eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517 306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385 (453)
Q Consensus 306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 385 (453)
.....|++.|+|||++.+. ..+.++|+||||+++++|++|+.||...... . ....+..+.....
T Consensus 157 --~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-------~-~~~~~~~~~~~~~---- 220 (255)
T cd08219 157 --ACTYVGTPYYVPPEIWENM--PYNNKSDIWSLGCILYELCTLKHPFQANSWK-------N-LILKVCQGSYKPL---- 220 (255)
T ss_pred --cccccCCccccCHHHHccC--CcCchhhhhhhchhheehhhccCCCCCCCHH-------H-HHHHHhcCCCCCC----
Confidence 1335688999999998764 6889999999999999999999998643211 1 1222222222211
Q ss_pred hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
+..++..+.+++.+||+.+|++|||+.+++..
T Consensus 221 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 --PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 12244568899999999999999999999864
No 195
>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom
Probab=100.00 E-value=1.1e-33 Score=271.71 Aligned_cols=226 Identities=22% Similarity=0.368 Sum_probs=167.3
Q ss_pred cccCccCceEEEEEEEcC-------------CcEEEEEEecCCCCCH-HHHHHH--------------HhcccccCcceE
Q 048517 167 HKLGQGGFGSVYKGQLHT-------------GRLIAVKMMENSKFSA-EEFINE--------------LLGLCSEGFKRA 218 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~-------------g~~VAVK~l~~~~~~~-~~~i~e--------------l~g~~~~~~~~~ 218 (453)
+.||+|+||.||+|.+.+ ...||+|.+....... ..+..+ +++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358999887643322 122222 567777778889
Q ss_pred EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc-------eEEE
Q 048517 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI-------PKVS 291 (453)
Q Consensus 219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~-------~kl~ 291 (453)
++|||+++|+|+.++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +|++
T Consensus 81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999998887432 34689999999999999999999998 9999999999999986654 8999
Q ss_pred ecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHH-cCCCCCCCCccccccccchHHHH
Q 048517 292 DFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMA-GGRRNSNMNATRSSKAYFPSWVY 370 (453)
Q Consensus 292 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ell-tg~~p~~~~~~~~~~~~~~~~~~ 370 (453)
|||++...... ....++..|+|||.+... ..++.++|||||||++|||+ +|+.|+....... .
T Consensus 155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--------~- 218 (262)
T cd05077 155 DPGIPITVLSR------QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--------K- 218 (262)
T ss_pred CCCCCccccCc------ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--------H-
Confidence 99998754322 234578899999988632 46888999999999999998 5777765322110 0
Q ss_pred HHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517 371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421 (453)
Q Consensus 371 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le 421 (453)
..+...... .. . .....+.+++.+||+.||++||++.++++.|+
T Consensus 219 ~~~~~~~~~-~~--~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 219 ERFYEGQCM-LV--T----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHHHhcCcc-CC--C----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 111111111 00 0 11246788999999999999999999998763
No 196
>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=2e-34 Score=275.76 Aligned_cols=235 Identities=21% Similarity=0.332 Sum_probs=194.2
Q ss_pred HHHhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCHHHHHH------------------HHhcccccCcceEE
Q 048517 159 IAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFIN------------------ELLGLCSEGFKRAL 219 (453)
Q Consensus 159 ~~~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~~~~i~------------------el~g~~~~~~~~~l 219 (453)
.+-+|.|.+.||+|.||.|-++. ...|+.||||.+.+++...++-+. .++.++...++..|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 34578889999999999999998 568999999999886654433211 16778889999999
Q ss_pred EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517 220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 299 (453)
||||..+|.|.+|+.. ...|+..+...++.||.+|+.|+|.+ +++|||||.+|||||.|+++||+||||+.++
T Consensus 131 vMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 131 VMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence 9999999999999943 36799999999999999999999998 9999999999999999999999999999988
Q ss_pred CCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517 300 PKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL 379 (453)
Q Consensus 300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~ 379 (453)
..+.- ..+.+|++-|.+||.+.+. +.-.+..|-||+|++||.|+.|..||+..+.. ....++..+...
T Consensus 204 ~~~kf---LqTFCGSPLYASPEIvNG~-PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk--------~lvrQIs~GaYr 271 (668)
T KOG0611|consen 204 ADKKF---LQTFCGSPLYASPEIVNGT-PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK--------RLVRQISRGAYR 271 (668)
T ss_pred ccccH---HHHhcCCcccCCccccCCC-CCCCCccchhhHHHHHHHHhhcccccCCchHH--------HHHHHhhccccc
Confidence 76542 3567899999999999875 23367999999999999999999999875432 244556655443
Q ss_pred cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517 380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 420 (453)
Q Consensus 380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 420 (453)
+.... ....-+++|||-.||++|.|+.+|...-
T Consensus 272 EP~~P--------SdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 272 EPETP--------SDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred CCCCC--------chHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 33222 2456799999999999999999998753
No 197
>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5. Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p
Probab=100.00 E-value=6.6e-34 Score=275.56 Aligned_cols=234 Identities=25% Similarity=0.343 Sum_probs=175.3
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYMP 225 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~ 225 (453)
+++.+.||+|+||.||+|.. .+++.||+|++..... ...++..| +++.+......++|+||++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 35668899999999999984 5789999999865422 22334444 4556667777899999999
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 305 (453)
+++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 83 GGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 99996542 467888899999999999999998 99999999999999999999999999998654322
Q ss_pred eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517 306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385 (453)
Q Consensus 306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 385 (453)
.....||..|+|||++.+. .++.++||||||+++|||++|+.||.............. ....+........
T Consensus 150 --~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~---- 220 (279)
T cd06619 150 --AKTYVGTNAYMAPERISGE--QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQ-LLQCIVDEDPPVL---- 220 (279)
T ss_pred --ccCCCCChhhcCceeecCC--CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHH-HHHHHhccCCCCC----
Confidence 2345789999999999764 688999999999999999999999865332211111111 1111111111110
Q ss_pred hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
.....+..+.+++.+|++.+|++||+++++++.
T Consensus 221 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 -PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011234568899999999999999999999873
No 198
>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1. Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25
Probab=100.00 E-value=1.3e-33 Score=273.05 Aligned_cols=233 Identities=24% Similarity=0.341 Sum_probs=179.7
Q ss_pred HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
..|...+.||+|+||.||+|... +++.||+|.+..... ..+.+..| +++.+..+...++|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 45566688999999999999854 688999999875332 12223232 66777788889999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++++|.+++. ...+++..+..++.++++||.|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 84 LGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred cCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 99999998873 24689999999999999999999998 99999999999999999999999999997654322
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
. ......++..|+|||++.+. .++.++||||||++++||++|+.|+....... ....+.......
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~~~~~~~~--- 220 (277)
T cd06642 156 I--KRNTFVGTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNSDLHPMR--------VLFLIPKNSPPT--- 220 (277)
T ss_pred h--hhhcccCcccccCHHHhCcC--CCchhhhHHHHHHHHHHHHhCCCCCcccchhh--------HHhhhhcCCCCC---
Confidence 1 11234588999999998764 68899999999999999999999986432111 111111111111
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
.....+..+.+++.+||+.+|++||++.++++.
T Consensus 221 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 ---LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 122344568899999999999999999999983
No 199
>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a
Probab=100.00 E-value=1.3e-33 Score=268.85 Aligned_cols=234 Identities=26% Similarity=0.355 Sum_probs=181.9
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
.+.+.++||+|+||.||+|... +++.+|+|.+..... .+++..| +++.+......++++||+++
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 4567789999999999999966 489999999876432 4444444 45666777888999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 83 ~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 83 GSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred CcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 999998843 235789999999999999999999998 999999999999999999999999999987644321
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+........ .......... ...
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~----~~~ 220 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--------IFMIPNKPPP----TLS 220 (256)
T ss_pred ccccccCCccccCHHHHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--------hhhhccCCCC----CCC
Confidence 12334578899999998764 788999999999999999999999875332110 0011110010 011
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.+..+...+.+++.+||+.+|++|||++++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 22334567889999999999999999999986
No 200
>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.
Probab=100.00 E-value=1e-34 Score=293.65 Aligned_cols=236 Identities=23% Similarity=0.278 Sum_probs=171.2
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
|.+.++||+|+||.||+++. .+++.||||++..... ....+..| +++.+..+...++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 45678999999999999995 4689999999865211 11222222 45566677889999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++|+|.+++.. ...++...+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 83 ~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 83 IPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999843 24678888999999999999999998 99999999999999999999999999975321000
Q ss_pred C-----------------------------------------ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHH
Q 048517 304 D-----------------------------------------FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMV 342 (453)
Q Consensus 304 ~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvv 342 (453)
. ........||+.|+|||++.+. .++.++|||||||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvi 233 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC--CCCcceeeeeccce
Confidence 0 0001124699999999999764 68899999999999
Q ss_pred HHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 048517 343 LLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRP---SMTKVLEM 419 (453)
Q Consensus 343 l~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP---s~~evl~~ 419 (453)
+|||++|+.||....... ................ ...++..+.+++.+|+ .+|.+|+ |+.++++.
T Consensus 234 lyell~G~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 234 LYEMLVGQPPFLADTPAE-------TQLKVINWETTLHIPS----QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred eeehhhCCCCCCCCCHHH-------HHHHHhccCccccCCC----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999999997543211 1111111111111111 1123345666777765 4999999 88888864
No 201
>PHA03207 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=7.8e-34 Score=288.85 Aligned_cols=249 Identities=20% Similarity=0.211 Sum_probs=179.6
Q ss_pred HHhhhhhcccCccCceEEEEEEEc---CCcEEEEEEecCCCCCHHH--H--------HHHHhcccccCcceEEEEEecCC
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQLH---TGRLIAVKMMENSKFSAEE--F--------INELLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~~~---~g~~VAVK~l~~~~~~~~~--~--------i~el~g~~~~~~~~~lv~E~~~~ 226 (453)
..+|.+.++||+|+||.||++... .++.||||.+........+ . +.++++.+......+++||++.
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 169 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK- 169 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-
Confidence 446778899999999999999743 4678999998764332221 1 2225566667778899999995
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
++|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 170 ~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 170 CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 68888772 235789999999999999999999998 99999999999999999999999999998665433322
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh------------
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN------------ 374 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~------------ 374 (453)
......||+.|+|||++... .++.++|||||||++|||++|+.||...........+.. +.+.+.
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~-i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALD--PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRS-IIRCMQVHPLEFPQNGST 319 (392)
T ss_pred cccccccccCccCHhHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHH-HHHHhccCccccCCccch
Confidence 23345799999999999764 788999999999999999999999965433221111100 111000
Q ss_pred -------h---CCCccccchhh-hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 375 -------K---GGDLELRNVTE-IESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 375 -------~---~~~~~~~~~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
+ ........... ........+.+++.+||+.||++|||+.|++..
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 00000000000 001223467789999999999999999999874
No 202
>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an
Probab=100.00 E-value=1.7e-34 Score=292.68 Aligned_cols=235 Identities=22% Similarity=0.252 Sum_probs=169.1
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC----HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS----AEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~----~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
+.+.++||+|+||.||+|+. .+++.||||++...... ...+..| +++.+..+...++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 44568899999999999985 57899999998753211 1122222 45666777889999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 83 IPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999998843 24678889999999999999999998 99999999999999999999999999975321100
Q ss_pred C---------------------------------------------ceeecccCCCCCccChhhhcccCCCCCccchHHH
Q 048517 304 D---------------------------------------------FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYG 338 (453)
Q Consensus 304 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S 338 (453)
. ........||+.|+|||++.+. .++.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwS 233 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC--CCCCeeeEEe
Confidence 0 0001123689999999999764 7889999999
Q ss_pred HHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCC---HHH
Q 048517 339 FGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS---MTK 415 (453)
Q Consensus 339 ~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---~~e 415 (453)
+||++|||++|+.||....... .....+.......... ...++....+++.+++ .+|++|++ +.+
T Consensus 234 lGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~~~~~p~----~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLE-------TQMKVINWQTSLHIPP----QAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHH-------HHHHHHccCCCcCCCC----cccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 9999999999999997543211 1111111111111111 1122344556666655 49999997 777
Q ss_pred HHH
Q 048517 416 VLE 418 (453)
Q Consensus 416 vl~ 418 (453)
+++
T Consensus 302 i~~ 304 (382)
T cd05625 302 IKA 304 (382)
T ss_pred Hhc
Confidence 665
No 203
>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2
Probab=100.00 E-value=1.1e-33 Score=274.04 Aligned_cols=248 Identities=24% Similarity=0.297 Sum_probs=176.1
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
|.+.++||+|+||.||+|+.. +++.||||.+..... ..+.+..| +++++..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 455688999999999999964 789999999865321 12233333 566677778899999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
+ ++|.+++... .....+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 82 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 82 S-MDLKKYLDSL-PKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred C-CCHHHHHhcC-CCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 7 6888877432 2235789999999999999999999998 999999999999999999999999999976533221
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc------------cchHHH--H
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA------------YFPSWV--Y 370 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~------------~~~~~~--~ 370 (453)
......+++.|+|||.+.+. ..++.++||||||++++||++|+.|+.......... .++.+. .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred --cccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 12334678999999988653 357889999999999999999999986433211000 000000 0
Q ss_pred HHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 371 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
+...................++..+.+++.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000000000011224567789999999999999999999875
No 204
>PHA03209 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=8.5e-34 Score=285.03 Aligned_cols=180 Identities=21% Similarity=0.296 Sum_probs=146.3
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHH---------HHHHHhcccccCcceEEEEEecCCCChhh
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEE---------FINELLGLCSEGFKRALVYEYMPNGSLDR 231 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~---------~i~el~g~~~~~~~~~lv~E~~~~gsL~~ 231 (453)
.|.+.+.||+|+||.||+|+.. +++.||+|+........+. .+.++++++......++|+|++ .++|.+
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~ 145 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYT 145 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCcHHH
Confidence 4667789999999999999965 6789999986543332222 2333778888888899999999 568888
Q ss_pred hhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeeccc
Q 048517 232 HIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311 (453)
Q Consensus 232 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 311 (453)
++.. ....+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 146 ~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---~~~~ 216 (357)
T PHA03209 146 YLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA---FLGL 216 (357)
T ss_pred HHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCcc---cccc
Confidence 7743 235689999999999999999999998 999999999999999999999999999975432221 2345
Q ss_pred CCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCC
Q 048517 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS 353 (453)
Q Consensus 312 ~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~ 353 (453)
.||+.|+|||++.+. .++.++|||||||++|||+++..++
T Consensus 217 ~gt~~y~aPE~~~~~--~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 217 AGTVETNAPEVLARD--KYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccCCeecCCC--CCCchhhHHHHHHHHHHHHHcCCcc
Confidence 689999999999764 7899999999999999999866554
No 205
>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an
Probab=100.00 E-value=3e-34 Score=289.76 Aligned_cols=240 Identities=21% Similarity=0.276 Sum_probs=177.5
Q ss_pred HHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEE
Q 048517 159 IAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRAL 219 (453)
Q Consensus 159 ~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~l 219 (453)
....+.+.+.||+|+||.||+++.. +++.||+|++..... ....+..| +++.+..+...++
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3456677789999999999999955 789999999864211 11122222 4555667778899
Q ss_pred EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517 220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 299 (453)
||||+++|+|.+++.. ..++...+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 121 v~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 121 VMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 9999999999988732 3478888899999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCceeecccCCCCCccChhhhcccC--CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC-
Q 048517 300 PKENDFVSISDTRGTIGYLAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG- 376 (453)
Q Consensus 300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~- 376 (453)
...... ......||+.|+|||++.... +.++.++|||||||++|||++|+.||...... ..+..+...
T Consensus 193 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~ 263 (371)
T cd05622 193 NKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKIMNHK 263 (371)
T ss_pred CcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCC
Confidence 433221 123457999999999987532 24788999999999999999999999754321 122223221
Q ss_pred CCccccchhhhHHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 048517 377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAAD--RPSMTKVLEM 419 (453)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~~ 419 (453)
...... ....++..+..++.+|++.++.+ ||++.++++.
T Consensus 264 ~~~~~~----~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 264 NSLTFP----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CcccCC----CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 111111 11234566788999999844433 7799988874
No 206
>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,
Probab=100.00 E-value=8e-34 Score=282.24 Aligned_cols=239 Identities=19% Similarity=0.238 Sum_probs=173.5
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC---C-CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK---F-SAEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~---~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
|.+.+.||+|+||.||+++.. +++.||||++.... . ..+.+..| +++.+..+...++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 567789999999999999954 68999999986421 1 11222222 45566677889999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 83 YVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred CCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999998843 234688999999999999999999998 99999999999999999999999999987654332
Q ss_pred CceeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh-CCCc
Q 048517 304 DFVSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK-GGDL 379 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~-~~~~ 379 (453)
.. ......||+.|+|||++... .+.++.++|||||||++|||++|+.||...... . .+..+.. ....
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-------~-~~~~i~~~~~~~ 227 (331)
T cd05597 157 TV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------E-TYGKIMNHKEHF 227 (331)
T ss_pred Cc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-------H-HHHHHHcCCCcc
Confidence 21 11234699999999998641 235788999999999999999999998643211 1 1112211 1111
Q ss_pred cccchhhhHHHHHHHHHHHHHHhccc--CCCCCCCHHHHHHH
Q 048517 380 ELRNVTEIESMIARKLCMIGLWCIQV--KAADRPSMTKVLEM 419 (453)
Q Consensus 380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~--~p~~RPs~~evl~~ 419 (453)
.+.. .....+..+.+++.+|+.. ++..||++.++++.
T Consensus 228 ~~~~---~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 228 QFPP---DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cCCC---ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1111 1112445677777777654 34448899988875
No 207
>smart00219 TyrKc Tyrosine kinase, catalytic domain. Phosphotransferases. Tyrosine-specific kinase subfamily.
Probab=100.00 E-value=2.3e-33 Score=267.10 Aligned_cols=234 Identities=32% Similarity=0.524 Sum_probs=179.7
Q ss_pred hhcccCccCceEEEEEEEcC-----CcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 165 FTHKLGQGGFGSVYKGQLHT-----GRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 165 ~~~~LG~G~fG~Vy~g~~~~-----g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
+.+.||+|+||.||+++..+ +..||+|++..... ..+.+..| +++.+......+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 56789999999999999653 38899999976543 23344333 45566667788999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++++|.+++..... ..+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++......
T Consensus 83 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 83 MEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred cCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999998854321 2289999999999999999999998 99999999999999999999999999998765543
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 382 (453)
.... ....++..|+|||.+.. ..++.++||||+|++++||++ |+.|+..... ....+.+........
T Consensus 158 ~~~~-~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~- 225 (258)
T smart00219 158 YYKK-KGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EEVLEYLKKGYRLPK- 225 (258)
T ss_pred cccc-ccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcCCCCCC-
Confidence 3221 13347889999999854 478899999999999999998 7777754221 112223333322221
Q ss_pred chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517 383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 420 (453)
Q Consensus 383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 420 (453)
....+..+.+++.+|++.+|++|||+.++++.|
T Consensus 226 -----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 -----PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 112456788999999999999999999999865
No 208
>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=1.5e-33 Score=270.84 Aligned_cols=239 Identities=21% Similarity=0.252 Sum_probs=177.3
Q ss_pred HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC-HHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
..+.+.++||+|+||.||+|+. .+++.||+|.+...... ...+.+| +++.+......++++||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4567788999999999999985 47899999998764322 2222232 344555677889999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
++++|.+++.. ...+++.++..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 99999998742 24689999999999999999999998 999999999999999999999999999876543211
Q ss_pred ceeecccCCCCCccChhhhcc-cCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 305 FVSISDTRGTIGYLAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~-~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
......|+..|+|||++.. ..+.++.++||||+||++|||++|+.|+....... ... .......... .
T Consensus 162 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-------~~~-~~~~~~~~~~-~ 230 (267)
T cd06645 162 --KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-------ALF-LMTKSNFQPP-K 230 (267)
T ss_pred --ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-------hHH-hhhccCCCCC-c
Confidence 2234568999999998742 12467889999999999999999999985432111 011 1111110000 0
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
......++..+.+++.+||+.+|++|||++++++
T Consensus 231 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 -LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0011123456889999999999999999999875
No 209
>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI
Probab=100.00 E-value=8.4e-34 Score=275.08 Aligned_cols=247 Identities=22% Similarity=0.324 Sum_probs=178.4
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---HHHHHH--------------HHhcccccCcceEEEEEe
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---AEEFIN--------------ELLGLCSEGFKRALVYEY 223 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---~~~~i~--------------el~g~~~~~~~~~lv~E~ 223 (453)
+|++.++||+|+||.||+|..+ +++.||+|++...... .+.+.. .+++++..+...++|+||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 3566789999999999999965 6899999987653221 222322 267778888889999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++++|.++.. ....++|.++..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 82 VDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred CCccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 99999887653 224589999999999999999999998 99999999999999999999999999998654432
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc-------ccchHHHHHHhhhC
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-------AYFPSWVYDQLNKG 376 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~-------~~~~~~~~~~l~~~ 376 (453)
. ......++..|+|||++.+. ..++.++||||||++++||++|++|+......... ..+...........
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 155 E--VYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred c--ccCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 2 12334578899999998653 35778999999999999999999888643321000 00000000000000
Q ss_pred -----C-Cccccc---hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 377 -----G-DLELRN---VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 377 -----~-~~~~~~---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
. ...... .......++..+.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 000000 00011234567899999999999999999999875
No 210
>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.
Probab=100.00 E-value=2.1e-33 Score=267.83 Aligned_cols=233 Identities=26% Similarity=0.346 Sum_probs=177.1
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---HHHHHHH--------------Hhcccc-cCcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---AEEFINE--------------LLGLCS-EGFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~-~~~~~~lv~E~ 223 (453)
|.+.+.||+|++|.||+++.. +++.||+|.+...... .+.+..| +.+.+. .....+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 567789999999999999954 6889999998753322 2223333 223332 33457899999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++++|.+++... ....+++.++..++.+++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 82 CEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999999988532 335689999999999999999999998 99999999999999999999999999998664332
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
. ......+++.|+|||.+.+. .++.++||||+|++++||++|+.|+..... ..... .+..+....
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-------~~~~~-~~~~~~~~~--- 221 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFNAKDM-------NSLVY-RIIEGKLPP--- 221 (257)
T ss_pred C--ccccccCCcCccChhHhcCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHH-HHHhcCCCC---
Confidence 2 12344688999999998764 788899999999999999999999864321 11112 222222111
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.+...+..+.+++.+|++.+|++|||+.++++
T Consensus 222 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 222 ---MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ---CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 12235567899999999999999999999986
No 211
>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt
Probab=100.00 E-value=1.2e-33 Score=273.40 Aligned_cols=225 Identities=24% Similarity=0.368 Sum_probs=167.3
Q ss_pred ccCccCceEEEEEEEcC-------------------------CcEEEEEEecCCCCC-HHHHHHH--------------H
Q 048517 168 KLGQGGFGSVYKGQLHT-------------------------GRLIAVKMMENSKFS-AEEFINE--------------L 207 (453)
Q Consensus 168 ~LG~G~fG~Vy~g~~~~-------------------------g~~VAVK~l~~~~~~-~~~~i~e--------------l 207 (453)
.||+|+||.||+|++.. ...||+|++...... ..++..+ +
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998521 135899998754322 2233332 5
Q ss_pred hcccccCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC-
Q 048517 208 LGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF- 286 (453)
Q Consensus 208 ~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~- 286 (453)
+++|......++||||+++|+|..++.. ....+++..+..++.|+++||+|||+. +|+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 6777778888999999999999888743 234688999999999999999999998 999999999999997543
Q ss_pred ------ceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHH-cCCCCCCCCccc
Q 048517 287 ------IPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMA-GGRRNSNMNATR 359 (453)
Q Consensus 287 ------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ell-tg~~p~~~~~~~ 359 (453)
.+|++|||++...... ....++..|+|||.+.+. ..++.++||||||+++|||+ +|+.|+......
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 4799999998644322 223477889999988653 46889999999999999995 788888643221
Q ss_pred cccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517 360 SSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421 (453)
Q Consensus 360 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le 421 (453)
. ............ ......+.+++.+||+.+|++|||+.++++.|.
T Consensus 229 ~--------~~~~~~~~~~~~--------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 E--------KERFYEKKHRLP--------EPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H--------HHHHHHhccCCC--------CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 111111111110 111245888999999999999999999998873
No 212
>PRK13184 pknD serine/threonine-protein kinase; Reviewed
Probab=100.00 E-value=7.2e-34 Score=307.01 Aligned_cols=247 Identities=24% Similarity=0.311 Sum_probs=182.0
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC----HHHHHHH--------------HhcccccCcceEEEEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS----AEEFINE--------------LLGLCSEGFKRALVYE 222 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~----~~~~i~e--------------l~g~~~~~~~~~lv~E 222 (453)
.|.+.++||+|+||.||+|+.. +|+.||||++...... .+++.+| +++++.++...+++||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 3566789999999999999954 6899999998753221 2344444 4567777888899999
Q ss_pred ecCCCChhhhhhhccC-------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCC
Q 048517 223 YMPNGSLDRHIFSKEN-------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL 295 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl 295 (453)
|+++|+|.+++..... ....+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCc
Confidence 9999999998854211 123467788899999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCC----------------ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccc
Q 048517 296 AKFHPKEND----------------FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATR 359 (453)
Q Consensus 296 a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~ 359 (453)
++....... ........||+.|+|||.+.+. .++.++|||||||+++||++|+.||......
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~--~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV--PASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC--CCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 986521110 0001124699999999998764 7899999999999999999999999653221
Q ss_pred cccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhCCCC
Q 048517 360 SSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRP-SMTKVLEMLEGSID 425 (453)
Q Consensus 360 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-s~~evl~~Le~~~~ 425 (453)
.. . ....+... .. ......++..+.+++.+|++.||++|| +++++.+.|+..+.
T Consensus 238 ki--~----~~~~i~~P--~~----~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 238 KI--S----YRDVILSP--IE----VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hh--h----hhhhccCh--hh----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 10 0 00001000 00 001123456688899999999999996 67778777776543
No 213
>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase. Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina
Probab=100.00 E-value=1.2e-33 Score=271.77 Aligned_cols=239 Identities=25% Similarity=0.302 Sum_probs=176.8
Q ss_pred HHhhhhh--cccCccCceEEEEEEE-cCCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEE
Q 048517 160 AVTNHFT--HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVY 221 (453)
Q Consensus 160 ~~~~~~~--~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~ 221 (453)
.+++++. ..||+|+||.||+|+. ++++.||+|.+..... ..+.+.+| +++++..+...++++
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 3444443 5799999999999994 4688999998876433 22333333 566777778899999
Q ss_pred EecCCCChhhhhhhccCCCCCC--CchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-CCceEEEecCCccc
Q 048517 222 EYMPNGSLDRHIFSKENKGQTF--GLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKF 298 (453)
Q Consensus 222 E~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~ 298 (453)
||+++++|.+++.... ..+ ++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++..
T Consensus 85 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 85 EQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred ecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999885432 234 7788889999999999999998 9999999999999986 67999999999876
Q ss_pred cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517 299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD 378 (453)
Q Consensus 299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~ 378 (453)
...... ......++..|+|||++.+....++.++||||||+++|||++|+.|+........ ..+ ........
T Consensus 159 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~----~~~--~~~~~~~~ 230 (268)
T cd06624 159 LAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA----AMF--KVGMFKIH 230 (268)
T ss_pred cccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh----hHh--hhhhhccC
Confidence 543222 1223458899999999865433578899999999999999999999864321110 000 00000001
Q ss_pred ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
. ..+......+..++.+||+.+|++|||+.++++
T Consensus 231 ~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 231 P------EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred C------CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 1 122234567889999999999999999999976
No 214
>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p
Probab=100.00 E-value=5.5e-33 Score=273.98 Aligned_cols=186 Identities=25% Similarity=0.333 Sum_probs=140.9
Q ss_pred hcccCccCceEEEEEEEc---CCcEEEEEEecCCCCCHHHHHHH--------------Hhcccc--cCcceEEEEEecCC
Q 048517 166 THKLGQGGFGSVYKGQLH---TGRLIAVKMMENSKFSAEEFINE--------------LLGLCS--EGFKRALVYEYMPN 226 (453)
Q Consensus 166 ~~~LG~G~fG~Vy~g~~~---~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~--~~~~~~lv~E~~~~ 226 (453)
..+||+|+||.||+|+.. +++.||+|.+...... ....+| +++.+. .+...++++||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc-HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 468999999999999854 5688999998764322 122222 333332 2345789999985
Q ss_pred CChhhhhhhcc-----CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE----cCCCceEEEecCCcc
Q 048517 227 GSLDRHIFSKE-----NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAK 297 (453)
Q Consensus 227 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl----~~~~~~kl~DFGla~ 297 (453)
++|.+++.... .....+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 57777663221 1223588899999999999999999998 99999999999999 456789999999998
Q ss_pred ccCCCCC-ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCc
Q 048517 298 FHPKEND-FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA 357 (453)
Q Consensus 298 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~ 357 (453)
....... ........||+.|+|||++.+. ..++.++||||+||+++||++|++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 7643321 1122345789999999998753 357889999999999999999999996543
No 215
>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=1.5e-33 Score=283.34 Aligned_cols=244 Identities=21% Similarity=0.204 Sum_probs=171.4
Q ss_pred HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccC------cc
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEG------FK 216 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~------~~ 216 (453)
..|.+.+.||+|+||.||+++. .+|+.||||++..... ...++.+| +++++... ..
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 4566778999999999999985 4789999999865321 22333333 33333222 34
Q ss_pred eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517 217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA 296 (453)
Q Consensus 217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 296 (453)
.++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 101 ~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 101 VYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred eEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 6899999965 5555552 2478889999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccc--------cccch--
Q 048517 297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS--------KAYFP-- 366 (453)
Q Consensus 297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~--------~~~~~-- 366 (453)
+...... ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||........ .....
T Consensus 171 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 171 RTACTNF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred cccccCc---cCCCCcccCCCCCchhccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 7643322 12345689999999999764 788999999999999999999999975432100 00000
Q ss_pred -----HHHHHHhhhCCCcc---c---------cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 367 -----SWVYDQLNKGGDLE---L---------RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 367 -----~~~~~~l~~~~~~~---~---------~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
..+........... . .............+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000011000000 0 00000111224568899999999999999999999883
No 216
>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase. Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.
Probab=100.00 E-value=1.8e-33 Score=272.63 Aligned_cols=236 Identities=24% Similarity=0.323 Sum_probs=177.9
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
|++.++||+|+||.||+|... ++..+|+|.+..... ..+.+.+| +++.+..+...++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 556788999999999999965 588899999865332 23334443 45566677788999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|+|..++... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 87 ~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-- 158 (282)
T cd06643 87 GAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-- 158 (282)
T ss_pred CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc--
Confidence 9998877432 24689999999999999999999998 999999999999999999999999999876533221
Q ss_pred eecccCCCCCccChhhhcc---cCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 307 SISDTRGTIGYLAPELISR---NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~---~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
......+|..|+|||++.. ....++.++|||||||++|||++|+.|+...... . .............
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~-~~~~~~~~~~~~~-- 228 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-------R-VLLKIAKSEPPTL-- 228 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-------H-HHHHHhhcCCCCC--
Confidence 1234568999999999852 1235778999999999999999999998643211 0 1111111111111
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
..+..++..+.+++.+||+.+|++||++.++++
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112234467889999999999999999999875
No 217
>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase. Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki
Probab=100.00 E-value=1.3e-33 Score=269.30 Aligned_cols=232 Identities=28% Similarity=0.457 Sum_probs=177.7
Q ss_pred hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPNG 227 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g 227 (453)
.+.+.+.||+|+||.||+|.. +++.||+|++.... ..+.+..| +++.+.. ...+++|||+++|
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~~~ 83 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKG 83 (254)
T ss_pred HceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCCCC
Confidence 456778999999999999975 57889999986542 23344444 2334433 3468999999999
Q ss_pred ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517 228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 307 (453)
Q Consensus 228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 307 (453)
+|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 84 ~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 84 NLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 999998543 234688999999999999999999997 99999999999999999999999999997643221
Q ss_pred ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
.....+..|+|||.+.. +.++.++|+||||++++||++ |+.|+...... . ....+.++.....
T Consensus 155 -~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~-~~~~~~~~~~~~~----- 218 (254)
T cd05083 155 -DNSKLPVKWTAPEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-------E-VKECVEKGYRMEP----- 218 (254)
T ss_pred -CCCCCCceecCHHHhcc--CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-------H-HHHHHhCCCCCCC-----
Confidence 22344678999998865 378899999999999999997 88888643221 1 2223333322211
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
...++..+.+++.+||+.+|++||++.++++.|++
T Consensus 219 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 -PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 12234678899999999999999999999999975
No 218
>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi
Probab=100.00 E-value=1.3e-33 Score=273.72 Aligned_cols=228 Identities=25% Similarity=0.372 Sum_probs=170.4
Q ss_pred ccCccCceEEEEEEE-cCCcEEEEEEecCCCCC----HHHHHHH-----------------HhcccccCcceEEEEEecC
Q 048517 168 KLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS----AEEFINE-----------------LLGLCSEGFKRALVYEYMP 225 (453)
Q Consensus 168 ~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~----~~~~i~e-----------------l~g~~~~~~~~~lv~E~~~ 225 (453)
.||+|+||.||++.. .+|+.+|||.+...... ...+..+ +.+.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999995 46899999988653221 1111111 1223345567889999999
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 305 (453)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999988742 24689999999999999999999998 99999999999999999999999999987543322
Q ss_pred eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517 306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385 (453)
Q Consensus 306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 385 (453)
.....||..|+|||.+.+. ..++.++||||+|++++||++|+.||........ .... ........
T Consensus 152 --~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~-~~~~~~~~------ 216 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEID-RMTLTVNV------ 216 (279)
T ss_pred --ccCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-----HHHH-HHhhcCCc------
Confidence 1234689999999988642 3578899999999999999999999965432110 0011 11111111
Q ss_pred hhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 048517 386 EIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLEM 419 (453)
Q Consensus 386 ~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 419 (453)
..+...+..+.+++.+||+.||++|| |++++++.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 12233456788999999999999999 69999884
No 219
>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=3.9e-34 Score=279.06 Aligned_cols=241 Identities=23% Similarity=0.319 Sum_probs=179.7
Q ss_pred HHhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCH---------------HHHHHH--------------Hhc
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA---------------EEFINE--------------LLG 209 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~---------------~~~i~e--------------l~g 209 (453)
-.+|.+.+.||+|.||.|-+|+ ..+++.||||++.+.+... ++...| |+.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 3466778899999999999999 5589999999997643221 122222 233
Q ss_pred ccc--cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc
Q 048517 210 LCS--EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI 287 (453)
Q Consensus 210 ~~~--~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~ 287 (453)
+.. .....|||+|||..|.+... ......|+..++++++.++..||+|||.+ +|+||||||+|+||+++++
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred eecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCc
Confidence 332 34568999999999988532 12223399999999999999999999998 9999999999999999999
Q ss_pred eEEEecCCccccCCCC---CceeecccCCCCCccChhhhcccC--CCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc
Q 048517 288 PKVSDFGLAKFHPKEN---DFVSISDTRGTIGYLAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK 362 (453)
Q Consensus 288 ~kl~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~ 362 (453)
+||+|||.+...+... .........|||.|+|||...+.. ...+.+.||||+||+||.|+.|+.||......
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~--- 325 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL--- 325 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH---
Confidence 9999999998663221 111234468999999999987621 23467999999999999999999999754321
Q ss_pred ccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517 363 AYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 420 (453)
Q Consensus 363 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 420 (453)
..++.+..... .+. ...++.+.+.+|++++|+.||+.|.+..+|....
T Consensus 326 -----~l~~KIvn~pL-~fP----~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 326 -----ELFDKIVNDPL-EFP----ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred -----HHHHHHhcCcc-cCC----CcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 13333333221 111 2224567789999999999999999999998755
No 220
>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t
Probab=100.00 E-value=1.5e-33 Score=269.72 Aligned_cols=235 Identities=26% Similarity=0.301 Sum_probs=178.1
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC------HHHHHHH--------------HhcccccCcceEEEE
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS------AEEFINE--------------LLGLCSEGFKRALVY 221 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~------~~~~i~e--------------l~g~~~~~~~~~lv~ 221 (453)
+...+.||+|++|.||++.. .+++.||+|.+...... ...+..| +++++..+...++++
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 45668999999999999985 57899999988653221 1122222 456677778899999
Q ss_pred EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517 222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 301 (453)
Q Consensus 222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 301 (453)
||+++++|.+++.. ...+++..+..++.+++.||.|||+. +|+|+||||+||++++++.++|+|||+++....
T Consensus 84 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 84 EYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999998843 24588899999999999999999998 999999999999999999999999999976543
Q ss_pred CCCcee-ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517 302 ENDFVS-ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 380 (453)
Q Consensus 302 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 380 (453)
...... .....++..|+|||.+.+. .++.++||||+|+++|||++|+.||...... ..............
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~ 227 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGE--GYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKIATQPTNPQ 227 (263)
T ss_pred cccccccccCCCcCccccCcceeccC--CCCchhhhHHHHHHHHHHHhCCCCccccchH-------HHHHHHhccCCCCC
Confidence 221110 1234578899999999864 6889999999999999999999998643211 00111111111111
Q ss_pred ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
.+......+.+++.+||+.+|++|||+.++++.
T Consensus 228 ------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 228 ------LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ------CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 222345568889999999999999999999864
No 221
>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=1.3e-33 Score=276.33 Aligned_cols=234 Identities=25% Similarity=0.360 Sum_probs=180.2
Q ss_pred HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC-HHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
..|.+.++||+|+||.||+|+. .+++.||+|.+...... .+.+..| +++.+..+...++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 4566778999999999999995 57999999998764333 2333333 456667777889999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
++++|.+++.. ..+++.++..++.+++.||.|||+. +++|+||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999998732 3578999999999999999999998 999999999999999999999999999876543322
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 384 (453)
......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||........ ... ........
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~-------~~~-~~~~~~~~---- 234 (297)
T cd06656 171 --KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-------LYL-IATNGTPE---- 234 (297)
T ss_pred --CcCcccCCccccCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh-------eee-eccCCCCC----
Confidence 12334688999999998763 678999999999999999999999965332110 000 01111111
Q ss_pred hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
...+..+...+.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1122334566888999999999999999999987
No 222
>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin. Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre
Probab=100.00 E-value=2.1e-33 Score=273.51 Aligned_cols=240 Identities=26% Similarity=0.319 Sum_probs=177.0
Q ss_pred hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHHHHHH---------------Hhccccc-----CcceEEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEFINE---------------LLGLCSE-----GFKRALV 220 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~i~e---------------l~g~~~~-----~~~~~lv 220 (453)
.+.+.+.||+|+||.||++.. .+++.+|+|.+.......+++..| +++++.. ....++|
T Consensus 23 ~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv 102 (291)
T cd06639 23 TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV 102 (291)
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence 355668899999999999995 578999999987643333332222 2333332 2357899
Q ss_pred EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517 221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 300 (453)
+||+++|+|.+++.........+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++...
T Consensus 103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179 (291)
T ss_pred EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence 999999999998854333456789999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCceeecccCCCCCccChhhhcccC---CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC
Q 048517 301 KENDFVSISDTRGTIGYLAPELISRNF---GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG 377 (453)
Q Consensus 301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 377 (453)
..... .....|+..|+|||.+.... ..++.++|||||||++|||++|+.|+....... .+. .+....
T Consensus 180 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-------~~~-~~~~~~ 249 (291)
T cd06639 180 STRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-------TLF-KIPRNP 249 (291)
T ss_pred ccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-------HHH-HHhcCC
Confidence 32211 13346889999999886421 136889999999999999999999986432211 011 111111
Q ss_pred CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
..... ........+.+++.+||+.+|++||++.++++
T Consensus 250 ~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 250 PPTLL----HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCCC----cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111 11223456889999999999999999999986
No 223
>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I
Probab=100.00 E-value=2.1e-33 Score=269.93 Aligned_cols=241 Identities=27% Similarity=0.349 Sum_probs=181.6
Q ss_pred HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH---------------Hhccccc------CcceE
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE---------------LLGLCSE------GFKRA 218 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e---------------l~g~~~~------~~~~~ 218 (453)
..|.+.+.||+|+||.||+|... +++.+|+|++.......+++..| +++++.. +...+
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence 45667789999999999999964 68899999988755444444443 2333432 33478
Q ss_pred EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298 (453)
Q Consensus 219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 298 (453)
++|||+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++..
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 99999999999998855443456789999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCCceeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh
Q 048517 299 HPKENDFVSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 375 (453)
Q Consensus 299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~ 375 (453)
...... ......|+..|+|||.+... ...++.++||||||++++||++|+.||....... ....+..
T Consensus 163 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~ 232 (275)
T cd06608 163 LDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--------ALFKIPR 232 (275)
T ss_pred cccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--------HHHHhhc
Confidence 543221 12345689999999988542 1356789999999999999999999986432110 1111111
Q ss_pred CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 376 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
..... ...+...+..+.+++.+||+.||++|||+.++++
T Consensus 233 ~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 NPPPT----LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred cCCCC----CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111 1122335567889999999999999999999986
No 224
>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=1.3e-33 Score=276.12 Aligned_cols=232 Identities=25% Similarity=0.375 Sum_probs=179.3
Q ss_pred hhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCC-HHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517 163 NHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
|.+.++||.|+||.||+|. ..+|+.||+|.+...... .+.+.+| +++.+......++|+||+++
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 100 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence 4566889999999999998 457999999998764332 3333333 55667777889999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
++|.+++.. ..+++.++..++.+++.||+|||+. +++|+||||+||+++.++.+||+|||++.........
T Consensus 101 ~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 171 (296)
T cd06655 101 GSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK- 171 (296)
T ss_pred CcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence 999998732 3589999999999999999999998 9999999999999999999999999998865433221
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||....... ... .+........ .
T Consensus 172 -~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-------~~~-~~~~~~~~~~----~ 236 (296)
T cd06655 172 -RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALY-LIATNGTPEL----Q 236 (296)
T ss_pred -CCCcCCCccccCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHH-HHHhcCCccc----C
Confidence 1334688999999998764 68899999999999999999999986543211 011 1111111111 1
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.+..+...+.+++.+||+.+|++|||+.++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 12234456888999999999999999999987
No 225
>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=7.8e-34 Score=255.66 Aligned_cols=230 Identities=23% Similarity=0.344 Sum_probs=190.1
Q ss_pred hhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC------------------HHHHHHHHhcccccCcceEEEEEec
Q 048517 164 HFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS------------------AEEFINELLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~------------------~~~~i~el~g~~~~~~~~~lv~E~~ 224 (453)
++.+.||+|.||.||.|+. +++-.||+|++.++... .+..|.++++++.+....+|++||.
T Consensus 25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya 104 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA 104 (281)
T ss_pred cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence 4568899999999999995 47889999998764211 1234556999999999999999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
.+|+|.+.|... ....++......+..|+|.||.|+|.. +++||||||+|+|++.++..|++|||-+...+...
T Consensus 105 ~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~k- 178 (281)
T KOG0580|consen 105 PRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNK- 178 (281)
T ss_pred CCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCCCC-
Confidence 999999999643 346788899999999999999999998 99999999999999999999999999998665322
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 384 (453)
-...+||.-|.+||...+. ..+.+.|+|++|++.+|++.|.+||...... ..++.+.+....
T Consensus 179 ---R~tlcgt~dyl~pEmv~~~--~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~--------etYkrI~k~~~~----- 240 (281)
T KOG0580|consen 179 ---RKTLCGTLDYLPPEMVEGR--GHDKFVDLWSLGVLCYEFLVGLPPFESQSHS--------ETYKRIRKVDLK----- 240 (281)
T ss_pred ---ceeeecccccCCHhhcCCC--CccchhhHHHHHHHHHHHHhcCCchhhhhhH--------HHHHHHHHcccc-----
Confidence 2456799999999999875 7889999999999999999999999865522 255566553322
Q ss_pred hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
.+..++....+++.+|+..+|.+|.+..|+++.
T Consensus 241 --~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 241 --FPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred --CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 223455678889999999999999999999863
No 226
>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3. Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac
Probab=100.00 E-value=1.5e-33 Score=271.41 Aligned_cols=241 Identities=27% Similarity=0.401 Sum_probs=176.6
Q ss_pred hhhcccCccCceEEEEEEEc----CCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccC------cc
Q 048517 164 HFTHKLGQGGFGSVYKGQLH----TGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEG------FK 216 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~~----~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~------~~ 216 (453)
.+.+.||+|+||.||+|... +++.||||++...... .+++..| +++++... ..
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 45678999999999999853 4689999998764322 2334344 22322221 12
Q ss_pred eEEEEEecCCCChhhhhhhccC--CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecC
Q 048517 217 RALVYEYMPNGSLDRHIFSKEN--KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG 294 (453)
Q Consensus 217 ~~lv~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 294 (453)
.++++||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECccc
Confidence 3688999999999988754321 223578899999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHh
Q 048517 295 LAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQL 373 (453)
Q Consensus 295 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l 373 (453)
+++...............++..|++||.+... .++.++||||||+++|||++ |+.|+...... .....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--------~~~~~~ 228 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADN--VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--------EIYNYL 228 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcC--ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--------HHHHHH
Confidence 99876443322222333456789999998754 67889999999999999999 77877533211 122223
Q ss_pred hhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCC
Q 048517 374 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 423 (453)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~ 423 (453)
........ .......+.+++.+||+.+|++|||+.++++.|+++
T Consensus 229 ~~~~~~~~------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 IKGNRLKQ------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HcCCcCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 22222111 112345789999999999999999999999999864
No 227
>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity
Probab=100.00 E-value=8.9e-34 Score=271.40 Aligned_cols=226 Identities=23% Similarity=0.320 Sum_probs=167.3
Q ss_pred cccCccCceEEEEEEEc-C-------CcEEEEEEecCCCCC-HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 167 HKLGQGGFGSVYKGQLH-T-------GRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~-~-------g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
+.||+|+||.||+|... . ...||+|.+...... .+++..+ +++.+..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 46999999999999853 2 234888987653322 2233222 56677777788999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc--------eEEEecCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI--------PKVSDFGL 295 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~--------~kl~DFGl 295 (453)
+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +|++|||+
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999998533 23689999999999999999999998 9999999999999987665 69999998
Q ss_pred ccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCC-CCCCCCccccccccchHHHHHHhh
Q 048517 296 AKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNATRSSKAYFPSWVYDQLN 374 (453)
Q Consensus 296 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~l~ 374 (453)
+...... ....+++.|+|||++.+. ..++.++||||||+++|||++|+ .|+....... ......
T Consensus 155 ~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--------~~~~~~ 219 (258)
T cd05078 155 SITVLPK------EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--------KLQFYE 219 (258)
T ss_pred ccccCCc------hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--------HHHHHH
Confidence 8754322 234578899999999753 35788999999999999999995 4443221100 011111
Q ss_pred hCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517 375 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421 (453)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le 421 (453)
. ...+. .....++.+++.+||+.+|++|||++++++.|+
T Consensus 220 ~--~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 D--RHQLP------APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c--cccCC------CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1 11111 112346889999999999999999999999874
No 228
>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=5.9e-33 Score=269.48 Aligned_cols=239 Identities=26% Similarity=0.335 Sum_probs=179.7
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
.+++.+.||+|+||.||++..+ +|+.||+|.+...... ..++++| +++.+......++|+||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 3567789999999999999965 7999999988653221 2233333 566777788899999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
++++|..++.... ....+++..+..++.+++.||.|||+. .+|+|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 82 DAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred CCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 9999988875321 234789999999999999999999963 289999999999999999999999999997653322
Q ss_pred ceeecccCCCCCccChhhhcccC----CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517 305 FVSISDTRGTIGYLAPELISRNF----GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 380 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~----~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 380 (453)
.....++.+|+|||.+.+.. ..++.++|+|||||++|||++|+.||...... .....+.......
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~ 226 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--------NIFAQLSAIVDGD 226 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh--------hHHHHHHHHhhcC
Confidence 13345888999999885421 23588999999999999999999998643211 1112221111100
Q ss_pred ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
. ...+..+...+..++.+||+.+|++||++.++++
T Consensus 227 ~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 P---PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred C---CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 0 0122235667889999999999999999999987
No 229
>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte
Probab=100.00 E-value=2.6e-33 Score=269.82 Aligned_cols=240 Identities=26% Similarity=0.374 Sum_probs=178.2
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC---C--------HHHHHHH--------------HhcccccCcc
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF---S--------AEEFINE--------------LLGLCSEGFK 216 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~---~--------~~~~i~e--------------l~g~~~~~~~ 216 (453)
|...+.||+|+||.||+|.. .+|+.||||.+..... . .+.+..| +++++.....
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 34457899999999999984 4789999998754211 1 0122222 4567777788
Q ss_pred eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517 217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA 296 (453)
Q Consensus 217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 296 (453)
.++|+||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred eEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 89999999999999988432 4689999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517 297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG 376 (453)
Q Consensus 297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~ 376 (453)
+...............|+..|+|||.+......++.++||||||++++|+++|+.|+...... ....+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~ 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-------AAMFKLGNKR 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-------HHHHHhhccc
Confidence 865432222222345688999999998764224789999999999999999999998533211 0011111111
Q ss_pred CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
...... ......+...+.+++.+||+.+|++|||+.+|++
T Consensus 229 ~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 SAPPIP--PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCcCC--ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111111 1122234567889999999999999999999986
No 230
>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha. Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype
Probab=100.00 E-value=2.5e-33 Score=278.01 Aligned_cols=249 Identities=17% Similarity=0.216 Sum_probs=174.5
Q ss_pred hhcccCcc--CceEEEEEEE-cCCcEEEEEEecCCCCC--HHHHHH-H--------------HhcccccCcceEEEEEec
Q 048517 165 FTHKLGQG--GFGSVYKGQL-HTGRLIAVKMMENSKFS--AEEFIN-E--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 165 ~~~~LG~G--~fG~Vy~g~~-~~g~~VAVK~l~~~~~~--~~~~i~-e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
+.++||+| +||+||+++. ++|+.||||++...... ..+++. | +++++..+...++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7899999985 57999999998764322 112222 2 456777788899999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999884322 24589999999999999999999998 999999999999999999999999986543321111
Q ss_pred ce-----eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc-----ccchH------H
Q 048517 305 FV-----SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-----AYFPS------W 368 (453)
Q Consensus 305 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~-----~~~~~------~ 368 (453)
.. ......++..|+|||++.+....++.++|||||||+++||++|+.||......... ...+. .
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 00 01123467789999999764346889999999999999999999999643211100 00000 0
Q ss_pred HHHHhh-------------hCCC-------ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 369 VYDQLN-------------KGGD-------LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 369 ~~~~l~-------------~~~~-------~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
..+.+. .+.. ............++..+.+++.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000000 0000 0000000122234567899999999999999999999986
No 231
>PTZ00266 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=1.1e-33 Score=306.72 Aligned_cols=244 Identities=25% Similarity=0.343 Sum_probs=180.8
Q ss_pred HHHHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC---HHHHHHH--------------Hhcccc--cCcce
Q 048517 158 IIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCS--EGFKR 217 (453)
Q Consensus 158 ~~~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~--~~~~~ 217 (453)
.....|.+.++||+|+||+||+++. .+++.||+|.+...... ...++.| +++++. .....
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3344677889999999999999995 46889999998754322 2334444 344332 33457
Q ss_pred EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCC----CceeecccCCcceEEcC---------
Q 048517 218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCD----VCILHFDIKPHNILLDH--------- 284 (453)
Q Consensus 218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivH~Dikp~NILl~~--------- 284 (453)
+|||||+++|+|.++|.........+++..++.|+.||+.||.|||+... .+|+||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 89999999999999986543334579999999999999999999998521 36999999999999964
Q ss_pred --------CCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 048517 285 --------NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMN 356 (453)
Q Consensus 285 --------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~ 356 (453)
...+||+|||+++....... .....||+.|+|||++......++.++|||||||+||||++|+.||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 34589999999986543321 2345699999999998654346889999999999999999999999643
Q ss_pred ccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 357 ATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 357 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.. + ..+...+........ ...+..+.+++.+||+.+|.+||++.+++.
T Consensus 247 ~~------~-~qli~~lk~~p~lpi-------~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NN------F-SQLISELKRGPDLPI-------KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred Cc------H-HHHHHHHhcCCCCCc-------CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 21 1 112223332222111 112456889999999999999999999984
No 232
>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi
Probab=100.00 E-value=3.2e-33 Score=266.95 Aligned_cols=239 Identities=23% Similarity=0.328 Sum_probs=182.4
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC---HHHHHHH--------------Hhcccc--cCcceEEEEE
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCS--EGFKRALVYE 222 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~--~~~~~~lv~E 222 (453)
|++.+.||.|+||.||++.. .+|+.||+|.+..+... .+++..| +++.+. .+...+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 45668899999999999984 57899999998754322 2233333 233332 3445789999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCC--CCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC--DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 300 (453)
|+++++|.+++.........+++..++.++.+++.||.|||..+ +.+++|+||||+||+++.++.+||+|||++....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 99999999998654444567999999999999999999999332 3499999999999999999999999999998765
Q ss_pred CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517 301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 380 (453)
Q Consensus 301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 380 (453)
..... .....++..|+|||.+... .++.++||||||+++++|++|+.|+..... ....+.+..+....
T Consensus 162 ~~~~~--~~~~~~~~~~~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~ 229 (265)
T cd08217 162 HDSSF--AKTYVGTPYYMSPEQLNHM--SYDEKSDIWSLGCLIYELCALSPPFTARNQ--------LQLASKIKEGKFRR 229 (265)
T ss_pred CCccc--ccccccCCCccChhhhcCC--CCCchhHHHHHHHHHHHHHHCCCcccCcCH--------HHHHHHHhcCCCCC
Confidence 44321 2345689999999998764 688999999999999999999999875431 11222333322211
Q ss_pred ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
.+...+..+.+++.+|++.+|++||++.+|+++
T Consensus 230 ------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 230 ------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 223445678999999999999999999999874
No 233
>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=4.1e-34 Score=283.32 Aligned_cols=235 Identities=26% Similarity=0.342 Sum_probs=189.7
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHH---HHHHH--------------HhcccccCcc-eEEEEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAE---EFINE--------------LLGLCSEGFK-RALVYE 222 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~---~~i~e--------------l~g~~~~~~~-~~lv~E 222 (453)
.|...+++|+|+||.++..+.+ +++.+++|.+...+.... ..++| ....+.+++. .+|||+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 4667789999999999999844 788999999887543322 22333 2344445555 899999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 302 (453)
|++||+|.+.|... ++..++.+++..++.|++.|+.|||+. .|+|||||+.||+++.+..+||+|||+|+....+
T Consensus 85 Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred ecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999988543 367899999999999999999999987 9999999999999999999999999999988776
Q ss_pred CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517 303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382 (453)
Q Consensus 303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 382 (453)
... .....||+.||.||.+.+. +|..|+||||+||++|||++-+++|...+. ...+.+.... ..
T Consensus 160 ~~~--a~tvvGTp~YmcPEil~d~--pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-------~~Li~ki~~~-~~---- 223 (426)
T KOG0589|consen 160 DSL--ASTVVGTPYYMCPEILSDI--PYNEKSDIWSLGCCLYEMCTLKPAFKASNM-------SELILKINRG-LY---- 223 (426)
T ss_pred hhh--hheecCCCcccCHHHhCCC--CCCccCcchhhcchHHHHHhcccccCccch-------HHHHHHHhhc-cC----
Confidence 533 2457899999999999986 899999999999999999999999975432 2223333222 11
Q ss_pred chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
...+..++..+..++..|++.+|+.||++.+++.+
T Consensus 224 --~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 --SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 22455677889999999999999999999999875
No 234
>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is
Probab=100.00 E-value=2.3e-33 Score=280.06 Aligned_cols=244 Identities=20% Similarity=0.231 Sum_probs=171.0
Q ss_pred HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC---CHHHHHHH--------------Hhccccc------Ccc
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSE------GFK 216 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~------~~~ 216 (453)
..|...+.||+|+||.||+|.. .+++.||||++..... ..+++.+| +++++.. ...
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 3566778999999999999984 5788999999875322 12223233 3443322 134
Q ss_pred eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517 217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA 296 (453)
Q Consensus 217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 296 (453)
.++++|++ +++|.+.+. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 95 VYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred EEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccc
Confidence 68999988 788887662 24689999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc-------cchHHH
Q 048517 297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA-------YFPSWV 369 (453)
Q Consensus 297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~-------~~~~~~ 369 (453)
+..... .....||+.|+|||++.+. ..++.++||||+||+++||++|+.||........-. ......
T Consensus 166 ~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 166 RQADDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred eecCCC-----cCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 865432 1344689999999998753 367889999999999999999999986432110000 000000
Q ss_pred HHHhhhC---------CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 370 YDQLNKG---------GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 370 ~~~l~~~---------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
...+... ..................+.+++.+|++.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 0000000000001123457789999999999999999999963
No 235
>PHA02882 putative serine/threonine kinase; Provisional
Probab=100.00 E-value=8.6e-34 Score=277.24 Aligned_cols=247 Identities=19% Similarity=0.219 Sum_probs=166.5
Q ss_pred HHHHHhhhhhcccCccCceEEEEEEEcC----CcEEEEEEecCCCCC--HHH----------HHHH--------------
Q 048517 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHT----GRLIAVKMMENSKFS--AEE----------FINE-------------- 206 (453)
Q Consensus 157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~~----g~~VAVK~l~~~~~~--~~~----------~i~e-------------- 206 (453)
++....|.+.++||+|+||.||+|+..+ +..+|+|+....... .+. .+.+
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 4445567888999999999999999653 456777764432211 111 1111
Q ss_pred HhcccccC----cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE
Q 048517 207 LLGLCSEG----FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL 282 (453)
Q Consensus 207 l~g~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl 282 (453)
+++.+... ...++++|++. .++.+.+.. ....++..+..|+.|++.||+|||+. +|+||||||+|||+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill 159 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMV 159 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 11111111 12356666653 345444421 13357888899999999999999998 99999999999999
Q ss_pred cCCCceEEEecCCccccCCCCCc-----eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCc
Q 048517 283 DHNFIPKVSDFGLAKFHPKENDF-----VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA 357 (453)
Q Consensus 283 ~~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~ 357 (453)
+.++.+||+|||+|+........ .......||+.|+|||++.+. .++.++|||||||+++||++|+.||....
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~--~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA--CVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999876432211 111234699999999998764 78999999999999999999999997553
Q ss_pred ccccccc-chHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517 358 TRSSKAY-FPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421 (453)
Q Consensus 358 ~~~~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le 421 (453)
....... ...-....+.++.. .. ....+.+.+++..|++.+|++||++.++++.|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~-~~-------~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 238 HNGNLIHAAKCDFIKRLHEGKI-KI-------KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred cchHHHHHhHHHHHHHhhhhhh-cc-------CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 2211000 00001122222111 11 112466889999999999999999999998764
No 236
>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6. Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs
Probab=100.00 E-value=2.4e-33 Score=271.54 Aligned_cols=238 Identities=25% Similarity=0.376 Sum_probs=177.1
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC--HHHHHHH---------------HhcccccCcceEEEEEec
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~~~~~~lv~E~~ 224 (453)
+.+.+.||+|+||.||+++.. +|+.||||.+...... ..++..| +++.+..+...+++|||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 456688999999999999954 7999999998764322 2223222 445566677889999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
+ |+|.+++.........+++..++.++.|++.||+|||++ .+++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 158 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV- 158 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 6 788887754333446799999999999999999999974 379999999999999999999999999998654321
Q ss_pred ceeecccCCCCCccChhhhccc--CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517 305 FVSISDTRGTIGYLAPELISRN--FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~--~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 382 (453)
......++..|+|||.+.+. ...++.++|+||||+++|||++|+.|+...... +. .....+ ++.....
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~-~~~~~~-~~~~~~~- 228 (283)
T cd06617 159 --AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQ-QLKQVV-EEPSPQL- 228 (283)
T ss_pred --ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HH-HHHHHH-hcCCCCC-
Confidence 11234588899999988642 135688999999999999999999998642211 00 011111 1111111
Q ss_pred chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
....++..+.+++.+||+.+|++||++.++++
T Consensus 229 ----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 229 ----PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ----CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11124567889999999999999999999987
No 237
>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=3.4e-33 Score=281.23 Aligned_cols=244 Identities=22% Similarity=0.214 Sum_probs=171.7
Q ss_pred HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC---CHHHHHHH--------------Hhccccc------Ccc
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSE------GFK 216 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~------~~~ 216 (453)
..|.+.+.||+|+||.||++.. ..++.||||++..... ...++.+| +++.+.. ...
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 4566778999999999999985 4689999999875322 22233333 2333322 234
Q ss_pred eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517 217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA 296 (453)
Q Consensus 217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 296 (453)
.++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred EEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 6899999965 6666652 2478899999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccc--------cccchHH
Q 048517 297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS--------KAYFPSW 368 (453)
Q Consensus 297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~--------~~~~~~~ 368 (453)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ....+.+
T Consensus 174 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 174 RTAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred cccCCCC---cccCCcccCCcCCHHHHhCC--CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 8654322 12345689999999999764 788999999999999999999999965432110 0000000
Q ss_pred -------HHHHhhhCCCcc------------ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 369 -------VYDQLNKGGDLE------------LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 369 -------~~~~l~~~~~~~------------~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
+........... ..............+.+++.+||+.||.+|||+.++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000000 000000111123567899999999999999999999884
No 238
>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is
Probab=100.00 E-value=4.7e-33 Score=271.77 Aligned_cols=243 Identities=24% Similarity=0.338 Sum_probs=177.7
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC------HHHHHHH--------------HhcccccCcceEEEE
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS------AEEFINE--------------LLGLCSEGFKRALVY 221 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~------~~~~i~e--------------l~g~~~~~~~~~lv~ 221 (453)
|++.+.||+|+||.||+|... +|+.||||.+...... ...+..| +++++......++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 456678999999999999954 7899999998764322 1122222 567777778889999
Q ss_pred EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517 222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 301 (453)
Q Consensus 222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 301 (453)
||+ +|+|.+++.... ..+++..+..++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||+++....
T Consensus 82 e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 82 EFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred ccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 999 999999884321 3699999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh-------
Q 048517 302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN------- 374 (453)
Q Consensus 302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~------- 374 (453)
... ......+++.|+|||.+.+. ..++.++||||||++++||++|.+++....... .+.. ....+.
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~-~~~~~~~~~~~~~ 227 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGK-IFEALGTPTEENW 227 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHH-HHHHcCCCchhhh
Confidence 322 12334578889999988643 367889999999999999999977775432210 0000 000000
Q ss_pred -------hCCCc---cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 375 -------KGGDL---ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 375 -------~~~~~---~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
..... ............+..+.+++.+||+.+|++|||++|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000 0000001112345678999999999999999999999983
No 239
>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase. Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down
Probab=100.00 E-value=1.2e-33 Score=277.89 Aligned_cols=240 Identities=23% Similarity=0.301 Sum_probs=176.6
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYMP 225 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~ 225 (453)
+++.++||+|+||.||+++. .+|..+|+|.+..... ..+++..| +++.+..+...++++||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 45678899999999999985 4788999998875322 12334343 4566677788999999999
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 305 (453)
+++|.+++... ..+++..+..++.|+++||.|||+. .+++|+||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 83 GGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 99999998432 5688999999999999999999973 289999999999999999999999999987553321
Q ss_pred eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHH-----------------
Q 048517 306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW----------------- 368 (453)
Q Consensus 306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~----------------- 368 (453)
.....++..|+|||.+.+. .++.++||||||++++||++|+.|+...........+...
T Consensus 155 --~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 155 --ANSFVGTRSYMSPERLQGT--HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred --cccCCCCcCccChhHhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 1345688999999998754 6889999999999999999999998643321100000000
Q ss_pred -----------HHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 369 -----------VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 369 -----------~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
..+.+........ ....++..+.+++.+||+.+|++|||+.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKL-----PSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccC-----cCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000000 001134568899999999999999999999874
No 240
>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw
Probab=100.00 E-value=1.4e-33 Score=280.46 Aligned_cols=239 Identities=19% Similarity=0.234 Sum_probs=173.6
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC---C-CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK---F-SAEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~---~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
+.+.++||+|+||.||+++.+ +++.+|+|++.+.. . ....+..| +.+.+......++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 556789999999999999965 57889999986421 1 11112222 34455667788999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 83 YVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred cCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999998532 24689999999999999999999998 99999999999999999999999999997553332
Q ss_pred CceeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC-CCc
Q 048517 304 DFVSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG-GDL 379 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~-~~~ 379 (453)
.. ......||+.|+|||++... .+.++.++|||||||++|||++|+.||...... . ....+... ...
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-------~-~~~~i~~~~~~~ 227 (332)
T cd05623 157 TV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------E-TYGKIMNHKERF 227 (332)
T ss_pred cc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-------H-HHHHHhCCCccc
Confidence 21 22345699999999998631 236788999999999999999999999643211 1 12222221 111
Q ss_pred cccchhhhHHHHHHHHHHHHHHhcccCCC--CCCCHHHHHHH
Q 048517 380 ELRNVTEIESMIARKLCMIGLWCIQVKAA--DRPSMTKVLEM 419 (453)
Q Consensus 380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~--~RPs~~evl~~ 419 (453)
.... ....++..+.+++.+|+..+++ .||++.++++.
T Consensus 228 ~~p~---~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 QFPA---QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cCCC---ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 1111 1122345677788887765444 47899988765
No 241
>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul
Probab=100.00 E-value=2.5e-34 Score=289.15 Aligned_cols=234 Identities=23% Similarity=0.300 Sum_probs=169.9
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
+++.+.||+|+||.||+++.. +++.||||++..... ....+..| +++.+..+...++||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 445688999999999999854 789999999875211 11222222 34556677788999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 83 LPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred CCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999998843 34689999999999999999999998 99999999999999999999999999987543211
Q ss_pred Cc---------------------------------eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCC
Q 048517 304 DF---------------------------------VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350 (453)
Q Consensus 304 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~ 350 (453)
.. .......||+.|+|||++.+. .++.++|||||||++|||++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC--CCCCcceeccccceeeecccCC
Confidence 00 001234699999999999764 7889999999999999999999
Q ss_pred CCCCCCccccccccchHHHHHHhhh-CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 048517 351 RNSNMNATRSSKAYFPSWVYDQLNK-GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS---MTKVLE 418 (453)
Q Consensus 351 ~p~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---~~evl~ 418 (453)
.||...... .....+.. .......... ..+..+.+++.+++ .+|.+|++ +.++++
T Consensus 234 ~Pf~~~~~~--------~~~~~i~~~~~~~~~p~~~----~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 234 PPFCSETPQ--------ETYRKVMNWKETLVFPPEV----PISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCCHH--------HHHHHHHcCCCceecCCCC----CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 999654321 12222222 1111111111 13345666777766 49999996 555554
No 242
>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa
Probab=100.00 E-value=3.3e-33 Score=266.51 Aligned_cols=235 Identities=25% Similarity=0.334 Sum_probs=182.5
Q ss_pred hhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 163 NHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
|.+.+.||+|+||.||.++ ..+++.+++|.+..... ...++.+| +++++.+....+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 5567899999999999998 45789999998875432 22334343 456667778889999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
++|+|.+++... ....+++.++..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 82 NGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred CCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 999999988533 235689999999999999999999998 999999999999999999999999999987644332
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 384 (453)
......+++.|+|||.+.+. ..+.++||||||++++||++|+.|+...... . ....+..+....
T Consensus 157 --~~~~~~~~~~y~ape~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------~-~~~~~~~~~~~~---- 220 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGV--KYNFKSDIWALGCVLYELLTLKRTFDATNPL-------N-LVVKIVQGNYTP---- 220 (256)
T ss_pred --cccccCCCccccCHhhcCCC--CCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-------H-HHHHHHcCCCCC----
Confidence 12345689999999998764 5788999999999999999999998643211 1 122222222111
Q ss_pred hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 420 (453)
Q Consensus 385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 420 (453)
.....+..+.+++.+||+.+|++|||++++++.+
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 --VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1133456788999999999999999999998753
No 243
>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)
Probab=100.00 E-value=4.3e-33 Score=268.78 Aligned_cols=232 Identities=25% Similarity=0.330 Sum_probs=179.7
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
.|++.+.||.|+||.||+|+.. +++.||+|++..... ....+..| +.+.+..+...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 3567789999999999999954 789999999876432 12233333 445556677889999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++.......
T Consensus 82 ~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 82 GGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 99999998842 2789999999999999999999998 999999999999999999999999999987654321
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 384 (453)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...... .....+.......+.
T Consensus 154 --~~~~~~~~~~y~~PE~~~~~--~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--------~~~~~~~~~~~~~~~-- 219 (274)
T cd06609 154 --KRNTFVGTPFWMAPEVIKQS--GYDEKADIWSLGITAIELAKGEPPLSDLHPM--------RVLFLIPKNNPPSLE-- 219 (274)
T ss_pred --ccccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCcccCchH--------HHHHHhhhcCCCCCc--
Confidence 12345688899999999764 5899999999999999999999998643311 111122222111111
Q ss_pred hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
...++..+.+++.+||+.+|++|||++++++
T Consensus 220 ---~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 220 ---GNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ---ccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0114556889999999999999999999987
No 244
>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=6.6e-33 Score=269.68 Aligned_cols=244 Identities=27% Similarity=0.342 Sum_probs=180.3
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------Hhccccc--CcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSE--GFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~--~~~~~lv~E~ 223 (453)
+.+.++||.|++|.||++... +++.+|+|.+..... ..+++.+| +++++.. ....++||||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 345678999999999999964 689999999875432 23444444 3444432 3457899999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999999988765444456789999999999999999999998 99999999999999999999999999987543321
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
. ....++..|+|||.+.+. .++.++||||+|+++|||++|+.|+....... ..+......+.......+..
T Consensus 160 ~----~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd06621 160 A----GTFTGTSFYMAPERIQGK--PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP---LGPIELLSYIVNMPNPELKD 230 (287)
T ss_pred c----ccccCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCcccCCC---CChHHHHHHHhcCCchhhcc
Confidence 1 234578899999998753 78899999999999999999999997553210 01111122222211111111
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
...........+.+++.+||+.+|.+|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11111224567899999999999999999999987
No 245
>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase. Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.
Probab=100.00 E-value=3.6e-33 Score=272.12 Aligned_cols=238 Identities=26% Similarity=0.329 Sum_probs=178.6
Q ss_pred HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
..|++.++||+|+||.||+|+.. +++.||+|.+..... ..+++..| +++.+......++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 35677889999999999999965 589999999876432 22334333 455566677889999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
++++|..++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 92 PGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 999998877432 24689999999999999999999998 999999999999999999999999999875432211
Q ss_pred ceeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517 305 FVSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 381 (453)
......+++.|+|||++... ...++.++|||||||++|||++|+.|+...... .....+.+......
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~~~~~ 235 (292)
T cd06644 166 --RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSEPPTL 235 (292)
T ss_pred --ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--------HHHHHHhcCCCccC
Confidence 11334588899999988531 135688999999999999999999998543211 11112222111111
Q ss_pred cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
..+..++..+.+++.+||+.+|++||++.++++
T Consensus 236 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 236 ----SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 112234456888999999999999999999976
No 246
>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express
Probab=100.00 E-value=4.3e-33 Score=272.05 Aligned_cols=229 Identities=25% Similarity=0.345 Sum_probs=175.3
Q ss_pred cccCccCceEEEEEEE-cCCcEEEEEEecCCCCC-HHHHHHH--------------HhcccccCcceEEEEEecCCCChh
Q 048517 167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLD 230 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL~ 230 (453)
.+||+|+||.||++.. .+++.||||.+...... .+.+.+| +++.+..+...++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 5799999999999985 46899999998653322 2233333 566677788899999999999999
Q ss_pred hhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecc
Q 048517 231 RHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISD 310 (453)
Q Consensus 231 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 310 (453)
+++.. ..+++.++..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||++........ ....
T Consensus 108 ~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~ 177 (292)
T cd06658 108 DIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKS 177 (292)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCce
Confidence 87732 3588999999999999999999998 999999999999999999999999999876543221 1233
Q ss_pred cCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHH
Q 048517 311 TRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESM 390 (453)
Q Consensus 311 ~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 390 (453)
..|+..|+|||.+.+. .++.++||||||++++||++|+.|+....... ....+......... ....
T Consensus 178 ~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~----~~~~ 243 (292)
T cd06658 178 LVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--------AMRRIRDNLPPRVK----DSHK 243 (292)
T ss_pred eecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcCCCccc----cccc
Confidence 4688999999998754 68889999999999999999999986432110 11112111111111 1122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 391 IARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 391 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
.+..+..++.+|++.+|++|||++++++.
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 34567889999999999999999999974
No 247
>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea
Probab=100.00 E-value=3.1e-33 Score=270.87 Aligned_cols=238 Identities=26% Similarity=0.325 Sum_probs=176.5
Q ss_pred HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHHHHHH---------------Hhcccc------cCcceE
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEFINE---------------LLGLCS------EGFKRA 218 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~i~e---------------l~g~~~------~~~~~~ 218 (453)
..+.+.+.||+|+||.||+|+. .+++.||+|++........++..| +++++. .....+
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 4566778999999999999995 578999999987654333333333 222332 235678
Q ss_pred EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298 (453)
Q Consensus 219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 298 (453)
++|||+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++..
T Consensus 96 iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 999999999999988532 234578888999999999999999998 999999999999999999999999999875
Q ss_pred cCCCCCceeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh
Q 048517 299 HPKENDFVSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 375 (453)
Q Consensus 299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~ 375 (453)
...... ......|+..|+|||.+... ...++.++||||||+++|||++|+.||....... ....+..
T Consensus 171 ~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~--------~~~~~~~ 240 (282)
T cd06636 171 LDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR--------ALFLIPR 240 (282)
T ss_pred hhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh--------hhhhHhh
Confidence 532211 12335688999999987531 2357889999999999999999999986432111 1111111
Q ss_pred CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 376 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
..... ......+..+.+++.+||+.+|.+||++.|+++
T Consensus 241 ~~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 241 NPPPK-----LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CCCCC-----CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 11111 012234567899999999999999999999875
No 248
>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i
Probab=100.00 E-value=4.5e-33 Score=272.58 Aligned_cols=230 Identities=25% Similarity=0.352 Sum_probs=176.7
Q ss_pred hcccCccCceEEEEEEE-cCCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEEecCCCCh
Q 048517 166 THKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSL 229 (453)
Q Consensus 166 ~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL 229 (453)
..+||+|+||.||++.. .+++.||||.+..... ..+.+.+| +++++..+...++++||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 34799999999999985 4789999999865332 22333333 56777778889999999999999
Q ss_pred hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeec
Q 048517 230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 309 (453)
Q Consensus 230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 309 (453)
..++.. ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++........ ...
T Consensus 106 ~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~ 175 (297)
T cd06659 106 TDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRK 175 (297)
T ss_pred HHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--ccc
Confidence 887622 4589999999999999999999998 999999999999999999999999999876543321 123
Q ss_pred ccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHH
Q 048517 310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 389 (453)
Q Consensus 310 ~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 389 (453)
...|+..|+|||++.+. .++.++||||||++++||++|+.||....... ....+......... ...
T Consensus 176 ~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~----~~~ 241 (297)
T cd06659 176 SLVGTPYWMAPEVISRT--PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--------AMKRLRDSPPPKLK----NAH 241 (297)
T ss_pred ceecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhccCCCCcc----ccC
Confidence 45689999999999764 67899999999999999999999986432110 11222221111111 112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 390 MIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 390 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
.....+.+++.+||+.+|++||+++++++.
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 234568889999999999999999999983
No 249
>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter
Probab=100.00 E-value=6.1e-33 Score=268.42 Aligned_cols=233 Identities=23% Similarity=0.349 Sum_probs=179.9
Q ss_pred HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
..|...++||+|+||.||+|... +++.||||.+..... ....+..| +++.+..+...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34556688999999999999954 689999999875432 12233333 45566677789999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++|+|.+++.. ..+++.++..++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999998732 3588899999999999999999998 99999999999999999999999999997664432
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
. ......++..|+|||++.+. ..+.++||||||+++|||++|+.|+....... ....+.....
T Consensus 156 ~--~~~~~~~~~~y~apE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~~~~~~----- 218 (277)
T cd06640 156 I--KRNTFVGTPFWMAPEVIQQS--AYDSKADIWSLGITAIELAKGEPPNSDMHPMR--------VLFLIPKNNP----- 218 (277)
T ss_pred c--ccccccCcccccCHhHhccC--CCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--------HhhhhhcCCC-----
Confidence 1 12334678899999998754 68899999999999999999999986433211 1111111111
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
.......+..+.+++.+||+.+|++||++.++++.
T Consensus 219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 -PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11233455678899999999999999999999764
No 250
>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4. Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.
Probab=100.00 E-value=2.8e-33 Score=268.53 Aligned_cols=235 Identities=26% Similarity=0.380 Sum_probs=177.1
Q ss_pred hhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCH-------HHHHHH--------------HhcccccCcceEEEE
Q 048517 163 NHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA-------EEFINE--------------LLGLCSEGFKRALVY 221 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~-------~~~i~e--------------l~g~~~~~~~~~lv~ 221 (453)
+...+.||+|+||.||+|...+|+.+|||.+....... ..+.+| +.+++.+....++++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 34567899999999999998889999999887532211 122222 456667778889999
Q ss_pred EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517 222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 301 (453)
Q Consensus 222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 301 (453)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+++....
T Consensus 82 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 82 EFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999998843 24578999999999999999999998 999999999999999999999999999876532
Q ss_pred CCCc----eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC
Q 048517 302 ENDF----VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG 377 (453)
Q Consensus 302 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 377 (453)
.... .......|+..|+|||++.+. .++.++||||||++++||++|+.||....... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~~ 224 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINES--GYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--------AMFYIGAHR 224 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCC--CCcchhhHHHHHHHHHHHHhCCCccccCChHH--------HHHHhhhcc
Confidence 1110 111234689999999998764 67899999999999999999999996432211 001111111
Q ss_pred CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
... ...+..+...+..++.+||+.+|++||++.++++
T Consensus 225 ~~~----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 GLM----PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCC----CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 100 0112234567889999999999999999999875
No 251
>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio
Probab=100.00 E-value=2.9e-33 Score=271.16 Aligned_cols=246 Identities=23% Similarity=0.288 Sum_probs=176.9
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
|++.+.||+|+||.||+|+.. +|+.||+|++..... ..+.+..| +++.+......++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 566788999999999999965 689999998865321 12233333 456666777889999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
++++|...+. ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 83 DHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred CccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 9998877652 234689999999999999999999997 999999999999999999999999999987654332
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccc----hHHHH---HHhhhCC
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF----PSWVY---DQLNKGG 377 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~----~~~~~---~~l~~~~ 377 (453)
......++..|+|||.+.+. ..++.++||||||+++|||++|+.||............ ..+.. +......
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 156 --DYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred --cccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 11234578899999998653 35788999999999999999999998644321100000 00000 0000000
Q ss_pred ------Cccccc---hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 378 ------DLELRN---VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 378 ------~~~~~~---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
...... .......++..+.+++.+||+.+|++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000 00011223567889999999999999999999875
No 252
>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti
Probab=100.00 E-value=3e-33 Score=266.76 Aligned_cols=233 Identities=25% Similarity=0.342 Sum_probs=179.8
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
|.+.++||+|+||.||+++. .+|+.||+|.+..... ...++..| +.+++......++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 55678999999999999984 5789999999875322 22233333 455667778899999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
++++|.+++... ....+++.++..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 82 EGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999988432 234678999999999999999999998 999999999999999999999999999986644322
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 384 (453)
. .....|++.|+|||++.+. ..+.++|+||||++++||++|+.|+..... ...+... ..+....
T Consensus 157 ~--~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~-~~~~~~~---- 220 (256)
T cd08218 157 L--ARTCIGTPYYLSPEICENR--PYNNKSDIWALGCVLYEMCTLKHAFEAGNM-------KNLVLKI-IRGSYPP---- 220 (256)
T ss_pred h--hhhccCCccccCHHHhCCC--CCCCccchhHHHHHHHHHHcCCCCccCCCH-------HHHHHHH-hcCCCCC----
Confidence 1 1234588899999998764 678899999999999999999999864321 1112222 2222211
Q ss_pred hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.+...+..+.+++.+||+.+|++||++.+|++
T Consensus 221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 --VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred --CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 12234567899999999999999999999987
No 253
>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also
Probab=100.00 E-value=4.1e-33 Score=270.18 Aligned_cols=244 Identities=20% Similarity=0.260 Sum_probs=174.4
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
|.+.++||+|+||.||+|+.. +|+.||+|.+...... ...+..| +++++......++++||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 456788999999999999954 7999999998643211 1112222 566677778899999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
+ ++|.+++... ...+++..+..++.||++||.|||+. +|+|+||||+||+++.++.+||+|||+++.......
T Consensus 82 ~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 82 D-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred C-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 6 5787776432 24689999999999999999999998 999999999999999999999999999986543221
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccch----------HHHHHHhh
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP----------SWVYDQLN 374 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~----------~~~~~~l~ 374 (453)
......++..|+|||.+.+. ..++.++||||||+++|||++|+.|+....... ..+. ...+..+.
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred --CcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhh
Confidence 12345678999999998653 356889999999999999999998864332211 0000 00000010
Q ss_pred hCCC---c-cccch---hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 375 KGGD---L-ELRNV---TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 375 ~~~~---~-~~~~~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.... . ..... ......++..+.+++.+||+.||.+|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 0 00000 0011224567889999999999999999999975
No 254
>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as
Probab=100.00 E-value=1.1e-32 Score=271.48 Aligned_cols=185 Identities=24% Similarity=0.335 Sum_probs=140.2
Q ss_pred cccCccCceEEEEEEEc---CCcEEEEEEecCCCCCHHHHHHH--------------Hhccc--ccCcceEEEEEecCCC
Q 048517 167 HKLGQGGFGSVYKGQLH---TGRLIAVKMMENSKFSAEEFINE--------------LLGLC--SEGFKRALVYEYMPNG 227 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~---~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~--~~~~~~~lv~E~~~~g 227 (453)
.+||+|+||.||+|+.. +++.||+|.+...... ..+.+| +++++ ..+...++++||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc-HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 58999999999999865 4578999998764322 222222 23333 234567899999864
Q ss_pred Chhhhhhhcc-----CCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE----cCCCceEEEecCCccc
Q 048517 228 SLDRHIFSKE-----NKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAKF 298 (453)
Q Consensus 228 sL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl----~~~~~~kl~DFGla~~ 298 (453)
+|.+++.... .....+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 6766663211 1224588899999999999999999998 99999999999999 5667999999999987
Q ss_pred cCCCCCc-eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCc
Q 048517 299 HPKENDF-VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA 357 (453)
Q Consensus 299 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~ 357 (453)
....... .......||+.|+|||.+.+. ..++.++|||||||++|||+||+.||....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 6433211 122345689999999998753 357899999999999999999999996543
No 255
>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.
Probab=100.00 E-value=1.3e-33 Score=280.70 Aligned_cols=239 Identities=19% Similarity=0.252 Sum_probs=174.1
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---C-HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---S-AEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~-~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
|.+.++||+|+||.||+++.. +++.||+|++..... . ...+..| +.+.+......++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 566789999999999999954 788999999865211 1 1112222 34455677788999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 83 YVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred CCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999998532 24688999999999999999999998 99999999999999999999999999998665433
Q ss_pred CceeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh-CCCc
Q 048517 304 DFVSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK-GGDL 379 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~-~~~~ 379 (453)
.. ......||++|+|||++.+. .+.++.++||||||+++|||++|+.||...... . ....+.. ....
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~-~~~~i~~~~~~~ 227 (331)
T cd05624 157 TV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------E-TYGKIMNHEERF 227 (331)
T ss_pred ce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-------H-HHHHHHcCCCcc
Confidence 22 12335699999999998642 135788999999999999999999999643321 1 1222221 1111
Q ss_pred cccchhhhHHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 048517 380 ELRNVTEIESMIARKLCMIGLWCIQVKAAD--RPSMTKVLEM 419 (453)
Q Consensus 380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~~ 419 (453)
.... ....++..+.+++.+|++.++++ |++++++++.
T Consensus 228 ~~p~---~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 QFPS---HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cCCC---ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 1111 11223456778888888865544 4678888653
No 256
>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl
Probab=100.00 E-value=2.8e-33 Score=274.20 Aligned_cols=252 Identities=21% Similarity=0.328 Sum_probs=178.5
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
.|.+.++||+|+||.||+|+.. +++.||+|.+..... ....+..| +++++......++|+||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 4566789999999999999854 689999999875322 22223232 556667777889999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
+ ++|.+++... ...+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+++.......
T Consensus 87 ~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 87 D-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred c-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 7 6888877432 34688999999999999999999998 999999999999999999999999999976433221
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccc-------hHHHHHHh-hhC
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------PSWVYDQL-NKG 376 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~-------~~~~~~~l-~~~ 376 (453)
......+++.|+|||.+.+. ..++.++||||||+++|||++|+.||............ ....+..+ ...
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred --cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 12334578999999998753 35788999999999999999999998654321100000 00000000 000
Q ss_pred C--Cccccc-----hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhCC
Q 048517 377 G--DLELRN-----VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEGS 423 (453)
Q Consensus 377 ~--~~~~~~-----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~~ 423 (453)
. ...... .......++..+.+++.+||+.||.+|||++|+++ .++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0 000000 00011223456789999999999999999999987 44443
No 257
>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate
Probab=100.00 E-value=4.4e-33 Score=267.34 Aligned_cols=233 Identities=27% Similarity=0.389 Sum_probs=176.4
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH----------HHHHHH--------------HhcccccCcce
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA----------EEFINE--------------LLGLCSEGFKR 217 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~----------~~~i~e--------------l~g~~~~~~~~ 217 (453)
+.+...||+|+||.||+|.. .+++.||+|.+....... +.+..| +++++......
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 45678899999999999985 468999999886532211 112222 45566677788
Q ss_pred EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517 218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297 (453)
Q Consensus 218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 297 (453)
++++||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++
T Consensus 82 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred EEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999998843 24688999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCce----eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHh
Q 048517 298 FHPKENDFV----SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL 373 (453)
Q Consensus 298 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l 373 (453)
......... ......|+..|+|||.+.+. .++.++||||+|+++|||++|+.||....... ....+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~ 224 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT--SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--------AIFKI 224 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccC--CCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--------HHHHH
Confidence 765321110 11234588899999998763 67889999999999999999999996532210 11111
Q ss_pred hhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 374 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
....... .+...+..+.+++.+||+.+|++||++.++++
T Consensus 225 ~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 225 GENASPE------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred hccCCCc------CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111111 12234567889999999999999999999976
No 258
>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok
Probab=100.00 E-value=4.5e-33 Score=279.34 Aligned_cols=243 Identities=22% Similarity=0.208 Sum_probs=171.0
Q ss_pred hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC---HHHHHHH--------------Hhccccc------Ccce
Q 048517 162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSE------GFKR 217 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~------~~~~ 217 (453)
.|.+.+.||+|+||.||++.. ..++.||||++...... ..++..| +++++.. ....
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 97 (355)
T cd07874 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV 97 (355)
T ss_pred ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence 455678899999999999984 47899999998753222 2233333 3343322 2346
Q ss_pred EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517 218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297 (453)
Q Consensus 218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 297 (453)
++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 98 ~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 98 YLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred EEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 899999965 5656552 2478899999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc--------ccchH--
Q 048517 298 FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK--------AYFPS-- 367 (453)
Q Consensus 298 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~--------~~~~~-- 367 (453)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ...+.
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 168 TAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cCCCcc---ccCCccccCCccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 654322 12345689999999999764 6889999999999999999999999643311000 00000
Q ss_pred -----HHHHHhhhCCC---cccc---------chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 368 -----WVYDQLNKGGD---LELR---------NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 368 -----~~~~~l~~~~~---~~~~---------~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
.+......... .... ............+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00001110000 0000 0000112234568899999999999999999999984
No 259
>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=8.3e-34 Score=269.70 Aligned_cols=244 Identities=22% Similarity=0.274 Sum_probs=177.0
Q ss_pred hcccCccCceEEEEEE-EcCCcEEEEEEecC---CCCCHHHHHHHH--------------hccc-----ccCcceEEEEE
Q 048517 166 THKLGQGGFGSVYKGQ-LHTGRLIAVKMMEN---SKFSAEEFINEL--------------LGLC-----SEGFKRALVYE 222 (453)
Q Consensus 166 ~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~---~~~~~~~~i~el--------------~g~~-----~~~~~~~lv~E 222 (453)
.+.||+|+||.|+.+. ..+|+.||||++.. .....++-.+|+ .... ..-...++|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 4679999999999998 45899999999874 222333434441 1111 23456789999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 302 (453)
+| .-+|...+. .+..|+.....-+.+|+++||.|+|+. +|+|||+||+|+|++.+...||+|||+|+.....
T Consensus 107 lM-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 107 LM-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred HH-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeecccc
Confidence 99 667777773 334599999999999999999999998 9999999999999999999999999999987543
Q ss_pred CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc-------ccchHH-------
Q 048517 303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-------AYFPSW------- 368 (453)
Q Consensus 303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~-------~~~~~~------- 368 (453)
.....++....|..|.|||.+.. ...++.+.||||.||++.||++|++-|...+.-..- ..-+..
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~-~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLN-SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred CcccchhcceeeeeecCHHHHhc-cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 22223466778999999999865 468999999999999999999999988765432110 000011
Q ss_pred --HHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 369 --VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 369 --~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
+...+..-...........-.......++++.+||..||.+|+|++|.++
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11112111111111111111234457889999999999999999999987
No 260
>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4. Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s
Probab=100.00 E-value=7.9e-33 Score=266.90 Aligned_cols=241 Identities=26% Similarity=0.388 Sum_probs=179.6
Q ss_pred hhhhcccCccCceEEEEEEEc------CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEE
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH------TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALV 220 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~------~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv 220 (453)
+....+||+|+||.||+|+.+ +.+.||+|.+...... .+++..| +++++......++|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (275)
T cd05046 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMI 86 (275)
T ss_pred ceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEE
Confidence 345578999999999999853 3567999988764332 2334443 55677777788999
Q ss_pred EEecCCCChhhhhhhccCC-----CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCC
Q 048517 221 YEYMPNGSLDRHIFSKENK-----GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL 295 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl 295 (453)
|||+++|+|.+++...... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++++|||+
T Consensus 87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 87 LEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred EEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccccc
Confidence 9999999999998543311 12689999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhh
Q 048517 296 AKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLN 374 (453)
Q Consensus 296 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~ 374 (453)
++....... .......++..|+|||.+.+. ..+.++||||||++++||++ |..||....... ......
T Consensus 164 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--------~~~~~~ 232 (275)
T cd05046 164 SKDVYNSEY-YKLRNALIPLRWLAPEAVQED--DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--------VLNRLQ 232 (275)
T ss_pred ccccCcccc-cccCCceeEEeecChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccchHH--------HHHHHH
Confidence 875432221 122334567789999988753 67889999999999999998 777775332111 122222
Q ss_pred hCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 375 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
.+.. ... .....+..+.+++.+||+.+|++|||+.+++++|.+
T Consensus 233 ~~~~-~~~----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 233 AGKL-ELP----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred cCCc-CCC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 1111 110 111234578899999999999999999999998863
No 261
>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-33 Score=284.06 Aligned_cols=231 Identities=28% Similarity=0.384 Sum_probs=185.0
Q ss_pred ccCccCceEEEEEE-EcCCcEEEEEEecCCCCC---------------HHHHHHHHhcccccCcceEEEEEecCCCChhh
Q 048517 168 KLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS---------------AEEFINELLGLCSEGFKRALVYEYMPNGSLDR 231 (453)
Q Consensus 168 ~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~---------------~~~~i~el~g~~~~~~~~~lv~E~~~~gsL~~ 231 (453)
.||+|.||+||-|+ .++...+|||.+...... .+..|.+.+|.|++++..-+.||-++||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 49999999999999 556778999988652211 23456668999999999999999999999999
Q ss_pred hhhhccCCCCCC--CchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-CCceEEEecCCccccCCCCCceee
Q 048517 232 HIFSKENKGQTF--GLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVSI 308 (453)
Q Consensus 232 ~l~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~ 308 (453)
.|.+.. .++ .+.+.--+.+||++||.|||.+ .|||||||-+|+|++. .|.+||+|||-++....-.. .+
T Consensus 662 LLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~T 733 (1226)
T KOG4279|consen 662 LLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CT 733 (1226)
T ss_pred HHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc--cc
Confidence 885443 455 6777888999999999999998 9999999999999975 78999999999987655443 23
Q ss_pred cccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhH
Q 048517 309 SDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 388 (453)
Q Consensus 309 ~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 388 (453)
.+..||.-|||||++......|..++|||||||++.||.|||+||-.....+. ....-| ... -..+.+
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---------AMFkVG-myK--vHP~iP 801 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---------AMFKVG-MYK--VHPPIP 801 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---------hhhhhc-cee--cCCCCc
Confidence 45679999999999987656889999999999999999999999964322110 111111 111 123467
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 389 SMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 389 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.+++.+...++++|+.++|.+||+++++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 788889999999999999999999999987
No 262
>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do
Probab=100.00 E-value=3.9e-33 Score=266.77 Aligned_cols=229 Identities=25% Similarity=0.291 Sum_probs=174.5
Q ss_pred cccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH----HHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517 167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA----EEFINE---------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~----~~~i~e---------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
+.||+|+||.||+|.. .+|+.||||.+....... ..+..| +++.+..+...++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4699999999999985 468999999987543211 111111 45566677788999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||+++.....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 150 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN---- 150 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc----
Confidence 999998843 24688999999999999999999998 9999999999999999999999999998754331
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
....++..|+|||.+.+. .++.++||||||++++||++|..|+...... -....+..+.... ...
T Consensus 151 --~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~---~~~ 215 (260)
T cd05611 151 --KKFVGTPDYLAPETILGV--GDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--------AVFDNILSRRINW---PEE 215 (260)
T ss_pred --ccCCCCcCccChhhhcCC--CCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhcccCC---CCc
Confidence 234588899999998764 5789999999999999999999998643221 1222222221110 011
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le 421 (453)
....++..+.+++.+||+.+|++|||+.++.+.|.
T Consensus 216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 11234567899999999999999998877766665
No 263
>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=4.4e-33 Score=296.71 Aligned_cols=244 Identities=26% Similarity=0.423 Sum_probs=193.7
Q ss_pred hhhcccCccCceEEEEEEEc----C----CcEEEEEEecCCCCC--HHHHHHH---------------HhcccccCcceE
Q 048517 164 HFTHKLGQGGFGSVYKGQLH----T----GRLIAVKMMENSKFS--AEEFINE---------------LLGLCSEGFKRA 218 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~~----~----g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~~~~~~ 218 (453)
.+.+.||+|.||.|++|... . ...||||+++..... .+.+..| ++|.|..+...+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 45669999999999999843 1 457999999874333 3334333 789999989999
Q ss_pred EEEEecCCCChhhhhhhcc---CC-------C--CCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC
Q 048517 219 LVYEYMPNGSLDRHIFSKE---NK-------G--QTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF 286 (453)
Q Consensus 219 lv~E~~~~gsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~ 286 (453)
+|.||++.|+|.++|...+ .. . ..++...++.++.|||.|++||++. +++||||..+|||+..+.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCC
Confidence 9999999999999997654 00 1 2388899999999999999999998 999999999999999999
Q ss_pred ceEEEecCCccccCCCCCceeeccc-CCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCcccccccc
Q 048517 287 IPKVSDFGLAKFHPKENDFVSISDT-RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAY 364 (453)
Q Consensus 287 ~~kl~DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~ 364 (453)
.+||+|||+|+.......+...... .-...|||||.+... .++.|+||||||++||||+| |..|+....
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~--~ft~kSDVWSfGI~L~EifsLG~~PYp~~~------- 526 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR--VFTSKSDVWSFGILLWEIFTLGGTPYPGIP------- 526 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccC--cccccchhhHHHHHHHHHhhCCCCCCCCCC-------
Confidence 9999999999977666555422211 245679999999864 89999999999999999998 667775311
Q ss_pred chHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517 365 FPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID 425 (453)
Q Consensus 365 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~ 425 (453)
...-+.+.+.+|.+.+.+. ....++.++++.||+.+|++||++.++++.|+..+.
T Consensus 527 ~~~~l~~~l~~G~r~~~P~------~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 527 PTEELLEFLKEGNRMEQPE------HCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred cHHHHHHHHhcCCCCCCCC------CCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 1222466788887765433 234678899999999999999999999999998543
No 264
>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti
Probab=100.00 E-value=4.6e-33 Score=269.40 Aligned_cols=238 Identities=23% Similarity=0.314 Sum_probs=180.4
Q ss_pred HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
..|.+.++||+|+||.||+|+.. +++.||+|.+..... ..+.+..| +++.+..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 35677889999999999999964 689999999875432 23344444 455666777889999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
++++|.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 85 DGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred CCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 999999987432 24689999999999999999999998 999999999999999999999999999876533221
Q ss_pred ceeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517 305 FVSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 381 (453)
......+|+.|+|||.+... ...++.++||||||+++|||++|+.|+....... ....+..+....+
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~ 228 (280)
T cd06611 159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--------VLLKILKSEPPTL 228 (280)
T ss_pred --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--------HHHHHhcCCCCCc
Confidence 11334689999999998532 1356789999999999999999999986432110 1112222211111
Q ss_pred cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
..+..++..+.+++.+||+.+|++||++.++++
T Consensus 229 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 229 ----DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred ----CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 112234456888999999999999999999976
No 265
>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops
Probab=100.00 E-value=6.7e-33 Score=264.13 Aligned_cols=232 Identities=28% Similarity=0.360 Sum_probs=178.1
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC------CHHHHHHH--------------HhcccccCcceEEEE
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF------SAEEFINE--------------LLGLCSEGFKRALVY 221 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~------~~~~~i~e--------------l~g~~~~~~~~~lv~ 221 (453)
+...+.||+|+||.||+|... +++.|++|.+..... ..+.+..| +.+++..+...++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 455678999999999999965 799999998865321 12233333 456677778889999
Q ss_pred EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517 222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 301 (453)
Q Consensus 222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 301 (453)
||+++++|.+++.. ...+++..+..++.+++.||+|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 82 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 82 ELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999998842 24588999999999999999999998 999999999999999999999999999886544
Q ss_pred CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517 302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381 (453)
Q Consensus 302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 381 (453)
.. ......++..|+|||.+... ..++.++|+||||+++++|++|+.||...... ..............
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~- 222 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-------AAVFKIGRSKELPP- 222 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-------HHHHHHHhcccCCC-
Confidence 32 12345688999999998654 13889999999999999999999998643311 11111111111111
Q ss_pred cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.+..+...+.+++.+||+.+|++||++.++++
T Consensus 223 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 -----IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -----cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 12234567888999999999999999999975
No 266
>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi
Probab=100.00 E-value=1.4e-32 Score=268.44 Aligned_cols=247 Identities=25% Similarity=0.345 Sum_probs=186.8
Q ss_pred HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
.++.+.+.||+|+||.||+|.. .+++.||+|.+..... ..+.+..| +.+.+......++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 4666778999999999999984 4789999999865332 23334433 456666777889999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
++++|.+++.. ..+++.++..++.+++.||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999998832 3578999999999999999999998 999999999999999999999999999876544332
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 384 (453)
......+++.|+|||.+... .++.++||||||+++||+++|+.||......... . .+.......
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-------~-~~~~~~~~~---- 234 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------Y-LIATNGTPE---- 234 (293)
T ss_pred --ccccccCChhhcCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-------e-ehhcCCCCC----
Confidence 12334688999999998753 6789999999999999999999999754321100 0 011111111
Q ss_pred hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhCCCCCCCCCC
Q 048517 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM--LEGSIDDLQMPP 431 (453)
Q Consensus 385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--Le~~~~~~~~p~ 431 (453)
......+...+.+++.+||+.+|++||++.+++.+ ++......++||
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~~ 283 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTP 283 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccccccc
Confidence 11122344568889999999999999999999984 555554455544
No 267
>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ
Probab=100.00 E-value=1.1e-32 Score=263.56 Aligned_cols=239 Identities=23% Similarity=0.273 Sum_probs=180.0
Q ss_pred hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC-HHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517 162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEGFKRALVYEYMP 225 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~~~~~lv~E~~~ 225 (453)
.+++.+.||+|+||.||++.. .+++.+|+|.+...... .+.+..| +++.+..+...+++|||++
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 456778999999999999995 46889999998764322 2333333 4556667778899999999
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 305 (453)
+++|.+++... ...+++.++..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 84 GGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 99999987432 24688999999999999999999998 999999999999999999999999999986543221
Q ss_pred eeecccCCCCCccChhhhccc-CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517 306 VSISDTRGTIGYLAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384 (453)
Q Consensus 306 ~~~~~~~gt~~y~aPE~~~~~-~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 384 (453)
......++..|+|||.+... .+.++.++||||||+++|||++|+.|+....... .......... ... .
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--------~~~~~~~~~~-~~~-~ 225 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--------ALFLISKSNF-PPP-K 225 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhccC-CCc-c
Confidence 12345688899999998642 1267889999999999999999999986433111 1111111100 000 0
Q ss_pred hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.......+..+.+++.+||+.+|.+|||+++++.
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1123345567899999999999999999999975
No 268
>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent
Probab=100.00 E-value=1.2e-32 Score=266.04 Aligned_cols=232 Identities=23% Similarity=0.350 Sum_probs=176.2
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC--CHHHHHHH-----------------HhcccccCcceEEEEE
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF--SAEEFINE-----------------LLGLCSEGFKRALVYE 222 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~--~~~~~i~e-----------------l~g~~~~~~~~~lv~E 222 (453)
|++.+.||+|+||.||+|.. .+++.||||.+..... ...++..| +++.+..+...+++||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 45667899999999999995 5799999999865322 22233222 3445566777889999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 302 (453)
|+++++|.+++.. ..+++..++.++.+++.||.|||+. +|+|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 83 YAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred cCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 9999999988732 3689999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517 303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382 (453)
Q Consensus 303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 382 (453)
.. ......|+..|+|||.+.+. ..++.++||||||+++|+|++|+.|+....... +. ..+.......+
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-------~~-~~~~~~~~~~~- 222 (277)
T cd06917 155 SS--KRSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-------AM-MLIPKSKPPRL- 222 (277)
T ss_pred cc--ccccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhh-------hh-hccccCCCCCC-
Confidence 32 12344688999999998642 256889999999999999999999986432211 11 11111111111
Q ss_pred chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
........+.+++.+||+.+|++||++.++++
T Consensus 223 ----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 ----EDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ----CcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 01114457889999999999999999999986
No 269
>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase. Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea
Probab=100.00 E-value=7.2e-33 Score=268.37 Aligned_cols=244 Identities=22% Similarity=0.318 Sum_probs=179.2
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
|.+.+.||+|+||.||+|+. .+|+.||||++..... ..+.+..| +++.+..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 56778999999999999995 4789999999876432 22334443 455566677889999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
+++|.+++... ...+++.++..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 82 -~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 82 -PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred -CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 99999987532 25689999999999999999999998 999999999999999999999999999987654322
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC--------
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG-------- 376 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~-------- 376 (453)
.......++..|+|||.+.+. ..++.++||||+|++++||++|++++....... ....+.+.+...
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE----QLAIVFRTLGTPNEETWPGL 228 (286)
T ss_pred -CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH----HHHHHHHHcCCCChHHHhhc
Confidence 112345689999999988653 356889999999999999999987775432210 000111111000
Q ss_pred ------CCccccc-----hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 377 ------GDLELRN-----VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 377 ------~~~~~~~-----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
....... ......+....+.+++.+||+.+|++|||++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 001112335788999999999999999999999863
No 270
>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase. Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1
Probab=100.00 E-value=1.2e-32 Score=263.61 Aligned_cols=242 Identities=23% Similarity=0.297 Sum_probs=181.2
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYMP 225 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~ 225 (453)
+++.+.||+|+||+||+|.. .++..+|+|++..... ....+..| +++.+......++++|+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 56778999999999999994 4788999999876433 22333333 3444556777899999999
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 305 (453)
+++|.+++..... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.........
T Consensus 83 ~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 83 GGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred CCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 9999998854321 24689999999999999999999998 9999999999999999999999999999876543322
Q ss_pred e--eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 306 V--SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 306 ~--~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
. ......|+..|+|||.+... ...+.++|+||||++++||++|+.|+....... ...+.+.. .......
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-------~~~~~~~~-~~~~~~~ 229 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMK-------VLMLTLQN-DPPSLET 229 (267)
T ss_pred cccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhh-------hHHHHhcC-CCCCcCC
Confidence 1 11234588999999998753 367899999999999999999999986432211 01111111 1111110
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
. .....++..+.+++.+||+.+|++|||+.++++
T Consensus 230 ~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 230 G-ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred c-cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 011245567889999999999999999999986
No 271
>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc
Probab=100.00 E-value=1.1e-32 Score=266.93 Aligned_cols=246 Identities=22% Similarity=0.275 Sum_probs=176.4
Q ss_pred hhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517 164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYMP 225 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~ 225 (453)
++.++||.|++|.||+|..+ +|+.||||++..... ..+.+.+| +++++..+...+++|||+
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~- 80 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL- 80 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-
Confidence 45678999999999999854 799999999875321 12233333 567777888899999999
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 305 (453)
+++|.+++.... ...+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 DLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred CcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 478988874322 24689999999999999999999998 999999999999999999999999999976533221
Q ss_pred eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccccc-------chHHHHHHh-----
Q 048517 306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-------FPSWVYDQL----- 373 (453)
Q Consensus 306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~-------~~~~~~~~l----- 373 (453)
......++..|+|||++.+. ..++.++||||||+++|||++|+.||........... ...+.+...
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred -ccCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 12334568899999988653 3568899999999999999999999865432110000 000000000
Q ss_pred --hhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 374 --NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 374 --~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.................++..+.+++.+|++.+|++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000011112234467889999999999999999999985
No 272
>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase. Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm
Probab=100.00 E-value=1.2e-32 Score=268.42 Aligned_cols=245 Identities=21% Similarity=0.303 Sum_probs=173.0
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH---------------HhcccccCcc-----eE
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE---------------LLGLCSEGFK-----RA 218 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e---------------l~g~~~~~~~-----~~ 218 (453)
|...+.||+|+||.||+|... +|+.||||.+..... ....+..| +++++..... .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 456688999999999999954 799999998765322 12233333 3334443333 78
Q ss_pred EEEEecCCCChhhhhhhccCC-CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-CCceEEEecCCc
Q 048517 219 LVYEYMPNGSLDRHIFSKENK-GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLA 296 (453)
Q Consensus 219 lv~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla 296 (453)
++|||+++ +|.+++...... ...+++..+..++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999985 888887543322 35689999999999999999999998 9999999999999998 899999999999
Q ss_pred cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517 297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG 376 (453)
Q Consensus 297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~ 376 (453)
+....... ......+++.|+|||.+.+. ..++.++||||||+++|||++|+.||........ +. -+...+...
T Consensus 159 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~---~~-~~~~~~~~~ 231 (295)
T cd07837 159 RAFSIPVK--SYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ---LL-HIFKLLGTP 231 (295)
T ss_pred eecCCCcc--ccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH---HH-HHHHHhCCC
Confidence 86533211 11334578899999988653 3578999999999999999999999864322110 00 000000000
Q ss_pred CC-----------------ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 377 GD-----------------LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 377 ~~-----------------~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.. .............+..+.+++.+||+.+|.+|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0000000111234567889999999999999999999875
No 273
>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with
Probab=100.00 E-value=1.2e-32 Score=262.27 Aligned_cols=232 Identities=24% Similarity=0.367 Sum_probs=176.6
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
|.+.+.||+|+||.||++.. .+++.+|||.+...... ..++..| +++.+..+...++|+||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 45678999999999999985 47899999998764322 2233333 344455667789999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC-CceEEEecCCccccCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFGla~~~~~~~ 303 (453)
++++|.+++... ....+++..+..++.+++.||+|||++ +++|+||||+||+++.+ ..+||+|||++.......
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 82 PGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 999999998542 234689999999999999999999998 99999999999999854 568999999998764432
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
. .....++..|+|||.+.+. ..+.++||||||+++|+|++|+.|+..... ........ ......
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-------~~~~~~~~-~~~~~~--- 220 (256)
T cd08220 157 K---AYTVVGTPCYISPELCEGK--PYNQKSDIWALGCVLYELASLKRAFEAANL-------PALVLKIM-SGTFAP--- 220 (256)
T ss_pred c---ccccccCCcccCchhccCC--CCCcccchHHHHHHHHHHHhCCCCcccCch-------HHHHHHHH-hcCCCC---
Confidence 1 1234588899999998753 678899999999999999999999864321 11122221 111111
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.+...+..+.+++.+||+.+|++|||+.++++
T Consensus 221 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 ---ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ---CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11224567889999999999999999999986
No 274
>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity
Probab=100.00 E-value=2.1e-32 Score=262.13 Aligned_cols=236 Identities=27% Similarity=0.370 Sum_probs=179.9
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYMP 225 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~ 225 (453)
+.+.+.||+|+||.||++... +++.||+|.+..... ..+++.+| +++.+......++++||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 456788999999999999965 789999999876432 22334333 4566667788899999999
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHc-CCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
+++|.+++.... ..+++..+..++.+++.||+|||+ . +++|+||||+||+++.++.+||+|||.+........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 83 GGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 999999885332 568889999999999999999999 6 999999999999999999999999999876533221
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 384 (453)
....++..|+|||.+.+. .++.++||||||+++++|++|+.|+....... ..... ..+..........
T Consensus 157 ----~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~-~~~~~~~~~~~~~--- 224 (265)
T cd06605 157 ----KTFVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATGRFPYPPENDPP--DGIFE-LLQYIVNEPPPRL--- 224 (265)
T ss_pred ----hcccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCcccccc--ccHHH-HHHHHhcCCCCCC---
Confidence 125688899999998764 78899999999999999999999986543211 01111 1122222111111
Q ss_pred hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
....++..+.+++.+||+.+|++|||+.+++.
T Consensus 225 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 225 --PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred --ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 11125567889999999999999999999975
No 275
>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=9.3e-33 Score=267.73 Aligned_cols=250 Identities=25% Similarity=0.349 Sum_probs=179.0
Q ss_pred hhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH-------------HhcccccC-------cceEEEEEe
Q 048517 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE-------------LLGLCSEG-------FKRALVYEY 223 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e-------------l~g~~~~~-------~~~~lv~E~ 223 (453)
.+.+.||+|.||.||+|+++ |..||||++.... +..+.+| ++||.-.+ .+++||.+|
T Consensus 214 ~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd--E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdY 290 (513)
T KOG2052|consen 214 VLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD--ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDY 290 (513)
T ss_pred EEEEEecCccccceeecccc-CCceEEEEecccc--hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeec
Confidence 45578999999999999999 8999999997532 2222222 45554211 257899999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcC-----CCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNG-----CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 298 (453)
.++|||.|||.. ..++-+..++++..+|.||++||-. ..+.|.|||||+.|||+..|+...|+|+|||..
T Consensus 291 He~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~ 365 (513)
T KOG2052|consen 291 HEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 365 (513)
T ss_pred ccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence 999999999942 5789999999999999999999953 457899999999999999999999999999987
Q ss_pred cCCCCCce--eecccCCCCCccChhhhcccCC--C--CCccchHHHHHHHHHHHHcCC----------CCCCCCcccccc
Q 048517 299 HPKENDFV--SISDTRGTIGYLAPELISRNFG--T--VSCKSDVYGFGMVLLEMAGGR----------RNSNMNATRSSK 362 (453)
Q Consensus 299 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~--~--~s~k~DV~S~Gvvl~elltg~----------~p~~~~~~~~~~ 362 (453)
...+.+.. ..+...||.+|||||++..... . --..+||||||.++||+.-+- .||...... +
T Consensus 366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~--D 443 (513)
T KOG2052|consen 366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS--D 443 (513)
T ss_pred ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC--C
Confidence 76553322 2355689999999999975311 1 112689999999999997421 344322111 1
Q ss_pred ccchHHHHHHh-hhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517 363 AYFPSWVYDQL-NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID 425 (453)
Q Consensus 363 ~~~~~~~~~~l-~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~ 425 (453)
..+.. ..+.+ .+..+..+++.. ...+....|.++++.||..+|.-|-|+-.+-+.|.+..+
T Consensus 444 Ps~ee-MrkVVCv~~~RP~ipnrW-~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 444 PSFEE-MRKVVCVQKLRPNIPNRW-KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCHHH-HhcceeecccCCCCCccc-ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 11111 11111 112222222222 334566789999999999999999999888888876543
No 276
>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]
Probab=100.00 E-value=3e-33 Score=283.88 Aligned_cols=188 Identities=27% Similarity=0.338 Sum_probs=156.4
Q ss_pred HHHHHhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCHHHHHHH--------------------HhcccccCc
Q 048517 157 EIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINE--------------------LLGLCSEGF 215 (453)
Q Consensus 157 ~~~~~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~~~~i~e--------------------l~g~~~~~~ 215 (453)
+.+..+|.+.+.||+|+||.|-+|. ..+++.||||++++.+.-..+-..| +++++....
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 5555678888999999999999999 5679999999999865544333222 567778888
Q ss_pred ceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC--CCceEEEec
Q 048517 216 KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH--NFIPKVSDF 293 (453)
Q Consensus 216 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~--~~~~kl~DF 293 (453)
+.+||+|.+ .-+|.++|. .++...|+...+..|+.||+.||.+||+. +|||+||||+||||.+ ...+||+||
T Consensus 262 HlciVfELL-~~NLYellK--~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 262 HLCIVFELL-STNLYELLK--NNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred ceeeeehhh-hhhHHHHHH--hcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEec
Confidence 999999999 678999884 45567799999999999999999999998 9999999999999964 348999999
Q ss_pred CCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCc
Q 048517 294 GLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA 357 (453)
Q Consensus 294 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~ 357 (453)
|.|......- ..-.-+..|+|||++.+- +|+.+.|||||||++.||++|.+-|...+
T Consensus 336 GSSc~~~q~v-----ytYiQSRfYRAPEVILGl--pY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 336 GSSCFESQRV-----YTYIQSRFYRAPEVILGL--PYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred ccccccCCcc-----eeeeeccccccchhhccC--CCCCccceeehhhhHHhHhcCccccCCCC
Confidence 9998765432 234567899999999985 89999999999999999999977665443
No 277
>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]
Probab=100.00 E-value=9.4e-34 Score=259.20 Aligned_cols=232 Identities=26% Similarity=0.316 Sum_probs=185.1
Q ss_pred hcccCccCceEEEEEE-EcCCcEEEEEEecCCC-----CCHHHH----HHH---------------HhcccccCcceEEE
Q 048517 166 THKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSK-----FSAEEF----INE---------------LLGLCSEGFKRALV 220 (453)
Q Consensus 166 ~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~-----~~~~~~----i~e---------------l~g~~~~~~~~~lv 220 (453)
++.||+|..++|-++. ..+|+..|+|++.... ....+. +.| |..+++.....++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 4679999999999887 4578999999986521 111111 111 55667777788999
Q ss_pred EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517 221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 300 (453)
+|.|+.|.|.++|. ....++++....|+.|+..|++|||.. +||||||||+|||+|+|.++||+|||.|...+
T Consensus 102 Fdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 102 FDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccC
Confidence 99999999999994 446799999999999999999999998 99999999999999999999999999999887
Q ss_pred CCCCceeecccCCCCCccChhhhccc----CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517 301 KENDFVSISDTRGTIGYLAPELISRN----FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG 376 (453)
Q Consensus 301 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~ 376 (453)
.+.. ....+|||||+|||.+... .+.|+...|.|+.||++|.|+.|.+||.-..+ ......+.+|
T Consensus 175 ~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ--------mlMLR~ImeG 243 (411)
T KOG0599|consen 175 PGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ--------MLMLRMIMEG 243 (411)
T ss_pred Cchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH--------HHHHHHHHhc
Confidence 6653 4667899999999988642 35788899999999999999999999853221 1123344444
Q ss_pred CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
+-. ...+...+++....+++.+|||.||.+|.|++|+++
T Consensus 244 kyq---F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 244 KYQ---FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ccc---cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 321 122345567778899999999999999999999986
No 278
>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-33 Score=284.63 Aligned_cols=234 Identities=24% Similarity=0.414 Sum_probs=190.0
Q ss_pred hhhcccCccCceEEEEEEEc--CCc--EEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 164 HFTHKLGQGGFGSVYKGQLH--TGR--LIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~~--~g~--~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
.+.++||+|.||.|++|.+. +|+ .||||.+...... ..+|+.| |+|+..+ ....+|+|.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 35578999999999999864 454 5899999886554 5678887 5666655 567799999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
++.|||.+.|.. .....|-...+-.++.|||.|+.||.++ ++|||||..+|+||-....+||+||||.+.....+
T Consensus 192 aplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 192 APLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred cccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999965 3456788888999999999999999998 99999999999999999999999999999887666
Q ss_pred Cceeecc-cCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517 304 DFVSISD-TRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381 (453)
Q Consensus 304 ~~~~~~~-~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 381 (453)
.+..+.. ..-...|.|||.+.. ..++.++|||+|||+||||+| |..|+..... ..+.+.+++++++.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--------~qIL~~iD~~erLp- 335 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--------IQILKNIDAGERLP- 335 (1039)
T ss_pred cceEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCCCH--------HHHHHhccccccCC-
Confidence 5544433 345678999999975 489999999999999999998 5567654332 23666666665543
Q ss_pred cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
-+...++.++++++.||..+|++|||+..+.+.
T Consensus 336 -----RPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 336 -----RPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred -----CCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 334467889999999999999999999999743
No 279
>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase. Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.
Probab=100.00 E-value=7.9e-33 Score=267.53 Aligned_cols=243 Identities=21% Similarity=0.249 Sum_probs=173.9
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC--HHHHHHH---------------HhcccccC--cceEEEEE
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSEG--FKRALVYE 222 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~~--~~~~lv~E 222 (453)
|++.++||+|+||.||+|+. .+++.||+|.+...... ......| +++++... ...++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 35678899999999999995 47899999998763221 1111122 44555555 77899999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 302 (453)
|++ |+|.+.+... ...++|.++..++.|++.||+|||+. +++|+||||+||+++. +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 5887777432 24689999999999999999999998 9999999999999999 99999999999866443
Q ss_pred CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccc--------cccchHHHHHHhh
Q 048517 303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS--------KAYFPSWVYDQLN 374 (453)
Q Consensus 303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~--------~~~~~~~~~~~l~ 374 (453)
... ....++..|+|||.+... +.++.++||||+||++|||++|+.||........ ......| .....
T Consensus 153 ~~~---~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 227 (282)
T cd07831 153 PPY---TEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKFR 227 (282)
T ss_pred CCc---CCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhhc
Confidence 221 234578899999987543 3578899999999999999999999965432110 0000111 11111
Q ss_pred hCCCccc--cc-----hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 375 KGGDLEL--RN-----VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 375 ~~~~~~~--~~-----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
....... .. ........+..+.+++.+||+.+|++|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 1110000 00 00112234678999999999999999999999976
No 280
>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex
Probab=100.00 E-value=1.7e-32 Score=265.75 Aligned_cols=240 Identities=21% Similarity=0.297 Sum_probs=175.9
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
|+..+.||.|+||.||+|+.. +|+.||||++...... ...+.+| +++++..+...++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 345678999999999999854 7899999988753221 1233333 677777888899999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
. ++|.+++... ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||+++.......
T Consensus 82 ~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 82 H-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred c-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 5 6888887533 235689999999999999999999998 999999999999999999999999999876543221
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC-------
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG------- 377 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~------- 377 (453)
......++..|+|||.+.+. ..++.++||||||++++||+||+.||....... ...+......
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~ 225 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-------QLFRIFRTLGTPDEVVW 225 (284)
T ss_pred --ccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHHHhCCCChhhh
Confidence 12334578899999988653 346889999999999999999999986433211 0111000000
Q ss_pred --------------CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 378 --------------DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 378 --------------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.............+...+.+++.+||+.||++|||++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 226 PGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000111223456788999999999999999999975
No 281
>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4
Probab=100.00 E-value=2e-32 Score=261.90 Aligned_cols=238 Identities=27% Similarity=0.404 Sum_probs=179.2
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
|+..+.||+|+||.||+|... +++.||+|.+...... ..++..| +++.+......++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 556789999999999999854 7899999998875443 2233333 455666677889999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
++++|.+++.. ...+++..+..++.++++||.|||+. +|+|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 82 SGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999998843 24588999999999999999999998 999999999999999999999999999987654332
Q ss_pred cee--ecccCCCCCccChhhhcccC-CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517 305 FVS--ISDTRGTIGYLAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381 (453)
Q Consensus 305 ~~~--~~~~~gt~~y~aPE~~~~~~-~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 381 (453)
... .....++..|+|||++.... ...+.++||||||++++||++|+.||....... .... .+..+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~------~~~~-~~~~~~~~~~ 227 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF------QIMF-HVGAGHKPPI 227 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH------HHHH-HHhcCCCCCC
Confidence 111 12346789999999987642 237889999999999999999999986432110 0011 1111111111
Q ss_pred cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
. ........+.+++.+||+.+|++|||+.+++.
T Consensus 228 ~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 228 P----DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred C----cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1 11123556788999999999999999999864
No 282
>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase
Probab=100.00 E-value=1.6e-32 Score=273.34 Aligned_cols=251 Identities=22% Similarity=0.246 Sum_probs=176.2
Q ss_pred hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCC--CCCHHHHHHH--------------Hhccccc-----CcceEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENS--KFSAEEFINE--------------LLGLCSE-----GFKRAL 219 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~--~~~~~~~i~e--------------l~g~~~~-----~~~~~l 219 (453)
.|.+.++||+|+||.||+|+. .+|+.||||.+... .....++..| +++++.. ....++
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 456678999999999999984 57999999998642 1222333333 3333322 235789
Q ss_pred EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517 220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 299 (453)
++||+. ++|.+.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~-~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 86 VQELME-TDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred Eehhcc-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 999996 47776662 24689999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCCce-eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh---
Q 048517 300 PKENDFV-SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK--- 375 (453)
Q Consensus 300 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~--- 375 (453)
....... ......||..|+|||.+.+. ..++.++||||+|++++||++|+.||........ ...+.+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~----~~~~~~~~~~~~~ 231 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ----LNLILGVLGTPSQ 231 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHcCCCCH
Confidence 4332211 11234688999999987543 3678899999999999999999999864321100 0000000000
Q ss_pred -----------------CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhCCCCC
Q 048517 376 -----------------GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM--LEGSIDD 426 (453)
Q Consensus 376 -----------------~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--Le~~~~~ 426 (453)
................+..+.+++.+||+.+|++|||+.++++. ++...+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 00000000000111235678899999999999999999999986 6655444
No 283
>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a
Probab=100.00 E-value=7.2e-33 Score=271.88 Aligned_cols=239 Identities=20% Similarity=0.228 Sum_probs=178.3
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
+++.+.||+|+||.||++... +++.||+|.+..... ....+..| +++.+..+...++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 456788999999999999954 688999999876432 12233333 44556667778999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++++|.+++.. ...+++..+..++.+++.||.|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 83 VEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999843 24689999999999999999999998 99999999999999999999999999987421110
Q ss_pred C-------------ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHH
Q 048517 304 D-------------FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY 370 (453)
Q Consensus 304 ~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 370 (453)
. ........++..|+|||.+... .++.++|+||||+++|||++|+.||..... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~vl~el~~g~~pf~~~~~--------~~~~ 225 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTP--------EELF 225 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHH
Confidence 0 0011123578899999998753 688999999999999999999999864321 1122
Q ss_pred HHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 371 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
.....+...... .....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 226 ~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 226 GQVISDDIEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHhcccCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 222221111110 111344668899999999999999998888888875
No 284
>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=5.7e-34 Score=283.39 Aligned_cols=226 Identities=27% Similarity=0.374 Sum_probs=179.3
Q ss_pred cccCccCceEEEEEE-EcCCcEEEEEEecCCCC-CHH---HHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517 167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKF-SAE---EFINE--------------LLGLCSEGFKRALVYEYMPNG 227 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~-~~~---~~i~e--------------l~g~~~~~~~~~lv~E~~~~g 227 (453)
+.||.|+||.||.++ ..+...||||++..+.. ..+ +.+.| .-|++...+..+|||||| -|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence 579999999999999 55788999999876432 332 22333 356777777889999999 55
Q ss_pred ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517 228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 307 (453)
Q Consensus 228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 307 (453)
|-.+.+ +...+++....+..|..+.+.||+|||+. +.||||||..||||++.+.+||+|||.|......
T Consensus 111 SAsDll---eVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----- 179 (948)
T KOG0577|consen 111 SASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----- 179 (948)
T ss_pred cHHHHH---HHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch-----
Confidence 666666 23446789999999999999999999998 9999999999999999999999999999876554
Q ss_pred ecccCCCCCccChhhhcc-cCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 308 ISDTRGTIGYLAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 308 ~~~~~gt~~y~aPE~~~~-~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
....|||.|||||++.. ..|+|+-|+||||+|++..||..+++|....+.-+ ..-++.+.....+
T Consensus 180 -nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS--------ALYHIAQNesPtL----- 245 (948)
T KOG0577|consen 180 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNESPTL----- 245 (948)
T ss_pred -hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH--------HHHHHHhcCCCCC-----
Confidence 34569999999999865 34799999999999999999999999976544221 2234444333222
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
...+.+..++.++..||+.-|.+|||..+++.
T Consensus 246 qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 246 QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 23456678999999999999999999988765
No 285
>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the
Probab=100.00 E-value=1.4e-32 Score=270.31 Aligned_cols=251 Identities=21% Similarity=0.276 Sum_probs=175.7
Q ss_pred hhhhcccCccCceEEEEEEEc---CCcEEEEEEecCCC----CCHHHHHHH--------------HhcccccC--cceEE
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH---TGRLIAVKMMENSK----FSAEEFINE--------------LLGLCSEG--FKRAL 219 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~---~g~~VAVK~l~~~~----~~~~~~i~e--------------l~g~~~~~--~~~~l 219 (453)
|.+.++||+|+||.||+|+.. +++.||+|.+.... ...+....| +++++... ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 456788999999999999954 58999999987632 112222222 55666666 77899
Q ss_pred EEEecCCCChhhhhhhccC-CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC----CCceEEEecC
Q 048517 220 VYEYMPNGSLDRHIFSKEN-KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH----NFIPKVSDFG 294 (453)
Q Consensus 220 v~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~----~~~~kl~DFG 294 (453)
||||+++ +|.+.+..... ....++...+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 66665533222 224788999999999999999999998 9999999999999999 9999999999
Q ss_pred CccccCCCCC-ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc-cchHH----
Q 048517 295 LAKFHPKEND-FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA-YFPSW---- 368 (453)
Q Consensus 295 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~---- 368 (453)
+++....... ........+|..|+|||.+.+. ..++.++||||||++++||++|+.|+.......... .+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 9987643322 1122344678999999988653 357889999999999999999999997554332000 00000
Q ss_pred HHHHhh---------------------hCCCccccc--hhh-hHH--HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 369 VYDQLN---------------------KGGDLELRN--VTE-IES--MIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 369 ~~~~l~---------------------~~~~~~~~~--~~~-~~~--~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
+...+. ......... ... .+. ..+..+.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 000000000 000 011 33457889999999999999999999976
No 286
>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co
Probab=100.00 E-value=1.1e-32 Score=266.99 Aligned_cols=227 Identities=25% Similarity=0.356 Sum_probs=170.4
Q ss_pred ccCccCceEEEEEEE-cCCcEEEEEEecCCCCC----HHHHHHH-----------------HhcccccCcceEEEEEecC
Q 048517 168 KLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS----AEEFINE-----------------LLGLCSEGFKRALVYEYMP 225 (453)
Q Consensus 168 ~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~----~~~~i~e-----------------l~g~~~~~~~~~lv~E~~~ 225 (453)
.||+|+||.||++.. .+++.||+|.+...... ...+..+ +.+.+......++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 56899999988653211 1111111 2333455667889999999
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 305 (453)
+|+|.+++.. ...+++..+..++.|+++||+|||+. +|+|+||||+||+++.++.+||+|||+++.......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 9999888732 35699999999999999999999998 999999999999999999999999999875533221
Q ss_pred eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517 306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385 (453)
Q Consensus 306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 385 (453)
....|+..|+|||.+.+. ..++.++||||+|++++||++|+.||........ ....... ......
T Consensus 153 ---~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~-~~~~~~----- 217 (278)
T cd05606 153 ---HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMT-LTMAVE----- 217 (278)
T ss_pred ---cCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-----HHHHHHh-hccCCC-----
Confidence 234689999999998642 2578899999999999999999999965422110 0011111 111111
Q ss_pred hhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517 386 EIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE 418 (453)
Q Consensus 386 ~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 418 (453)
.+...+..+.+++.+|++.+|.+|| ++.++++
T Consensus 218 -~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 -LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1222356788999999999999999 9999986
No 287
>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int
Probab=100.00 E-value=2.5e-32 Score=264.12 Aligned_cols=233 Identities=24% Similarity=0.340 Sum_probs=178.9
Q ss_pred HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
..+.+.++||+|+||.||+|.. .+++.||||++...... ..++.+| +++.+..+...++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 3456678899999999999985 47899999998654321 2233333 45556677788999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++++|.+++. ...+++..+..++.+++.|+.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 84 LGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 99999998873 24589999999999999999999998 99999999999999999999999999987654322
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
. ......++..|+|||.+... ..+.++||||||++++||++|+.|+..... ......+.......
T Consensus 156 ~--~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~--- 220 (277)
T cd06641 156 I--KRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELAKGEPPHSELHP--------MKVLFLIPKNNPPT--- 220 (277)
T ss_pred h--hhccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCccch--------HHHHHHHhcCCCCC---
Confidence 1 11334688899999998753 678899999999999999999999864321 11122222221111
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
....++..+.+++.+||+.+|++||++.++++.
T Consensus 221 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 ---LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 122344668889999999999999999999983
No 288
>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin
Probab=100.00 E-value=3.1e-32 Score=268.54 Aligned_cols=236 Identities=25% Similarity=0.301 Sum_probs=177.4
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH----HHHHHH--------------HhcccccCcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA----EEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~----~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
+++.+.||+|+||.||++... +++.||+|.+....... +.+..| +++.+..+...++||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 456688999999999999965 59999999987644332 223232 45666777788999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+.+++|.+++... ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 83 CPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred cCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999987432 335789999999999999999999998 99999999999999999999999999987553221
Q ss_pred Cce---------------------------eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCC
Q 048517 304 DFV---------------------------SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMN 356 (453)
Q Consensus 304 ~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~ 356 (453)
... ......||..|+|||++.+. .++.++||||||+++|+|++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD--GHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC--CCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 100 01123578899999999764 6789999999999999999999998644
Q ss_pred ccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 048517 357 ATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS----MTKVLE 418 (453)
Q Consensus 357 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs----~~evl~ 418 (453)
.... ...+..... .... ....++..+.+++.+||+.+|++||| +.++++
T Consensus 236 ~~~~-------~~~~~~~~~--~~~~----~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRDE-------TFSNILKKE--VTFP----GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chHH-------HHHHHhcCC--ccCC----CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 3211 011111111 1111 11115567999999999999999999 666555
No 289
>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional
Probab=100.00 E-value=2.3e-32 Score=263.39 Aligned_cols=224 Identities=21% Similarity=0.287 Sum_probs=171.7
Q ss_pred cCccCceEEEEEEE-cCCcEEEEEEecCCCCCH-HHHHHH----------HhcccccCcceEEEEEecCCCChhhhhhhc
Q 048517 169 LGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA-EEFINE----------LLGLCSEGFKRALVYEYMPNGSLDRHIFSK 236 (453)
Q Consensus 169 LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~-~~~i~e----------l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~ 236 (453)
||+|+||.||+++. .+++.+|+|.+....... +....+ +++.+......++||||+++|+|.+++...
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~ 103 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE 103 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc
Confidence 59999999999985 578999999987643322 222222 455566677889999999999999988432
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC-ceEEEecCCccccCCCCCceeecccCCCC
Q 048517 237 ENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISDTRGTI 315 (453)
Q Consensus 237 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 315 (453)
..++|.++..++.|+++||.|||+. +++|+||||+||+++.++ .++|+|||+++..... ....++.
T Consensus 104 ----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~~~~~ 170 (267)
T PHA03390 104 ----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYDGTL 170 (267)
T ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------ccCCCCC
Confidence 3789999999999999999999998 999999999999999988 9999999998765432 2235889
Q ss_pred CccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHH
Q 048517 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKL 395 (453)
Q Consensus 316 ~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l 395 (453)
.|+|||++.+. .++.++||||+|++++||++|+.|+....... .....+.... . ... ......+..+
T Consensus 171 ~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~--~-~~~------~~~~~~~~~~ 237 (267)
T PHA03390 171 DYFSPEKIKGH--NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESLLKRQ--Q-KKL------PFIKNVSKNA 237 (267)
T ss_pred cccChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHHHHhh--c-ccC------CcccccCHHH
Confidence 99999999764 68899999999999999999999997432211 1111111111 1 111 1122455678
Q ss_pred HHHHHHhcccCCCCCCC-HHHHHH
Q 048517 396 CMIGLWCIQVKAADRPS-MTKVLE 418 (453)
Q Consensus 396 ~~l~~~Cl~~~p~~RPs-~~evl~ 418 (453)
.+++.+||+.+|.+||+ ++++++
T Consensus 238 ~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 238 NDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHhccChhhCCchHHHHhc
Confidence 99999999999999995 688874
No 290
>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]
Probab=100.00 E-value=5.1e-33 Score=290.40 Aligned_cols=242 Identities=20% Similarity=0.231 Sum_probs=180.6
Q ss_pred hhhcccCccCceEEEEEEEcCC-cEEEEEEecCCCC-CHH------HHHHH------Hhcccc---------c-CcceEE
Q 048517 164 HFTHKLGQGGFGSVYKGQLHTG-RLIAVKMMENSKF-SAE------EFINE------LLGLCS---------E-GFKRAL 219 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~~~g-~~VAVK~l~~~~~-~~~------~~i~e------l~g~~~---------~-~~~~~l 219 (453)
.+.+.|.+|||+.||.++...+ ..+|+|++..... ..+ ++++. +++|+. . ....+|
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll 119 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL 119 (738)
T ss_pred EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence 4567899999999999996655 9999998765422 222 22333 233443 1 235679
Q ss_pred EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517 220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 299 (453)
.||||++|+|-+++..+.. ..|++.++++|+.++++|+++||.. .++|||||||-+||||+.+++.||||||.|.-.
T Consensus 120 LmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 120 LMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred ehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 9999999999999965543 3499999999999999999999984 778999999999999999999999999998743
Q ss_pred CCCC-Cceee------cccCCCCCccChhhhcccC-CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHH
Q 048517 300 PKEN-DFVSI------SDTRGTIGYLAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD 371 (453)
Q Consensus 300 ~~~~-~~~~~------~~~~gt~~y~aPE~~~~~~-~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 371 (453)
-..- ..... -...-|+-|+|||++.-.- -.++.|+|||++||+||-|+....||+....-.
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----------- 265 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----------- 265 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-----------
Confidence 2211 10000 1224689999999986421 278999999999999999999999997542110
Q ss_pred HhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517 372 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID 425 (453)
Q Consensus 372 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~ 425 (453)
+..+.-. ......++..|..|+..||+.+|++||++-+|++.+-.+..
T Consensus 266 -Ilng~Y~-----~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 266 -ILNGNYS-----FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred -EEecccc-----CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 1111110 11224577889999999999999999999999998765543
No 291
>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.
Probab=100.00 E-value=4.9e-32 Score=258.20 Aligned_cols=233 Identities=26% Similarity=0.371 Sum_probs=178.5
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC---CCHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK---FSAEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
+.+.+.||+|+||.||+|..+ +|+.||+|.+.... ...+.+..| +++.+......++++||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 456788999999999999965 68999999986532 122223222 667777888899999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC-ceEEEecCCccccCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~~~~~ 303 (453)
++++|.+++... ....+++..+..++.+++.||.|||+. +++|+||||+||++++++ .+||+|||.+.......
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 82 DGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999988532 234689999999999999999999998 999999999999998875 57999999998664432
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
.. .....|++.|+|||.+... .++.++||||||++++||++|+.|+..... ..++...... ....
T Consensus 157 ~~--~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~-~~~~--- 221 (257)
T cd08225 157 EL--AYTCVGTPYYLSPEICQNR--PYNNKTDIWSLGCVLYELCTLKHPFEGNNL-------HQLVLKICQG-YFAP--- 221 (257)
T ss_pred cc--ccccCCCccccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHhcc-cCCC---
Confidence 21 1234689999999988754 688999999999999999999999864321 1222222221 1111
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.....+..+.+++.+|++.+|++|||+.++++
T Consensus 222 ---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 222 ---ISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ---CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11123456889999999999999999999976
No 292
>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7. Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it
Probab=100.00 E-value=3.4e-32 Score=265.81 Aligned_cols=238 Identities=23% Similarity=0.359 Sum_probs=176.1
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC--HHH---------------HHHHHhcccccCcceEEEEEe
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS--AEE---------------FINELLGLCSEGFKRALVYEY 223 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~--~~~---------------~i~el~g~~~~~~~~~lv~E~ 223 (453)
.+.+.+.||+|+||.||+|..+ +++.||||.+...... ..+ .+.++++++......+++|||
T Consensus 16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 95 (296)
T cd06618 16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL 95 (296)
T ss_pred hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence 4566789999999999999976 4899999998753221 111 223367788888889999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+. +++.+.+... ...+++..+..++.+++.||+|||+. .+|+||||+|+||++++++.+||+|||++.......
T Consensus 96 ~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 96 MS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred cC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 85 5676655332 24789999999999999999999973 289999999999999999999999999997654332
Q ss_pred CceeecccCCCCCccChhhhcccC--CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 381 (453)
. .....++..|+|||.+.+.. +.++.++||||||+++|||++|+.|+...... + . .............
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~-~-~~~~~~~~~~~~~ 239 (296)
T cd06618 170 A---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----F-E-VLTKILQEEPPSL 239 (296)
T ss_pred c---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----H-H-HHHHHhcCCCCCC
Confidence 2 12345788999999987542 45789999999999999999999998642211 0 0 1111111111111
Q ss_pred cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
. ....+...+.+++.+||+.+|++||++.++++.
T Consensus 240 ~----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 P----PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C----CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 111234568999999999999999999999864
No 293
>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development
Probab=100.00 E-value=2.3e-32 Score=262.67 Aligned_cols=233 Identities=27% Similarity=0.329 Sum_probs=169.5
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC------HHHHHHH--------------Hhccccc--CcceEE
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS------AEEFINE--------------LLGLCSE--GFKRAL 219 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~------~~~~i~e--------------l~g~~~~--~~~~~l 219 (453)
+...+.||+|+||.||++.. .+++.||+|.+...... .+.+.+| +++++.. +...++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 45568899999999999985 46899999988653211 1223223 2343332 345789
Q ss_pred EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517 220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 299 (453)
++||+++++|.+++.. ...+++.....++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+++..
T Consensus 84 ~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 84 FMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 9999999999998843 24588999999999999999999987 9999999999999999999999999999765
Q ss_pred CCCCC-ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517 300 PKEND-FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD 378 (453)
Q Consensus 300 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~ 378 (453)
..... ........++.+|+|||.+.+. .++.++||||||+++|||++|+.||...... ..+.........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-------~~~~~~~~~~~~ 227 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGE--GYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-------AAIFKIATQPTN 227 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCC--CCCchhhhHHHHHHHHHHHHCCCCccccchH-------HHHHHHhcCCCC
Confidence 32111 0111234588999999998764 6889999999999999999999998643211 111111111111
Q ss_pred ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
. ..+......+..++ +||..+|++||+++|+++
T Consensus 228 ~------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 228 P------QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred C------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1 11223344555565 788899999999999975
No 294
>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning
Probab=100.00 E-value=1.5e-32 Score=266.45 Aligned_cols=248 Identities=21% Similarity=0.266 Sum_probs=178.2
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
.|++.++||+|+||.||+|..+ +++.||||.++.... ..+.+..| +++++..+...++++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 3567789999999999999965 688999998865321 22333333 56777777889999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
++++.+..... ....+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 82 VERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred CCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 99877765442 234589999999999999999999998 99999999999999999999999999998765443
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc-------cchHHHHHHhhhC
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA-------YFPSWVYDQLNKG 376 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~-------~~~~~~~~~l~~~ 376 (453)
.. ......++..|+|||++.+. ..++.++||||||+++|||++|+.|+.......... .++..........
T Consensus 155 ~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 155 AS-PLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred cc-cccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 21 12345678899999998753 367889999999999999999999886432210000 0000000000000
Q ss_pred ------CCccccchhh----hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 377 ------GDLELRNVTE----IESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 377 ------~~~~~~~~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
...+...... .+..++..+.+++.+||+.+|++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000000 11223677999999999999999999999875
No 295
>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili
Probab=100.00 E-value=4.1e-32 Score=262.86 Aligned_cols=246 Identities=24% Similarity=0.349 Sum_probs=177.4
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHH-----------------HHHHHHhcccccCcceEEEEEec
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAE-----------------EFINELLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~-----------------~~i~el~g~~~~~~~~~lv~E~~ 224 (453)
|++.+.||+|+||+||+|+.. +++.||||.+.......+ ..+..+++.+..+...++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 356788999999999999965 588999999876432111 11223566777788899999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
+|+|.+++.... +..+++.++..++.|++.+|.|||+. +++|+||+|+||+++.++.++|+|||+++.......
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 889988885432 35789999999999999999999998 999999999999999999999999999986544322
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc---------ccchHHHHHH-hh
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK---------AYFPSWVYDQ-LN 374 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~---------~~~~~~~~~~-l~ 374 (453)
.....++..|+|||.+.+. ..++.++|+||||++++||++|+.|+......... ..-..|.... +.
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 155 ---YTDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred ---cCCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence 1234578899999988653 36789999999999999999999988654321100 0000010000 00
Q ss_pred hCCCccccc-----hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 375 KGGDLELRN-----VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 375 ~~~~~~~~~-----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
......... ...........+.+++.+||+.+|++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000000 00001112467889999999999999999999976
No 296
>PLN03225 Serine/threonine-protein kinase SNT7; Provisional
Probab=100.00 E-value=3e-32 Score=287.73 Aligned_cols=252 Identities=23% Similarity=0.240 Sum_probs=162.5
Q ss_pred HhhhhhcccCccCceEEEEEEEc-C----CcEEEEEEecCCCCCHHHHHHH-------------Hhcc-----cccCcce
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLH-T----GRLIAVKMMENSKFSAEEFINE-------------LLGL-----CSEGFKR 217 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~-~----g~~VAVK~l~~~~~~~~~~i~e-------------l~g~-----~~~~~~~ 217 (453)
..+.+.++||+|+||.||+|++. + ++.||||++...... +.++.+ +.++ +..+...
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNERVRRACPNSCADFVYGFLEPVSSKKEDEY 210 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHHHHHhhchhhHHHHHHhhhcccccccCCce
Confidence 34566789999999999999964 5 789999988653221 111111 1111 2455678
Q ss_pred EEEEEecCCCChhhhhhhccCC----------------CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceE
Q 048517 218 ALVYEYMPNGSLDRHIFSKENK----------------GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNIL 281 (453)
Q Consensus 218 ~lv~E~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIL 281 (453)
++|+||+++++|.+++...... ........+..++.|++.||+|||+. +|+||||||+|||
T Consensus 211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NIL 287 (566)
T PLN03225 211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNII 287 (566)
T ss_pred EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEE
Confidence 9999999999999888533210 01112334567999999999999998 9999999999999
Q ss_pred EcC-CCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCC--------------------CCCccchHHHHH
Q 048517 282 LDH-NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFG--------------------TVSCKSDVYGFG 340 (453)
Q Consensus 282 l~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--------------------~~s~k~DV~S~G 340 (453)
++. ++.+||+|||+|+......... .....+|+.|+|||.+..... .++.++||||||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 986 6899999999998654332221 234578999999996642111 234567999999
Q ss_pred HHHHHHHcCCCCCCCCccc------cccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHH
Q 048517 341 MVLLEMAGGRRNSNMNATR------SSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMT 414 (453)
Q Consensus 341 vvl~elltg~~p~~~~~~~------~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ 414 (453)
|+||||+++..+.+..... .....+..|... +......+.....+..........+++.+||+.||++|||+.
T Consensus 367 viL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~ 445 (566)
T PLN03225 367 LIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL-VEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAK 445 (566)
T ss_pred HHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh-hccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHH
Confidence 9999999876554321100 000111111110 000000000000000011123455899999999999999999
Q ss_pred HHHH
Q 048517 415 KVLE 418 (453)
Q Consensus 415 evl~ 418 (453)
++++
T Consensus 446 e~L~ 449 (566)
T PLN03225 446 AALA 449 (566)
T ss_pred HHhC
Confidence 9987
No 297
>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=4.3e-32 Score=271.68 Aligned_cols=238 Identities=25% Similarity=0.322 Sum_probs=190.4
Q ss_pred HHHHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC----HHHHHHH---------------HhcccccCcc
Q 048517 157 EIIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS----AEEFINE---------------LLGLCSEGFK 216 (453)
Q Consensus 157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~----~~~~i~e---------------l~g~~~~~~~ 216 (453)
+-....|.+.+.||+|.||.||+++.+ +|+.+|+|.+.+.... .+...+| +.+.+.....
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 344556778899999999999999965 5999999999874432 1233222 4566777788
Q ss_pred eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC----CCceEEEe
Q 048517 217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH----NFIPKVSD 292 (453)
Q Consensus 217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~----~~~~kl~D 292 (453)
.++|||++.+|.|.+.+... .++...+..++.|++.++.|||+. +|+||||||+|+|+.. ++.+|++|
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEee
Confidence 89999999999999999644 399999999999999999999997 9999999999999954 35799999
Q ss_pred cCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHH
Q 048517 293 FGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ 372 (453)
Q Consensus 293 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 372 (453)
||++....... ......||+.|+|||++... .++..+||||+|+++|.|++|.+||....... ....
T Consensus 183 FGla~~~~~~~---~~~~~~Gtp~y~APEvl~~~--~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~--------~~~~ 249 (382)
T KOG0032|consen 183 FGLAKFIKPGE---RLHTIVGTPEYVAPEVLGGR--PYGDEVDVWSIGVILYILLSGVPPFWGETEFE--------IFLA 249 (382)
T ss_pred CCCceEccCCc---eEeeecCCccccCchhhcCC--CCCcccchhHHHHHHHHHhhCCCCCcCCChhH--------HHHH
Confidence 99999876632 34678899999999999853 89999999999999999999999998655322 1223
Q ss_pred hhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 373 LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 373 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
+..+.. ....+....++....+++..|+..||.+|+|+.++++
T Consensus 250 i~~~~~---~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 250 ILRGDF---DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HHcCCC---CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 333222 1112234456778899999999999999999999998
No 298
>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]
Probab=100.00 E-value=1.2e-33 Score=268.97 Aligned_cols=242 Identities=26% Similarity=0.309 Sum_probs=175.0
Q ss_pred hhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHH-HHHHH--------Hhccccc---C--cceEEEEEecCCC
Q 048517 165 FTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAE-EFINE--------LLGLCSE---G--FKRALVYEYMPNG 227 (453)
Q Consensus 165 ~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~-~~i~e--------l~g~~~~---~--~~~~lv~E~~~~g 227 (453)
-.+.+|.|+||.||+|++. +++.||||+.-.++. +.| +++.+ |.-++.. . -...+|||||+.
T Consensus 28 ~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~- 106 (364)
T KOG0658|consen 28 AVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE- 106 (364)
T ss_pred eeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-
Confidence 3478999999999999955 679999998765433 222 23332 2223221 1 134589999964
Q ss_pred ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC-CceEEEecCCccccCCCCCce
Q 048517 228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFGla~~~~~~~~~~ 306 (453)
+|.+.+......+..++...+.-+..||.+||.|||+. +|+||||||+|+|+|.+ +.+||||||.|+....++..
T Consensus 107 tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn- 182 (364)
T KOG0658|consen 107 TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN- 182 (364)
T ss_pred HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc-
Confidence 88888865444557788888999999999999999997 99999999999999976 99999999999987665533
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC--------
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD-------- 378 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~-------- 378 (453)
..-.-|..|+|||.+.+. ..|+.+.||||.||++.||+-|++-|........ -..+.+.+....+
T Consensus 183 --iSYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ----L~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 183 --ISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ----LVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred --eeEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH----HHHHHHHhCCCCHHHHhhcCc
Confidence 233568899999999886 5899999999999999999999998876443211 0111111111100
Q ss_pred -------ccccchh--h-hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 379 -------LELRNVT--E-IESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 379 -------~~~~~~~--~-~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
..+.... . .......+..+++.++++.+|.+|.++.|++.
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0000000 0 22334567899999999999999999999886
No 299
>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1. Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron
Probab=100.00 E-value=7.6e-32 Score=266.24 Aligned_cols=235 Identities=26% Similarity=0.325 Sum_probs=177.2
Q ss_pred hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCH----HHHHHH--------------HhcccccCcceEEEEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSA----EEFINE--------------LLGLCSEGFKRALVYE 222 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~----~~~i~e--------------l~g~~~~~~~~~lv~E 222 (453)
.+...+.||+|+||.||+++. .+|+.||+|.+....... .++..| +++++..+...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 355667899999999999995 478999999987543221 233333 4556667778899999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 302 (453)
|+. |+|.+.+... ...++|.++..++.+++.||.|||+. +|+|+||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 106 YCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 996 5777766432 35689999999999999999999998 9999999999999999999999999998754332
Q ss_pred CCceeecccCCCCCccChhhhcc-cCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517 303 NDFVSISDTRGTIGYLAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381 (453)
Q Consensus 303 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 381 (453)
....|+..|+|||.+.. ..+.++.++||||||+++|||++|+.|+....... ....+........
T Consensus 179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~ 244 (317)
T cd06635 179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNESPTL 244 (317)
T ss_pred ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--------HHHHHHhccCCCC
Confidence 23468899999999753 22468899999999999999999999986432110 1112222111111
Q ss_pred cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
........+.+++.+||+.+|++||++.++++.+.-
T Consensus 245 -----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 245 -----QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred -----CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 112244568899999999999999999999986554
No 300
>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun
Probab=100.00 E-value=4.7e-32 Score=263.63 Aligned_cols=229 Identities=25% Similarity=0.332 Sum_probs=175.7
Q ss_pred hcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC-HHHHHHH--------------HhcccccCcceEEEEEecCCCCh
Q 048517 166 THKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSEGFKRALVYEYMPNGSL 229 (453)
Q Consensus 166 ~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL 229 (453)
.+.||+|++|.||++.. .+++.||+|.+...... .+.+.+| +++++......++++||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 46899999999999985 57899999988653322 2333333 34455667788999999999999
Q ss_pred hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeec
Q 048517 230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 309 (453)
Q Consensus 230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 309 (453)
.+++.. ..+++.++..++.+++.||+|||+. +|+||||+|+||+++.++.++|+|||++........ ...
T Consensus 104 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~ 173 (285)
T cd06648 104 TDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRK 173 (285)
T ss_pred HHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccc
Confidence 998843 4589999999999999999999998 999999999999999999999999999876543221 123
Q ss_pred ccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHH
Q 048517 310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 389 (453)
Q Consensus 310 ~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 389 (453)
...|+..|+|||.+.+. .++.++||||||++++||++|+.|+...... .....+......... ...
T Consensus 174 ~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--------~~~~~~~~~~~~~~~----~~~ 239 (285)
T cd06648 174 SLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--------QAMKRIRDNLPPKLK----NLH 239 (285)
T ss_pred cccCCccccCHHHhcCC--CCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--------HHHHHHHhcCCCCCc----ccc
Confidence 34689999999998764 6889999999999999999999998643211 112222222111111 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 390 MIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 390 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.++..+.+++.+||+.+|++|||+.++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 24467899999999999999999999986
No 301
>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an
Probab=100.00 E-value=5.5e-32 Score=257.51 Aligned_cols=233 Identities=30% Similarity=0.410 Sum_probs=182.3
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
+++.++||+|+||.||+++. .+++.+|+|.+...... ..++..| +.+.+......++|+||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 45678999999999999984 47889999998764322 2233333 455666677889999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
++++|.+++.........+++..+..++.+++.||+|||+. +++|+||+|+||+++.++.+||+|||+++......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~- 157 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM- 157 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC-
Confidence 99999999865444456789999999999999999999998 99999999999999999999999999998765542
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 384 (453)
.....++..|+|||.+.+. .++.++|+||+|++++||++|+.|+...... . .......+....
T Consensus 158 ---~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-------~-~~~~~~~~~~~~---- 220 (256)
T cd08530 158 ---AKTQIGTPHYMAPEVWKGR--PYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-------D-LRYKVQRGKYPP---- 220 (256)
T ss_pred ---cccccCCccccCHHHHCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHhcCCCCC----
Confidence 1334588899999998764 6788999999999999999999998643311 0 111222221111
Q ss_pred hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.+......+.+++.+|++.+|++|||+.++++
T Consensus 221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 --IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred --CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 22245567899999999999999999999986
No 302
>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines
Probab=100.00 E-value=2e-32 Score=266.13 Aligned_cols=241 Identities=22% Similarity=0.286 Sum_probs=178.6
Q ss_pred hhhhcccCccCceEEEEEEE----cCCcEEEEEEecCCCC-----CHHHHHHH---------------HhcccccCcceE
Q 048517 163 NHFTHKLGQGGFGSVYKGQL----HTGRLIAVKMMENSKF-----SAEEFINE---------------LLGLCSEGFKRA 218 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~----~~g~~VAVK~l~~~~~-----~~~~~i~e---------------l~g~~~~~~~~~ 218 (453)
+.+.+.||+|+||.||+++. .+++.||||.+..... ..+.+..| +.+.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 45668899999999999974 3578899999875321 11222222 444555667788
Q ss_pred EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298 (453)
Q Consensus 219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 298 (453)
+||||+++|+|.+++.. ...+++..+..++.|+++||.|||+. +++|+||||+||+++.++.++|+|||+++.
T Consensus 82 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 82 LILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999998843 24688999999999999999999997 999999999999999999999999999986
Q ss_pred cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517 299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD 378 (453)
Q Consensus 299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~ 378 (453)
........ .....|+..|+|||.+.+.....+.++||||||++++||++|+.|+....... .... ..........
T Consensus 155 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~-~~~~~~~~~~ 229 (288)
T cd05583 155 FLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN---SQSE-ISRRILKSKP 229 (288)
T ss_pred cccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc---hHHH-HHHHHHccCC
Confidence 54433211 12345889999999987643347889999999999999999999986432211 0111 1111111111
Q ss_pred ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
. .+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 230 -~------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 230 -P------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -C------CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 1 112234567889999999999999999999888874
No 303
>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins. Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily
Probab=100.00 E-value=4.2e-32 Score=266.69 Aligned_cols=233 Identities=27% Similarity=0.331 Sum_probs=175.8
Q ss_pred HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC-H---HHHHHH--------------HhcccccCcceEEEE
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS-A---EEFINE--------------LLGLCSEGFKRALVY 221 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~-~---~~~i~e--------------l~g~~~~~~~~~lv~ 221 (453)
..|.+.++||+|+||.||+|+.. +|+.||+|.+...... . .++.+| +.++|......++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 34667789999999999999954 7899999988653221 1 234343 455666777889999
Q ss_pred EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517 222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 301 (453)
Q Consensus 222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 301 (453)
||+. |++.+.+... ...+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.+||+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9996 6776665322 24689999999999999999999998 999999999999999999999999999976543
Q ss_pred CCCceeecccCCCCCccChhhhcc-cCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517 302 ENDFVSISDTRGTIGYLAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 380 (453)
Q Consensus 302 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 380 (453)
. ....++..|+|||.+.+ ..+.++.++||||||+++|||++|+.|+....... ... .+.......
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-------~~~-~~~~~~~~~ 233 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALY-HIAQNDSPT 233 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-------HHH-HHhcCCCCC
Confidence 2 23457889999998753 12468889999999999999999999986432111 111 111111111
Q ss_pred ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
. .....+..+.+++.+||+.+|++||++.+++..
T Consensus 234 ~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 L-----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred C-----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1 122345678999999999999999999999874
No 304
>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the
Probab=100.00 E-value=1.9e-32 Score=266.53 Aligned_cols=244 Identities=24% Similarity=0.361 Sum_probs=173.1
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
.|.+.+.||+|+||.||+|+.. +++.||||.+...... ...+.+| +.+++..+...++||||+
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence 3556789999999999999965 7899999998653221 1222222 456777778899999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
+ ++|.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||+++.......
T Consensus 86 ~-~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 86 D-TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred C-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 7 4898877432 24688999999999999999999998 999999999999999999999999999875432211
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC--------
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG-------- 376 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~-------- 376 (453)
......++..|+|||.+.+. ..++.++||||+|+++|||++|+.||........+ ...+.+.+...
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ---LHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred --cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH---HHHHHHhcCCCChhhhhhh
Confidence 11233568899999988653 35788999999999999999999998643311000 00000000000
Q ss_pred ------C--Cccc---cchhhhHHHHH--HHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 377 ------G--DLEL---RNVTEIESMIA--RKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 377 ------~--~~~~---~~~~~~~~~~~--~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
. .... ........... ..+.+++.+||+.+|++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 0000 00000000112 56778999999999999999999875
No 305
>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po
Probab=100.00 E-value=3.5e-32 Score=263.27 Aligned_cols=242 Identities=24% Similarity=0.290 Sum_probs=175.3
Q ss_pred hhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC---CCHHHHHHH--------------HhcccccC--cceEEEEEe
Q 048517 164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK---FSAEEFINE--------------LLGLCSEG--FKRALVYEY 223 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~i~e--------------l~g~~~~~--~~~~lv~E~ 223 (453)
++.++||+|+||.||+|+.. +|+.+|+|.+.... .....+..| +.+++... ...++|+||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 45678999999999999965 68999999998652 122333333 45566655 788999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
++ ++|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~-~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 82 MD-HDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cc-ccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 97 4888877432 24789999999999999999999998 99999999999999999999999999998765433
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC-------
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG------- 376 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~------- 376 (453)
. .......++..|+|||.+.+. ..++.++||||||+++|||++|+.|+........ + ..+.+.....
T Consensus 155 ~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~-~~~~~~~~~~~~~~~~~ 228 (287)
T cd07840 155 S-ADYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---L-EKIFELCGSPTDENWPG 228 (287)
T ss_pred c-ccccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---H-HHHHHHhCCCchhhccc
Confidence 1 112334578899999987653 3578899999999999999999999865432110 0 0011100000
Q ss_pred ---------CCcccc---chhhhHHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 377 ---------GDLELR---NVTEIESM-IARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 377 ---------~~~~~~---~~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
...... ...+.... ++..+.+++.+||+.+|++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000 00001111 2567899999999999999999999976
No 306
>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]
Probab=100.00 E-value=1.3e-32 Score=258.31 Aligned_cols=238 Identities=24% Similarity=0.270 Sum_probs=175.2
Q ss_pred hcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCH------HHHHHHHhcc-------------cccCcceEEEEEecC
Q 048517 166 THKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA------EEFINELLGL-------------CSEGFKRALVYEYMP 225 (453)
Q Consensus 166 ~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~------~~~i~el~g~-------------~~~~~~~~lv~E~~~ 225 (453)
.++|++|.||.||+|+ .++++.||+|+++.++... -+-|+-|... ..+-+..++|||||+
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 4689999999999999 5589999999998754211 1112222111 123345899999996
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 305 (453)
. +|...+... +..++..++.-+..|+++|++|||.. -|+||||||+|+|+...|.+||+|||+||.+....
T Consensus 161 h-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~-- 231 (419)
T KOG0663|consen 161 H-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL-- 231 (419)
T ss_pred h-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCc--
Confidence 5 677777433 36899999999999999999999998 99999999999999999999999999999886543
Q ss_pred eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC--------
Q 048517 306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG-------- 377 (453)
Q Consensus 306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~-------- 377 (453)
...+...-|..|.|||.+.+. ..|+...|+||+||++.||+++++-|....+-.. -..+...+....
T Consensus 232 k~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ----l~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ----LDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred ccCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH----HHHHHHHhCCCccccCCCcc
Confidence 245667889999999999885 6899999999999999999999988865543210 111111111100
Q ss_pred --------------CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 378 --------------DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 378 --------------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
...++..... ..+++.-.+++...+..||.+|.|+++.++
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~-~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGA-LSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccchhhccccCCCCchhhhhhccc-cccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0000000000 003456678889999999999999999987
No 307
>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their
Probab=100.00 E-value=8.6e-32 Score=258.32 Aligned_cols=237 Identities=26% Similarity=0.392 Sum_probs=178.0
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC-------HHHHHHH--------------HhcccccCcceEEE
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS-------AEEFINE--------------LLGLCSEGFKRALV 220 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~-------~~~~i~e--------------l~g~~~~~~~~~lv 220 (453)
|...+.||+|+||.||+|.. .+++.||+|.+...... .+++..| +++.+.+....++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 34557899999999999984 57899999998753211 1223333 56777788889999
Q ss_pred EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC-ceEEEecCCcccc
Q 048517 221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFH 299 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~ 299 (453)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++ .+||+|||++...
T Consensus 82 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 82 VEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999998843 24688999999999999999999998 999999999999998775 6999999999766
Q ss_pred CCCCCce--eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC
Q 048517 300 PKENDFV--SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG 377 (453)
Q Consensus 300 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 377 (453)
....... ......+|..|+|||.+.+. .++.++||||+|++++||++|+.|+....... .............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~ 228 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGE--QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN----HLALIFKIASATT 228 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCcc----hHHHHHHHhccCC
Confidence 4331110 11234578899999998754 67899999999999999999999986432211 0111111111111
Q ss_pred CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
. ...+......+.+++.+|++.+|++|||+.++++
T Consensus 229 ~------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 A------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred C------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 1 1133345677889999999999999999999975
No 308
>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]
Probab=100.00 E-value=8.4e-34 Score=262.52 Aligned_cols=235 Identities=25% Similarity=0.359 Sum_probs=185.0
Q ss_pred hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517 162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
...+..+||+|+||.||++.+ .+|+.||||.+.... ...+.+.| .+|.+-....+++|||||..
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 345668999999999999985 479999999987643 33444444 56766777889999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|++.+.+.. ..++|+..++..++...++||+|||.- .-+|||||..||||+.+|.+||+|||.|-..... ..
T Consensus 113 GSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MA 184 (502)
T KOG0574|consen 113 GSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MA 184 (502)
T ss_pred CcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh--HH
Confidence 999998843 347899999999999999999999986 8899999999999999999999999999765432 11
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
..+...||+.|||||++..- .|..++||||+|+...||..|++|+.....- ...| .+.. .......
T Consensus 185 KRNTVIGTPFWMAPEVI~EI--GY~~~ADIWSLGITaIEMAEG~PPYsDIHPM--RAIF------MIPT----~PPPTF~ 250 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEI--GYDTKADIWSLGITAIEMAEGRPPYSDIHPM--RAIF------MIPT----KPPPTFK 250 (502)
T ss_pred hhCccccCcccccHHHHHHh--ccchhhhHhhhcchhhhhhcCCCCccccccc--ceeE------eccC----CCCCCCC
Confidence 23556799999999999874 7899999999999999999999998643210 0000 0000 0111112
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
-+.+.+..+.++++.||-.+|++|-|+.++++.
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 455667789999999999999999999888763
No 309
>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re
Probab=100.00 E-value=5.6e-32 Score=258.35 Aligned_cols=231 Identities=23% Similarity=0.333 Sum_probs=176.3
Q ss_pred cCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHH--------------HHhcccccCcceEEEEEecCCCCh
Q 048517 169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFIN--------------ELLGLCSEGFKRALVYEYMPNGSL 229 (453)
Q Consensus 169 LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~--------------el~g~~~~~~~~~lv~E~~~~gsL 229 (453)
||.|+||.||+++.. +|+.+|+|.+..... ..+.+.. ++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 699999999999976 599999999876432 1222222 255666777889999999999999
Q ss_pred hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC-----
Q 048517 230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND----- 304 (453)
Q Consensus 230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~----- 304 (453)
.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9988532 3689999999999999999999998 999999999999999999999999999886543321
Q ss_pred -ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 305 -FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 305 -~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
........++..|+|||..... ..+.++||||||++++||++|+.|+...... -....+..+.. ....
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~-~~~~ 222 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQ--GHSKTVDWWSLGCILYEFLVGIPPFHGETPE--------EIFQNILNGKI-EWPE 222 (265)
T ss_pred ccccccCcccCccccCHHHhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhcCCc-CCCc
Confidence 0112334578899999998764 5788999999999999999999998644321 12222222211 1111
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le 421 (453)
....+..+..++.+||+.+|++|||+.++.+.|+
T Consensus 223 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 223 ----DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ----cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 1113567889999999999999999977777775
No 310
>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They
Probab=100.00 E-value=1e-31 Score=259.73 Aligned_cols=241 Identities=21% Similarity=0.266 Sum_probs=178.1
Q ss_pred hhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517 164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGFKRALVYEYMP 225 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~~~~lv~E~~~ 225 (453)
...+.||+|++|.||+|..+ +|+.+|+|.+...... ...+..| +++.+..+...++++||++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 45678999999999999954 7899999998764332 2223222 4566777788999999997
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 305 (453)
+ +|.+++... ...+++..+..++.+++.||.|||+. +|+|+||||+||+++.++.+||+|||.+........
T Consensus 82 ~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 82 T-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred C-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 5 887777432 25789999999999999999999998 999999999999999999999999999987654431
Q ss_pred eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC---------
Q 048517 306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG--------- 376 (453)
Q Consensus 306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~--------- 376 (453)
......++..|+|||.+.+. ...+.++|+||+|+++++|++|+.||........ ...+.+.+...
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ----LFKIFRTLGTPDPEVWPKFT 227 (283)
T ss_pred -cccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHcCCCchHhcccch
Confidence 12334578899999998753 3678999999999999999999998865432110 00000000000
Q ss_pred ----------CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 377 ----------GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 377 ----------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
...............+..+.+++.+||+.+|.+||++++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000111223446778999999999999999999999975
No 311
>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of
Probab=100.00 E-value=7.3e-32 Score=257.87 Aligned_cols=235 Identities=27% Similarity=0.373 Sum_probs=182.9
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYMP 225 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~ 225 (453)
+++.+.||+|++|.||+++.. +++.||||++..... ..+++..| +++++......++++||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 356689999999999999965 599999999877543 23445444 3455667778899999999
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHc-CCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
+++|.+++... ..+++..++.++.|+++||+|||+ . +++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 83 GGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 99999998432 568999999999999999999999 7 999999999999999999999999999987654332
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 384 (453)
. .....++..|+|||.+... .++.++|+||||+++|||++|+.|+...... .... ....+.......
T Consensus 156 ~--~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----~~~~-~~~~~~~~~~~~---- 222 (264)
T cd06623 156 Q--CNTFVGTVTYMSPERIQGE--SYSYAADIWSLGLTLLECALGKFPFLPPGQP----SFFE-LMQAICDGPPPS---- 222 (264)
T ss_pred c--ccceeecccccCHhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCcccccc----CHHH-HHHHHhcCCCCC----
Confidence 1 1234588899999998764 7888999999999999999999998654321 1111 112222211111
Q ss_pred hhhHHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 385 TEIESM-IARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 385 ~~~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
.... ++..+.+++.+||+.+|++|||+.++++.
T Consensus 223 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 --LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1122 55679999999999999999999999873
No 312
>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou
Probab=100.00 E-value=5.9e-32 Score=262.62 Aligned_cols=235 Identities=29% Similarity=0.361 Sum_probs=180.9
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
.+.+.+.||+|+||.||+|..+ +++.||+|.+.......+++..| +++.+......++++||+++
T Consensus 20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 99 (286)
T cd06614 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG 99 (286)
T ss_pred cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCC
Confidence 3556688999999999999976 78999999998654444455444 34455666788999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
++|.+++.... ..+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 100 ~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 171 (286)
T cd06614 100 GSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-- 171 (286)
T ss_pred CcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--
Confidence 99999985432 4799999999999999999999997 999999999999999999999999999875543221
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.|+....... ....+........ .
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~----~ 237 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRK--DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--------ALFLITTKGIPPL----K 237 (286)
T ss_pred hhccccCCcccCCHhHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcCCCCC----c
Confidence 11234578899999998754 67899999999999999999999986432110 1111111111111 1
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
....+...+.+++.+||+.+|.+|||+.++++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 12224567889999999999999999999986
No 313
>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases. Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core
Probab=100.00 E-value=9.5e-32 Score=254.26 Aligned_cols=233 Identities=28% Similarity=0.423 Sum_probs=179.2
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
|...+.||+|++|.||++... +++.+++|++..... ...++.+| +.+.+......++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 345678999999999999965 789999999977543 33344444 34555666778999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
++|.+++... ...+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 82 GSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 9999987432 25789999999999999999999997 999999999999999999999999999987654431
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
.....++..|+|||.+... ..+.++||||||+++++|++|+.|+...... ..... ..........
T Consensus 154 -~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~-~~~~~~~~~~---- 218 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGK--PYDYKADIWSLGITAIELAEGKPPYSELPPM-------KALFK-IATNGPPGLR---- 218 (253)
T ss_pred -ccceecCCcccCHHHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCchH-------HHHHH-HHhcCCCCcC----
Confidence 2344688899999998764 5788999999999999999999998643211 11111 1111111111
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
....+...+.+++.+||+.+|++|||+.++++
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11112467899999999999999999999976
No 314
>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re
Probab=100.00 E-value=7.2e-32 Score=258.93 Aligned_cols=233 Identities=24% Similarity=0.287 Sum_probs=170.2
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---C---HHHHHHH--------------Hhccccc--CcceEE
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---S---AEEFINE--------------LLGLCSE--GFKRAL 219 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~---~~~~i~e--------------l~g~~~~--~~~~~l 219 (453)
+...+.||+|+||.||+|... +|+.||||.+..... . .+.+..| +.+++.+ ....++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 345688999999999999954 689999998754211 1 1222223 2343433 345779
Q ss_pred EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517 220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 299 (453)
++||+++++|.+++... ..+++.....++.+++.||+|||+. +++|+||||+||+++.++.+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 84 FMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 99999999999988432 3578889999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCCc-eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517 300 PKENDF-VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD 378 (453)
Q Consensus 300 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~ 378 (453)
...... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....... -..+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~~ 227 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGE--GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-------AIFKIATQPTN 227 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCC--CCCcchhHHHHHHHHHHHhhCCCCCCccchHH-------HHHHHhcCCCC
Confidence 322111 112234588999999998764 68899999999999999999999986432110 01111111111
Q ss_pred ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
...+......+..++.+|+. +|++||+++++++
T Consensus 228 ------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 228 ------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 11233455677888889985 9999999999975
No 315
>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati
Probab=100.00 E-value=7.6e-32 Score=268.58 Aligned_cols=252 Identities=21% Similarity=0.261 Sum_probs=176.5
Q ss_pred hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCC---CCCHHHHHHH--------------HhcccccC-----cceE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENS---KFSAEEFINE--------------LLGLCSEG-----FKRA 218 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~---~~~~~~~i~e--------------l~g~~~~~-----~~~~ 218 (453)
.|...+.||+|+||+||+|+. .+|+.||||.+... .....++..| +++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 355667899999999999984 57999999988652 1122233233 34444322 2478
Q ss_pred EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298 (453)
Q Consensus 219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 298 (453)
+++||+. ++|.+++. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.
T Consensus 86 lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 86 IVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 9999995 68887773 235689999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccc-------------
Q 048517 299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF------------- 365 (453)
Q Consensus 299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~------------- 365 (453)
...... ......++..|+|||.+... ..++.++||||||++++||++|+.||............
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 158 TSEKGD--FMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred cCCCcc--cccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 644321 12334578899999988653 35889999999999999999999998643211000000
Q ss_pred ---hHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhCCC
Q 048517 366 ---PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM--LEGSI 424 (453)
Q Consensus 366 ---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--Le~~~ 424 (453)
.....+.+..................+..+.+++.+||+.+|++|||++++++. ++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 000000110000000000011122345678999999999999999999999986 65543
No 316
>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1. Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.
Probab=100.00 E-value=4.1e-32 Score=259.41 Aligned_cols=231 Identities=25% Similarity=0.329 Sum_probs=179.5
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
|++.+.||+|+||.||+++.. +++.||+|.+..... ..+++..| +++++..+...++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 456789999999999999965 689999999875321 22333333 56677778889999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++++|.+++... ..+++..+..++.++++||.|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 82 LLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999988432 4788999999999999999999998 99999999999999999999999999998665432
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
......|+..|+|||.+... ..+.++|+||||+++++|++|+.|+...... ...+....... ...
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~---- 219 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQ--GYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQET-ADV---- 219 (258)
T ss_pred ---cccccCCChhhcCHHHHccc--CCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhcc-ccc----
Confidence 12345688899999998764 5889999999999999999999998755432 11112222111 111
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPSM--TKVL 417 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~--~evl 417 (453)
..+...+..+.+++.+||+.+|.+||++ +|++
T Consensus 220 --~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 --LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1222344778899999999999999999 5543
No 317
>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4. Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates
Probab=100.00 E-value=5e-32 Score=263.20 Aligned_cols=237 Identities=27% Similarity=0.359 Sum_probs=171.4
Q ss_pred hhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC--HHHHHHH---------------HhcccccCcceEEEEEecC
Q 048517 164 HFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSEGFKRALVYEYMP 225 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~~~~~~lv~E~~~ 225 (453)
.+.++||+|+||.||++.. .+|+.||+|.+...... ..++..| +++++......+++|||+.
T Consensus 7 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~ 86 (288)
T cd06616 7 KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD 86 (288)
T ss_pred HHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc
Confidence 3457899999999999985 46899999998753322 2233333 3455556667889999985
Q ss_pred CCChhhhhhh-ccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 226 NGSLDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 226 ~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
+++.+.... .......+++..+..++.+++.||+|||+. .+++||||||+||+++.++.+||+|||+++.......
T Consensus 87 -~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 87 -ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred -CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 455443211 112235689999999999999999999974 3899999999999999999999999999976543221
Q ss_pred ceeecccCCCCCccChhhhcccC-CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh---CCCcc
Q 048517 305 FVSISDTRGTIGYLAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK---GGDLE 380 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~-~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~---~~~~~ 380 (453)
.....|+..|+|||.+.... ..++.++||||||+++|||++|+.||..... ..+.+.+ +....
T Consensus 164 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------~~~~~~~~~~~~~~~ 230 (288)
T cd06616 164 ---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----------VFDQLTQVVKGDPPI 230 (288)
T ss_pred ---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----------HHHHHhhhcCCCCCc
Confidence 12346889999999987531 2578899999999999999999999864321 1111111 11111
Q ss_pred ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
+. ......++..+.+++.+||+.+|++|||+.+|++
T Consensus 231 ~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 231 LS--NSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CC--CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 1111235567899999999999999999999987
No 318
>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi
Probab=99.98 E-value=6.9e-32 Score=262.88 Aligned_cols=227 Identities=28% Similarity=0.395 Sum_probs=176.3
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~ 223 (453)
|.+.+.||+|+||.||++... +++.||+|.+..... ..+.+..| +++++..+...++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 556789999999999999954 689999999875321 12223332 45566677788999999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||+++.....
T Consensus 83 ~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 83 VPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred CCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999988432 5689999999999999999999998 9999999999999999999999999999876443
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
.....+++.|+|||.+... ..+.++||||||++++||++|+.|+..... ......+..+. ..
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~-~~--- 216 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSK--GYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKILEGK-VR--- 216 (290)
T ss_pred ----CCCCCCCccccChhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCC-cc---
Confidence 1334688999999998754 678899999999999999999999864331 11222222221 11
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE 418 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 418 (453)
.+...+..+.+++.+||+.+|.+|| +++|+++
T Consensus 217 ---~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 217 ---FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ---CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1122346788999999999999999 6666653
No 319
>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They
Probab=99.98 E-value=1e-31 Score=255.32 Aligned_cols=235 Identities=29% Similarity=0.415 Sum_probs=182.2
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
|.+.+.||+|+||.||++... +++.||+|.+..... ...++..| +.+.+..+...++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 456678999999999999954 789999999876433 22233333 234445567789999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
++++|.+++.........+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 99999998865443457899999999999999999999998 999999999999999999999999999987654431
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 384 (453)
......|++.|+|||.+... .++.++||||+|+++++|++|+.|+...... -+...+.......+
T Consensus 159 --~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~--- 223 (258)
T cd08215 159 --LAKTVVGTPYYLSPELCQNK--PYNYKSDIWSLGCVLYELCTLKHPFEGENLL--------ELALKILKGQYPPI--- 223 (258)
T ss_pred --eecceeeeecccChhHhccC--CCCccccHHHHHHHHHHHHcCCCCCCCCcHH--------HHHHHHhcCCCCCC---
Confidence 22344688899999988764 6889999999999999999999998643211 12222222222211
Q ss_pred hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
+......+.+++.+||+.+|++|||+.++++
T Consensus 224 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 ---PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1134467889999999999999999999986
No 320
>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess
Probab=99.98 E-value=3.4e-32 Score=264.91 Aligned_cols=245 Identities=23% Similarity=0.289 Sum_probs=170.6
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEYMP 225 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~~~ 225 (453)
|.+.+.||+|+||.||+|.. .+|+.||+|.+...... ...+.+| +.+++..+...++|+||+.
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 45668899999999999985 47899999998653221 1222232 3455666778899999995
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 305 (453)
++|.+++... ...+.+..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||+++.......
T Consensus 87 -~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 158 (291)
T cd07870 87 -TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ- 158 (291)
T ss_pred -CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-
Confidence 6777766432 24578888999999999999999998 999999999999999999999999999975433221
Q ss_pred eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHH---------HHHHhhh-
Q 048517 306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW---------VYDQLNK- 375 (453)
Q Consensus 306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---------~~~~l~~- 375 (453)
......++..|+|||.+.+. ..++.++||||||+++|||++|+.||....... +.....| ....+..
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 159 -TYSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred -CCCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHHHHHHHHcCCCChhhhhhhhhc
Confidence 11334578999999998653 357889999999999999999999986443210 0000000 0000000
Q ss_pred --CCC----cc-ccchhhhH--HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 376 --GGD----LE-LRNVTEIE--SMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 376 --~~~----~~-~~~~~~~~--~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
... .. ........ ......+.+++.+|++.||.+|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000 00 00000000 011346778999999999999999999874
No 321
>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein. Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc
Probab=99.98 E-value=2e-31 Score=262.34 Aligned_cols=248 Identities=17% Similarity=0.169 Sum_probs=172.6
Q ss_pred hhcccCccCceEEEEEEEcCCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEecCCC
Q 048517 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYMPNG 227 (453)
Q Consensus 165 ~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~g 227 (453)
+.+.+|.|+++.||++.. +++.||||++..... ..+.+..| +++.+......+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344556666666666655 699999999875422 22233333 566677778899999999999
Q ss_pred ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc--
Q 048517 228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF-- 305 (453)
Q Consensus 228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~-- 305 (453)
+|.+++... ....+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+|++|||.+.........
T Consensus 85 ~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 85 SCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 999988543 234588899999999999999999998 9999999999999999999999999988754322110
Q ss_pred ---eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc-----ccchHHH----HHH-
Q 048517 306 ---VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-----AYFPSWV----YDQ- 372 (453)
Q Consensus 306 ---~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~-----~~~~~~~----~~~- 372 (453)
.......++..|+|||++......++.++||||||+++|||++|+.||......... ...+.+. ...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 011234577899999998764346888999999999999999999999754321100 0000000 000
Q ss_pred ---hhh----CCC--ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 373 ---LNK----GGD--LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 373 ---l~~----~~~--~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
... ... ............+...+.+++.+||+.+|++|||++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000 000 0000011123345567889999999999999999999987
No 322
>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85. Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.
Probab=99.98 E-value=8.6e-32 Score=260.73 Aligned_cols=248 Identities=22% Similarity=0.310 Sum_probs=177.3
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC--CHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF--SAEEFINE--------------LLGLCSEGFKRALVYEYMP 225 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~--~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~ 225 (453)
|++.++||+|++|.||+|+.. +|+.||||.+..... ..+.+..| +++++......++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 456789999999999999965 689999999876422 22233333 5666777778899999998
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 305 (453)
+ +|.+++.... ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++.......
T Consensus 82 ~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 82 K-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred c-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 4 8888774432 234689999999999999999999998 999999999999999999999999999976533221
Q ss_pred eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccc-------hHHHHHHhhhCCC
Q 048517 306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------PSWVYDQLNKGGD 378 (453)
Q Consensus 306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~-------~~~~~~~l~~~~~ 378 (453)
......++..|++||++.+. ..++.++||||||+++|||++|+.|+............ ....++.+.....
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred -ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 12334578899999998653 35688999999999999999999998654321100000 0000011111000
Q ss_pred c--ccc-----chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 379 L--ELR-----NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 379 ~--~~~-----~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
. ... .........+..+.+++.+|++.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 000 000111233567889999999999999999999975
No 323
>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul
Probab=99.98 E-value=3.6e-32 Score=270.76 Aligned_cols=250 Identities=23% Similarity=0.273 Sum_probs=175.0
Q ss_pred HHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC---CCHHHHHHH---------------Hhccccc--CcceE
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK---FSAEEFINE---------------LLGLCSE--GFKRA 218 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~i~e---------------l~g~~~~--~~~~~ 218 (453)
...+.+.+.||+|+||.||+|... +|+.||||.+.... .....+..| +++++.. +...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 345677789999999999999965 68899999885421 111122222 3444433 33578
Q ss_pred EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298 (453)
Q Consensus 219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 298 (453)
+||||++ ++|..++.. ..++|..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+++.
T Consensus 86 lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 86 LVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 9999997 588887732 2688999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCc---eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc-------ccchHH
Q 048517 299 HPKENDF---VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-------AYFPSW 368 (453)
Q Consensus 299 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~-------~~~~~~ 368 (453)
....... .......||..|+|||.+.+. ..++.++||||||+++|||++|+.||......... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred cccccccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 6543321 122334689999999988653 46788999999999999999999998643221100 000000
Q ss_pred HHH---------HhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 369 VYD---------QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 369 ~~~---------~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
... .+..................+..+.+++.+||+.+|++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000 000000000000111112245678999999999999999999999974
No 324
>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the
Probab=99.98 E-value=9.8e-32 Score=261.97 Aligned_cols=247 Identities=21% Similarity=0.260 Sum_probs=174.6
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccC--cceEEEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEG--FKRALVY 221 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~--~~~~lv~ 221 (453)
.|.+.+.||+|+||.||+|..+ +++.+|+|.++..... ...+..| +.+++... ...++|+
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 4667789999999999999965 6899999998753221 1122222 34444444 7789999
Q ss_pred EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517 222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 301 (453)
Q Consensus 222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 301 (453)
||++ ++|.+.+... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 86 EYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred hhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 9997 5888877432 23689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccc---------hHHHH-H
Q 048517 302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF---------PSWVY-D 371 (453)
Q Consensus 302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~---------~~~~~-~ 371 (453)
... ......+++.|+|||.+.+. ...+.++|+||+|++++||++|+.||............ ..|.. .
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred Ccc--ccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 321 12344578899999998753 34688999999999999999999998643321100000 00000 0
Q ss_pred HhhhCC---Ccccc--ch-hhhHHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 372 QLNKGG---DLELR--NV-TEIESM-IARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 372 ~l~~~~---~~~~~--~~-~~~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.+.... ..... .. ...+.. +...+.+++.+||+.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000 00000 00 001111 3567889999999999999999999985
No 325
>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK
Probab=99.98 E-value=2e-31 Score=253.03 Aligned_cols=235 Identities=27% Similarity=0.346 Sum_probs=180.4
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccC--cceEEEEE
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEG--FKRALVYE 222 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~--~~~~lv~E 222 (453)
+...+.||+|++|.||+|... +++.|++|++..... ..+.+..| +++.+... ...++++|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 345578999999999999966 799999999876542 23333333 33455555 67899999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 302 (453)
|+++++|.+++... ..+++..++.++.+++.||+|||+. +++|+||+|+||+++.++.+||+|||.+......
T Consensus 82 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 82 YVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred ecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999988432 3789999999999999999999997 9999999999999999999999999999877654
Q ss_pred CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcccc
Q 048517 303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELR 382 (453)
Q Consensus 303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 382 (453)
..........++..|+|||.+... ..+.++||||||+++++|++|+.|+...... ..............
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~--- 223 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGE--EYGRAADIWSLGCTVIEMATGKPPWSELGNP------MAALYKIGSSGEPP--- 223 (260)
T ss_pred cccccccCCCCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCch------HHHHHhccccCCCc---
Confidence 321112345688999999998764 5889999999999999999999998654311 01111111101111
Q ss_pred chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 383 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 383 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
..+......+.+++.+|++.+|++||++.++++
T Consensus 224 ---~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 ---EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ---CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 122233577999999999999999999999986
No 326
>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=99.98 E-value=4.6e-32 Score=263.92 Aligned_cols=237 Identities=22% Similarity=0.283 Sum_probs=174.4
Q ss_pred hhhhcccCccCceEEEEEEE----cCCcEEEEEEecCCCC-----CHHHHHHH---------------HhcccccCcceE
Q 048517 163 NHFTHKLGQGGFGSVYKGQL----HTGRLIAVKMMENSKF-----SAEEFINE---------------LLGLCSEGFKRA 218 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~----~~g~~VAVK~l~~~~~-----~~~~~i~e---------------l~g~~~~~~~~~ 218 (453)
+++.+.||+|+||.||+++. .+|+.||+|++..... ..+++..| +.+.+..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 45668899999999999985 3789999999875221 11222222 334455666788
Q ss_pred EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298 (453)
Q Consensus 219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 298 (453)
+|+||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.
T Consensus 82 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 82 LILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999998843 24688999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517 299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD 378 (453)
Q Consensus 299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~ 378 (453)
....... ......|+..|+|||.+.......+.++||||||+++|||++|+.|+....... .... ..+.+.....
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~~-~~~~~~~~~~ 229 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN---SQAE-ISRRILKSEP 229 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc---cHHH-HHHHhhccCC
Confidence 5433211 122345889999999987543457889999999999999999999986432211 1111 1122221111
Q ss_pred ccccchhhhHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517 379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE 418 (453)
Q Consensus 379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 418 (453)
. .+..+...+.+++.+||+.+|++|| ++.++++
T Consensus 230 -~------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 230 -P------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -C------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1 1122445688999999999999997 6666655
No 327
>PLN00009 cyclin-dependent kinase A; Provisional
Probab=99.98 E-value=1e-31 Score=261.97 Aligned_cols=240 Identities=22% Similarity=0.309 Sum_probs=173.5
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
+++.++||+|++|.||+|... +|+.||+|.+..... ..+.+..| +++++..+...++||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 556789999999999999954 789999998865322 12233333 456677778899999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-CCceEEEecCCccccCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~~ 303 (453)
+ ++|.+++... ....+++..+..++.|++.||+|||+. +++|+||||+||+++. +..+||+|||+++......
T Consensus 84 ~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 84 D-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred c-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 5 5787776332 223467888889999999999999998 9999999999999985 5679999999998654322
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh---hC----
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN---KG---- 376 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~---~~---- 376 (453)
. ......+++.|+|||++.+. ..++.++||||+|+++|||++|+.||........ ....+. ..
T Consensus 158 ~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~-------~~~~~~~~~~~~~~~ 227 (294)
T PLN00009 158 R--TFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE-------LFKIFRILGTPNEET 227 (294)
T ss_pred c--ccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHHHhCCCChhh
Confidence 1 12334578899999998653 3578899999999999999999999865432110 111000 00
Q ss_pred --------------CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 377 --------------GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 377 --------------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
...............+..+.+++.+|++.+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 228 WPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000000111234567889999999999999999999986
No 328
>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi
Probab=99.98 E-value=2.2e-31 Score=254.98 Aligned_cols=226 Identities=26% Similarity=0.356 Sum_probs=173.0
Q ss_pred cCccCceEEEEEEEc-CCcEEEEEEecCCCCC----HHHHHHH--------------HhcccccCcceEEEEEecCCCCh
Q 048517 169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS----AEEFINE--------------LLGLCSEGFKRALVYEYMPNGSL 229 (453)
Q Consensus 169 LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~----~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL 229 (453)
||.|+||.||+++.. +++.||+|.+...... .+.+..| +++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999965 5899999998764321 2233333 45566677788999999999999
Q ss_pred hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeec
Q 048517 230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 309 (453)
Q Consensus 230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 309 (453)
.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 9988432 4589999999999999999999998 99999999999999999999999999998765432 113
Q ss_pred ccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh-CCCccccchhhhH
Q 048517 310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK-GGDLELRNVTEIE 388 (453)
Q Consensus 310 ~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~~~ 388 (453)
...++..|+|||.+... .++.++|+||+|+++|||++|+.|+....... .. ....... ..... .+
T Consensus 151 ~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~-~~~~~~~~~~~~~------~~ 216 (262)
T cd05572 151 TFCGTPEYVAPEIILNK--GYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-----ME-IYNDILKGNGKLE------FP 216 (262)
T ss_pred cccCCcCccChhHhcCC--CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-----HH-HHHHHhccCCCCC------CC
Confidence 34688899999998753 67899999999999999999999986543211 11 1122221 11111 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 048517 389 SMIARKLCMIGLWCIQVKAADRPS-----MTKVLE 418 (453)
Q Consensus 389 ~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 418 (453)
......+..++.+||+.+|++||+ ++|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 122567899999999999999999 566554
No 329
>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of
Probab=99.98 E-value=6.7e-32 Score=261.13 Aligned_cols=229 Identities=28% Similarity=0.362 Sum_probs=171.5
Q ss_pred cCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEEEEEecCCCCh
Q 048517 169 LGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSL 229 (453)
Q Consensus 169 LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL 229 (453)
||+|+||+||++.. .+|+.||+|.+..... ....+..| +++.+......++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 79999999999984 4789999999865321 12223333 34555666778999999999999
Q ss_pred hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeec
Q 048517 230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 309 (453)
Q Consensus 230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 309 (453)
.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++........ ..
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~ 152 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IK 152 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cc
Confidence 99885432 24689999999999999999999998 999999999999999999999999999986543221 23
Q ss_pred ccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHH
Q 048517 310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 389 (453)
Q Consensus 310 ~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 389 (453)
...++..|+|||.+.+. .++.++||||+|+++++|++|+.||........ .+.+.+.... .....+.
T Consensus 153 ~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~---~~~~~~~ 219 (277)
T cd05577 153 GRAGTPGYMAPEVLQGE--VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE--------KEELKRRTLE---MAVEYPD 219 (277)
T ss_pred cccCCCCcCCHHHhcCC--CCCchhhhHHHHHHHHHHhhCCCCCCCCccccc--------HHHHHhcccc---ccccCCc
Confidence 34578899999998764 688999999999999999999999865432111 0111111000 0011222
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 048517 390 MIARKLCMIGLWCIQVKAADRP-----SMTKVLE 418 (453)
Q Consensus 390 ~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 418 (453)
..+..+.+++.+||+.+|++|| ++.++++
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 3456788999999999999999 5555654
No 330
>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=99.98 E-value=2.8e-32 Score=270.29 Aligned_cols=234 Identities=21% Similarity=0.266 Sum_probs=177.6
Q ss_pred hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCC---CCHHHHHHH---------------HhcccccCcceEEEEEe
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSK---FSAEEFINE---------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~---~~~~~~i~e---------------l~g~~~~~~~~~lv~E~ 223 (453)
.|...++||.||-+.||++.-.+.+.+|+|.+.... ....-|.+| |+.+-..+...|+||||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~ 441 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC 441 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence 455668899999999999998888889998765532 223344444 55566667889999998
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 303 (453)
= .-+|.+.|.... .....| .+..+..|++.++.+.|++ +|||.||||.|.|+- .|.+||.|||+|.....+.
T Consensus 442 G-d~DL~kiL~k~~--~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 442 G-DIDLNKILKKKK--SIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred c-cccHHHHHHhcc--CCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 5 678888884332 233345 7889999999999999998 999999999999994 5689999999999998887
Q ss_pred CceeecccCCCCCccChhhhcccCC---------CCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFG---------TVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN 374 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~---------~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~ 374 (453)
.........||+.||+||++..... .++.++||||+||+||+|+.|+.||..-.. .+..+.
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n----------~~aKl~ 583 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN----------QIAKLH 583 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH----------HHHHHH
Confidence 7666677899999999999864311 278899999999999999999999963211 111121
Q ss_pred hC----CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 375 KG----GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 375 ~~----~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.- -.++.+.... . ..+.++++.||+.||++|||+.|+++
T Consensus 584 aI~~P~~~Iefp~~~~---~--~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 584 AITDPNHEIEFPDIPE---N--DELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred hhcCCCccccccCCCC---c--hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 11 1122222111 1 12899999999999999999999987
No 331
>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5. Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the
Probab=99.98 E-value=1.7e-31 Score=265.75 Aligned_cols=248 Identities=19% Similarity=0.244 Sum_probs=173.9
Q ss_pred hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC---CHHHHHHH--------------Hhcccc----cCcceEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCS----EGFKRAL 219 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~----~~~~~~l 219 (453)
.+.+.+.||+|+||.||+|.. .+|+.||+|++..... ....+..| +.+++. .....++
T Consensus 6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 85 (334)
T cd07855 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV 85 (334)
T ss_pred ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence 455668899999999999994 5799999999875321 22233332 233332 2345789
Q ss_pred EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517 220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 299 (453)
|+||+. |+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 86 VMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 999995 688887732 34589999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCCce--eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc------------cc
Q 048517 300 PKENDFV--SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA------------YF 365 (453)
Q Consensus 300 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~------------~~ 365 (453)
....... ......++..|+|||.+.+. ..++.++||||||+++|||++|+.||.......... .+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 4322111 11234688999999998653 357899999999999999999999996432210000 00
Q ss_pred ----hHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 366 ----PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 366 ----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
...+......................+..+.+++.+||+.+|++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00000001000000000000111234577999999999999999999999987
No 332
>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both
Probab=99.98 E-value=2.1e-31 Score=258.08 Aligned_cols=240 Identities=23% Similarity=0.329 Sum_probs=172.9
Q ss_pred hhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---HHHHHHH-----------------HhcccccCcc-----e
Q 048517 164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---AEEFINE-----------------LLGLCSEGFK-----R 217 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---~~~~i~e-----------------l~g~~~~~~~-----~ 217 (453)
++.+.||+|+||.||+|+.+ +++.||+|.+...... ...+..| +.+++..... .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 45678999999999999976 5899999998743211 1122122 3444444444 8
Q ss_pred EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517 218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297 (453)
Q Consensus 218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 297 (453)
+++|||+. ++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.
T Consensus 82 ~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 82 TLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred EEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 89999996 58888774322 24689999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC
Q 048517 298 FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG 377 (453)
Q Consensus 298 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 377 (453)
....... .....++..|+|||.+.+. .++.++||||||++++||++|+.|+....... .+.. +.+......
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~--~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~---~~~~-~~~~~~~~~ 226 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQS--SYATPVDMWSVGCIFAELFRRRPLFRGTSEAD---QLDK-IFDVIGLPS 226 (287)
T ss_pred eccCCcc---cccccccccccChHHhccC--CCCCcchhhhHHHHHHHHHhCCCcccCCChHH---HHHH-HHHHcCCCC
Confidence 7644322 1233578899999999764 68899999999999999999998886543211 0111 111100000
Q ss_pred ----------------CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 378 ----------------DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 378 ----------------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.................+.+++.+||+.||++||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000011122344567889999999999999999999874
No 333
>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely
Probab=99.98 E-value=1.8e-31 Score=260.92 Aligned_cols=246 Identities=24% Similarity=0.262 Sum_probs=173.3
Q ss_pred HHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccC-------
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEG------- 214 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~------- 214 (453)
...+.+.++||+|+||.||+|..+ +|+.||||.++.... ....+..| +++++...
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 345667789999999999999965 689999999865321 11222222 34444332
Q ss_pred ---cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEE
Q 048517 215 ---FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS 291 (453)
Q Consensus 215 ---~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~ 291 (453)
...++++||+++ ++.+.+.. ....+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence 368899999976 66666632 234689999999999999999999998 99999999999999999999999
Q ss_pred ecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHH
Q 048517 292 DFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD 371 (453)
Q Consensus 292 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 371 (453)
|||++........ .......++..|+|||.+.+. ...+.++||||||++++||++|+.|+........ +.. +.+
T Consensus 159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~---~~~-~~~ 232 (302)
T cd07864 159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ---LEL-ISR 232 (302)
T ss_pred cccccccccCCcc-cccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHH-HHH
Confidence 9999987654332 111233467889999988643 3568899999999999999999999865432110 000 000
Q ss_pred HhhhCC-------------------CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 372 QLNKGG-------------------DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 372 ~l~~~~-------------------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
...... .............++..+.+++.+||+.+|.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000 00000000011123567899999999999999999999875
No 334
>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check
Probab=99.98 E-value=2.6e-31 Score=254.23 Aligned_cols=234 Identities=24% Similarity=0.324 Sum_probs=175.6
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC------CCHHHH--------------HHHHhcccccCcceEEEE
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK------FSAEEF--------------INELLGLCSEGFKRALVY 221 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~------~~~~~~--------------i~el~g~~~~~~~~~lv~ 221 (453)
|.+.++||+|+||.||+++.. .+..+++|+++... ....++ +.++++.+.+....++++
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 567789999999999999854 45556666655311 111111 223566777777889999
Q ss_pred EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517 222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 301 (453)
Q Consensus 222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 301 (453)
||+++++|.+.+.........+++..++.++.|++.||.|||+. +++|+||||+||+++. ..+||+|||+++....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999998865444456799999999999999999999998 9999999999999976 4699999999987644
Q ss_pred CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517 302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381 (453)
Q Consensus 302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 381 (453)
... ......|++.|+|||.+... .++.++|+||||+++|+|++|+.|+..... .. .......+....
T Consensus 158 ~~~--~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-------~~-~~~~~~~~~~~~- 224 (260)
T cd08222 158 SCD--LATTFTGTPYYMSPEALKHQ--GYDSKSDIWSLGCILYEMCCLAHAFEGQNF-------LS-VVLRIVEGPTPS- 224 (260)
T ss_pred Ccc--cccCCCCCcCccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HH-HHHHHHcCCCCC-
Confidence 322 12345688999999988653 678899999999999999999999853221 11 111222221111
Q ss_pred cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.+..++..+.+++.+||+.+|++||++.++++
T Consensus 225 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 225 -----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 22345567889999999999999999999976
No 335
>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=99.98 E-value=2.6e-33 Score=252.77 Aligned_cols=235 Identities=23% Similarity=0.322 Sum_probs=185.4
Q ss_pred HhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCH---HHHHHH--------------HhcccccCcceEEEEE
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA---EEFINE--------------LLGLCSEGFKRALVYE 222 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~~~~~~~lv~E 222 (453)
..|.+.+.||+|.|+.||++. .++|+.+|+|+++..+... ++..+| |....++.+..++|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 356677899999999999997 5689999999987644332 222222 5555667778899999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC---CCceEEEecCCcccc
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKFH 299 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~---~~~~kl~DFGla~~~ 299 (453)
+|.||+|..-|..+ ..+++..+-....||+.+|.|.|.+ +|||||+||+|+||.. .--+||+|||+|...
T Consensus 91 ~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred cccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999998777433 4577888889999999999999998 9999999999999953 456899999999877
Q ss_pred CCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517 300 PKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL 379 (453)
Q Consensus 300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~ 379 (453)
.... ......|||+|||||++.+. +++..+|||+.||+|+-|+.|+.||...... -+++++.++...
T Consensus 164 ~~g~---~~~G~~GtP~fmaPEvvrkd--py~kpvDiW~cGViLfiLL~G~~PF~~~~~~--------rlye~I~~g~yd 230 (355)
T KOG0033|consen 164 NDGE---AWHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQH--------RLYEQIKAGAYD 230 (355)
T ss_pred CCcc---ccccccCCCcccCHHHhhcC--CCCCcchhhhhhHHHHHHHhCCCCCCCccHH--------HHHHHHhccccC
Confidence 6322 34567899999999999875 8999999999999999999999999764322 266777665432
Q ss_pred cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
-. ......+++...+++.+||..||.+|.|+.|.+.
T Consensus 231 ~~---~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 231 YP---SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CC---CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11 1133445667888999999999999999988764
No 336
>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo
Probab=99.98 E-value=2.7e-31 Score=259.40 Aligned_cols=228 Identities=25% Similarity=0.340 Sum_probs=173.5
Q ss_pred cccCccCceEEEEEEE-cCCcEEEEEEecCCCC-CHHHHHHH--------------HhcccccCcceEEEEEecCCCChh
Q 048517 167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF-SAEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLD 230 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~-~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL~ 230 (453)
.+||+|+||.||++.. .+|+.||||.+..... ..+.+..| +++.+..+...+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999986 5799999998865332 22333333 455666778899999999999998
Q ss_pred hhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecc
Q 048517 231 RHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISD 310 (453)
Q Consensus 231 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 310 (453)
+++.. ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++........ ....
T Consensus 106 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~ 175 (292)
T cd06657 106 DIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS 175 (292)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence 87632 3579999999999999999999998 999999999999999999999999999876543221 1233
Q ss_pred cCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHH
Q 048517 311 TRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESM 390 (453)
Q Consensus 311 ~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 390 (453)
..|+.+|+|||.+.+. .++.++|+||+|++++||++|+.|+....... ....+......... ....
T Consensus 176 ~~~~~~y~~pE~~~~~--~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~--------~~~~~~~~~~~~~~----~~~~ 241 (292)
T cd06657 176 LVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--------AMKMIRDNLPPKLK----NLHK 241 (292)
T ss_pred cccCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhhCCcccC----Cccc
Confidence 4688999999988653 67889999999999999999999986432110 11112111111110 1112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 391 IARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 391 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
+...+.+++.+||+.+|.+||++.++++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 3456788999999999999999999987
No 337
>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.98 E-value=1.8e-32 Score=274.24 Aligned_cols=236 Identities=24% Similarity=0.318 Sum_probs=180.4
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecC-CCCCHHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMEN-SKFSAEEFINE--------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~-~~~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
+++...||.|+||.||+++.+ ++-..|-|++.. +....++|+.| |++.+...+.++++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 455678999999999999965 455567777754 33334455444 56656667788999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|-++..+.. -+..|+..++.-++++++.||.|||++ +|||||||..|||++-+|.++|+|||.+...... ..
T Consensus 114 GAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~q 185 (1187)
T KOG0579|consen 114 GAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQ 185 (1187)
T ss_pred chHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH--Hh
Confidence 999888753 346899999999999999999999998 9999999999999999999999999998643221 11
Q ss_pred eecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 307 SISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
......|||.|||||+.... ..+|..++||||||++|.||..+.+|....+ .+..+.+....+.+-
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-----------pMRVllKiaKSePPT 254 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-----------PMRVLLKIAKSEPPT 254 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-----------hHHHHHHHhhcCCCc
Confidence 22456799999999988642 2478999999999999999999998864322 223332222222111
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
...+...+..+.+++.+||..||..||++.++++
T Consensus 255 -LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 255 -LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1245556678999999999999999999988875
No 338
>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2. Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin
Probab=99.97 E-value=2.7e-31 Score=261.25 Aligned_cols=236 Identities=25% Similarity=0.323 Sum_probs=175.7
Q ss_pred HHHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC----CHHHHHHH--------------HhcccccCcceEE
Q 048517 159 IAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF----SAEEFINE--------------LLGLCSEGFKRAL 219 (453)
Q Consensus 159 ~~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~----~~~~~i~e--------------l~g~~~~~~~~~l 219 (453)
...++...+.||+|+||.||+|+. .+++.||+|.+..... ...++..| +.+++......++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 334556668899999999999995 4688999998864322 12233333 3455666777899
Q ss_pred EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517 220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 299 (453)
|+||+. |+|.+.+... ...+++.++..++.+++.||.|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 93 v~e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 93 VMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred EEEccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceee
Confidence 999996 6887766432 24588999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCCceeecccCCCCCccChhhhcc-cCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517 300 PKENDFVSISDTRGTIGYLAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD 378 (453)
Q Consensus 300 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~ 378 (453)
... ....++..|+|||.+.+ ..+.++.++||||||+++|||++|+.|+...... .... .+..+..
T Consensus 166 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~-~~~~~~~ 231 (308)
T cd06634 166 APA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALY-HIAQNES 231 (308)
T ss_pred cCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-------HHHH-HHhhcCC
Confidence 432 23457889999999853 1246788999999999999999999997543211 1111 1111111
Q ss_pred ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517 379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 420 (453)
Q Consensus 379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 420 (453)
... .....+..+.+++.+||+.+|++||++.++++..
T Consensus 232 ~~~-----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 232 PAL-----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred CCc-----CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 111 1223456688999999999999999999998753
No 339
>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta. Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig
Probab=99.97 E-value=4.6e-31 Score=261.94 Aligned_cols=247 Identities=21% Similarity=0.292 Sum_probs=171.9
Q ss_pred cccCcc--CceEEEEEEE-cCCcEEEEEEecCCCCCH---HHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517 167 HKLGQG--GFGSVYKGQL-HTGRLIAVKMMENSKFSA---EEFINE--------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 167 ~~LG~G--~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~---~~~i~e--------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
.+||+| +||+||+++. .+|+.||||++....... +.+..| +++++..+...++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456776 9999999995 479999999987643322 222222 45666677788999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99998875432 24588999999999999999999998 99999999999999999999999998654332211100
Q ss_pred e-----ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc-------c-------cchH
Q 048517 307 S-----ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-------A-------YFPS 367 (453)
Q Consensus 307 ~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~-------~-------~~~~ 367 (453)
. .....++..|+|||++.+....++.++||||||++++||++|+.||......... . .++.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 0 0112345679999999765446789999999999999999999998654321100 0 0000
Q ss_pred HHHH---------------HhhhC---CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 368 WVYD---------------QLNKG---GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 368 ~~~~---------------~l~~~---~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
-... ..... ..................+.+++.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0000 00000 000000001123345678899999999999999999999975
No 340
>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK
Probab=99.97 E-value=2.9e-31 Score=266.14 Aligned_cols=244 Identities=21% Similarity=0.210 Sum_probs=171.5
Q ss_pred HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC---CHHHHHHH--------------Hhccccc------Ccc
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSE------GFK 216 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~------~~~ 216 (453)
..|...+.||+|+||.||+++. .+|+.||||.+..... ...++..| +++++.. ...
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 3456668899999999999994 5799999999865321 12233333 2333321 234
Q ss_pred eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517 217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA 296 (453)
Q Consensus 217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 296 (453)
.++|+||+. ++|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 96 ~~lv~e~~~-~~l~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 96 VYLVMELMD-ANLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred EEEEEeccC-CCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 689999995 57877663 1288899999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccc--------cccchHH
Q 048517 297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS--------KAYFPSW 368 (453)
Q Consensus 297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~--------~~~~~~~ 368 (453)
+....... .....+|..|+|||.+.+. .++.++|||||||++++|++|+.||........ ......+
T Consensus 166 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 166 RTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred eeCCCCCC---CCCCcccccccCHHHHhCC--CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 86543321 2334588999999999764 788999999999999999999999864432100 0000000
Q ss_pred -------HHHHhhhCCCcc---c----------cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 369 -------VYDQLNKGGDLE---L----------RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 369 -------~~~~l~~~~~~~---~----------~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
......+..... . .............+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000010000000 0 00000012345668899999999999999999999873
No 341
>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10. Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing
Probab=99.97 E-value=3.7e-31 Score=260.08 Aligned_cols=247 Identities=21% Similarity=0.285 Sum_probs=171.8
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccC--cceEEEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEG--FKRALVY 221 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~--~~~~lv~ 221 (453)
.+++.+.||+|+||.||+|... +|+.||+|.+...... ......| +++++... ...++||
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 3556788999999999999964 6999999998643211 1111222 23343322 4578999
Q ss_pred EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517 222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 301 (453)
Q Consensus 222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 301 (453)
||++ ++|.+++... ...+++.++..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++....
T Consensus 88 e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 88 EYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred ecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 9996 5787777432 25689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccch-------HHHHHHhh
Q 048517 302 ENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-------SWVYDQLN 374 (453)
Q Consensus 302 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~-------~~~~~~l~ 374 (453)
... ......++..|+|||.+.+. ..++.++||||+|+++|||++|+.||............. ......+.
T Consensus 161 ~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 161 PAK--PMTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred ccC--CCCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 321 12334467889999998653 357889999999999999999999986443211000000 00000000
Q ss_pred h---CCCccc-----cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 375 K---GGDLEL-----RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 375 ~---~~~~~~-----~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
. ...... ..........++.+.+++.+||+.||++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 000000 0000011123567789999999999999999999986
No 342
>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl
Probab=99.97 E-value=3.5e-31 Score=259.52 Aligned_cols=249 Identities=22% Similarity=0.284 Sum_probs=169.3
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccC--------c
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEG--------F 215 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~--------~ 215 (453)
.|.+.++||+|+||.||+|... +++.||||.+..... ....+..| ++++|... .
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 4667789999999999999954 799999998864221 11122222 34444322 3
Q ss_pred ceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCC
Q 048517 216 KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL 295 (453)
Q Consensus 216 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl 295 (453)
..++||||+. ++|.+.+.. ....+++.++..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+
T Consensus 93 ~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 93 SFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred eEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCC
Confidence 4589999996 477777632 224689999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCc--eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccccc-------ch
Q 048517 296 AKFHPKENDF--VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-------FP 366 (453)
Q Consensus 296 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~-------~~ 366 (453)
+......... .......++..|+|||.+.+. ..++.++||||||++++||++|+.|+........... ++
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9866432211 112334578899999988653 3468899999999999999999998865432110000 00
Q ss_pred HHHHHHh---hhCCCccccchh--hhHH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 367 SWVYDQL---NKGGDLELRNVT--EIES-----MIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 367 ~~~~~~l---~~~~~~~~~~~~--~~~~-----~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
..+.... ............ .... .....+.+++.+||+.+|++|||++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000000 000000000000 0000 11245678999999999999999999975
No 343
>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast
Probab=99.97 E-value=5.1e-31 Score=250.35 Aligned_cols=231 Identities=25% Similarity=0.362 Sum_probs=178.2
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCcceEEEEEec
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~~~~lv~E~~ 224 (453)
|.+.+.||+|++|.||+++.. +++.||+|.+..... ..+++..| +.+++..+...++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 456789999999999999855 688999999987543 22334333 244555667789999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
++++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 82 ENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999988432 5689999999999999999999998 999999999999999999999999999987654332
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 384 (453)
. .....++..|+|||...+. ..+.++||||+|+++++|++|+.|+...... . ............
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~--~~~~~~~~~~~~---- 218 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMS--GASTASDIWSLGCTVIELLTGNPPYYDLNPM------A--ALFRIVQDDHPP---- 218 (254)
T ss_pred c--ccccccchhhcCHhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCCccHH------H--HHHHHhccCCCC----
Confidence 1 2334688999999998764 5788999999999999999999998643211 0 111111111111
Q ss_pred hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.+......+..++.+||+.+|++|||+.+++.
T Consensus 219 --~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 --LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 12223467889999999999999999999874
No 344
>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]
Probab=99.97 E-value=1.5e-32 Score=266.45 Aligned_cols=227 Identities=27% Similarity=0.402 Sum_probs=175.4
Q ss_pred hhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC---CH------HHHHHH---------HhcccccCcceEEEEEecC
Q 048517 165 FTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF---SA------EEFINE---------LLGLCSEGFKRALVYEYMP 225 (453)
Q Consensus 165 ~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~---~~------~~~i~e---------l~g~~~~~~~~~lv~E~~~ 225 (453)
.-+.||+||||.||-++. .+|+.+|.|.+.+... .. +..|.+ |---+.....++||+..|.
T Consensus 189 ~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMN 268 (591)
T KOG0986|consen 189 VYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMN 268 (591)
T ss_pred eeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeec
Confidence 346899999999999985 4799999998765211 11 112222 1122456778999999999
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 305 (453)
||+|.-+|+... ...++...+.-++.+|+-||++||+. +||.||+||+|||||+.|+++|+|.|||.-++....
T Consensus 269 GGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~- 342 (591)
T KOG0986|consen 269 GGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP- 342 (591)
T ss_pred CCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCc-
Confidence 999999886443 36799999999999999999999998 999999999999999999999999999998877653
Q ss_pred eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517 306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385 (453)
Q Consensus 306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 385 (453)
.....||.||||||++.+. .|+...|.||+||+||||+.|+.||....++.. | +.+.+. .+....
T Consensus 343 --~~~rvGT~GYMAPEvl~ne--~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk------~--eEvdrr---~~~~~~ 407 (591)
T KOG0986|consen 343 --IRGRVGTVGYMAPEVLQNE--VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK------R--EEVDRR---TLEDPE 407 (591)
T ss_pred --cccccCcccccCHHHHcCC--cccCCccHHHHHhHHHHHHcccCchhhhhhhhh------H--HHHHHH---Hhcchh
Confidence 3455899999999999875 699999999999999999999999976544321 1 111111 011122
Q ss_pred hhHHHHHHHHHHHHHHhcccCCCCCCC
Q 048517 386 EIESMIARKLCMIGLWCIQVKAADRPS 412 (453)
Q Consensus 386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs 412 (453)
+.++..+++...+....|+.||++|--
T Consensus 408 ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 408 EYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred hcccccCHHHHHHHHHHHccCHHHhcc
Confidence 344556677788888889999999863
No 345
>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1. Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto
Probab=99.97 E-value=5.1e-31 Score=254.19 Aligned_cols=232 Identities=22% Similarity=0.314 Sum_probs=177.1
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC----HHHHHH---------------HHhcccccCcceEEEEE
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS----AEEFIN---------------ELLGLCSEGFKRALVYE 222 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~----~~~~i~---------------el~g~~~~~~~~~lv~E 222 (453)
|.+.+.||+|+||.||+|+.. +|+.||+|++..+... .+.+.. ++++++..+...+++||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 556788999999999999965 7999999998763221 112222 24556677778999999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 302 (453)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 83 YAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 9999999998843 24799999999999999999999998 9999999999999999999999999999865433
Q ss_pred CCc------------------eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccccc
Q 048517 303 NDF------------------VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY 364 (453)
Q Consensus 303 ~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~ 364 (453)
... .......++..|+|||.+... ..+.++||||||++++++++|+.|+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----- 228 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGKPPFRGSNEY----- 228 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCC--CCChhhhHHHHHHHHHHHHhCCCCCCCccHH-----
Confidence 211 111233578899999988764 6888999999999999999999998754311
Q ss_pred chHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 048517 365 FPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSM----TKVLE 418 (453)
Q Consensus 365 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~----~evl~ 418 (453)
........... . .+..++..+.+++.+||+.+|++|||+ +++++
T Consensus 229 ---~~~~~~~~~~~-~------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 ---LTFQKILKLEY-S------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ---HHHHHHHhcCC-C------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11122211111 1 112235678999999999999999999 66653
No 346
>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3. Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co
Probab=99.97 E-value=1.3e-30 Score=257.01 Aligned_cols=228 Identities=28% Similarity=0.366 Sum_probs=170.6
Q ss_pred hhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC----HHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517 165 FTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS----AEEFINE--------------LLGLCSEGFKRALVYEYMP 225 (453)
Q Consensus 165 ~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~----~~~~i~e--------------l~g~~~~~~~~~lv~E~~~ 225 (453)
..++||+|+||.||+|+. .+|+.||+|.+...... ..++..| +.+++..+...++||||+.
T Consensus 25 ~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 104 (313)
T cd06633 25 GLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL 104 (313)
T ss_pred cceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC
Confidence 346799999999999995 47899999998753221 1233333 3456667778899999995
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 305 (453)
|++.+.+.. ....+++.++..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 105 -~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~--- 174 (313)
T cd06633 105 -GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA--- 174 (313)
T ss_pred -CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC---
Confidence 577776632 235689999999999999999999998 9999999999999999999999999998643221
Q ss_pred eeecccCCCCCccChhhhcc-cCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517 306 VSISDTRGTIGYLAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384 (453)
Q Consensus 306 ~~~~~~~gt~~y~aPE~~~~-~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 384 (453)
....|+..|+|||++.. ..+.++.++||||||+++|||++|+.|+....... ...... .......
T Consensus 175 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~-------~~~~~~-~~~~~~~--- 240 (313)
T cd06633 175 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIA-QNDSPTL--- 240 (313)
T ss_pred ---CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHH-hcCCCCC---
Confidence 23468899999999853 12468889999999999999999999986543211 111111 1111111
Q ss_pred hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.....+..+.+++.+||+.+|++||++.+++.
T Consensus 241 --~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 241 --QSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred --CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11123356888999999999999999999985
No 347
>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]
Probab=99.97 E-value=1e-30 Score=251.90 Aligned_cols=240 Identities=25% Similarity=0.338 Sum_probs=183.7
Q ss_pred hhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH------HH------------HHHHHhcccccCcceEEEEEec
Q 048517 164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA------EE------------FINELLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~------~~------------~i~el~g~~~~~~~~~lv~E~~ 224 (453)
++.+.||.|.-|+||++++. ++..+|+|++.+..... -+ |+-.|+..++..+..+|+||||
T Consensus 80 ~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyC 159 (459)
T KOG0610|consen 80 RLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYC 159 (459)
T ss_pred HHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecC
Confidence 44578999999999999977 46899999998742221 11 2223788888899999999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCC-
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN- 303 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~- 303 (453)
+||+|...++ ++.+..++...+.-++.+++-||+|||-. +||.|||||+|||+.++|++-|+||.|+..+...-
T Consensus 160 pGGdL~~Lrq--kQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 160 PGGDLHSLRQ--KQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred CCccHHHHHh--hCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 9999987664 45668899999999999999999999987 99999999999999999999999999975432100
Q ss_pred --------------------------------Cc---------------------eeecccCCCCCccChhhhcccCCCC
Q 048517 304 --------------------------------DF---------------------VSISDTRGTIGYLAPELISRNFGTV 330 (453)
Q Consensus 304 --------------------------------~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 330 (453)
.. .......||-.|+|||++.+. .-
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~--GH 312 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE--GH 312 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC--CC
Confidence 00 001123589999999999986 67
Q ss_pred CccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCC
Q 048517 331 SCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADR 410 (453)
Q Consensus 331 s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R 410 (453)
+.++|+|+||++||||+.|+.||.....+. . ....+.+. .... .....+..+.+|++..|..||.+|
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~---T----l~NIv~~~--l~Fp----~~~~vs~~akDLIr~LLvKdP~kR 379 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKE---T----LRNIVGQP--LKFP----EEPEVSSAAKDLIRKLLVKDPSKR 379 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchh---h----HHHHhcCC--CcCC----CCCcchhHHHHHHHHHhccChhhh
Confidence 889999999999999999999998765432 1 22222221 1111 111455678899999999999999
Q ss_pred CC----HHHHHH--HHhCC
Q 048517 411 PS----MTKVLE--MLEGS 423 (453)
Q Consensus 411 Ps----~~evl~--~Le~~ 423 (453)
.- +.||-+ +++|.
T Consensus 380 lg~~rGA~eIK~HpFF~gV 398 (459)
T KOG0610|consen 380 LGSKRGAAEIKRHPFFEGV 398 (459)
T ss_pred hccccchHHhhcCccccCC
Confidence 98 777765 45553
No 348
>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and
Probab=99.97 E-value=5.6e-31 Score=261.14 Aligned_cols=251 Identities=22% Similarity=0.251 Sum_probs=178.8
Q ss_pred hhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC---CCHHHHHHH--------------HhcccccCc-----ceEE
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK---FSAEEFINE--------------LLGLCSEGF-----KRAL 219 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~i~e--------------l~g~~~~~~-----~~~l 219 (453)
|.+.+.||+|+||.||+|+.. +|+.||||.+.... ...+.+..| +.+++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 566789999999999999965 58999999887632 122233333 455555543 6899
Q ss_pred EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517 220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 299 (453)
+|||++ ++|.+++.. ...+++..+..++.+++.||+|||+. +|+|+||||+|||++.++.++|+|||++...
T Consensus 82 v~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 82 VTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred Eecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 999997 578887732 24799999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCC-ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc---------c-----
Q 048517 300 PKEND-FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA---------Y----- 364 (453)
Q Consensus 300 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~---------~----- 364 (453)
..... ........+|..|+|||.+.+. ..++.++|+||+|+++++|++|+.||.......... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred cccccccccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 54321 0112344678899999998764 268899999999999999999999986543211000 0
Q ss_pred --chHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhC
Q 048517 365 --FPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM--LEG 422 (453)
Q Consensus 365 --~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--Le~ 422 (453)
......+.+.....................+.+++.+||+.+|++|||+.++++. +++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 0000000000000000000001112245678999999999999999999999983 554
No 349
>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the
Probab=99.97 E-value=1.2e-30 Score=252.09 Aligned_cols=245 Identities=24% Similarity=0.304 Sum_probs=176.4
Q ss_pred hhhcccCccCceEEEEEEEc-CCcEEEEEEecCCC---CCHHHHHHH--------------HhcccccCcceEEEEEecC
Q 048517 164 HFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSK---FSAEEFINE--------------LLGLCSEGFKRALVYEYMP 225 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~---~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~ 225 (453)
.+.++||+|+||.||+|+.. +++.||+|++.... ...+.+..| +.+++......++|+||++
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 35578999999999999965 69999999988642 112222222 5677777788999999997
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 305 (453)
++|.+++.... ..+++..+..++.+++.||+|||+. +|+|+||+|+||++++++.+||+|||+++.......
T Consensus 82 -~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 82 -MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred -cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 58999885321 4689999999999999999999998 999999999999999999999999999987644322
Q ss_pred eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccccc-------chHHHHHHhhhC--
Q 048517 306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-------FPSWVYDQLNKG-- 376 (453)
Q Consensus 306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~-------~~~~~~~~l~~~-- 376 (453)
......++..|+|||.+.+. ..++.++||||||++++||++|+.|+........... .....+......
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred -ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 12234467789999998653 3678899999999999999999998865432110000 000000000000
Q ss_pred --CCcc---ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 377 --GDLE---LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 377 --~~~~---~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.... ..............+.+++.+||+.+|++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000 00000111123567999999999999999999999975
No 350
>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi
Probab=99.97 E-value=9.6e-31 Score=261.24 Aligned_cols=248 Identities=19% Similarity=0.234 Sum_probs=169.7
Q ss_pred HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC-HHHHHHH--------------Hhccccc-----------
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS-AEEFINE--------------LLGLCSE----------- 213 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~-~~~~i~e--------------l~g~~~~----------- 213 (453)
.+|.+.+.||.|+||.||+|.. .+|+.||+|.+...... .+.+.+| +++++..
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 3456678999999999999985 57899999998664332 2223222 3333222
Q ss_pred ---CcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc-CCCceE
Q 048517 214 ---GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPK 289 (453)
Q Consensus 214 ---~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~-~~~~~k 289 (453)
....++|+||++ ++|.+++. ...+++..+..++.|++.||.|||+. +|+||||||+||+++ .+..+|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence 234689999997 58877762 23588999999999999999999998 999999999999997 466789
Q ss_pred EEecCCccccCCCCCce-eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccccc----
Q 048517 290 VSDFGLAKFHPKENDFV-SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY---- 364 (453)
Q Consensus 290 l~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~---- 364 (453)
++|||+++......... ......++..|+|||.+.+. ..++.++|||||||++|||++|+.||...........
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999997653321111 11223578899999987542 3578899999999999999999999964432110000
Q ss_pred -----------chHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 365 -----------FPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 365 -----------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
+..........................+..+.+++.+||+.||++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000000000000000000111234467889999999999999999999985
No 351
>PHA03210 serine/threonine kinase US3; Provisional
Probab=99.97 E-value=1.9e-31 Score=279.24 Aligned_cols=253 Identities=18% Similarity=0.221 Sum_probs=164.0
Q ss_pred HHhhhhhcccCccCceEEEEEEEc--CCcEEEEE------------------EecCCCCCHHHHHHH-------------
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQLH--TGRLIAVK------------------MMENSKFSAEEFINE------------- 206 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~~~--~g~~VAVK------------------~l~~~~~~~~~~i~e------------- 206 (453)
...|.+.++||+|+||+||++..+ ++..+++| .+.........+.+|
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 346777899999999999998754 22222222 111111112223333
Q ss_pred -HhcccccCcceEEEEEecCCCChhhhhhhccCC-CCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC
Q 048517 207 -LLGLCSEGFKRALVYEYMPNGSLDRHIFSKENK-GQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH 284 (453)
Q Consensus 207 -l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~ 284 (453)
+++++......++++|++ .++|.+++...... .......++..|+.|++.||+|||+. +|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence 556666777789999998 45777776432211 12234556778999999999999998 9999999999999999
Q ss_pred CCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCC-CCCCccccccc
Q 048517 285 NFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNATRSSKA 363 (453)
Q Consensus 285 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p-~~~~~~~~~~~ 363 (453)
++.+||+|||+++........ ......||..|+|||++.+. .++.++|||||||++|||++|+.+ +..........
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGD--GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 999999999999876543221 11335699999999999764 789999999999999999998754 33221110000
Q ss_pred -------------cch---HHHHHHhhhCCCcccc-chhh--hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 364 -------------YFP---SWVYDQLNKGGDLELR-NVTE--IESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 364 -------------~~~---~~~~~~l~~~~~~~~~-~~~~--~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
.++ ....+.+......... .... ........+.+++.+||+.||++|||+.|+++.
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 0111111111000000 0000 001123456778999999999999999999873
No 352
>PTZ00024 cyclin-dependent protein kinase; Provisional
Probab=99.97 E-value=5.9e-31 Score=261.74 Aligned_cols=241 Identities=21% Similarity=0.272 Sum_probs=173.0
Q ss_pred hhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH---------------HHHHHH--------------HhcccccC
Q 048517 165 FTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA---------------EEFINE--------------LLGLCSEG 214 (453)
Q Consensus 165 ~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~---------------~~~i~e--------------l~g~~~~~ 214 (453)
+.+.||+|+||.||+|... +++.||||.+....... ..+..| +++++..+
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 4467999999999999954 79999999886532211 012232 45666677
Q ss_pred cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecC
Q 048517 215 FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG 294 (453)
Q Consensus 215 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG 294 (453)
...+++|||+. |+|.+++.. ...+++.....++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCcc
Confidence 78899999996 688888732 34689999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCC------------ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc
Q 048517 295 LAKFHPKEND------------FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK 362 (453)
Q Consensus 295 la~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~ 362 (453)
+++....... ........++..|+|||.+.+. ..++.++||||+|++++||++|+.|+........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~- 242 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ- 242 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 9986541110 0111234568899999998653 3578899999999999999999999865432110
Q ss_pred ccchHHHHHHhhhCCCc-----------------cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 363 AYFPSWVYDQLNKGGDL-----------------ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 363 ~~~~~~~~~~l~~~~~~-----------------~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
...+...+...... ............+..+.+++.+||+.+|++|||+.+++.
T Consensus 243 ---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 243 ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred ---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 00111111100000 000000111223467889999999999999999999987
No 353
>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.97 E-value=2.4e-31 Score=248.57 Aligned_cols=222 Identities=25% Similarity=0.359 Sum_probs=175.6
Q ss_pred hhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCC------------------HHHHHHHHhcccccCcceEEEEEec
Q 048517 164 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS------------------AEEFINELLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~------------------~~~~i~el~g~~~~~~~~~lv~E~~ 224 (453)
.|.+.||+|.||.|.+++ ..+|+.+|+|++++.-.- .+.|+..|--.++.+.++++||||.
T Consensus 171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeya 250 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYA 250 (516)
T ss_pred hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEc
Confidence 467899999999999999 558999999999874221 1234555666677888999999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
.||.|.-+|. ....++.....-+-.+|+.||.|||++ +||.||+|.+|.|||.+|++||+||||++-.-....
T Consensus 251 nGGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 251 NGGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred cCceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence 9999998883 346789999999999999999999998 999999999999999999999999999985432222
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 384 (453)
.+...+|||.|+|||++..+ .|..+.|.|.+||++|||+.|+.||....... ..+.+.-. +
T Consensus 324 --t~kTFCGTPEYLAPEVleDn--DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k--------LFeLIl~e---d---- 384 (516)
T KOG0690|consen 324 --TTKTFCGTPEYLAPEVLEDN--DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK--------LFELILME---D---- 384 (516)
T ss_pred --eeccccCChhhcCchhhccc--cccceeehhhhhHHHHHHHhccCcccccchhH--------HHHHHHhh---h----
Confidence 34677999999999999875 88999999999999999999999997544321 11211111 1
Q ss_pred hhhHHHHHHHHHHHHHHhcccCCCCCC
Q 048517 385 TEIESMIARKLCMIGLWCIQVKAADRP 411 (453)
Q Consensus 385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RP 411 (453)
...+..++.+...++.-.|..||.+|-
T Consensus 385 ~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 385 LKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 113334445566777888899999997
No 354
>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co
Probab=99.97 E-value=1e-30 Score=259.87 Aligned_cols=247 Identities=21% Similarity=0.232 Sum_probs=168.9
Q ss_pred hhhhcccCccCceEEEEEEEc-C--CcEEEEEEecCCC---CCHHHHHHH---------------Hhccc----ccCcce
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH-T--GRLIAVKMMENSK---FSAEEFINE---------------LLGLC----SEGFKR 217 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~-~--g~~VAVK~l~~~~---~~~~~~i~e---------------l~g~~----~~~~~~ 217 (453)
+.+.+.||+|+||.||+++.. + ++.||||.+.... .....++.| +++.+ ......
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 456788999999999999954 4 7899999886521 112233333 12211 112346
Q ss_pred EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517 218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297 (453)
Q Consensus 218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 297 (453)
++++||+. ++|.+.+. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 82 ~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 82 YLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 78888885 68888773 235689999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCc--eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc--------ccchH
Q 048517 298 FHPKENDF--VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK--------AYFPS 367 (453)
Q Consensus 298 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~--------~~~~~ 367 (453)
........ .......||..|+|||.+.+. ..++.++||||+|+++++|++|+.||........- .....
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 65432211 111234689999999987652 36789999999999999999999998653311000 00000
Q ss_pred HHHH--------HhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 368 WVYD--------QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 368 ~~~~--------~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
+... .......................+.+++.+|++.+|++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 00000000000000011112457889999999999999999999876
No 355
>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]
Probab=99.97 E-value=4.6e-32 Score=248.26 Aligned_cols=234 Identities=23% Similarity=0.324 Sum_probs=168.8
Q ss_pred hhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC--HHHHHHH---------------HhcccccCcceEEEEEecCC
Q 048517 165 FTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 165 ~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
+...||.|..|.|++++.. +|+.+|||.+...... .++.+.. .+|++-.+...++.||.|.
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs- 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS- 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence 3467999999999999955 6899999998764322 2233322 3444444444555566652
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
--+++.+.. ...++++..+-++...+++||.||-.+ .+|+|||+||+|||+|+.|++|++|||++-..-...
T Consensus 175 ~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--- 246 (391)
T KOG0983|consen 175 TCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--- 246 (391)
T ss_pred HHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccc---
Confidence 223333321 235577777788999999999999987 599999999999999999999999999987553322
Q ss_pred eecccCCCCCccChhhhccc-CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517 307 SISDTRGTIGYLAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~-~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 385 (453)
..+...|-+.|||||.+.-+ ...|..++||||||+.|+||.||+.||.....+ |. +...+.+.....+.
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-----Fe--~ltkvln~ePP~L~--- 316 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-----FE--VLTKVLNEEPPLLP--- 316 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-----HH--HHHHHHhcCCCCCC---
Confidence 12345688899999999754 457888999999999999999999999875432 11 22222222221111
Q ss_pred hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.....+..++++...||+.|+.+||...++++
T Consensus 317 -~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 317 -GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred -cccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 22226788999999999999999999998876
No 356
>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12
Probab=99.97 E-value=1.6e-30 Score=259.82 Aligned_cols=247 Identities=20% Similarity=0.257 Sum_probs=172.9
Q ss_pred hhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCC---HHHHHHH--------------HhcccccCc------ce
Q 048517 162 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSEGF------KR 217 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~~~------~~ 217 (453)
+|.+.+.||+|+||.||++. ..+|+.||||++...... .+.+..| +++.+.... ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF 95 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence 45667889999999999998 457999999998653221 2233333 233333222 35
Q ss_pred EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517 218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297 (453)
Q Consensus 218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 297 (453)
++||||+ +++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 96 ~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 96 YLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred EEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 8999998 778887763 24689999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc-------ccchHHHH
Q 048517 298 FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-------AYFPSWVY 370 (453)
Q Consensus 298 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~-------~~~~~~~~ 370 (453)
...... ....+++.|+|||.+.+. ..++.++|+||+|+++++|++|+.||......... ...+....
T Consensus 167 ~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 167 QTDSEM-----TGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240 (343)
T ss_pred ccccCc-----cccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 653321 234578899999998753 35788999999999999999999998644321000 00000000
Q ss_pred HHhhhC---------CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhCC
Q 048517 371 DQLNKG---------GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEGS 423 (453)
Q Consensus 371 ~~l~~~---------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~~ 423 (453)
+.+... ..................+.+++.+|++.||++|||+.++++ .++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 000000 000000000011233456889999999999999999999994 55544
No 357
>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13
Probab=99.97 E-value=1.5e-30 Score=259.89 Aligned_cols=244 Identities=22% Similarity=0.306 Sum_probs=169.2
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCC---CCHHHHHHH--------------HhcccccC------cceE
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSK---FSAEEFINE--------------LLGLCSEG------FKRA 218 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~---~~~~~~i~e--------------l~g~~~~~------~~~~ 218 (453)
+...+.||+|+||.||+|+. .+|+.||||++.... .....+..| +++++... ...+
T Consensus 17 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 96 (342)
T cd07879 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFY 96 (342)
T ss_pred eEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEE
Confidence 44457899999999999995 579999999986521 112223333 34444322 3458
Q ss_pred EEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517 219 LVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298 (453)
Q Consensus 219 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 298 (453)
+|+||+.. +|..++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 97 lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 97 LVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred EEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 99999964 665543 23589999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc--------ccchHHHH
Q 048517 299 HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK--------AYFPSWVY 370 (453)
Q Consensus 299 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~ 370 (453)
..... ....+|..|+|||.+.+. ..++.++||||||+++|||++|+.||........- ..-+.+ .
T Consensus 167 ~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~ 239 (342)
T cd07879 167 ADAEM-----TGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF-V 239 (342)
T ss_pred CCCCC-----CCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH-H
Confidence 53321 234578899999998652 35788999999999999999999999753211000 000000 0
Q ss_pred HHhhhC---------CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhCC
Q 048517 371 DQLNKG---------GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEGS 423 (453)
Q Consensus 371 ~~l~~~---------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~~ 423 (453)
+.+... ...............+..+.+++.+||+.||++||+++++++ .+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000000 000000000001123456889999999999999999999995 46654
No 358
>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins. Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic
Probab=99.97 E-value=1.7e-30 Score=254.79 Aligned_cols=249 Identities=24% Similarity=0.264 Sum_probs=169.2
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCC---HHHHHHH--------------Hhccccc--------Cc
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSE--------GF 215 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~--------~~ 215 (453)
.|.+.++||+|+||.||+|+.. +++.||||++...... ...+.+| +++++.. ..
T Consensus 9 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 88 (311)
T cd07866 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG 88 (311)
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence 4566789999999999999954 6899999988542211 1122222 3333322 23
Q ss_pred ceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCC
Q 048517 216 KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL 295 (453)
Q Consensus 216 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl 295 (453)
..++|+||+.+ +|...+.. ....+++.++..++.|+++||+|||+. +|+|+||||+||+++.++.+||+|||+
T Consensus 89 ~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 89 SVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred eEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence 46899999964 66665532 235699999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCce---------eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccccc--
Q 048517 296 AKFHPKENDFV---------SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-- 364 (453)
Q Consensus 296 a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~-- 364 (453)
++......... ..+...+++.|+|||.+.+. ..++.++||||||++++||++|++||...........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 98654322111 11233568889999988653 3578899999999999999999999865432110000
Q ss_pred -----chHHHHH---HhhhCC--Ccccc---chhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 365 -----FPSWVYD---QLNKGG--DLELR---NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 365 -----~~~~~~~---~l~~~~--~~~~~---~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
...+.+. .+.... ..... ............+.+++.+||+.+|++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000 000000 00000 000011122356889999999999999999999875
No 359
>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the
Probab=99.97 E-value=3.9e-30 Score=244.03 Aligned_cols=221 Identities=30% Similarity=0.389 Sum_probs=171.7
Q ss_pred cCccCceEEEEEEEc-CCcEEEEEEecCCCCC----HHHHHHH--------------HhcccccCcceEEEEEecCCCCh
Q 048517 169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS----AEEFINE--------------LLGLCSEGFKRALVYEYMPNGSL 229 (453)
Q Consensus 169 LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~----~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL 229 (453)
||+|+||.||++... +++.+|+|.+...... .+++..| +++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999965 6899999998764321 2223222 46667778889999999999999
Q ss_pred hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeec
Q 048517 230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 309 (453)
Q Consensus 230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 309 (453)
.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~ 151 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTN 151 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC--ccc
Confidence 9988432 3689999999999999999999997 999999999999999999999999999987644321 224
Q ss_pred ccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHH
Q 048517 310 DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 389 (453)
Q Consensus 310 ~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 389 (453)
...++..|+|||.+.+. ..+.++|+||||+++|||++|+.|+..... ......+... ... .+.
T Consensus 152 ~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~-~~~------~~~ 214 (250)
T cd05123 152 TFCGTPEYLAPEVLLGK--GYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILKD-PLR------FPE 214 (250)
T ss_pred CCcCCccccChHHhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhcC-CCC------CCC
Confidence 45688899999998764 578899999999999999999999864432 1112222221 111 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHH
Q 048517 390 MIARKLCMIGLWCIQVKAADRPSMTK 415 (453)
Q Consensus 390 ~~~~~l~~l~~~Cl~~~p~~RPs~~e 415 (453)
..+..+.+++.+||+.+|++||++.+
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 22467889999999999999999955
No 360
>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins. Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha
Probab=99.97 E-value=8e-31 Score=248.04 Aligned_cols=211 Identities=19% Similarity=0.140 Sum_probs=162.3
Q ss_pred cCceEEEEEEE-cCCcEEEEEEecCCCCCHHH----------HHHHHhcccccCcceEEEEEecCCCChhhhhhhccCCC
Q 048517 172 GGFGSVYKGQL-HTGRLIAVKMMENSKFSAEE----------FINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKG 240 (453)
Q Consensus 172 G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~----------~i~el~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~ 240 (453)
|.||.||+++. .+|+.+|+|++........+ .+..+++++......+++|||+++|+|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---- 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF---- 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh----
Confidence 89999999995 57899999999764322211 1222566677778899999999999999988432
Q ss_pred CCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccCh
Q 048517 241 QTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAP 320 (453)
Q Consensus 241 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 320 (453)
..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++++|||.+....... ....++..|+||
T Consensus 80 ~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~aP 151 (237)
T cd05576 80 LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYCAP 151 (237)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccccCC
Confidence 3589999999999999999999998 99999999999999999999999999886553321 234467789999
Q ss_pred hhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHH
Q 048517 321 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGL 400 (453)
Q Consensus 321 E~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~ 400 (453)
|.+... .++.++||||+|++++||++|+.++...... ........ .+..++..+..++.
T Consensus 152 E~~~~~--~~~~~~DvwslG~il~el~~g~~~~~~~~~~-------------~~~~~~~~------~~~~~~~~~~~li~ 210 (237)
T cd05576 152 EVGGIS--EETEACDWWSLGAILFELLTGKTLVECHPSG-------------INTHTTLN------IPEWVSEEARSLLQ 210 (237)
T ss_pred cccCCC--CCCchhhHHHHHHHHHHHHHCcchhhcCchh-------------cccccccC------CcccCCHHHHHHHH
Confidence 988653 6788999999999999999999876432110 00000111 12234567889999
Q ss_pred HhcccCCCCCCCHHH
Q 048517 401 WCIQVKAADRPSMTK 415 (453)
Q Consensus 401 ~Cl~~~p~~RPs~~e 415 (453)
+|++.||++||++.+
T Consensus 211 ~~l~~dp~~R~~~~~ 225 (237)
T cd05576 211 QLLQFNPTERLGAGV 225 (237)
T ss_pred HHccCCHHHhcCCCc
Confidence 999999999999743
No 361
>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]
Probab=99.97 E-value=1.9e-31 Score=268.77 Aligned_cols=230 Identities=24% Similarity=0.363 Sum_probs=177.7
Q ss_pred hhhcccCccCceEEEEEEEc-CCcEEE---EEEecCCCC--CHHHHHHH--------------Hhccccc--CcceEEEE
Q 048517 164 HFTHKLGQGGFGSVYKGQLH-TGRLIA---VKMMENSKF--SAEEFINE--------------LLGLCSE--GFKRALVY 221 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~~-~g~~VA---VK~l~~~~~--~~~~~i~e--------------l~g~~~~--~~~~~lv~ 221 (453)
.|...||+|+|=+||+|... +|..|| ||.-+..+. ..++|..| ++..+.+ +....+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 35678999999999999854 677776 332222222 23555555 2333322 23366899
Q ss_pred EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-CCceEEEecCCccccC
Q 048517 222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHP 300 (453)
Q Consensus 222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~ 300 (453)
|.|..|+|..|+.. .+..+...+..++.||++||.|||++ +++|+|||||.+||+++. -|.+||+|+|||.+..
T Consensus 123 EL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999999843 35678889999999999999999996 789999999999999986 4899999999999876
Q ss_pred CCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCcc
Q 048517 301 KENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 380 (453)
Q Consensus 301 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 380 (453)
.... ....|||.|||||++.. .|....|||||||.++||+|+..|+. +..-++-+|+.+..|....
T Consensus 198 ~s~a----ksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYs-------EC~n~AQIYKKV~SGiKP~ 263 (632)
T KOG0584|consen 198 KSHA----KSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYS-------ECTNPAQIYKKVTSGIKPA 263 (632)
T ss_pred cccc----ceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChh-------hhCCHHHHHHHHHcCCCHH
Confidence 5432 33679999999999974 68999999999999999999999985 3334556787777665432
Q ss_pred ccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 381 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 381 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
. ...--...+.+++..||.. ..+|||+.|+++
T Consensus 264 s-----l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 264 A-----LSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred H-----hhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1 1222235688999999999 999999999987
No 362
>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho
Probab=99.97 E-value=2.4e-30 Score=248.30 Aligned_cols=233 Identities=24% Similarity=0.277 Sum_probs=171.3
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCC------CHHHHHHH--------------Hhccccc--CcceEE
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF------SAEEFINE--------------LLGLCSE--GFKRAL 219 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~------~~~~~i~e--------------l~g~~~~--~~~~~l 219 (453)
+.+.+.||+|+||.||+|.. .+|+.||+|.+..... ....+..| +++++.. ....++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 55678999999999999985 4699999998754211 11223222 2333333 345789
Q ss_pred EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517 220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 299 (453)
++||+++++|.+++... ..+++..+..++.+++.||.|||+. +++|+||||+||+++.++.++|+|||+++..
T Consensus 84 v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 84 FVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 99999999999988432 3578999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCC-ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517 300 PKEND-FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD 378 (453)
Q Consensus 300 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~ 378 (453)
..... ........++..|+|||.+.+. ..+.++|+||||++++||++|+.||...... .-+.+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~ 227 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGE--GYGRKADVWSVACTVVEMLTEKPPWAEYEAM-------AAIFKIATQPTK 227 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccCHH-------HHHHHHHcCCCC
Confidence 32110 0111234588999999998764 6789999999999999999999998643211 111111111111
Q ss_pred ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
. ..+..+.+.+.+++.+|++ +|..||+..+++.
T Consensus 228 ~------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 228 P------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred C------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1 1233455678999999999 5799999998765
No 363
>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK
Probab=99.97 E-value=2.4e-30 Score=258.41 Aligned_cols=242 Identities=20% Similarity=0.256 Sum_probs=171.2
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC---CHHHHHHH--------------HhcccccCc------ce
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSEGF------KR 217 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~~~------~~ 217 (453)
.|.+.+.||+|+||.||+|+.. +++.||||++..... ..+++..| +.+++.... ..
T Consensus 16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07851 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV 95 (343)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence 4556788999999999999965 688999999865321 11222222 333343333 37
Q ss_pred EEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517 218 ALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297 (453)
Q Consensus 218 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 297 (453)
++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+|+||||+||+++.++.+||+|||++.
T Consensus 96 ~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 96 YLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred EEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccccc
Confidence 8999998 6799887732 4689999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc--------cchHHH
Q 048517 298 FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA--------YFPSWV 369 (453)
Q Consensus 298 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~--------~~~~~~ 369 (453)
..... .....+|..|+|||.+.+. ...+.++||||||++++||++|+.||.......... ..+.+.
T Consensus 167 ~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 167 HTDDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred ccccc-----ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 65432 1334578899999998653 367889999999999999999999986433210000 000000
Q ss_pred HH--------HhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 370 YD--------QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 370 ~~--------~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.. .+..................+..+.+++.+||+.+|++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00 00000000000000111123567899999999999999999999976
No 364
>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]
Probab=99.97 E-value=1.1e-30 Score=276.74 Aligned_cols=237 Identities=22% Similarity=0.261 Sum_probs=181.5
Q ss_pred HhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecC---CCCCHH---------------HHHHHHhcccccCcceEEEE
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMEN---SKFSAE---------------EFINELLGLCSEGFKRALVY 221 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~---~~~~~~---------------~~i~el~g~~~~~~~~~lv~ 221 (453)
..+.+.+.||+|+||.|...+. .+++.+|+|++++ .+.... +++..|.--+++...+|+||
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence 3455678999999999999995 5789999999987 222222 34444666678889999999
Q ss_pred EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517 222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 301 (453)
Q Consensus 222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 301 (453)
|||+||+|-..+. +...++.+.+.-++.+|.-||.-||+- ++|||||||+|||||..|++||+|||.+-.+..
T Consensus 155 dY~pGGDlltLlS----k~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLS----KFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred ecccCchHHHHHh----hcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 9999999988883 223688999999999999999999997 999999999999999999999999999987776
Q ss_pred CCCceeecccCCCCCccChhhhccc--C-CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC-C
Q 048517 302 ENDFVSISDTRGTIGYLAPELISRN--F-GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG-G 377 (453)
Q Consensus 302 ~~~~~~~~~~~gt~~y~aPE~~~~~--~-~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~-~ 377 (453)
++... .....|||-|++||++... . |.|...+|.||+||++|||+.|..||...+-- ..|..+... .
T Consensus 228 dG~V~-s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv--------eTY~KIm~hk~ 298 (1317)
T KOG0612|consen 228 DGTVR-SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV--------ETYGKIMNHKE 298 (1317)
T ss_pred CCcEE-eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH--------HHHHHHhchhh
Confidence 66543 4678899999999998642 2 57889999999999999999999999643311 123333222 2
Q ss_pred CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 048517 378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS---MTKVLE 418 (453)
Q Consensus 378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---~~evl~ 418 (453)
.+.++. ..+++....+++.+.+. +|+.|-. ++++-.
T Consensus 299 ~l~FP~----~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 299 SLSFPD----ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred hcCCCc----ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 222221 12255666677776654 7788877 777654
No 365
>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.97 E-value=6.1e-31 Score=252.45 Aligned_cols=229 Identities=24% Similarity=0.331 Sum_probs=182.1
Q ss_pred HHHHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC-------------------CHHHHHHHHhcccccCcc
Q 048517 157 EIIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF-------------------SAEEFINELLGLCSEGFK 216 (453)
Q Consensus 157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~-------------------~~~~~i~el~g~~~~~~~ 216 (453)
.+.....+|...||+|+||.|.++.-+ +.+.+|||+|+++-. ....|+..|..+++.-++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 444455688899999999999999855 567899999876311 112466778888888899
Q ss_pred eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517 217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA 296 (453)
Q Consensus 217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 296 (453)
+++||||+.+|+|--++. .-..+.++.+.-+|.+||-||-+||++ +|+.||||..|||||.++++||+|||++
T Consensus 425 LyFVMEyvnGGDLMyhiQ----Q~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQ----QVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eeeEEEEecCchhhhHHH----HhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence 999999999999988883 335688889999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517 297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG 376 (453)
Q Consensus 297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~ 376 (453)
+-.--+. ..+.+..|||.|+|||.+.- .+|...+|.|||||+||||+.|++||+...+.+ +...+.+.
T Consensus 498 KEni~~~--~TTkTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e--------lF~aI~eh 565 (683)
T KOG0696|consen 498 KENIFDG--VTTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--------LFQAIMEH 565 (683)
T ss_pred cccccCC--cceeeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHHc
Confidence 8533222 23456789999999999874 488999999999999999999999998765432 23333332
Q ss_pred CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCC
Q 048517 377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRP 411 (453)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 411 (453)
.. ..+..++.+...+....|...|.+|-
T Consensus 566 nv-------syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 NV-------SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cC-------cCcccccHHHHHHHHHHhhcCCcccc
Confidence 22 14444566677778888888888885
No 366
>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U
Probab=99.97 E-value=2.6e-30 Score=256.67 Aligned_cols=242 Identities=21% Similarity=0.234 Sum_probs=170.5
Q ss_pred hhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCC---CCHHHHHHH--------------Hhcccc-cCcceEEEEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSK---FSAEEFINE--------------LLGLCS-EGFKRALVYE 222 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~---~~~~~~i~e--------------l~g~~~-~~~~~~lv~E 222 (453)
.|.+.+.||+|+||.||++.. .+|+.||||.+.... ...+.+..| +.+++. .+...++++|
T Consensus 11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e 90 (328)
T cd07856 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE 90 (328)
T ss_pred ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence 455668999999999999984 489999999875421 122333333 334443 3556889999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 302 (453)
|+ +++|.+++. ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||+++.....
T Consensus 91 ~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 91 LL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred hh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence 98 568887763 24578888899999999999999998 9999999999999999999999999999754322
Q ss_pred CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccccc--------chHHHHHHhh
Q 048517 303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY--------FPSWVYDQLN 374 (453)
Q Consensus 303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~--------~~~~~~~~l~ 374 (453)
.....++..|+|||.+.+. ..++.++||||||++++||++|+.||........... ..++.. .+.
T Consensus 162 -----~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 234 (328)
T cd07856 162 -----MTGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN-TIC 234 (328)
T ss_pred -----cCCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH-hcc
Confidence 1234578899999987542 3678999999999999999999999865432110000 000000 000
Q ss_pred hCCC------ccccch---hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 375 KGGD------LELRNV---TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 375 ~~~~------~~~~~~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
.... ...... .......+..+.+++.+||+.+|++|||+.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 000000 00111234678999999999999999999999764
No 367
>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]
Probab=99.97 E-value=2.4e-32 Score=249.32 Aligned_cols=237 Identities=24% Similarity=0.309 Sum_probs=179.7
Q ss_pred cccCccCceEEEEEEE-cCCcEEEEEEecCCCC--CHHHH---------------HHHHhcccccCcceEEEEEecCCCC
Q 048517 167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKF--SAEEF---------------INELLGLCSEGFKRALVYEYMPNGS 228 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~--~~~~~---------------i~el~g~~~~~~~~~lv~E~~~~gs 228 (453)
..||.|+||+|+|-.. +.|+..|||++..... ...++ |.+++|.+-.+...++.||.| ..|
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DIS 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhh
Confidence 4699999999999884 5899999999876433 22333 334788887888899999999 567
Q ss_pred hhhhhhh-ccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517 229 LDRHIFS-KENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 307 (453)
Q Consensus 229 L~~~l~~-~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 307 (453)
|+.+... .......+++.-+-.|..-+.+||.||-.. ..|+|||+||+|||||..|.+||+|||++-..... ..
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S---iA 223 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS---IA 223 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHH---HH
Confidence 7654321 112346788888889999999999999976 58999999999999999999999999998654321 12
Q ss_pred ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc--hh
Q 048517 308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN--VT 385 (453)
Q Consensus 308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~--~~ 385 (453)
.+...|-..|||||.+......+..+|||||+|++|+|+.||+-|+..... +.+++.+....+.+. ..
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----------vfeql~~Vv~gdpp~l~~~ 293 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----------VFEQLCQVVIGDPPILLFD 293 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----------HHHHHHHHHcCCCCeecCc
Confidence 244568889999999987655689999999999999999999999864322 445554432222111 11
Q ss_pred hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
......+..|..++.-|+..|..+||+..++.++
T Consensus 294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1223467789999999999999999999988763
No 368
>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=99.97 E-value=5.9e-32 Score=289.50 Aligned_cols=234 Identities=29% Similarity=0.372 Sum_probs=176.7
Q ss_pred hcccCccCceEEEEEE-EcCCcEEEEEEecCCCCC---H-----HHHHHH---------HhcccccCcceEEEEEecCCC
Q 048517 166 THKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS---A-----EEFINE---------LLGLCSEGFKRALVYEYMPNG 227 (453)
Q Consensus 166 ~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~---~-----~~~i~e---------l~g~~~~~~~~~lv~E~~~~g 227 (453)
..+||.|.||.||-|. .++|...|||.+...... . +.-+.| .+|+-.+....+|-||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 3579999999999998 678999999977542111 1 111112 355556677788999999999
Q ss_pred ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCc--
Q 048517 228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF-- 305 (453)
Q Consensus 228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~-- 305 (453)
+|.+.+. .+...++.....+..|++.|++|||++ +||||||||.||+|+.+|.+|++|||.|.........
T Consensus 1320 sLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1320 SLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred cHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 9999883 334456666677889999999999998 9999999999999999999999999999876544211
Q ss_pred eeecccCCCCCccChhhhcccC-CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHH-HHHHhhhCCCccccc
Q 048517 306 VSISDTRGTIGYLAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW-VYDQLNKGGDLELRN 383 (453)
Q Consensus 306 ~~~~~~~gt~~y~aPE~~~~~~-~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-~~~~l~~~~~~~~~~ 383 (453)
.......||+.|||||++.+.. ..-..+.||||+|||++||+||++|+...+.. | ++-+...+....
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--------~aIMy~V~~gh~Pq--- 1461 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--------WAIMYHVAAGHKPQ--- 1461 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--------hHHHhHHhccCCCC---
Confidence 1234567999999999998743 23456899999999999999999999654321 2 222333333322
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 420 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 420 (453)
.+..++..-.+++.+||+.||++|.++.|+++.=
T Consensus 1462 ---~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1462 ---IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred ---CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 3334677788999999999999999998877643
No 369
>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14
Probab=99.97 E-value=5.1e-30 Score=256.35 Aligned_cols=249 Identities=21% Similarity=0.238 Sum_probs=170.2
Q ss_pred hHHHHHh--hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC---HHHHHHH--------------Hhccccc--
Q 048517 156 PEIIAVT--NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS---AEEFINE--------------LLGLCSE-- 213 (453)
Q Consensus 156 ~~~~~~~--~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~---~~~~i~e--------------l~g~~~~-- 213 (453)
+++...+ |...+.||+|+||.||+|.. .+|+.||+|++...... .+.+.+| +.+++..
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 3444443 34457899999999999984 57999999998753221 2333333 2222221
Q ss_pred ----CcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceE
Q 048517 214 ----GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPK 289 (453)
Q Consensus 214 ----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~k 289 (453)
....+++++++ +++|.+.+. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+|
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEE
Confidence 12356778776 788877663 23589999999999999999999998 999999999999999999999
Q ss_pred EEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc------
Q 048517 290 VSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA------ 363 (453)
Q Consensus 290 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~------ 363 (453)
|+|||+++..... .....+|..|+|||.+.+. ..++.++||||||++++||++|+.||..........
T Consensus 161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (345)
T cd07877 161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234 (345)
T ss_pred Eeccccccccccc-----ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999864332 1334678999999988652 367889999999999999999999986433211000
Q ss_pred -cchHHHHHHhhhC---------CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 364 -YFPSWVYDQLNKG---------GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 364 -~~~~~~~~~l~~~---------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
..+......+... ...............+..+.+++.+|++.+|++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000000000 0000000000000124568899999999999999999999873
No 370
>PLN03224 probable serine/threonine protein kinase; Provisional
Probab=99.97 E-value=9.9e-30 Score=262.96 Aligned_cols=246 Identities=20% Similarity=0.228 Sum_probs=164.7
Q ss_pred hhhhhcccCccCceEEEEEEE-----------------cCCcEEEEEEecCCCCC-HHHHH-------------------
Q 048517 162 TNHFTHKLGQGGFGSVYKGQL-----------------HTGRLIAVKMMENSKFS-AEEFI------------------- 204 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~-----------------~~g~~VAVK~l~~~~~~-~~~~i------------------- 204 (453)
.+.+.++||+|+||+||+|.+ .+++.||||.+...... .++|+
T Consensus 146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~ 225 (507)
T PLN03224 146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM 225 (507)
T ss_pred CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence 445668999999999999964 24568999998653221 11221
Q ss_pred --------------HHHhccccc--------CcceEEEEEecCCCChhhhhhhccC--------------------CCCC
Q 048517 205 --------------NELLGLCSE--------GFKRALVYEYMPNGSLDRHIFSKEN--------------------KGQT 242 (453)
Q Consensus 205 --------------~el~g~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~~--------------------~~~~ 242 (453)
.+++++|.. ....+|||||+++|+|.++++.... ....
T Consensus 226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~ 305 (507)
T PLN03224 226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK 305 (507)
T ss_pred HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence 123444432 3457899999999999999864321 1124
Q ss_pred CCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhh
Q 048517 243 FGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPEL 322 (453)
Q Consensus 243 l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 322 (453)
++|..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++........ ......+|+.|+|||.
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEE 381 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChhh
Confidence 56788999999999999999998 9999999999999999999999999999765432221 1122345889999998
Q ss_pred hcccCC--------------------CCCccchHHHHHHHHHHHHcCCC-CCCCCcccc-----ccccchHHHHHHhhhC
Q 048517 323 ISRNFG--------------------TVSCKSDVYGFGMVLLEMAGGRR-NSNMNATRS-----SKAYFPSWVYDQLNKG 376 (453)
Q Consensus 323 ~~~~~~--------------------~~s~k~DV~S~Gvvl~elltg~~-p~~~~~~~~-----~~~~~~~~~~~~l~~~ 376 (453)
+..... ....+.||||+||+++||++|.. |+....... .......|.. ...
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~---~~~ 458 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM---YKG 458 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh---hcc
Confidence 753210 11235799999999999999875 553211100 0011111211 111
Q ss_pred CCccccchhhhHHHHHHHHHHHHHHhcccCC---CCCCCHHHHHH
Q 048517 377 GDLELRNVTEIESMIARKLCMIGLWCIQVKA---ADRPSMTKVLE 418 (453)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p---~~RPs~~evl~ 418 (453)
...... .....+....+++.++|..+| .+|+|++|+++
T Consensus 459 ~~~~~~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QKYDFS----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cCCCcc----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 111111 122234567888999998765 68999999986
No 371
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=99.97 E-value=2.5e-30 Score=261.56 Aligned_cols=226 Identities=23% Similarity=0.290 Sum_probs=181.3
Q ss_pred hhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCH------------HHHHHHHhcccccCcceEEEEEecCCCC
Q 048517 162 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA------------EEFINELLGLCSEGFKRALVYEYMPNGS 228 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~------------~~~i~el~g~~~~~~~~~lv~E~~~~gs 228 (453)
.|.+...+|.|+|+.|-.+. ..+++..+||++....... ++.+.++.+.+.++...++|||.+.+|-
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~e 402 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGE 402 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccH
Confidence 35566789999999999988 5678999999998752211 2334457888889999999999999998
Q ss_pred hhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE-cCCCceEEEecCCccccCCCCCcee
Q 048517 229 LDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL-DHNFIPKVSDFGLAKFHPKENDFVS 307 (453)
Q Consensus 229 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl-~~~~~~kl~DFGla~~~~~~~~~~~ 307 (453)
+.+.+... ..+. .++..|+.+|+.++.|||++ ++||||+||+|||+ ++.++++|+|||.++.....
T Consensus 403 ll~ri~~~----~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----- 469 (612)
T KOG0603|consen 403 LLRRIRSK----PEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----- 469 (612)
T ss_pred HHHHHHhc----chhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-----
Confidence 88877433 2233 77888999999999999998 99999999999999 58899999999999876554
Q ss_pred ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhh
Q 048517 308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEI 387 (453)
Q Consensus 308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 387 (453)
....+-|..|.|||+.... .+++++|+||||++||+|++|+.|+...... ..++..+..+. .
T Consensus 470 ~~tp~~t~~y~APEvl~~~--~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~~~---------~ 531 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAIQ--EYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQMPK---------F 531 (612)
T ss_pred hcccchhhcccChhhhccC--CCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcCCc---------c
Confidence 2455788999999999854 8999999999999999999999999754332 11333333321 1
Q ss_pred HHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 388 ESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 388 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
...++....+|+.+|||.||.+||+|.++..
T Consensus 532 s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 532 SECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 2446677889999999999999999999876
No 372
>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]
Probab=99.97 E-value=4e-30 Score=262.20 Aligned_cols=249 Identities=27% Similarity=0.382 Sum_probs=178.4
Q ss_pred hhhcccCccCceEEEEEE-EcCCcEEEEEEecC--CCCCHHHHHHH--------------Hhccccc------CcceEEE
Q 048517 164 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMEN--SKFSAEEFINE--------------LLGLCSE------GFKRALV 220 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~--~~~~~~~~i~e--------------l~g~~~~------~~~~~lv 220 (453)
...+.||+||||.||+|+ ..+|+.||||.++. .....+....| +++.-.. .....++
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 345789999999999999 56899999999877 23344444333 2222222 2345799
Q ss_pred EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc----CCCceEEEecCCc
Q 048517 221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD----HNFIPKVSDFGLA 296 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~----~~~~~kl~DFGla 296 (453)
||||.+|||+..|.+.++ ...|+..+.+.++.+++.||.|||++ +|+||||||.||++- ..-.-||+|||.|
T Consensus 96 mEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 999999999999976654 46799999999999999999999998 999999999999993 3345799999999
Q ss_pred cccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517 297 KFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG 376 (453)
Q Consensus 297 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~ 376 (453)
+-...+.. .....||..|.+||.+.+. +.++..+|.|||||++||++||..||........ .....+..+.+.
T Consensus 172 rel~d~s~---~~S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~---~~~~~~~~~tkk 244 (732)
T KOG4250|consen 172 RELDDNSL---FTSLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIPFGGPKN---NKEIMWHIITKK 244 (732)
T ss_pred ccCCCCCe---eeeecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCcCCCccc---cchhhhhhhccC
Confidence 98876663 4567899999999999852 4789999999999999999999999976443211 111111111111
Q ss_pred -------------CCcc----ccchhhhHHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHhCC
Q 048517 377 -------------GDLE----LRNVTEIESMIARKLCMIGLWCIQVKAADRP--SMTKVLEMLEGS 423 (453)
Q Consensus 377 -------------~~~~----~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP--s~~evl~~Le~~ 423 (453)
.... ++............+......+|..+|++|- ...+....+.++
T Consensus 245 p~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 245 PSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred CCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 0111 0111123344555677777778888888887 554444444433
No 373
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=99.97 E-value=3.4e-30 Score=274.89 Aligned_cols=182 Identities=26% Similarity=0.366 Sum_probs=135.2
Q ss_pred eEEEEEecCCCChhhhhhhccCCCCCC-CchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCC
Q 048517 217 RALVYEYMPNGSLDRHIFSKENKGQTF-GLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL 295 (453)
Q Consensus 217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l-~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl 295 (453)
+|+=||||+.-++.+++.... .. .....++++.+|+.||.|+|++ +||||||||.||+||++..+||+|||+
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~----~~~~~d~~wrLFreIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGL 743 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNH----FNSQRDEAWRLFREILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGL 743 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcc----cchhhHHHHHHHHHHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeeccccc
Confidence 467799999988888774321 11 4677899999999999999998 999999999999999999999999999
Q ss_pred ccccC----------C------CCCceeecccCCCCCccChhhhcccCC-CCCccchHHHHHHHHHHHHcCCCCCCCCcc
Q 048517 296 AKFHP----------K------ENDFVSISDTRGTIGYLAPELISRNFG-TVSCKSDVYGFGMVLLEMAGGRRNSNMNAT 358 (453)
Q Consensus 296 a~~~~----------~------~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~s~k~DV~S~Gvvl~elltg~~p~~~~~~ 358 (453)
|.... . .......+...||.-|+|||++.+... .++.|+|+||+|++++||+. ||....+
T Consensus 744 At~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME 820 (1351)
T KOG1035|consen 744 ATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME 820 (1351)
T ss_pred chhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH
Confidence 98621 0 011112356679999999999987522 69999999999999999985 3543322
Q ss_pred ccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 359 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 359 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
+ ..+...+.++..... ..........=..++.|+++.||.+|||+.|++.
T Consensus 821 R-------a~iL~~LR~g~iP~~---~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 821 R-------ASILTNLRKGSIPEP---ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred H-------HHHHHhcccCCCCCC---cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 2 124455554433222 1122233344567999999999999999999875
No 374
>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.97 E-value=7.8e-30 Score=250.53 Aligned_cols=235 Identities=19% Similarity=0.324 Sum_probs=189.4
Q ss_pred HHHhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCH---HHHHH--------------HHhcccccCcceEEE
Q 048517 159 IAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSA---EEFIN--------------ELLGLCSEGFKRALV 220 (453)
Q Consensus 159 ~~~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~---~~~i~--------------el~g~~~~~~~~~lv 220 (453)
++.-|.+.+.||+|.|..|-+++ .-+|..||||++.+.+... ...++ .||.+.....++|||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 34567788999999999999998 5589999999998865432 22233 267777788899999
Q ss_pred EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE-cCCCceEEEecCCcccc
Q 048517 221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL-DHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl-~~~~~~kl~DFGla~~~ 299 (453)
+|.=.+|+|.+||...+ ..+.++...+++.||..|+.|+|+- -+|||||||+|+.+ ..-|-+||.|||++..+
T Consensus 96 LELGD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEecCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 99999999999996443 5789999999999999999999997 89999999999987 45689999999999877
Q ss_pred CCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517 300 PKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL 379 (453)
Q Consensus 300 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~ 379 (453)
.... ..+..+|+..|-|||.+.+. ..-.++.||||+||+||-|+.|+.||...++.+ ....+.+-.
T Consensus 170 ~PG~---kL~TsCGSLAYSAPEILLGD-sYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE--------TLTmImDCK-- 235 (864)
T KOG4717|consen 170 QPGK---KLTTSCGSLAYSAPEILLGD-SYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE--------TLTMIMDCK-- 235 (864)
T ss_pred CCcc---hhhcccchhhccCchhhhcC-ccCCcchhhhHHHHHHHHHHhCCCccccccchh--------hhhhhhccc--
Confidence 6654 34677899999999999875 233679999999999999999999997554322 111111111
Q ss_pred cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
...+.-++.+..+++..||+.||.+|.|.+||+.
T Consensus 236 -----YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 236 -----YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred -----ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 1245567788999999999999999999999875
No 375
>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]
Probab=99.96 E-value=4.8e-31 Score=251.88 Aligned_cols=249 Identities=23% Similarity=0.305 Sum_probs=185.1
Q ss_pred hHHHHHhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHH--------------------HhcccccC
Q 048517 156 PEIIAVTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINE--------------------LLGLCSEG 214 (453)
Q Consensus 156 ~~~~~~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~e--------------------l~g~~~~~ 214 (453)
.+....+|...+.+|+|.||.|-++..+ .+..||||+++.-..-.+..+.| +..++.-.
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 4666778888899999999999999854 57899999998744333333222 44556677
Q ss_pred cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc-----------
Q 048517 215 FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD----------- 283 (453)
Q Consensus 215 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~----------- 283 (453)
++.++|+|.| |-|+.++| .++.-.+++...+..|+.|++++++|||+. +++|-||||+|||+-
T Consensus 164 ghiCivfell-G~S~~dFl--k~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFL--KENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred CceEEEEecc-ChhHHHHh--ccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccC
Confidence 7889999998 66889988 344557899999999999999999999998 999999999999992
Q ss_pred ---------CCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 048517 284 ---------HNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN 354 (453)
Q Consensus 284 ---------~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~ 354 (453)
.+..+||.|||.|+...... +....|..|.|||++.+- +++.++||||+||+|.|+.+|..-|.
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgL--GwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGL--GWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheecc--CcCCccCceeeeeEEEEeeccceecc
Confidence 24569999999999765544 344578999999999985 89999999999999999999998776
Q ss_pred CCccccc----c---ccchHHHHHH------hhhCCCcccc-------------------chhhhHHHHHHHHHHHHHHh
Q 048517 355 MNATRSS----K---AYFPSWVYDQ------LNKGGDLELR-------------------NVTEIESMIARKLCMIGLWC 402 (453)
Q Consensus 355 ~~~~~~~----~---~~~~~~~~~~------l~~~~~~~~~-------------------~~~~~~~~~~~~l~~l~~~C 402 (453)
.....+. + ..+|.-.... ...+ .++-. ......+.....+.+|+..|
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 5542210 0 1111111111 1111 11100 00111233456799999999
Q ss_pred cccCCCCCCCHHHHHH
Q 048517 403 IQVKAADRPSMTKVLE 418 (453)
Q Consensus 403 l~~~p~~RPs~~evl~ 418 (453)
|..||.+|+|+.|++.
T Consensus 390 L~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 390 LEFDPARRITLREALS 405 (415)
T ss_pred HccCccccccHHHHhc
Confidence 9999999999999976
No 376
>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481
Probab=99.96 E-value=1.3e-29 Score=273.77 Aligned_cols=129 Identities=28% Similarity=0.424 Sum_probs=106.6
Q ss_pred hhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH----HHHHHH--------------HhcccccCcceEEEEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA----EEFINE--------------LLGLCSEGFKRALVYE 222 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~----~~~i~e--------------l~g~~~~~~~~~lv~E 222 (453)
.|.+.++||+|+||.||+|... +++.||||++....... +.+..| +++.+......++|||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 3556789999999999999965 78999999997643221 223222 3444556677899999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 297 (453)
|+.+++|.+++.. ...+++..++.|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 85 y~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 85 YLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999998843 24588899999999999999999998 99999999999999999999999999986
No 377
>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]
Probab=99.96 E-value=6.3e-30 Score=236.95 Aligned_cols=235 Identities=21% Similarity=0.245 Sum_probs=185.2
Q ss_pred cccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHHHHHH-----------Hhccc----ccCcceEEEEEecCCCChh
Q 048517 167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEEFINE-----------LLGLC----SEGFKRALVYEYMPNGSLD 230 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~~i~e-----------l~g~~----~~~~~~~lv~E~~~~gsL~ 230 (453)
++||-|-.|.|-.+.. .+|+.+|+|+|..+...+.+.... ++.++ ....-+++|||.|+||.|.
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLf 147 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELF 147 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHH
Confidence 5799999999999985 479999999998765444432221 22222 2334467899999999999
Q ss_pred hhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc---CCCceEEEecCCccccCCCCCcee
Q 048517 231 RHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVS 307 (453)
Q Consensus 231 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~---~~~~~kl~DFGla~~~~~~~~~~~ 307 (453)
..+..+ ....+++.++.+|.+||+.|+.|||+. +|.||||||+|+|.. .|..+||+|||+|+...... .
T Consensus 148 sriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~---~ 219 (400)
T KOG0604|consen 148 SRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG---D 219 (400)
T ss_pred HHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCCCc---c
Confidence 988543 346799999999999999999999997 999999999999995 36689999999998654433 3
Q ss_pred ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhh
Q 048517 308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEI 387 (453)
Q Consensus 308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 387 (453)
..+.+-|+.|.|||++... .+....|+||+||++|-|+.|.+||..+.... ++......+..++-.- ..+.
T Consensus 220 L~TPc~TPyYvaPevlg~e--KydkscdmwSlgVimYIlLCGyPPFYS~hg~a----ispgMk~rI~~gqy~F---P~pE 290 (400)
T KOG0604|consen 220 LMTPCFTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKRRIRTGQYEF---PEPE 290 (400)
T ss_pred ccCCcccccccCHHHhCch--hcCCCCCccchhHHHHHhhcCCCcccccCCcc----CChhHHhHhhccCccC---CChh
Confidence 4667899999999999764 68889999999999999999999997665422 2333445555554322 2345
Q ss_pred HHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 388 ESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 388 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.+.+++...++++..|..+|.+|.|+.++.+
T Consensus 291 Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 291 WSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred HhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 6778888899999999999999999999986
No 378
>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]
Probab=99.96 E-value=2.7e-29 Score=260.63 Aligned_cols=238 Identities=27% Similarity=0.338 Sum_probs=185.9
Q ss_pred hhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCHHHHHHH---------------Hhcccc-----cCcceEEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINE---------------LLGLCS-----EGFKRALV 220 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~~~~i~e---------------l~g~~~-----~~~~~~lv 220 (453)
+..|.+.||.|.+|.||+++ .++|+.+|||++.......++...| .+|++- .+++++||
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV 99 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV 99 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence 45677899999999999999 6789999999998755444443333 333332 35678999
Q ss_pred EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517 221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 300 (453)
||||.+||..+.+.... +..+.|+.+.-|+.++++||.+||.+ .++|||||-.|||++.++.+||.|||++....
T Consensus 100 MEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 100 MEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred eeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 99999999999885543 78899999999999999999999998 99999999999999999999999999998664
Q ss_pred CCCCceeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC
Q 048517 301 KENDFVSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG 377 (453)
Q Consensus 301 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 377 (453)
.... ...+..||+.|||||++... ...++..+|+||+|++..||.-|.+|+..... ...+-...
T Consensus 175 sT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-----------mraLF~Ip 241 (953)
T KOG0587|consen 175 STVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-----------MRALFLIP 241 (953)
T ss_pred cccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-----------hhhhccCC
Confidence 4322 23556799999999999753 23677899999999999999999999854321 11121111
Q ss_pred CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 378 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 378 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
+.... ....+....+++.+++..||..|.+.||++.++++
T Consensus 242 RNPPP-kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 242 RNPPP-KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCCCc-cccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11111 11135566788999999999999999999988875
No 379
>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=99.96 E-value=8.8e-29 Score=231.05 Aligned_cols=259 Identities=22% Similarity=0.294 Sum_probs=190.2
Q ss_pred cccCccCceEEEEEE-EcCCcEEEEEEecCCCC-CH---------------HHHHHHHhcccccCcceEEEEEecCCCCh
Q 048517 167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKF-SA---------------EEFINELLGLCSEGFKRALVYEYMPNGSL 229 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~-~~---------------~~~i~el~g~~~~~~~~~lv~E~~~~gsL 229 (453)
+.||+|+|+.|--++ +.+|+.+|||++.+... .+ +..|.+|+.|+.+..+.|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 679999999999998 88999999999987422 12 23356689999999999999999999999
Q ss_pred hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC---CceEEEecCCccccCCCCC--
Q 048517 230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN---FIPKVSDFGLAKFHPKEND-- 304 (453)
Q Consensus 230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~---~~~kl~DFGla~~~~~~~~-- 304 (453)
..+|.. ...+++.++.++.++|+.||.+||.+ +|.|||+||+|||-... .-+||+||.|..-......
T Consensus 164 LshI~~----~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 164 LSHIQK----RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 999954 35799999999999999999999998 99999999999999643 3589999988764332221
Q ss_pred ---ceeecccCCCCCccChhhhcc---cCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc-------ccchHHHHH
Q 048517 305 ---FVSISDTRGTIGYLAPELISR---NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-------AYFPSWVYD 371 (453)
Q Consensus 305 ---~~~~~~~~gt~~y~aPE~~~~---~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~-------~~~~~~~~~ 371 (453)
.....++.|+..|||||+..- ...-|..+.|.||+||+||-|++|.+||-......-- ..-.+...+
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 123345678889999998643 2235678999999999999999999999765432110 011223344
Q ss_pred HhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhCCCCCCCCCCCCCC
Q 048517 372 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEGSIDDLQMPPKPFF 435 (453)
Q Consensus 372 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~Le~~~~~~~~p~~p~~ 435 (453)
.+.++.-.- +......++....+++...+..++.+|-++.+++. ...+...+-.+|..+.+
T Consensus 317 sIQEGkYeF---PdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalptp~v~ 379 (463)
T KOG0607|consen 317 SIQEGKYEF---PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPTPQVL 379 (463)
T ss_pred HHhccCCcC---ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCCCccc
Confidence 455543322 22233445556667777788899999999999887 34444444444444444
No 380
>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]
Probab=99.96 E-value=1.1e-29 Score=236.27 Aligned_cols=254 Identities=22% Similarity=0.273 Sum_probs=175.6
Q ss_pred hhhhhcccCccCceEEEEEE-Ec--C--CcEEEEEEecCCCCC----H---H--HHHHH--------Hhccccc-CcceE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQ-LH--T--GRLIAVKMMENSKFS----A---E--EFINE--------LLGLCSE-GFKRA 218 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~-~~--~--g~~VAVK~l~~~~~~----~---~--~~i~e--------l~g~~~~-~~~~~ 218 (453)
.|+...+||+|.||.||++. .+ + .+.+|||+++.++.. . + ...+| |..++.. +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 45667889999999999996 32 3 237899999875321 1 1 11222 3333333 67789
Q ss_pred EEEEecCCCChhhhhh-hccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC----CceEEEec
Q 048517 219 LVYEYMPNGSLDRHIF-SKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN----FIPKVSDF 293 (453)
Q Consensus 219 lv~E~~~~gsL~~~l~-~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~----~~~kl~DF 293 (453)
+++||.+. +|...|+ .+......++...+..|+.||+.|+.|||++ =|+||||||.|||+..+ |.+||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999976 5555553 3334456788999999999999999999998 89999999999999877 99999999
Q ss_pred CCccccCCCCCce-eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccc-cchHHHH-
Q 048517 294 GLAKFHPKENDFV-SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA-YFPSWVY- 370 (453)
Q Consensus 294 Gla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~- 370 (453)
|+++++...-... +.....-|..|.|||.+.+. ..||.+.|||+.||++.||+|-.+-|.....+.... .+..--.
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999986543322 23445679999999999885 589999999999999999999988776544332221 1111111
Q ss_pred ---HHhhhCCCc---cccchh-------h----------hH------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517 371 ---DQLNKGGDL---ELRNVT-------E----------IE------SMIARKLCMIGLWCIQVKAADRPSMTKVLEML 420 (453)
Q Consensus 371 ---~~l~~~~~~---~~~~~~-------~----------~~------~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 420 (453)
+.+...... .+..-. . .. ..-++....++..+|++||-+|.|+++.++..
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 111110000 000000 0 00 00112366788999999999999999998743
No 381
>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain. Phosphotransferases. Serine or threonine-specific kinase subfamily.
Probab=99.96 E-value=2.1e-28 Score=229.56 Aligned_cols=223 Identities=26% Similarity=0.353 Sum_probs=172.7
Q ss_pred CceEEEEEEEc-CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEecCCCChhhhhhh
Q 048517 173 GFGSVYKGQLH-TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLDRHIFS 235 (453)
Q Consensus 173 ~fG~Vy~g~~~-~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL~~~l~~ 235 (453)
+||.||+|+.. +|+.+|+|++...... .+.+..| +.+++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 68999999976 5899999999764332 2344333 56677777888999999999999998843
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecccCCCC
Q 048517 236 KENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTI 315 (453)
Q Consensus 236 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 315 (453)
. ..+++..+..++.++++++.|||+. +++|+||+|+||+++.++.++++|||.+....... ......++.
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 2 2289999999999999999999998 99999999999999999999999999998765542 223456888
Q ss_pred CccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHH
Q 048517 316 GYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKL 395 (453)
Q Consensus 316 ~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l 395 (453)
.|++||.+.. ..++.++||||||+++++|++|+.|+...... .-..+.+......... ....+...+
T Consensus 151 ~~~~pE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-------~~~~~~~~~~~~~~~~----~~~~~~~~~ 217 (244)
T smart00220 151 EYMAPEVLLG--KGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-------LELFKKIGKPKPPFPP----PEWKISPEA 217 (244)
T ss_pred CCCCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHhccCCCCcc----ccccCCHHH
Confidence 9999999875 36788999999999999999999998653111 1122333322211100 111144678
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 048517 396 CMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 396 ~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.+++.+|++.+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 89999999999999999999986
No 382
>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]
Probab=99.96 E-value=7.7e-30 Score=246.70 Aligned_cols=239 Identities=27% Similarity=0.370 Sum_probs=176.0
Q ss_pred hhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCHHHH----------------------HHHHhcccc-cCcceEE
Q 048517 164 HFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEF----------------------INELLGLCS-EGFKRAL 219 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~~~~----------------------i~el~g~~~-~~~~~~l 219 (453)
-+.+.||+|||+.||++. +..++.||||+-...+.+.++- |.+++.+++ +.+..+-
T Consensus 466 LlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCT 545 (775)
T KOG1151|consen 466 LLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCT 545 (775)
T ss_pred HHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccccee
Confidence 344679999999999998 6779999999865544333211 112566655 4456789
Q ss_pred EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC---CCceEEEecCCc
Q 048517 220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLA 296 (453)
Q Consensus 220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~---~~~~kl~DFGla 296 (453)
|+||++|.+|+-||. ....++.+++..|+.||+.||.||... .++|||-||||.||||-+ -|.+||.||||+
T Consensus 546 VLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 546 VLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred eeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 999999999999883 346789999999999999999999986 679999999999999943 478999999999
Q ss_pred cccCCCCCce-----eecccCCCCCccChhhhccc--CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHH
Q 048517 297 KFHPKENDFV-----SISDTRGTIGYLAPELISRN--FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWV 369 (453)
Q Consensus 297 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 369 (453)
+.+..+.... -+....||..|++||.+.-. .+.++.|.||||.||++|.++.|++||..+....
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--------- 691 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--------- 691 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---------
Confidence 9987654331 12345799999999987532 3578999999999999999999999997654322
Q ss_pred HHHhhhCCCccccchh-hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 048517 370 YDQLNKGGDLELRNVT-EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417 (453)
Q Consensus 370 ~~~l~~~~~~~~~~~~-~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl 417 (453)
+.+.....+...... +....++.....++++||+..-++|....++.
T Consensus 692 -dILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 692 -DILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -HHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 122222111111100 01122334567799999999999997665543
No 383
>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]
Probab=99.96 E-value=4.6e-29 Score=251.26 Aligned_cols=230 Identities=21% Similarity=0.301 Sum_probs=182.4
Q ss_pred hhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHH---HH--------------HHHHhcccccCcceEEEEEec
Q 048517 163 NHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAE---EF--------------INELLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~---~~--------------i~el~g~~~~~~~~~lv~E~~ 224 (453)
|.+.++||+|.|+.|.+|+. .++..||||++.++..+.. .+ +.+|+.+.......++||||.
T Consensus 58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya 137 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA 137 (596)
T ss_pred eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence 45568899999999999994 4799999999988544332 12 222666677778899999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
.+|.+++|+.. ........+..++.|+.+|++|||++ .|+|||||++||||+.+.++||+|||++..+....
T Consensus 138 ~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~- 209 (596)
T KOG0586|consen 138 SGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL- 209 (596)
T ss_pred cCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecccc-
Confidence 99999999943 24455588899999999999999998 99999999999999999999999999999887543
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 384 (453)
...+..|++.|.|||++.+. ....+.+|+||+|++||-|+.|..||+...-.+. -...+....+
T Consensus 210 --~lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-------r~rvl~gk~r------ 273 (596)
T KOG0586|consen 210 --MLQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-------RPRVLRGKYR------ 273 (596)
T ss_pred --cccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCcccccc-------cchheeeeec------
Confidence 23567899999999999886 3568899999999999999999999986543321 1111211111
Q ss_pred hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 385 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.+.-++.....+++++|-.+|.+|++++++.+
T Consensus 274 --Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 274 --IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred --ccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 22223445777899999999999999999876
No 384
>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]
Probab=99.96 E-value=5.1e-29 Score=238.07 Aligned_cols=238 Identities=21% Similarity=0.309 Sum_probs=181.7
Q ss_pred hhcccCccCceEEEEEEE------cCCcEEEEEEecCCC--CCHHHHHHH---H-----------hcccc-cCcceEEEE
Q 048517 165 FTHKLGQGGFGSVYKGQL------HTGRLIAVKMMENSK--FSAEEFINE---L-----------LGLCS-EGFKRALVY 221 (453)
Q Consensus 165 ~~~~LG~G~fG~Vy~g~~------~~g~~VAVK~l~~~~--~~~~~~i~e---l-----------~g~~~-~~~~~~lv~ 221 (453)
+...+-+|.||.||.|.+ ++.+.|-||.++... .....++.| + .+.+. +....+++|
T Consensus 288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEE
Confidence 345688999999999954 345667788776532 233445555 2 23332 334567899
Q ss_pred EecCCCChhhhhhh----ccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517 222 EYMPNGSLDRHIFS----KENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297 (453)
Q Consensus 222 E~~~~gsL~~~l~~----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 297 (453)
.++.-|+|..+|.. ..+..+.++-.++..++.|++.|++|||+. ++||.||..+|++||+...+||+|=.++|
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhcc
Confidence 99999999999862 122345678888999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCceeec-ccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHHHHhhh
Q 048517 298 FHPKENDFVSIS-DTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNK 375 (453)
Q Consensus 298 ~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~l~~ 375 (453)
-.-..+.. ..+ ....+..||+||.+... .++.++|||||||+||||+| |+.|+...+ |..++..+.+
T Consensus 445 DLFP~DYh-cLGDnEnRPvkWMslEal~n~--~yssasDvWsfGVllWELmtlg~~PyaeID--------PfEm~~ylkd 513 (563)
T KOG1024|consen 445 DLFPGDYH-CLGDNENRPVKWMSLEALQNS--HYSSASDVWSFGVLLWELMTLGKLPYAEID--------PFEMEHYLKD 513 (563)
T ss_pred ccCccccc-ccCCCCCCcccccCHHHHhhh--hhcchhhhHHHHHHHHHHHhcCCCCccccC--------HHHHHHHHhc
Confidence 54332222 222 22356789999999876 89999999999999999998 777875433 2335667777
Q ss_pred CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 376 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
|.++. .+.+.+.++..++.-||...|++|||+++++.-|.+
T Consensus 514 GyRla------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 514 GYRLA------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred cceec------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 77654 333456779999999999999999999999987764
No 385
>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]
Probab=99.95 E-value=6.4e-29 Score=244.65 Aligned_cols=227 Identities=27% Similarity=0.352 Sum_probs=176.7
Q ss_pred cccCccCceEEEEEEE-cCCcEEEEEEecCCC---CCHHHHHHH--------------HhcccccCcceEEEEEecCCCC
Q 048517 167 HKLGQGGFGSVYKGQL-HTGRLIAVKMMENSK---FSAEEFINE--------------LLGLCSEGFKRALVYEYMPNGS 228 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~---~~~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gs 228 (453)
+.||.|-||+||-|+. ++|+.||||++.+.+ ...++..+| |...|+...+.++|||-+ +|+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cch
Confidence 5799999999999985 589999999997732 233444444 334566778889999999 556
Q ss_pred hhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC---CceEEEecCCccccCCCCCc
Q 048517 229 LDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN---FIPKVSDFGLAKFHPKENDF 305 (453)
Q Consensus 229 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~---~~~kl~DFGla~~~~~~~~~ 305 (453)
+.+.|.+.+ ..+|+.....-+..||+-||.|||.+ +|+|+||||+||||... ..+||+|||.|+..+...-.
T Consensus 649 MLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 649 MLEMILSSE--KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred HHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 666665543 46788888888999999999999998 99999999999999643 47999999999998765422
Q ss_pred eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517 306 VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385 (453)
Q Consensus 306 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 385 (453)
....|||.|+|||++... .+...-|+||.||++|--++|.-||+...+ +.+++...... -+.
T Consensus 724 ---rsVVGTPAYLaPEVLrnk--GyNrSLDMWSVGVIiYVsLSGTFPFNEdEd----------IndQIQNAaFM---yPp 785 (888)
T KOG4236|consen 724 ---RSVVGTPAYLAPEVLRNK--GYNRSLDMWSVGVIIYVSLSGTFPFNEDED----------INDQIQNAAFM---YPP 785 (888)
T ss_pred ---hhhcCCccccCHHHHhhc--cccccccceeeeEEEEEEecccccCCCccc----------hhHHhhccccc---cCC
Confidence 456899999999999875 788999999999999999999999975443 33444432221 122
Q ss_pred hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 048517 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417 (453)
Q Consensus 386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl 417 (453)
....+++...++++...||.+-.+|-|..+-+
T Consensus 786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred CchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 34456677788888888998888888887654
No 386
>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]
Probab=99.95 E-value=9.3e-29 Score=218.37 Aligned_cols=185 Identities=28% Similarity=0.417 Sum_probs=148.1
Q ss_pred cccCccCceEEEEEE-EcCCcEEEEEEecCCCCC--HHHHHHH---------------HhcccccCcceEEEEEecCCCC
Q 048517 167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS--AEEFINE---------------LLGLCSEGFKRALVYEYMPNGS 228 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~--~~~~i~e---------------l~g~~~~~~~~~lv~E~~~~gs 228 (453)
..||+|++|.|=+-+ ..+|+..|||.+...-.+ ..+.+.+ ++|-..+....++.||.| .-|
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tS 130 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTS 130 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhh
Confidence 579999999998887 458999999998764322 3344444 455555667789999999 568
Q ss_pred hhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceee
Q 048517 229 LDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 308 (453)
Q Consensus 229 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 308 (453)
|+.+....-..+..+++..+-+||..+.+||.|||++ ..++|||+||+|||++.+|.+|++|||++-.....- ..
T Consensus 131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi---Ak 205 (282)
T KOG0984|consen 131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI---AK 205 (282)
T ss_pred HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhh---HH
Confidence 8777654445677889999999999999999999997 799999999999999999999999999987553321 22
Q ss_pred cccCCCCCccChhhhccc--CCCCCccchHHHHHHHHHHHHcCCCCCCCCc
Q 048517 309 SDTRGTIGYLAPELISRN--FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA 357 (453)
Q Consensus 309 ~~~~gt~~y~aPE~~~~~--~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~ 357 (453)
+...|-..|||||.+... ...|+-|+||||+|+.+.||.+++.|++...
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 334577889999998642 2368999999999999999999999987543
No 387
>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.95 E-value=4.2e-28 Score=227.62 Aligned_cols=229 Identities=20% Similarity=0.310 Sum_probs=176.3
Q ss_pred hhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCCHHH---H----------------HHHHhcccccCcceEEEEEec
Q 048517 165 FTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFSAEE---F----------------INELLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 165 ~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~~~~---~----------------i~el~g~~~~~~~~~lv~E~~ 224 (453)
+...||+|+|..|-.+++ ++.+.+|+|++++.-.+.++ + +.-|..+++...++++|.||.
T Consensus 254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv 333 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV 333 (593)
T ss_pred eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence 346799999999999995 47889999998764322211 1 111566778888999999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 304 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 304 (453)
++|+|--++. ....|+.+.+.-+..+|.-||.|||+. +|+.||+|..|+|+|..+++||.|+|+++-.-.+..
T Consensus 334 ~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~gd 406 (593)
T KOG0695|consen 334 NGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD 406 (593)
T ss_pred cCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence 9999977663 335689999999999999999999998 999999999999999999999999999986555444
Q ss_pred ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccch
Q 048517 305 FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNV 384 (453)
Q Consensus 305 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 384 (453)
. +++..|||.|+|||.+.+. .|....|.|++||+++||+.|+.||+.-.....+.+-.......+.+.+.-
T Consensus 407 ~--tstfcgtpnyiapeilrge--eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir----- 477 (593)
T KOG0695|consen 407 T--TSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR----- 477 (593)
T ss_pred c--cccccCCCcccchhhhccc--ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc-----
Confidence 2 3567899999999999886 788899999999999999999999986443333333333344443332221
Q ss_pred hhhHHHHHHHHHHHHHHhcccCCCCCC
Q 048517 385 TEIESMIARKLCMIGLWCIQVKAADRP 411 (453)
Q Consensus 385 ~~~~~~~~~~l~~l~~~Cl~~~p~~RP 411 (453)
.+..++-+...+++.-|..||.+|-
T Consensus 478 --iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 --IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --ccceeehhhHHHHHHhhcCCcHHhc
Confidence 2223344566677888889998885
No 388
>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]
Probab=99.95 E-value=3.4e-28 Score=251.46 Aligned_cols=230 Identities=25% Similarity=0.317 Sum_probs=163.0
Q ss_pred cccCccCceE-EEEEEEcCCcEEEEEEecCCCCCHH----HHHHH---------HhcccccCcceEEEEEecCCCChhhh
Q 048517 167 HKLGQGGFGS-VYKGQLHTGRLIAVKMMENSKFSAE----EFINE---------LLGLCSEGFKRALVYEYMPNGSLDRH 232 (453)
Q Consensus 167 ~~LG~G~fG~-Vy~g~~~~g~~VAVK~l~~~~~~~~----~~i~e---------l~g~~~~~~~~~lv~E~~~~gsL~~~ 232 (453)
+.+|.|+-|+ ||+|... |+.||||++-.+....- +.+.| .++.-++...+|+..|.| .-+|.++
T Consensus 515 eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~dl 592 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYE-GREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQDL 592 (903)
T ss_pred HHcccCCCCcEEEEEeeC-CceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHHHH
Confidence 5689999875 5999988 88999998865433211 11222 223334556678999999 6799999
Q ss_pred hhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-----CCceEEEecCCccccCCCC-Cce
Q 048517 233 IFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-----NFIPKVSDFGLAKFHPKEN-DFV 306 (453)
Q Consensus 233 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-----~~~~kl~DFGla~~~~~~~-~~~ 306 (453)
+...........-...+.+..|+++||++||+- +||||||||+||||+. ...++|+|||+++....+. ++.
T Consensus 593 ie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~ 669 (903)
T KOG1027|consen 593 IESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFS 669 (903)
T ss_pred HhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhh
Confidence 855311111122245678899999999999997 9999999999999965 3579999999999876543 333
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcC-CCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGG-RRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 385 (453)
......||-||+|||.+... .-+.++|++|+||++|+.++| ++||...-.++. .+..+....... .
T Consensus 670 r~s~~sGt~GW~APE~L~~~--~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~----------NIl~~~~~L~~L-~ 736 (903)
T KOG1027|consen 670 RLSGGSGTSGWQAPEQLRED--RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA----------NILTGNYTLVHL-E 736 (903)
T ss_pred cccCCCCcccccCHHHHhcc--ccCcccchhhcCceEEEEecCCccCCCchHHhhh----------hhhcCccceeee-c
Confidence 34566799999999999874 456699999999999999986 889976543321 111121111000 0
Q ss_pred hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 048517 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417 (453)
Q Consensus 386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl 417 (453)
...+. ...+++.+|++++|..||++.+|+
T Consensus 737 ~~~d~---eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 737 PLPDC---EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred cCchH---HHHHHHHHhcCCCcccCCCHHHHh
Confidence 11111 567899999999999999999986
No 389
>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]
Probab=99.94 E-value=7.2e-28 Score=236.58 Aligned_cols=221 Identities=24% Similarity=0.295 Sum_probs=179.8
Q ss_pred cccCccCceEEEEEEEcCCc-EEEEEEecCCCC----CH--------------HHHHHHHhcccccCcceEEEEEecCCC
Q 048517 167 HKLGQGGFGSVYKGQLHTGR-LIAVKMMENSKF----SA--------------EEFINELLGLCSEGFKRALVYEYMPNG 227 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~g~-~VAVK~l~~~~~----~~--------------~~~i~el~g~~~~~~~~~lv~E~~~~g 227 (453)
..||-||||.|=+.+.+..+ .+|+|++++... .. .+||.+|+..+.+....|++||-|-||
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 45999999999998877444 489998876211 11 246667899999999999999999999
Q ss_pred ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517 228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 307 (453)
Q Consensus 228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 307 (453)
.|-..| .....|...+..-++..+..|++|||++ +||.|||||+|.+||.+|-+||.|||.|+...... .
T Consensus 506 ElWTiL----rdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~---K 575 (732)
T KOG0614|consen 506 ELWTIL----RDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR---K 575 (732)
T ss_pred hhhhhh----hhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC---c
Confidence 998887 3446788899999999999999999998 99999999999999999999999999999886654 3
Q ss_pred ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhh
Q 048517 308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEI 387 (453)
Q Consensus 308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 387 (453)
+.+.+|||.|.|||.+... ....++|.||+|++++||++|++||...+. ...+..+.++-+. .+.
T Consensus 576 TwTFcGTpEYVAPEIILnK--GHD~avDyWaLGIli~ELL~G~pPFs~~dp--------mktYn~ILkGid~-----i~~ 640 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNK--GHDRAVDYWALGILIYELLTGSPPFSGVDP--------MKTYNLILKGIDK-----IEF 640 (732)
T ss_pred eeeecCCcccccchhhhcc--CcchhhHHHHHHHHHHHHHcCCCCCCCCch--------HHHHHHHHhhhhh-----hhc
Confidence 4667899999999999875 677899999999999999999999975542 2355555554321 234
Q ss_pred HHHHHHHHHHHHHHhcccCCCCCCC
Q 048517 388 ESMIARKLCMIGLWCIQVKAADRPS 412 (453)
Q Consensus 388 ~~~~~~~l~~l~~~Cl~~~p~~RPs 412 (453)
+..+.+....++++.-..+|.+|--
T Consensus 641 Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 641 PRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ccccchhHHHHHHHHHhcCcHhhhc
Confidence 5556677788888888899999985
No 390
>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=99.94 E-value=4.7e-27 Score=203.38 Aligned_cols=240 Identities=22% Similarity=0.290 Sum_probs=171.2
Q ss_pred hcccCccCceEEEEEE-EcCCcEEEEEEecCCCCC---HHHH--------------HHHHhcccccCcceEEEEEecCCC
Q 048517 166 THKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS---AEEF--------------INELLGLCSEGFKRALVYEYMPNG 227 (453)
Q Consensus 166 ~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~---~~~~--------------i~el~g~~~~~~~~~lv~E~~~~g 227 (453)
-++||+|.||+||+|+ .++++.||+|....+... .... +.+|+.......+.-+|+||| ..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dq 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQ 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hH
Confidence 4689999999999999 557899999988653221 1111 222666667778889999999 56
Q ss_pred ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee
Q 048517 228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 307 (453)
Q Consensus 228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 307 (453)
+|.++..+ -+..++.+....++.|+++||.+.|++ +++|||+||+|.|++.|+..|++|||+++-+.-.-. .
T Consensus 86 dlkkyfds---lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr--c 157 (292)
T KOG0662|consen 86 DLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--C 157 (292)
T ss_pred HHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE--e
Confidence 78777643 346788889999999999999999998 999999999999999999999999999998765432 3
Q ss_pred ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC-----------
Q 048517 308 ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG----------- 376 (453)
Q Consensus 308 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~----------- 376 (453)
.+...-|..|.+|.++.+. .-++...|+||-||++.|+....+|....+.-..+. .-+...+...
T Consensus 158 ysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddql---krif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL---KRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred eeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHH---HHHHHHhCCCccccCCccccC
Confidence 3556789999999999875 578999999999999999998555543332211110 0011111110
Q ss_pred ---CCccccchhh----hHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 377 ---GDLELRNVTE----IESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 377 ---~~~~~~~~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
....+-.+.. ....+...-.++....+.-+|..|.++++.++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 0000000111 11222234456777788889999999998765
No 391
>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.94 E-value=4.5e-27 Score=235.93 Aligned_cols=193 Identities=25% Similarity=0.374 Sum_probs=151.6
Q ss_pred cccCccCceEEEEEE-EcCCcEEEEEEecCCCC----------CHHHHHHH--------HhcccccCcceEEEEEecCCC
Q 048517 167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKF----------SAEEFINE--------LLGLCSEGFKRALVYEYMPNG 227 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~----------~~~~~i~e--------l~g~~~~~~~~~lv~E~~~~g 227 (453)
+.||-|+||.|.++. .++...+|+|.|.+... .+++.+.| |+-.+.++..+|+||+|++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 349999999999998 55677899998876321 12233433 777788899999999999999
Q ss_pred ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC-----
Q 048517 228 SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE----- 302 (453)
Q Consensus 228 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~----- 302 (453)
++-..|... ..|.++.+.-++.++..|+++.|.- ++|||||||+|||||.+|++||.||||+.-+...
T Consensus 715 DmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 715 DMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred cHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 999988543 4677888888899999999999986 9999999999999999999999999998533211
Q ss_pred ---CCce--------------------------------eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHH
Q 048517 303 ---NDFV--------------------------------SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMA 347 (453)
Q Consensus 303 ---~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ell 347 (453)
.+.. ......||+.|+|||++.+. .++-.+|.||.||+|+||+
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~--g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART--GYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc--CccccchhhHhhHHHHHHh
Confidence 0000 00122499999999999875 7888999999999999999
Q ss_pred cCCCCCCCCccccccccchHH
Q 048517 348 GGRRNSNMNATRSSKAYFPSW 368 (453)
Q Consensus 348 tg~~p~~~~~~~~~~~~~~~~ 368 (453)
.|+.||........+.-..+|
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINW 886 (1034)
T ss_pred hCCCCccCCCCCcceeeeeeh
Confidence 999999876655544444444
No 392
>smart00750 KIND kinase non-catalytic C-lobe domain. It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features
Probab=99.94 E-value=1.9e-26 Score=207.65 Aligned_cols=166 Identities=21% Similarity=0.228 Sum_probs=124.8
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|||.+++... +..++|.+++.|+.|+++||.|||+. + ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc----
Confidence 7888888432 35699999999999999999999997 4 999999999999999 9999865432
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
...||+.|||||++.+. .++.++|||||||++|||++|+.|+...... .......+.......... ..
T Consensus 63 ---~~~g~~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~-~~ 130 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQ--SYTEKADIYSLGITLYEALDYELPYNEEREL------SAILEILLNGMPADDPRD-RS 130 (176)
T ss_pred ---cCCCcccccChHHhcCC--CCcchhhHHHHHHHHHHHHhCCCCccccchh------cHHHHHHHHHhccCCccc-cc
Confidence 22589999999999764 7889999999999999999999998643221 111111111111111100 11
Q ss_pred hHHHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 387 IESMIAR--KLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 387 ~~~~~~~--~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
....... .+.+++.+||+.+|++|||+.++++.+..
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 1222333 68999999999999999999999998864
No 393
>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.94 E-value=9.6e-28 Score=217.65 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=169.0
Q ss_pred hhhhhcccCccCceEEEEEE-EcCCcEEEEEEecC--CCCC-HH--------------HHHHHHhccccc--------Cc
Q 048517 162 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMEN--SKFS-AE--------------EFINELLGLCSE--------GF 215 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~--~~~~-~~--------------~~i~el~g~~~~--------~~ 215 (453)
+|.-..+||+|.||.||+++ .++|+.||+|+.-. .+.+ .. +.+..++..|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 33444689999999999999 55788999986432 2221 11 222225555532 23
Q ss_pred ceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCC
Q 048517 216 KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL 295 (453)
Q Consensus 216 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl 295 (453)
..++|+.+|+. +|...|. +....++..++..++.++..||.|+|+. .|+|||+|+.|+||+.++.+||+|||+
T Consensus 98 t~ylVf~~ceh-DLaGlLs---n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLS---NRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhhh-hHHHHhc---CccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence 47899999964 5655552 3346789999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCc--eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHH---
Q 048517 296 AKFHPKENDF--VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY--- 370 (453)
Q Consensus 296 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~--- 370 (453)
++.+...... ...+...-|..|.+||.+.+. ..++++.|||.-||++.||.||.+-+..+.+.. +..+.+...
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqq-ql~~Is~LcGs~ 248 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQ-QLHLISQLCGSI 248 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHH-HHHHHHHHhccC
Confidence 9866432221 112344569999999999875 689999999999999999999987776554321 111100000
Q ss_pred -----HHhhh---CCCccccchhh----hHHHH------HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 371 -----DQLNK---GGDLELRNVTE----IESMI------ARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 371 -----~~l~~---~~~~~~~~~~~----~~~~~------~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
....+ -+..+++.... ...+. ....++++..++..||.+||.+.+++.
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 00000 00000000000 00111 125678999999999999999998875
No 394
>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.94 E-value=2.7e-26 Score=225.00 Aligned_cols=117 Identities=30% Similarity=0.493 Sum_probs=94.7
Q ss_pred HhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCCHHHHHHH----------------------Hhcccc----c
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFSAEEFINE----------------------LLGLCS----E 213 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~~~~~i~e----------------------l~g~~~----~ 213 (453)
.+|.+.+|||=|.|++||++. ..+.+.||+|+.+....-.+.-+.| |+..+. .
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 678889999999999999998 5678999999998754433333222 444443 4
Q ss_pred CcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE
Q 048517 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL 282 (453)
Q Consensus 214 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl 282 (453)
+.+.++|+|++ |-+|.+.|.... -+.++...+.+|+.||+.||.|||..| +|||-||||+|||+
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 56789999999 778888875433 356888999999999999999999987 99999999999997
No 395
>cd00180 PKc Catalytic domain of Protein Kinases. Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which
Probab=99.94 E-value=1.8e-25 Score=204.23 Aligned_cols=196 Identities=36% Similarity=0.579 Sum_probs=161.1
Q ss_pred cCccCceEEEEEEEc-CCcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEecCCCChhh
Q 048517 169 LGQGGFGSVYKGQLH-TGRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEYMPNGSLDR 231 (453)
Q Consensus 169 LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~gsL~~ 231 (453)
||+|++|.||++... +|+.+++|++...... .+.+.+| +++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999965 4899999999876542 3334333 3444555567899999999999999
Q ss_pred hhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-CCceEEEecCCccccCCCCCceeecc
Q 048517 232 HIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVSISD 310 (453)
Q Consensus 232 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~ 310 (453)
++.... ..+++..+..++.++++++.+||+. +++|+||+|.||+++. +..++|+|||.+........ ....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 884321 4689999999999999999999998 9999999999999999 89999999999987654321 1233
Q ss_pred cCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHH
Q 048517 311 TRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESM 390 (453)
Q Consensus 311 ~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 390 (453)
..+...|++||.+... ...+.++|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l-------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL-------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence 5578899999988653 3678899999999999999
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 391 IARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 391 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 468889999999999999999999864
No 396
>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.94 E-value=1.2e-27 Score=219.15 Aligned_cols=246 Identities=22% Similarity=0.302 Sum_probs=168.6
Q ss_pred hcccCccCceEEEEEEE-cCCcEEEEEEecCC---CCCHHHHHHHH--hcccccCc-----------------ceEEEEE
Q 048517 166 THKLGQGGFGSVYKGQL-HTGRLIAVKMMENS---KFSAEEFINEL--LGLCSEGF-----------------KRALVYE 222 (453)
Q Consensus 166 ~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~---~~~~~~~i~el--~g~~~~~~-----------------~~~lv~E 222 (453)
.+-||.|+||.||.... ++|+.||.|++.+- -....++..|+ +.++..++ ..|++.|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 36799999999999985 48999999988652 22334455553 22222211 2356777
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 302 (453)
.| ..+|.+.|. ....|+-+.+.-+.+||++||.|||+. +|+||||||.|.|++.|...||+|||+++....+
T Consensus 138 Lm-QSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 138 LM-QSDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HH-Hhhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence 77 456777663 446799999999999999999999998 9999999999999999999999999999987655
Q ss_pred CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccc-------hHHHHHHhhh
Q 048517 303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------PSWVYDQLNK 375 (453)
Q Consensus 303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~-------~~~~~~~l~~ 375 (453)
+.. .++...-|-.|.|||.+.+. ..|+.+.||||.||++.||+.++--|.....-+.-..+ ....++...+
T Consensus 210 ~~~-hMTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 210 DRL-NMTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhh-hhHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 433 23555678899999999885 58999999999999999999888666433221100000 0001111111
Q ss_pred CCC-------ccccch-----hhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517 376 GGD-------LELRNV-----TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421 (453)
Q Consensus 376 ~~~-------~~~~~~-----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le 421 (453)
|.. ....+. ...+..-...-..+...++..+|+.|.+.++.+..+.
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 100 000000 0001111223445667788999999999999887664
No 397
>PLN00181 protein SPA1-RELATED; Provisional
Probab=99.93 E-value=8.8e-26 Score=249.10 Aligned_cols=209 Identities=16% Similarity=0.187 Sum_probs=143.9
Q ss_pred CcEEEEEEecCCCCCHH-HHHHHHhcccc-------cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHH
Q 048517 185 GRLIAVKMMENSKFSAE-EFINELLGLCS-------EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTA 256 (453)
Q Consensus 185 g~~VAVK~l~~~~~~~~-~~i~el~g~~~-------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia 256 (453)
...||+--..+.+...+ +++..+++.+. +....+.++||+ +++|.++|.. ....+++.+++.++.||+
T Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~ 90 (793)
T PLN00181 15 TSGVSEFCTDGSKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIV 90 (793)
T ss_pred cccccccCCCccchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHH
Confidence 34466655555444444 68888888772 223567788987 6699999843 235699999999999999
Q ss_pred HHHHHhHcCCCCceeecccCCcceEEcC-------------------CCceEEEecCCccccCCCCC-------------
Q 048517 257 RGIEYLHNGCDVCILHFDIKPHNILLDH-------------------NFIPKVSDFGLAKFHPKEND------------- 304 (453)
Q Consensus 257 ~gL~yLH~~~~~~ivH~Dikp~NILl~~-------------------~~~~kl~DFGla~~~~~~~~------------- 304 (453)
+||.|||++ +|+||||||+||||+. ++.+|++|||+++.......
T Consensus 91 ~al~~lH~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~ 167 (793)
T PLN00181 91 EIVNAAHSQ---GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQP 167 (793)
T ss_pred HHHHHHHhC---CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCC
Confidence 999999998 9999999999999954 45566777777654211000
Q ss_pred -ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccc
Q 048517 305 -FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRN 383 (453)
Q Consensus 305 -~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 383 (453)
........||+.|||||++.+. .++.++|||||||+||||++|..|+..... ....+..... ..
T Consensus 168 ~~~~~~~~~gt~~Y~APE~~~~~--~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----------~~~~~~~~~~-~~-- 232 (793)
T PLN00181 168 FPMKQILAMEMSWYTSPEEDNGS--SSNCASDVYRLGVLLFELFCPVSSREEKSR----------TMSSLRHRVL-PP-- 232 (793)
T ss_pred CcccccccCCCcceEChhhhccC--CCCchhhhhhHHHHHHHHhhCCCchhhHHH----------HHHHHHHhhc-Ch--
Confidence 0001123578899999998764 789999999999999999998877542110 1111111100 00
Q ss_pred hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 384 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 384 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
...........++.+||+.+|.+||||.|+++
T Consensus 233 ---~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 233 ---QILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred ---hhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 00011233567888999999999999999986
No 398
>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]
Probab=99.92 E-value=8.2e-25 Score=200.59 Aligned_cols=240 Identities=20% Similarity=0.310 Sum_probs=176.4
Q ss_pred HhhhhhcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHHH-hc---------------ccccCcceEEEEEe
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINEL-LG---------------LCSEGFKRALVYEY 223 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~el-~g---------------~~~~~~~~~lv~E~ 223 (453)
..|++.+.||+|.||.+-++.++ +++.+++|.+........+|.+|+ ++ .++..+...+++||
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 35677889999999999999965 678899999998888888998883 22 23344456789999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE-cCC-CceEEEecCCccccCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL-DHN-FIPKVSDFGLAKFHPK 301 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl-~~~-~~~kl~DFGla~~~~~ 301 (453)
++.|+|...+ ....+.+.....++.|+++||.|+|++ ++||||||.+|||+ +.| -.+||+|||+++..+.
T Consensus 104 aP~gdL~snv-----~~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 104 APRGDLRSNV-----EAAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred Cccchhhhhc-----CcccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999998766 235677888899999999999999999 99999999999999 444 4799999999875432
Q ss_pred CCCceeecccCCCCCccChhhhccc---CCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCC
Q 048517 302 ENDFVSISDTRGTIGYLAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD 378 (453)
Q Consensus 302 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~ 378 (453)
.- .-..-+..|.+||..... .....+.+|||.||++++.++||+.|+.... ...-+.|-+.+..++..
T Consensus 176 tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~----~~d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 176 TV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS----IMDKPYWEWEQWLKRKN 246 (378)
T ss_pred ee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh----ccCchHHHHHHHhcccC
Confidence 11 222356679999977532 1245778999999999999999999997322 12223344444444333
Q ss_pred ccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517 379 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 420 (453)
Q Consensus 379 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 420 (453)
..++ ..-...+.++..+.++-+..++++|=.+.++-++-
T Consensus 247 ~~~P---~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 247 PALP---KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred ccCc---hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 2221 12223456677788888999999996666666554
No 399
>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]
Probab=99.92 E-value=2.6e-25 Score=219.19 Aligned_cols=254 Identities=20% Similarity=0.285 Sum_probs=185.5
Q ss_pred chhHHHHHhhhhhcccCccCceEEEEEEE-cCCcEEEEEEecCCCCC------HHHHHHH--------------Hhcccc
Q 048517 154 LLPEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGRLIAVKMMENSKFS------AEEFINE--------------LLGLCS 212 (453)
Q Consensus 154 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~~-~~g~~VAVK~l~~~~~~------~~~~i~e--------------l~g~~~ 212 (453)
.+.|+...+|.+....|+|-|++|-.|.. ..|+.||||++.+...- .-+++.+ |+..+.
T Consensus 425 ~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 425 RIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred ehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 45688889999999999999999999984 45889999999874221 1123332 555667
Q ss_pred cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC-CceEEE
Q 048517 213 EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVS 291 (453)
Q Consensus 213 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~-~~~kl~ 291 (453)
..++++||+|-+ ..+|.+.|... ..+..|....+..++.|+.-||..|-.. +|+|.||||.|||+++. ..+|||
T Consensus 505 hknHLClVFE~L-slNLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 505 HKNHLCLVFEPL-SLNLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred hcceeEEEehhh-hchHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeec
Confidence 788999999988 67888887433 3446788999999999999999999997 99999999999999874 578999
Q ss_pred ecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCcccccc-------cc
Q 048517 292 DFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-------AY 364 (453)
Q Consensus 292 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~-------~~ 364 (453)
|||.|......+ .+...-+..|.|||.+.+. +|+...|+||.||.||||.||+--|........- .-
T Consensus 580 DfGSA~~~~ene----itPYLVSRFYRaPEIiLG~--~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 580 DFGSASFASENE----ITPYLVSRFYRAPEIILGL--PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred cCcccccccccc----ccHHHHHHhccCcceeecC--cccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 999998765543 2333456689999999985 8899999999999999999999877654332111 11
Q ss_pred chHHHH-------HHhhhC--------------CC------ccc-cc----------hhhhHHHHHHHHHHHHHHhcccC
Q 048517 365 FPSWVY-------DQLNKG--------------GD------LEL-RN----------VTEIESMIARKLCMIGLWCIQVK 406 (453)
Q Consensus 365 ~~~~~~-------~~l~~~--------------~~------~~~-~~----------~~~~~~~~~~~l~~l~~~Cl~~~ 406 (453)
+|.-+. +++.+. .. +.+ .+ ..........++..|+..|+..|
T Consensus 654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 111111 011000 00 000 00 01122334467889999999999
Q ss_pred CCCCCCHHHHHH
Q 048517 407 AADRPSMTKVLE 418 (453)
Q Consensus 407 p~~RPs~~evl~ 418 (453)
|++|.|..+.++
T Consensus 734 P~KRit~nqAL~ 745 (752)
T KOG0670|consen 734 PEKRITVNQALK 745 (752)
T ss_pred hhhcCCHHHHhc
Confidence 999999999875
No 400
>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]
Probab=99.92 E-value=3.7e-25 Score=198.40 Aligned_cols=244 Identities=18% Similarity=0.287 Sum_probs=173.0
Q ss_pred HhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCC-CHHHHHHH------------Hhccccc--CcceEEEEEec
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKF-SAEEFINE------------LLGLCSE--GFKRALVYEYM 224 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~-~~~~~i~e------------l~g~~~~--~~~~~lv~E~~ 224 (453)
..|++.+++|+|.++.||.|. ..+++.++||+++.-+. ...+.+.- |+....+ .....||+||.
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v 117 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYV 117 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhh
Confidence 356778999999999999998 66788999999987332 22222222 2222222 33457999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-CCceEEEecCCccccCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~~ 303 (453)
.|.+..... ..|+-..+...+.+++.||.|+|+. +|.|||+||+|+++|. .-..+|.|+|+|.++....
T Consensus 118 ~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 118 NNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred ccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 988875544 5678888999999999999999998 9999999999999986 5679999999999887655
Q ss_pred CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccch------HHHHHHhhh--
Q 048517 304 DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP------SWVYDQLNK-- 375 (453)
Q Consensus 304 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~------~~~~~~l~~-- 375 (453)
.+ +....+..|--||.+.. +..+...-|+|||||+|.+|+..+.||.-..+...+.--. ......+.+
T Consensus 188 eY---nVRVASRyfKGPELLVd-y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 188 EY---NVRVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred ee---eeeeehhhcCCchheee-chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 43 33446677889998875 3578889999999999999999999997654432221000 001111111
Q ss_pred -------------CCCccccc--hhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 376 -------------GGDLELRN--VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 376 -------------~~~~~~~~--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
..+..... ..+...-...+..+++...|..|.++|||++|..+
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 11100000 00111123367888999999999999999999865
No 401
>smart00221 STYKc Protein kinase; unclassified specificity. Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.
Probab=99.92 E-value=6.2e-24 Score=197.48 Aligned_cols=184 Identities=33% Similarity=0.481 Sum_probs=148.7
Q ss_pred hhhcccCccCceEEEEEEEcC-CcEEEEEEecCCCCC--HHHHHHH--------------HhcccccCcceEEEEEecCC
Q 048517 164 HFTHKLGQGGFGSVYKGQLHT-GRLIAVKMMENSKFS--AEEFINE--------------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~~~-g~~VAVK~l~~~~~~--~~~~i~e--------------l~g~~~~~~~~~lv~E~~~~ 226 (453)
.+.+.||+|++|.||++...+ ++.+|+|.+...... .+.+..| +++++......++++||+++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 456789999999999999764 899999999875432 3333333 45566666788999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
++|.+++.... ..+++..+..++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 82 ~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 82 GDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 99999885322 1188999999999999999999998 9999999999999999999999999999877554200
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCC
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM 355 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~ 355 (453)
......++..|++||.+. ....++.++|||+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 113345778899999984 224778899999999999999999999954
No 402
>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]
Probab=99.91 E-value=4.2e-24 Score=206.91 Aligned_cols=183 Identities=25% Similarity=0.355 Sum_probs=143.6
Q ss_pred hhhhcccCccCceEEEEEEEc----CCcEEEEEEecCCCC-CH-------------HHHHHHHhcccccCcceEEEEEec
Q 048517 163 NHFTHKLGQGGFGSVYKGQLH----TGRLIAVKMMENSKF-SA-------------EEFINELLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~----~g~~VAVK~l~~~~~-~~-------------~~~i~el~g~~~~~~~~~lv~E~~ 224 (453)
+...++||+|.|++||++.+. .++.||+|.+..... .. ...+..+.++...++...+|+||+
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~ 117 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYF 117 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEeccc
Confidence 445689999999999999843 477899998876322 11 122333667777888999999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-CCceEEEecCCccccCCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKEN 303 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~~ 303 (453)
+.-...+++ ..++...+..++..+..||.++|++ +||||||||+|+|.+. ...-.|.|||+|.......
T Consensus 118 ~H~~f~~l~-------~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 118 EHDRFRDLY-------RSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred CccCHHHHH-------hcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 999988877 4577889999999999999999998 9999999999999986 4667899999997211000
Q ss_pred ---------------------------------Ccee---------ecccCCCCCccChhhhcccCCCCCccchHHHHHH
Q 048517 304 ---------------------------------DFVS---------ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGM 341 (453)
Q Consensus 304 ---------------------------------~~~~---------~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gv 341 (453)
.+.. .....||+||.|||++.+. +.-+.++||||.|+
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiDiws~GV 266 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCccceeeccc
Confidence 0000 0112499999999999874 67899999999999
Q ss_pred HHHHHHcCCCCCCCC
Q 048517 342 VLLEMAGGRRNSNMN 356 (453)
Q Consensus 342 vl~elltg~~p~~~~ 356 (453)
+++.+++++.||...
T Consensus 267 I~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFKA 281 (418)
T ss_pred eeehhhccccccccC
Confidence 999999999998643
No 403
>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]
Probab=99.90 E-value=2.3e-24 Score=214.95 Aligned_cols=177 Identities=24% Similarity=0.313 Sum_probs=147.9
Q ss_pred hcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCH--------------------------HHHHHHHhcccccCcceE
Q 048517 166 THKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSA--------------------------EEFINELLGLCSEGFKRA 218 (453)
Q Consensus 166 ~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~--------------------------~~~i~el~g~~~~~~~~~ 218 (453)
.+.||+|+||.|+.+.++ +...|+||++.+++... ++.|.+++.+++++...+
T Consensus 566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy 645 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY 645 (772)
T ss_pred eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence 367999999999999965 56789999987643221 244666999999999999
Q ss_pred EEEEec-CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517 219 LVYEYM-PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297 (453)
Q Consensus 219 lv~E~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 297 (453)
|++|-. ++.+|.++| ..+..+++++..-|++|++.|+++||++ +|||||||-+|+.+|.+|.+||.|||.|.
T Consensus 646 l~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 646 LETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred EEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchh
Confidence 999987 566888888 3446799999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 048517 298 FHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN 354 (453)
Q Consensus 298 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~ 354 (453)
..... .....+||.+|.|||++.+. ......-|||++|++||.++....|+.
T Consensus 719 ~~ksg----pfd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 719 YTKSG----PFDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhcCC----CcceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCc
Confidence 65433 22456899999999999875 234567899999999999998887763
No 404
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=99.90 E-value=3.4e-24 Score=216.92 Aligned_cols=236 Identities=22% Similarity=0.252 Sum_probs=177.1
Q ss_pred hhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCC---------------HHHHHHHHhcccccCcceEEEEEecCC
Q 048517 163 NHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS---------------AEEFINELLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~---------------~~~~i~el~g~~~~~~~~~lv~E~~~~ 226 (453)
|.+...+|.|.||.|||++ .++++..|||+++..... .+..+..++|.+....+.++.|||+.+
T Consensus 17 yellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgg 96 (829)
T KOG0576|consen 17 YELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGG 96 (829)
T ss_pred hhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCC
Confidence 4566789999999999999 668999999998763211 123344578888888899999999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|+|.+..+ ....++..++...+++..+||+|||+. +=+|||||-.|||+++.+.+|++|||.+..+... ..
T Consensus 97 gslQdiy~----~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~ 167 (829)
T KOG0576|consen 97 GSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IA 167 (829)
T ss_pred Ccccceee----ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh--hh
Confidence 99988764 236789999999999999999999998 8899999999999999999999999998655321 11
Q ss_pred eecccCCCCCccChhhhc-ccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchh
Q 048517 307 SISDTRGTIGYLAPELIS-RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVT 385 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~-~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 385 (453)
......||+.|||||+.. ...+.+..++|||+.|+...|+-.-++|...... .-+.....+... +.. ..
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp--------mr~l~LmTkS~~-qpp-~l 237 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--------MRALFLMTKSGF-QPP-TL 237 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch--------HHHHHHhhccCC-CCC-cc
Confidence 224567999999999763 3347889999999999999999877766432111 001111111111 110 01
Q ss_pred hhHHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 048517 386 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 417 (453)
Q Consensus 386 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl 417 (453)
.......+.+-++++.|+..+|++|||++..+
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 12233456788999999999999999997654
No 405
>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]
Probab=99.88 E-value=8.2e-23 Score=191.57 Aligned_cols=231 Identities=24% Similarity=0.248 Sum_probs=160.0
Q ss_pred cccCccCceEEEEEE-EcCCcEEEEEEecCCCC---CHHHHHHH--------------Hhccccc------CcceEEEEE
Q 048517 167 HKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKF---SAEEFINE--------------LLGLCSE------GFKRALVYE 222 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~---~~~~~i~e--------------l~g~~~~------~~~~~lv~E 222 (453)
..+|.|.- .|-.+. .-.+++||+|++...-. ..++.-.| ++.++.. -...++|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 34677766 454444 23588999998754211 11111111 3333322 224578999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 302 (453)
+| .++|...+. ..++-+++..|..|+..|++|||+. +|+||||||+||++..+..+||.|||+|+....+
T Consensus 102 ~m-~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 102 LM-DANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hh-hhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc
Confidence 99 667877664 3467788899999999999999998 9999999999999999999999999999865443
Q ss_pred CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHH------------
Q 048517 303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY------------ 370 (453)
Q Consensus 303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~------------ 370 (453)
..++....|..|.|||++.+. ++..++||||.||++.||++|+--|..... +..|..
T Consensus 172 ---~~mtpyVvtRyyrapevil~~--~~ke~vdiwSvGci~gEli~~~Vlf~g~d~------idQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 172 ---FMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELILGTVLFPGKDH------IDQWNKIIEQLGTPDPSF 240 (369)
T ss_pred ---cccCchhheeeccCchheecc--CCcccchhhhhhhHHHHHhhceEEecCchH------HHHHHHHHHHhcCCCHHH
Confidence 245667789999999999986 599999999999999999999987763322 111211
Q ss_pred -HHhhh-----------CC---------CccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 371 -DQLNK-----------GG---------DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 371 -~~l~~-----------~~---------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
+++.. -. +.......+.+.........++.+||-.+|++|.|+.+++..
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 11100 00 000001111122233457789999999999999999999874
No 406
>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]
Probab=99.86 E-value=3.5e-22 Score=183.40 Aligned_cols=237 Identities=20% Similarity=0.361 Sum_probs=176.3
Q ss_pred hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCC---CCHHHHHH--------------HHhcccccCcceEEEEEec
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSK---FSAEEFIN--------------ELLGLCSEGFKRALVYEYM 224 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~---~~~~~~i~--------------el~g~~~~~~~~~lv~E~~ 224 (453)
.-++.-+|.+..-|..|+|+++ |..+++|+++... ...++|-. .++|-|.......++..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 3456678999999999999998 5556668876522 22233333 3788898888899999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEE--ecCCccccCCC
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS--DFGLAKFHPKE 302 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~--DFGla~~~~~~ 302 (453)
+.|||...|+.. .+...+-.++.+++.++|+|++|||+- ++-|...-+.++.+++|++.+++|+ |--.+
T Consensus 270 p~gslynvlhe~--t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfs------ 340 (448)
T KOG0195|consen 270 PFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFS------ 340 (448)
T ss_pred cchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceee------
Confidence 999999999754 345677889999999999999999996 4456667899999999999998886 21111
Q ss_pred CCceeecccCCCCCccChhhhcccCCCC-CccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517 303 NDFVSISDTRGTIGYLAPELISRNFGTV-SCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381 (453)
Q Consensus 303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 381 (453)
++ .....-.|.||+||.+++..... -.++|+|||+++||||.|+..||.....-+. -.+...++-+..
T Consensus 341 --fq-e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec-------gmkialeglrv~- 409 (448)
T KOG0195|consen 341 --FQ-EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC-------GMKIALEGLRVH- 409 (448)
T ss_pred --ee-ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-------hhhhhhcccccc-
Confidence 11 12334578899999998753322 4589999999999999999999965432110 111222222222
Q ss_pred cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCC
Q 048517 382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI 424 (453)
Q Consensus 382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~ 424 (453)
.+..+++.+.+++.-|+..||.+||.+..|+-.||+..
T Consensus 410 -----ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 410 -----IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -----CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 44456788999999999999999999999999999753
No 407
>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.84 E-value=5.7e-20 Score=182.09 Aligned_cols=251 Identities=20% Similarity=0.233 Sum_probs=172.4
Q ss_pred hhhhhcccCccCceEEEEEEEcC--CcEEEEEEecCCCCCH------H-HHHHHHh------cc------c-ccCcceEE
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLHT--GRLIAVKMMENSKFSA------E-EFINELL------GL------C-SEGFKRAL 219 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~~--g~~VAVK~l~~~~~~~------~-~~i~el~------g~------~-~~~~~~~l 219 (453)
.+.+.++||+|+||.||++.... ...+|+|......... + ..+..+. ++ . ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 56778999999999999999654 3579999876532211 1 2222232 22 2 24446789
Q ss_pred EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC-----CceEEEecC
Q 048517 220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-----FIPKVSDFG 294 (453)
Q Consensus 220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~-----~~~kl~DFG 294 (453)
||+.. +-+|.+..... ....++..+.+.|+.|++.+|++||+. +++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~--~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRN--PPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhC--CCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99987 88998865322 257899999999999999999999998 99999999999999754 468999999
Q ss_pred Ccc--ccCCCCC---ce--e-ecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccch
Q 048517 295 LAK--FHPKEND---FV--S-ISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP 366 (453)
Q Consensus 295 la~--~~~~~~~---~~--~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 366 (453)
+++ .+..... .. . ....+||..|.++++..+. ..+.+.|+||++.++.|+..|..|+..........
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~--e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~--- 247 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI--EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS--- 247 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC--ccCCchhhhhHHHHHHHHhcCCCCCccccccchHH---
Confidence 999 3322221 00 1 1235699999999998875 78999999999999999999999885433221100
Q ss_pred HHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCCCC
Q 048517 367 SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMP 430 (453)
Q Consensus 367 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~~p 430 (453)
............ . ........+.++...+-..+..++|....+.+.|+.........
T Consensus 248 --~~~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~ 304 (322)
T KOG1164|consen 248 --KFEKDPRKLLTD--R---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSK 304 (322)
T ss_pred --HHHHHhhhhccc--c---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCC
Confidence 001111100000 0 00111234555666666689999999999999987765554333
No 408
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.82 E-value=1.2e-20 Score=199.58 Aligned_cols=238 Identities=21% Similarity=0.246 Sum_probs=168.3
Q ss_pred hhcccCccCceEEEEEE-EcCCcEEEEEEecC---CCCCHHHHHH----H--------------HhcccccCcceEEEEE
Q 048517 165 FTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMEN---SKFSAEEFIN----E--------------LLGLCSEGFKRALVYE 222 (453)
Q Consensus 165 ~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~---~~~~~~~~i~----e--------------l~g~~~~~~~~~lv~E 222 (453)
....+|.|.+|.|+... .......+.|.... .....+++.. | .+..+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 34679999999887776 33444444443321 1112222211 1 2222223333334599
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 302 (453)
|+++ +|...+- ....++-.++..+.+|+..|+.|||+. +|.|||+|++|++++.++.+||+|||.+..+...
T Consensus 402 ~~~~-Dlf~~~~----~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVM----SNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHh----cccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 9988773 224688899999999999999999998 9999999999999999999999999999876544
Q ss_pred CCc--eeecccCCCCCccChhhhcccCCCC-CccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCc
Q 048517 303 NDF--VSISDTRGTIGYLAPELISRNFGTV-SCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL 379 (453)
Q Consensus 303 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~ 379 (453)
... .......|+..|+|||.+.+. .+ ....||||.|+++..|++|+.||........+. .+........
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~--~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~~~~~~~~ 545 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGK--EYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTNNYSDQRN 545 (601)
T ss_pred cchhhhhhcCcccCCcCcCccccccc--ccCcchhhhhhccceEEEEecCCCccccccccccch------hhhccccccc
Confidence 332 445677899999999999875 44 458999999999999999999987654332111 1111111112
Q ss_pred cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 380 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 380 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
...........++.....++.++|+++|.+|.||++|++
T Consensus 546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 222233356677788899999999999999999999986
No 409
>PRK09188 serine/threonine protein kinase; Provisional
Probab=99.82 E-value=3.8e-20 Score=184.24 Aligned_cols=151 Identities=21% Similarity=0.187 Sum_probs=109.8
Q ss_pred HHhhhhhcccCccCceEEEEEEEc--CCcEEEEEEecCCCC------CHHHHHHHH-----------h-cccccCcceEE
Q 048517 160 AVTNHFTHKLGQGGFGSVYKGQLH--TGRLIAVKMMENSKF------SAEEFINEL-----------L-GLCSEGFKRAL 219 (453)
Q Consensus 160 ~~~~~~~~~LG~G~fG~Vy~g~~~--~g~~VAVK~l~~~~~------~~~~~i~el-----------~-g~~~~~~~~~l 219 (453)
...|.+.+.||+|+||+||+|+.. +++.||||++..... ..+.+.+|. . .+. .....++
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~-~~~~~~L 95 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLL-ATGKDGL 95 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEE-EcCCcEE
Confidence 345777899999999999999854 578889998753211 123344441 1 111 2235789
Q ss_pred EEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeeccc-CCcceEEcCCCceEEEecCCccc
Q 048517 220 VYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDI-KPHNILLDHNFIPKVSDFGLAKF 298 (453)
Q Consensus 220 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Di-kp~NILl~~~~~~kl~DFGla~~ 298 (453)
||||+++++|.. + . .. . ...++.+++++|.|||+. +|+|||| ||+|||++.++.+||+|||+|+.
T Consensus 96 VmE~~~G~~L~~-~-~--~~-~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 96 VRGWTEGVPLHL-A-R--PH-G------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred EEEccCCCCHHH-h-C--cc-c------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 999999999962 2 1 00 0 146788999999999998 9999999 99999999999999999999997
Q ss_pred cCCCCCcee------ecccCCCCCccChhhhcc
Q 048517 299 HPKENDFVS------ISDTRGTIGYLAPELISR 325 (453)
Q Consensus 299 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 325 (453)
......... .....+++.|+|||++..
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 755432111 134568888999998864
No 410
>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]
Probab=99.82 E-value=7.6e-20 Score=185.55 Aligned_cols=216 Identities=21% Similarity=0.352 Sum_probs=164.2
Q ss_pred HHHHHHHHhcccccCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCce-eecccCCc
Q 048517 200 AEEFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCI-LHFDIKPH 278 (453)
Q Consensus 200 ~~~~i~el~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i-vH~Dikp~ 278 (453)
.++.++.++|.+.++...+.|.+|+..|+|.+.+.. ....++|.....+.++|+.||+|||+. +| .|+.+++.
T Consensus 5 ~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s~ 78 (484)
T KOG1023|consen 5 DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKSS 78 (484)
T ss_pred chhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeeccc
Confidence 467788999999999999999999999999999954 346789999999999999999999987 55 99999999
Q ss_pred ceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhccc--CC---CCCccchHHHHHHHHHHHHcCCCCC
Q 048517 279 NILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN--FG---TVSCKSDVYGFGMVLLEMAGGRRNS 353 (453)
Q Consensus 279 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~---~~s~k~DV~S~Gvvl~elltg~~p~ 353 (453)
|+++|.++.+|++|||+..+..............-..-|.|||.+... .. ..+.+.||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999999876431111111222344569999998763 11 2577899999999999999999999
Q ss_pred CCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCC
Q 048517 354 NMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID 425 (453)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~ 425 (453)
+........ ..+...+.++.....+.......+....+..++..||..+|++||++.+|-..++....
T Consensus 159 ~~~~~~~~~----~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 159 DLRNLVEDP----DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccCCh----HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 875543322 22333344422222222222122444578999999999999999999999999887554
No 411
>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]
Probab=99.81 E-value=1.3e-18 Score=168.55 Aligned_cols=247 Identities=28% Similarity=0.349 Sum_probs=173.5
Q ss_pred hhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCC----HHHHHHH---------------HhcccccCcceEEEEEe
Q 048517 163 NHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS----AEEFINE---------------LLGLCSEGFKRALVYEY 223 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~----~~~~i~e---------------l~g~~~~~~~~~lv~E~ 223 (453)
+.....||.|+||.||++... ..+|+|.+...... ...+..| +...+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 345678999999999999977 88999998764332 3344433 12223333346899999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC-ceEEEecCCccccCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKE 302 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~~~~ 302 (453)
+.++++.+.+...... ..+.......+..+++.++.|+|+. +++|||+||+||+++... .++++|||+++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999998655322111 3688889999999999999999998 899999999999999988 7999999999865544
Q ss_pred CCce----eecccCCCCCccChhhhcccC-CCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCC
Q 048517 303 NDFV----SISDTRGTIGYLAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG 377 (453)
Q Consensus 303 ~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~ 377 (453)
.... ......||..|+|||.+.... ...+...|+||+|++++++++|..|+...... .......+.+....
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~ 231 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILELP 231 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHhcC
Confidence 3221 235667999999999997631 36888999999999999999999996543321 00111222222221
Q ss_pred Cc--cccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 048517 378 DL--ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 419 (453)
Q Consensus 378 ~~--~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 419 (453)
.. ...............+.+++..|+..+|..|.++.+....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11 0000000001223467788899999999999999887764
No 412
>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c
Probab=99.81 E-value=2.6e-19 Score=163.63 Aligned_cols=126 Identities=17% Similarity=0.195 Sum_probs=94.9
Q ss_pred hcccCccCceEEEEEEEcCCcEEEEEEecCCCC---C------------------------------HHHHHHHHhcccc
Q 048517 166 THKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF---S------------------------------AEEFINELLGLCS 212 (453)
Q Consensus 166 ~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~---~------------------------------~~~~i~el~g~~~ 212 (453)
...||+|+||.||+|...+|+.||||+++.+.. . +-+.+..+.....
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 367999999999999987899999999875421 1 0112222322111
Q ss_pred ------cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHh-HcCCCCceeecccCCcceEEcCC
Q 048517 213 ------EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL-HNGCDVCILHFDIKPHNILLDHN 285 (453)
Q Consensus 213 ------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dikp~NILl~~~ 285 (453)
.....++||||++++++..... ....+++.+...++.|++.+|.|| |+. +|+||||||+|||++ +
T Consensus 82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILLKSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEecCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence 0122379999999887765432 124688999999999999999999 676 999999999999998 4
Q ss_pred CceEEEecCCcccc
Q 048517 286 FIPKVSDFGLAKFH 299 (453)
Q Consensus 286 ~~~kl~DFGla~~~ 299 (453)
+.++|+|||+|...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999999743
No 413
>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.81 E-value=7.9e-19 Score=165.60 Aligned_cols=249 Identities=18% Similarity=0.263 Sum_probs=170.4
Q ss_pred hhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCC---CHHHH--HHH---------HhcccccCcceEEEEEecCC
Q 048517 162 TNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKF---SAEEF--INE---------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~---~~~~~--i~e---------l~g~~~~~~~~~lv~E~~~~ 226 (453)
-|.+.++||+|.||.++.|+ +-++++||||.-..... ...++ -+- ++-|..++.+..||+|.+ +
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G 107 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G 107 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence 45677999999999999999 66799999997544221 12222 111 344456777888999998 7
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC-----CceEEEecCCccccCC
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-----FIPKVSDFGLAKFHPK 301 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~-----~~~kl~DFGla~~~~~ 301 (453)
-||+|... --+..|+.+++..||+|++.-++|+|++ .+|.|||||+|.||... -.+.+.|||+|+.+..
T Consensus 108 PSLEDLFD---~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 108 PSLEDLFD---LCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred cCHHHHHH---HhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 78887662 2357899999999999999999999998 99999999999999643 3578999999998755
Q ss_pred CCCc-----eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517 302 ENDF-----VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG 376 (453)
Q Consensus 302 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~ 376 (453)
..+. .......||.+||+-....+. .-+.+-|.=|+|-++++.+-|..||....... -+..++.+.+.
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGr--EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t-----nK~kYeKIGe~ 254 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKADT-----NKEKYEKIGET 254 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccc--hhhhhhhHHHhhhhhhhhccCCCccccccCcc-----hHHHHHHhccc
Confidence 4332 222345699999998877765 67889999999999999999999997543221 11133444332
Q ss_pred CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCC
Q 048517 377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 426 (453)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~ 426 (453)
.... ...+.-..++.++..-+.-.-..+-.+-|...-+...+...++.
T Consensus 255 Kr~T--~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 255 KRST--PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred cccC--CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 2211 11122222334444444444445555666655444444443333
No 414
>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.79 E-value=3.9e-19 Score=160.97 Aligned_cols=260 Identities=20% Similarity=0.232 Sum_probs=174.8
Q ss_pred HHHHhhhhhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCC----HHHHHHH----------HhcccccCcceEEEEE
Q 048517 158 IIAVTNHFTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS----AEEFINE----------LLGLCSEGFKRALVYE 222 (453)
Q Consensus 158 ~~~~~~~~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~----~~~~i~e----------l~g~~~~~~~~~lv~E 222 (453)
+....|.+.++||.|+||.+|.|. ..+|..||||+-...... .+.-+-+ +..+..++....+||+
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 344567788999999999999998 778999999986653221 1111111 4455677788899999
Q ss_pred ecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC---CceEEEecCCcccc
Q 048517 223 YMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN---FIPKVSDFGLAKFH 299 (453)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~---~~~kl~DFGla~~~ 299 (453)
.+ +-||++...- -...++..+++-.+-|++.-++|+|.. +++||||||+|.|..-+ ..+.+.|||+|+.+
T Consensus 92 LL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 92 LL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence 98 7788876522 235789999999999999999999998 99999999999999654 35789999999977
Q ss_pred CCCCCc-----eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhh
Q 048517 300 PKENDF-----VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN 374 (453)
Q Consensus 300 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~ 374 (453)
....+. .......||..|.+-....+. .-+.+.|+=|+|.+|..+--|..|+......+.. -.++.+.
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~--eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~-----QKyEkI~ 237 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGI--EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK-----QKYEKIS 237 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhh--hhhhhhhhhhhcceeeeeecCCCcccccchhhHH-----HHHHHHH
Confidence 543221 122344699999988877653 5678899999999999999999999764432211 1222222
Q ss_pred hCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhCCCCCCCCCCCC
Q 048517 375 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPKP 433 (453)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~~~~~~~~p~~p 433 (453)
+...... ....-...+.++...+.-|-+.-=++-|...-+-++++-....+.....-
T Consensus 238 EkK~s~~--ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~ 294 (341)
T KOG1163|consen 238 EKKMSTP--IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDY 294 (341)
T ss_pred HhhcCCC--HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCe
Confidence 2211100 01122223344555666666666666665554444444333333333333
No 415
>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro
Probab=99.78 E-value=1.8e-18 Score=158.24 Aligned_cols=128 Identities=20% Similarity=0.214 Sum_probs=94.8
Q ss_pred hcccCccCceEEEEEEEcCCcEEEEEEecCCCCC----------------------HH-----------HHHHHHhcccc
Q 048517 166 THKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS----------------------AE-----------EFINELLGLCS 212 (453)
Q Consensus 166 ~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~----------------------~~-----------~~i~el~g~~~ 212 (453)
...||+|+||.||+|+..+|+.||||++...... .. +.+.++.....
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3579999999999999778999999998764211 00 11111211110
Q ss_pred c------CcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHc-CCCCceeecccCCcceEEcCC
Q 048517 213 E------GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHN 285 (453)
Q Consensus 213 ~------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dikp~NILl~~~ 285 (453)
. ....+|||||++++++..... ....++......++.+++.++.+||+ . +|+||||||+|||++ +
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C
Confidence 0 012379999999886544321 12356778889999999999999999 7 999999999999999 8
Q ss_pred CceEEEecCCccccCC
Q 048517 286 FIPKVSDFGLAKFHPK 301 (453)
Q Consensus 286 ~~~kl~DFGla~~~~~ 301 (453)
+.++|+|||+++....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 8999999999986543
No 416
>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A.
Probab=99.76 E-value=2.8e-18 Score=164.24 Aligned_cols=218 Identities=22% Similarity=0.301 Sum_probs=139.9
Q ss_pred hhcccCccCceEEEEEEEc-CCcEEEEEEecCCCC----CHHHHHHHHhcc-----------------------------
Q 048517 165 FTHKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKF----SAEEFINELLGL----------------------------- 210 (453)
Q Consensus 165 ~~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~----~~~~~i~el~g~----------------------------- 210 (453)
..+.||.|+++.||.++.. +|+.+|||+...... ..+++.+|-+..
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 3467999999999999966 699999998765322 223333331110
Q ss_pred ----cccCc--------ceEEEEEecCCCChhhhh---hhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeeccc
Q 048517 211 ----CSEGF--------KRALVYEYMPNGSLDRHI---FSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDI 275 (453)
Q Consensus 211 ----~~~~~--------~~~lv~E~~~~gsL~~~l---~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Di 275 (453)
...+. ..+++|+-+ .++|.+.+ +........+....++.+..|+++.+++||+. +++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence 00010 124566666 56776664 33322223455556677889999999999998 9999999
Q ss_pred CCcceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhccc------CCCCCccchHHHHHHHHHHHHcC
Q 048517 276 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN------FGTVSCKSDVYGFGMVLLEMAGG 349 (453)
Q Consensus 276 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~s~k~DV~S~Gvvl~elltg 349 (453)
||+|++++.+|.++|+||+......... .....+..|.+||..... .-.++.+.|.|++|+++|.|..+
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999999999999998776543311 113456789999977542 12578899999999999999999
Q ss_pred CCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCC
Q 048517 350 RRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADR 410 (453)
Q Consensus 350 ~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R 410 (453)
+.|++......... | +. ..-. ++++.+..++..+|+.+|++|
T Consensus 247 ~lPf~~~~~~~~~~----~-----------~f---~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPE----W-----------DF---SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSG----G-----------GG---TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCcccccc----c-----------cc---hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99998765432211 1 11 1112 566788999999999999988
No 417
>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=99.74 E-value=2.7e-17 Score=178.00 Aligned_cols=182 Identities=23% Similarity=0.254 Sum_probs=142.8
Q ss_pred HHHHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCH----HHHHHH-----------HhcccccCcceEEEE
Q 048517 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA----EEFINE-----------LLGLCSEGFKRALVY 221 (453)
Q Consensus 157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~----~~~i~e-----------l~g~~~~~~~~~lv~ 221 (453)
++-...+.+.+.||+|+||+||+|...+|+.||+|+-+...... .+.+.+ +.....-.+.-+||+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 33344556678899999999999997779999999876543221 111111 222222234457999
Q ss_pred EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc-------CCCceEEEecC
Q 048517 222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD-------HNFIPKVSDFG 294 (453)
Q Consensus 222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~-------~~~~~kl~DFG 294 (453)
||.+.|||.+++. ..+..+|.....++.|+++.++.||.. +|||+||||+|.||. .+..++|+|||
T Consensus 774 ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 774 EYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 9999999999984 557789999999999999999999998 999999999999993 34578999999
Q ss_pred Cccc---cCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCC
Q 048517 295 LAKF---HPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 350 (453)
Q Consensus 295 la~~---~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~ 350 (453)
-+-- ++... ......+|-++-.+|+..+. .++..+|-|.++.+++-|+.|+
T Consensus 847 ~siDm~lfp~~~---~F~~~~~td~f~C~EM~~gr--pWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 847 RSIDMKLFPDGT---KFKAVWHTDLFDCIEMREGR--PWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred cceeeeEcCCCc---EEeeeeccccchhHHHhcCC--CCchhhhhHHHHHHHHHHHHHH
Confidence 9853 33332 23556788899999999886 8999999999999999999986
No 418
>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]
Probab=99.71 E-value=6.6e-18 Score=179.83 Aligned_cols=237 Identities=23% Similarity=0.269 Sum_probs=158.6
Q ss_pred hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCC--CCCHHHHHHHHhccc----------------ccCcceEEEEEe
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENS--KFSAEEFINELLGLC----------------SEGFKRALVYEY 223 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~--~~~~~~~i~el~g~~----------------~~~~~~~lv~E~ 223 (453)
..++.+.||.+.|=+|.+|+.+.|. |+||++-+. ....+.|.++|.+.- ...+..+||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 3456788999999999999998887 999988663 334455544432211 122233466666
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc--CC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PK 301 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~--~~ 301 (453)
. .-+|.|.| ....-+..-+..-|+.|++.||.-.|.. +|+|||||.+|||++.=.=+.|+||..-+.. +.
T Consensus 103 v-khnLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 V-KHNLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred H-hhhhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 6 34666666 3334567777888999999999999998 9999999999999988656789999765532 22
Q ss_pred CC--C--ceeecccCCCCCccChhhhcccC---------CCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchH
Q 048517 302 EN--D--FVSISDTRGTIGYLAPELISRNF---------GTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPS 367 (453)
Q Consensus 302 ~~--~--~~~~~~~~gt~~y~aPE~~~~~~---------~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 367 (453)
++ + +.- .+.+.-..|+|||.+.... +..+++.||||.||++.||++ |+++|....-
T Consensus 175 DNPadf~fFF-DTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL--------- 244 (1431)
T KOG1240|consen 175 DNPADFTFFF-DTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL--------- 244 (1431)
T ss_pred CCcccceEEE-ecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH---------
Confidence 21 1 111 1222334799999886421 137889999999999999987 5777642210
Q ss_pred HHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhC
Q 048517 368 WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 422 (453)
Q Consensus 368 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le~ 422 (453)
... +.+...... ...+......++.+++.|+|.||..|-|+++.++.-+|
T Consensus 245 --~aY-r~~~~~~~e--~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 245 --LAY-RSGNADDPE--QLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred --HhH-hccCccCHH--HHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 000 011111000 00111222368899999999999999999999988554
No 419
>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional
Probab=99.71 E-value=3.1e-17 Score=152.62 Aligned_cols=160 Identities=14% Similarity=0.112 Sum_probs=113.5
Q ss_pred hhHHHHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHH----------HHH--------------Hhcc
Q 048517 155 LPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEF----------INE--------------LLGL 210 (453)
Q Consensus 155 ~~~~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~----------i~e--------------l~g~ 210 (453)
+.++...+++..+.||.|+||.||.... +++.+|||.+.......+.+ ..| ...+
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 4467777888889999999999999665 57789999997643332222 222 1111
Q ss_pred cc--c------CcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE
Q 048517 211 CS--E------GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL 282 (453)
Q Consensus 211 ~~--~------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl 282 (453)
.. . ....+|+|||++|.+|.+.. .++. ....+++.+|..+|+. +++|||+||.||++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili 168 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIV 168 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEE
Confidence 11 1 23578999999999997753 1221 3466999999999998 99999999999999
Q ss_pred cCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHH
Q 048517 283 DHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMA 347 (453)
Q Consensus 283 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ell 347 (453)
+.++ ++|+|||..+....+... ..+.... .+..++|+||||+.+.-+.
T Consensus 169 ~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler--~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 169 SKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLER--HYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred eCCC-EEEEECCCcccccchhhH--------------HHHHHHh--HhcccccccceeEeehHHH
Confidence 9988 999999988754322110 0022222 3457999999999987654
No 420
>smart00090 RIO RIO-like kinase.
Probab=99.69 E-value=1.8e-16 Score=149.82 Aligned_cols=129 Identities=17% Similarity=0.137 Sum_probs=95.3
Q ss_pred hhhhcccCccCceEEEEEE--EcCCcEEEEEEecCCCCC-------------------------------HHHHHHHHhc
Q 048517 163 NHFTHKLGQGGFGSVYKGQ--LHTGRLIAVKMMENSKFS-------------------------------AEEFINELLG 209 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~--~~~g~~VAVK~l~~~~~~-------------------------------~~~~i~el~g 209 (453)
+.+.+.||+|+||.||+|. ..+|+.||||++...... +.+.+.++..
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 3466889999999999998 568999999998753210 0011111221
Q ss_pred --ccc----cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCc-eeecccCCcceEE
Q 048517 210 --LCS----EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVC-ILHFDIKPHNILL 282 (453)
Q Consensus 210 --~~~----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivH~Dikp~NILl 282 (453)
... .....++||||+++++|..... ....+...+...++.|++.++.+||+. + |+|+||||+||++
T Consensus 110 ~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli 182 (237)
T smart00090 110 AGVPVPKPIAWRRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILV 182 (237)
T ss_pred cCCCCCeeeEecCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEE
Confidence 100 1123579999999988866542 123345556789999999999999998 8 9999999999999
Q ss_pred cCCCceEEEecCCcccc
Q 048517 283 DHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 283 ~~~~~~kl~DFGla~~~ 299 (453)
+ ++.++|+|||.+...
T Consensus 183 ~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 183 H-DGKVVIIDVSQSVEL 198 (237)
T ss_pred E-CCCEEEEEChhhhcc
Confidence 9 889999999998754
No 421
>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]
Probab=99.67 E-value=2.5e-17 Score=164.67 Aligned_cols=175 Identities=22% Similarity=0.289 Sum_probs=129.2
Q ss_pred ceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCC
Q 048517 216 KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL 295 (453)
Q Consensus 216 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl 295 (453)
..++.|+++...+|.++|.+++ .....+|...+.++.|++.|++| + +.+|+|+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 4678999999999999996443 34567888999999999999999 4 899999999999999999999999999
Q ss_pred ccccCCCC----CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHc-CCCCCCCCccccccccchHHHH
Q 048517 296 AKFHPKEN----DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVY 370 (453)
Q Consensus 296 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 370 (453)
........ .....+...||..||+||.+.+. .++.|+||||+|++|+|++. -..+++ + .-..
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~--~y~~kvdIyaLGlil~EL~~~f~T~~e----r-------~~t~ 469 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ--QYSEKVDIYALGLILAELLIQFSTQFE----R-------IATL 469 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhh--hhhhhcchhhHHHHHHHHHHHhccHHH----H-------HHhh
Confidence 88665544 22334566799999999999976 89999999999999999986 111111 0 0011
Q ss_pred HHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 048517 371 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 416 (453)
Q Consensus 371 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev 416 (453)
..+.++...+ . ...++ +.=..++.|++.+.|.+||++.++
T Consensus 470 ~d~r~g~ip~-~----~~~d~-p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 470 TDIRDGIIPP-E----FLQDY-PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hhhhcCCCCh-H----HhhcC-cHHHHHHHHhcCCCcccCchHHHH
Confidence 2222222110 0 11111 223568899999999999955443
No 422
>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom
Probab=99.67 E-value=4.1e-16 Score=143.55 Aligned_cols=126 Identities=23% Similarity=0.203 Sum_probs=95.0
Q ss_pred hhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCH-----------------------HHHHHH------Hhcc--
Q 048517 162 TNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA-----------------------EEFINE------LLGL-- 210 (453)
Q Consensus 162 ~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~-----------------------~~~i~e------l~g~-- 210 (453)
++.+.+.||+|+||.||++...+|+.||||++....... .....| +.+.
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 366678999999999999998889999999876432100 001111 2121
Q ss_pred ----cccCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC
Q 048517 211 ----CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF 286 (453)
Q Consensus 211 ----~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~ 286 (453)
.......+++|||+++++|.+... ......++.+++.++.++|+. +|+|+||||.||++++++
T Consensus 96 ~v~~~~~~~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 96 PVPKPIDWNRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCceeecCCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCCC
Confidence 011234589999999999865431 134567899999999999997 999999999999999999
Q ss_pred ceEEEecCCccccC
Q 048517 287 IPKVSDFGLAKFHP 300 (453)
Q Consensus 287 ~~kl~DFGla~~~~ 300 (453)
.++|+|||++....
T Consensus 163 ~~~liDfg~~~~~~ 176 (198)
T cd05144 163 KIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEEECCccccCC
Confidence 99999999996543
No 423
>PRK12274 serine/threonine protein kinase; Provisional
Probab=99.67 E-value=1.8e-16 Score=144.70 Aligned_cols=177 Identities=17% Similarity=0.091 Sum_probs=123.5
Q ss_pred hcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHH-----HHHHH------Hhccc-----ccCcceEEEEEecCCCCh
Q 048517 166 THKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAE-----EFINE------LLGLC-----SEGFKRALVYEYMPNGSL 229 (453)
Q Consensus 166 ~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~-----~~i~e------l~g~~-----~~~~~~~lv~E~~~~gsL 229 (453)
...|++|+||+||...- ++++++.+.+..+....+ .+..| |.+.- ..-...+++|||+.+.+|
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G~~L 85 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAGAAM 85 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecCccH
Confidence 45799999999997665 688888888877544222 23333 21100 011345899999999998
Q ss_pred hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeeccc-CCcceEEcCCCceEEEecCCccccCCCCCc---
Q 048517 230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDI-KPHNILLDHNFIPKVSDFGLAKFHPKENDF--- 305 (453)
Q Consensus 230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Di-kp~NILl~~~~~~kl~DFGla~~~~~~~~~--- 305 (453)
...+. . ....++.+++++|.++|+. +|+|||| ||.|||++.++.++|+|||++.........
T Consensus 86 ~~~~~----~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 86 YQRPP----R-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred Hhhhh----h-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 65331 0 1235778999999999998 9999999 799999999999999999999865443310
Q ss_pred -e-------eecccCCCCCccChhhhcccCCCCC-ccchHHHHHHHHHHHHcCCCCCCCCcc
Q 048517 306 -V-------SISDTRGTIGYLAPELISRNFGTVS-CKSDVYGFGMVLLEMAGGRRNSNMNAT 358 (453)
Q Consensus 306 -~-------~~~~~~gt~~y~aPE~~~~~~~~~s-~k~DV~S~Gvvl~elltg~~p~~~~~~ 358 (453)
. ...-...++.|++|+...-- ...+ ...+.++-|.-+|.++|++.+.....+
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l-~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVL-KRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhh-ccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0 00112478899999854321 1223 567888999999999999987654443
No 424
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=99.67 E-value=1.9e-17 Score=168.43 Aligned_cols=216 Identities=24% Similarity=0.254 Sum_probs=156.8
Q ss_pred cCccCceEEEEEE----EcCCcEEEEEEecCCCCC---------HHHHHHH---------HhcccccCcceEEEEEecCC
Q 048517 169 LGQGGFGSVYKGQ----LHTGRLIAVKMMENSKFS---------AEEFINE---------LLGLCSEGFKRALVYEYMPN 226 (453)
Q Consensus 169 LG~G~fG~Vy~g~----~~~g~~VAVK~l~~~~~~---------~~~~i~e---------l~g~~~~~~~~~lv~E~~~~ 226 (453)
+|+|.||.|+..+ .+.|+.+|+|.+++.... .+.+..+ +.-.++...+.+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999999865 335778898887762211 1111111 22233455667889999999
Q ss_pred CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCce
Q 048517 227 GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 306 (453)
Q Consensus 227 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 306 (453)
|.|...+ .....++..........++-+++++|+. +|+|||+|++||+++.+|++|+.|||+++..-...
T Consensus 82 g~lft~l----~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--- 151 (612)
T KOG0603|consen 82 GDLFTRL----SKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--- 151 (612)
T ss_pred chhhhcc----ccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhh---
Confidence 9987766 3345677778888888999999999998 99999999999999999999999999998654332
Q ss_pred eecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhh
Q 048517 307 SISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTE 386 (453)
Q Consensus 307 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 386 (453)
..+||.-|||||.+. .....+|.||||++.+||+||-.||.. .+...+.+.+. .
T Consensus 152 ---~~cgt~eymApEI~~----gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~~~-------~ 205 (612)
T KOG0603|consen 152 ---IACGTYEYRAPEIIN----GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKAEL-------E 205 (612)
T ss_pred ---hcccchhhhhhHhhh----ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhhcc-------C
Confidence 227999999999986 356689999999999999999999864 12233322111 2
Q ss_pred hHHHHHHHHHHHHHHhcccCCCCCCCH--HHHHHHH
Q 048517 387 IESMIARKLCMIGLWCIQVKAADRPSM--TKVLEML 420 (453)
Q Consensus 387 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~--~evl~~L 420 (453)
.+.+.+.....+...++..+|..|--. ..+.+.+
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 445555666667777777778887744 3444444
No 425
>cd05119 RIO RIO kinase family, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct
Probab=99.64 E-value=1.2e-15 Score=138.69 Aligned_cols=125 Identities=21% Similarity=0.203 Sum_probs=89.4
Q ss_pred hcccCccCceEEEEEEEcCCcEEEEEEecCCCCCH---HHHH----------------------HH------Hhccc---
Q 048517 166 THKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA---EEFI----------------------NE------LLGLC--- 211 (453)
Q Consensus 166 ~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~---~~~i----------------------~e------l~g~~--- 211 (453)
.+.||+|+||.||+|...+|+.||||++....... ...+ .| +....
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999987532211 1111 11 11110
Q ss_pred ---ccCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHc-CCCCceeecccCCcceEEcCCCc
Q 048517 212 ---SEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFI 287 (453)
Q Consensus 212 ---~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dikp~NILl~~~~~ 287 (453)
..-...+++|||++++++........ ... .....++.+++.++.++|+ . +|+|+||||+||+++ ++.
T Consensus 82 ~~~~~~~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 82 PKPIDLNRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CceEecCCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CCc
Confidence 00124589999999965432211110 011 6678999999999999998 6 999999999999999 899
Q ss_pred eEEEecCCcccc
Q 048517 288 PKVSDFGLAKFH 299 (453)
Q Consensus 288 ~kl~DFGla~~~ 299 (453)
++++|||.+...
T Consensus 153 ~~liDfg~a~~~ 164 (187)
T cd05119 153 VYIIDVPQAVEI 164 (187)
T ss_pred EEEEECcccccc
Confidence 999999999744
No 426
>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]
Probab=99.62 E-value=2e-15 Score=145.78 Aligned_cols=185 Identities=19% Similarity=0.198 Sum_probs=124.9
Q ss_pred CcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEE--cCCC--ceE
Q 048517 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILL--DHNF--IPK 289 (453)
Q Consensus 214 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl--~~~~--~~k 289 (453)
+..+++||.-. .-+|..++... ..+.....-|+.|+++|..|||++ +|.|||+|++|||+ |+|. ...
T Consensus 315 ~~tlylvMkrY-~~tLr~yl~~~-----~~s~r~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LV 385 (598)
T KOG4158|consen 315 PKTLYLVMKRY-RQTLREYLWTR-----HRSYRTGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLV 385 (598)
T ss_pred CceEEEehhcc-hhhHHHHHhcC-----CCchHHHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEE
Confidence 34467888776 45888888543 345566778899999999999998 99999999999999 4444 467
Q ss_pred EEecCCccccCCCCC---ceee-cccCCCCCccChhhhcccCCCC----CccchHHHHHHHHHHHHcCCCCCCCCccccc
Q 048517 290 VSDFGLAKFHPKEND---FVSI-SDTRGTIGYLAPELISRNFGTV----SCKSDVYGFGMVLLEMAGGRRNSNMNATRSS 361 (453)
Q Consensus 290 l~DFGla~~~~~~~~---~~~~-~~~~gt~~y~aPE~~~~~~~~~----s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~ 361 (453)
|+|||.+--.....- +.+. -...|.-.-||||+.....|+. -.|+|.|+.|.+.||+++...||....
T Consensus 386 vaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG---- 461 (598)
T KOG4158|consen 386 VADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG---- 461 (598)
T ss_pred EcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc----
Confidence 899998753322111 1111 1234667789999886543321 349999999999999999999986521
Q ss_pred cccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 048517 362 KAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 420 (453)
Q Consensus 362 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 420 (453)
+..+..-.+ .+.+.. ..++.+...+.+++...|+.||.+|||..=....|
T Consensus 462 em~L~~r~Y---qe~qLP------alp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 462 EMLLDTRTY---QESQLP------ALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred hheechhhh---hhhhCC------CCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 111111111 111111 13334456688899999999999999875544444
No 427
>PRK14879 serine/threonine protein kinase; Provisional
Probab=99.60 E-value=5.8e-15 Score=136.89 Aligned_cols=119 Identities=24% Similarity=0.334 Sum_probs=92.2
Q ss_pred cccCccCceEEEEEEEcCCcEEEEEEecCCCCCH---------HHHHHH------H--------hcccccCcceEEEEEe
Q 048517 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA---------EEFINE------L--------LGLCSEGFKRALVYEY 223 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~---------~~~i~e------l--------~g~~~~~~~~~lv~E~ 223 (453)
+.||+|++|.||+|.. +|..|+||+........ +++..| + ..++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4799999999999987 57789999865432111 122222 1 1123344567899999
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 298 (453)
+++++|.+.+... .+ .+..++.+++.+|.+||+. +++|+|++|.|||++ ++.++|+|||+++.
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999887321 12 7889999999999999998 999999999999999 78899999999874
No 428
>TIGR03724 arch_bud32 Kae1-associated kinase Bud32. Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.
Probab=99.57 E-value=1.5e-14 Score=132.91 Aligned_cols=115 Identities=24% Similarity=0.337 Sum_probs=86.9
Q ss_pred ccCccCceEEEEEEEcCCcEEEEEEecCCCCC---------HHHHHHH------Hh--c------ccccCcceEEEEEec
Q 048517 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS---------AEEFINE------LL--G------LCSEGFKRALVYEYM 224 (453)
Q Consensus 168 ~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~---------~~~~i~e------l~--g------~~~~~~~~~lv~E~~ 224 (453)
.||+|+||.||+|.. +|+.|++|........ .+++..| +. + ++......+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 4788999986542211 1122222 21 1 122344568999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 298 (453)
++++|.+.+.... . .++.+++.+|.+||+. +++|+|++|.||+++ ++.+++.|||+++.
T Consensus 80 ~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988763211 0 7899999999999998 999999999999999 88999999999875
No 429
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.54 E-value=4.7e-15 Score=158.20 Aligned_cols=204 Identities=21% Similarity=0.265 Sum_probs=132.7
Q ss_pred hcccCccCceEEEEEEEc-CCcEEEEEEecCCCCCHHHHHHHHhcccccCcceEEEEEecCCCChhhhhhhccCCCCCCC
Q 048517 166 THKLGQGGFGSVYKGQLH-TGRLIAVKMMENSKFSAEEFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFG 244 (453)
Q Consensus 166 ~~~LG~G~fG~Vy~g~~~-~g~~VAVK~l~~~~~~~~~~i~el~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~ 244 (453)
.+.|-.|++|.||..+++ ..+.+|+|+- +.+.-.+. ++.+- ++ .+.| |+-...+. ....++
T Consensus 88 IklisngAygavylvrh~~trqrfa~kiN-kq~lilRn----ilt~a-~n--pfvv------gDc~tllk----~~g~lP 149 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNLILRN----ILTFA-GN--PFVV------GDCATLLK----NIGPLP 149 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhccc-ccchhhhc----ccccc-CC--ccee------chhhhhcc----cCCCCc
Confidence 367889999999999865 5678888543 22211110 11111 11 1222 33222221 112233
Q ss_pred chhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCC-------------ceeeccc
Q 048517 245 LEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-------------FVSISDT 311 (453)
Q Consensus 245 ~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~-------------~~~~~~~ 311 (453)
.. .+.+++|||+. +|+|||+||+|.+++.-|++|+.|||+++....... .......
T Consensus 150 vd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqv 218 (1205)
T KOG0606|consen 150 VD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQV 218 (1205)
T ss_pred ch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccc
Confidence 22 27889999998 999999999999999999999999999875321100 0111344
Q ss_pred CCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHH
Q 048517 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 391 (453)
Q Consensus 312 ~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 391 (453)
+||+.|+|||++... .|...+|+|++|+++||.+.|..||.....+ ..|...+.+.+...+ ....+
T Consensus 219 cgTPeyiaPeVilrq--gygkpvdwwamGiIlyeFLVgcvpffGdtpe---elfg~visd~i~wpE---------~dea~ 284 (1205)
T KOG0606|consen 219 CGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFGQVISDDIEWPE---------EDEAL 284 (1205)
T ss_pred cCCccccChhhhhhh--ccCCCccHHHHHHHHHHHheeeeeccCCCHH---HHHhhhhhhhccccc---------cCcCC
Confidence 799999999999875 6888999999999999999999999866432 222222222222111 11223
Q ss_pred HHHHHHHHHHhcccCCCCCCC
Q 048517 392 ARKLCMIGLWCIQVKAADRPS 412 (453)
Q Consensus 392 ~~~l~~l~~~Cl~~~p~~RPs 412 (453)
..+..+++.+.|+.+|.+|--
T Consensus 285 p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 285 PPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred CHHHHHHHHHHHHhChHhhcc
Confidence 345777888899999999973
No 430
>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated
Probab=99.54 E-value=2.9e-14 Score=150.77 Aligned_cols=118 Identities=20% Similarity=0.276 Sum_probs=87.2
Q ss_pred hhcccCccCceEEEEEEEcCCcEEEEEEe-cCC-CC-------CHHHHHHH------H--------hcccccCcceEEEE
Q 048517 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMM-ENS-KF-------SAEEFINE------L--------LGLCSEGFKRALVY 221 (453)
Q Consensus 165 ~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l-~~~-~~-------~~~~~i~e------l--------~g~~~~~~~~~lv~ 221 (453)
..++||+|+||+||+|.+.+.. +++|+. .+. .. ..+++..| + ..++......++||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred ccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 3578999999999999876443 444432 221 10 11223333 1 12223344678999
Q ss_pred EecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517 222 EYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 222 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 299 (453)
||+++++|.+++. ....++.+++++|.|||+. +++||||||+|||+ .++.++|+|||+++..
T Consensus 416 E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 416 EYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999988773 4578999999999999998 99999999999999 5778999999999753
No 431
>PRK10345 hypothetical protein; Provisional
Probab=99.51 E-value=8.9e-14 Score=128.68 Aligned_cols=118 Identities=19% Similarity=0.273 Sum_probs=82.2
Q ss_pred cccCccCceEEEEEEEcCCcEEEEEEecCCCC-CHHHHHHH-------------------HhcccccCc---c-eEEEEE
Q 048517 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF-SAEEFINE-------------------LLGLCSEGF---K-RALVYE 222 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~-~~~~~i~e-------------------l~g~~~~~~---~-~~lv~E 222 (453)
+.||+|+||.||. ...++.. +||++..... ..+++.+| ++|+...+. . ..+|+|
T Consensus 8 ~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 5799999999996 3334444 6998875322 22333333 445554442 2 237899
Q ss_pred e--cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHH-HHhHcCCCCceeecccCCcceEEcC----CCceEEEecCC
Q 048517 223 Y--MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGI-EYLHNGCDVCILHFDIKPHNILLDH----NFIPKVSDFGL 295 (453)
Q Consensus 223 ~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~Dikp~NILl~~----~~~~kl~DFGl 295 (453)
| +.+|+|.+++.. ..++.. ..++.+++.++ +|||++ +|+||||||+|||++. +..++|+||+.
T Consensus 86 ~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 86 FDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred CCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 9 558999999932 224444 35677888777 999998 9999999999999974 34899999544
Q ss_pred c
Q 048517 296 A 296 (453)
Q Consensus 296 a 296 (453)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
No 432
>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family. The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves
Probab=99.47 E-value=4.8e-13 Score=115.91 Aligned_cols=121 Identities=23% Similarity=0.205 Sum_probs=93.7
Q ss_pred hcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH------H----------hcccccCcceEEEEEecCCCCh
Q 048517 166 THKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE------L----------LGLCSEGFKRALVYEYMPNGSL 229 (453)
Q Consensus 166 ~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e------l----------~g~~~~~~~~~lv~E~~~~gsL 229 (453)
.+.||+|.++.||++..++ +.++||....... ..++..| + +.........++++||++++++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 3679999999999999864 7899999876532 2222222 2 2223334567899999988877
Q ss_pred hhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517 230 DRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 230 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 299 (453)
... +......++.++++++++||.....+++|+|++|+||+++.++.+++.|||.++..
T Consensus 81 ~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 81 DEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 532 55677889999999999999875557999999999999999899999999998743
No 433
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.39 E-value=5.7e-14 Score=148.90 Aligned_cols=242 Identities=22% Similarity=0.259 Sum_probs=172.0
Q ss_pred HhhhhhcccCccCceEEEEEEEc--CCcEEEEEEecCCCCCH------------------HHHHHHHhcccccCcceEEE
Q 048517 161 VTNHFTHKLGQGGFGSVYKGQLH--TGRLIAVKMMENSKFSA------------------EEFINELLGLCSEGFKRALV 220 (453)
Q Consensus 161 ~~~~~~~~LG~G~fG~Vy~g~~~--~g~~VAVK~l~~~~~~~------------------~~~i~el~g~~~~~~~~~lv 220 (453)
..+.+.+.||+|+|+.|-..... ....+|+|.+....... +..+..+++........++.
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 34566778999999999887643 34567777665432111 11122255555666778899
Q ss_pred EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhH-cCCCCceeecccCCcceEEcCCC-ceEEEecCCccc
Q 048517 221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLH-NGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKF 298 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~ 298 (453)
.+|..++++.+-+. .......+....-....|+..++.|+| .. ++.|+||||+|.+++.++ ..|++|||+|..
T Consensus 100 ~~~s~g~~~f~~i~--~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKIS--HPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCcccccccccccc--cCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 99999999987663 112225667777889999999999999 76 999999999999999999 999999999998
Q ss_pred cCC-CCCceeecccCC-CCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhC
Q 048517 299 HPK-ENDFVSISDTRG-TIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG 376 (453)
Q Consensus 299 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~ 376 (453)
+.. .+.........| ++.|+|||...+. .......|+||.|+++.-+++|..|++...... ..+..|....
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~---- 247 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSNK---- 247 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCcccccccc--ccceeecccc----
Confidence 876 444444556678 9999999998763 345778999999999999999999987654432 2222222221
Q ss_pred CCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 377 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
... ..............+...++..+|..|.+.+++-.
T Consensus 248 ~~~----~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 GRF----TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccc----ccCccccCChhhhhcccccccCCchhccccccccc
Confidence 000 00112223345667778888899999999887654
No 434
>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase. This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.
Probab=99.35 E-value=7.6e-12 Score=128.60 Aligned_cols=125 Identities=21% Similarity=0.227 Sum_probs=89.7
Q ss_pred cccCccCceEEEEEEEcCCcEEEEEEecCCCCC---------------------------HHH--------------HHH
Q 048517 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS---------------------------AEE--------------FIN 205 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~---------------------------~~~--------------~i~ 205 (453)
+.||.|++|.||+|++++|+.||||+.+..... ..+ |..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 469999999999999999999999998653110 000 111
Q ss_pred H------Hhcccc-------------cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHH-HHHHhHcC
Q 048517 206 E------LLGLCS-------------EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR-GIEYLHNG 265 (453)
Q Consensus 206 e------l~g~~~-------------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~ 265 (453)
| +...+. .....+|||||++|++|.+...... ... .+..++..++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHhC
Confidence 1 111111 1224579999999999988763221 111 34567777666 46788887
Q ss_pred CCCceeecccCCcceEEcCCCceEEEecCCccccC
Q 048517 266 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 300 (453)
Q Consensus 266 ~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~ 300 (453)
+++|+|+||.||+++.++.+++.|||++....
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999997654
No 435
>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed
Probab=99.35 E-value=5.4e-12 Score=119.54 Aligned_cols=119 Identities=18% Similarity=0.201 Sum_probs=84.5
Q ss_pred cccC-ccCceEEEEEEEcCCcEEEEEEecCCC--------------CCHHHHHHH------H----------hccccc-C
Q 048517 167 HKLG-QGGFGSVYKGQLHTGRLIAVKMMENSK--------------FSAEEFINE------L----------LGLCSE-G 214 (453)
Q Consensus 167 ~~LG-~G~fG~Vy~g~~~~g~~VAVK~l~~~~--------------~~~~~~i~e------l----------~g~~~~-~ 214 (453)
..|| .||.|+||..... +..++||.+.... .....+..| | +++... .
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4688 8999999999876 7789999775311 111122222 2 111111 1
Q ss_pred c---ceEEEEEecCC-CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEE
Q 048517 215 F---KRALVYEYMPN-GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV 290 (453)
Q Consensus 215 ~---~~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl 290 (453)
. ..++|+|++++ .+|.+++.. ..++. ..+.+++.+|.+||+. +|+|+||||.|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE-----APLSE----EQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc-----CCCCH----HHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 1 23599999997 688877632 22333 2467899999999998 9999999999999999889999
Q ss_pred EecCCccc
Q 048517 291 SDFGLAKF 298 (453)
Q Consensus 291 ~DFGla~~ 298 (453)
+|||.++.
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99999874
No 436
>KOG1266 consensus Protein kinase [Signal transduction mechanisms]
Probab=99.33 E-value=2.2e-12 Score=122.35 Aligned_cols=185 Identities=23% Similarity=0.281 Sum_probs=122.6
Q ss_pred CcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEec
Q 048517 214 GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 293 (453)
Q Consensus 214 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DF 293 (453)
..+..++.|||..|++..+|.........+......+++.||..||.|||+ |+++|+|+++..+-|++..++-+|+.--
T Consensus 144 ~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~PpiihgnlTc~tifiq~ngLIkig~~ 222 (458)
T KOG1266|consen 144 KPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPIIHGNLTCDTIFIQHNGLIKIGSV 222 (458)
T ss_pred ccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCccccCCcchhheeecCCceEEeccc
Confidence 345678999999999999997766666778888888999999999999999 6899999999999999999998888521
Q ss_pred CCccccCCCCC--ceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHH
Q 048517 294 GLAKFHPKEND--FVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD 371 (453)
Q Consensus 294 Gla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 371 (453)
.-......-.. ........+-++|.|||+=.. ...+..+|||+||+..+||.-+.--.. .+...+.+. .
T Consensus 223 ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcAlemailEiq~t----nseS~~~~e---e 293 (458)
T KOG1266|consen 223 APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT--TNTTGASDIYKFGMCALEMAILEIQST----NSESKVEVE---E 293 (458)
T ss_pred CccccchhhhhhhHhhhhccccCCccccCCcCcc--cccccchhhhhhhHHHHHHHHheeccC----CCcceeehh---h
Confidence 11110000000 001122346789999996433 366779999999999999987653211 111111110 0
Q ss_pred HhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 372 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 372 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
.+... ...+.+ ..=+.++..|++.+|..||+|.+.+-
T Consensus 294 ~ia~~-i~~len---------~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 294 NIANV-IIGLEN---------GLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred hhhhh-eeeccC---------ccccCcCcccccCCCCCCcchhhhhc
Confidence 00000 000000 01134566799999999999988754
No 437
>cd05151 ChoK Choline Kinase (ChoK). The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph
Probab=99.14 E-value=2.8e-10 Score=101.45 Aligned_cols=116 Identities=20% Similarity=0.156 Sum_probs=82.0
Q ss_pred cccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHH------HHH---------HhcccccCcceEEEEEecCCCChhh
Q 048517 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEF------INE---------LLGLCSEGFKRALVYEYMPNGSLDR 231 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~------i~e---------l~g~~~~~~~~~lv~E~~~~gsL~~ 231 (453)
+.|+.|.++.||+++.. ++.+++|+..........+ +.. ++.+ .....++||||+++.++..
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcccc
Confidence 46889999999999876 7789999976543111111 111 1222 2223579999999988754
Q ss_pred hhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCC--CCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517 232 HIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC--DVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298 (453)
Q Consensus 232 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 298 (453)
. . .....++.+++++|+.||+.. ...++|+|++|.||+++ ++.+++.|||.+..
T Consensus 81 ~---------~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 E---------D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred c---------c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 2 0 112346789999999999872 22369999999999999 66899999998863
No 438
>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed
Probab=99.13 E-value=1.3e-10 Score=121.36 Aligned_cols=125 Identities=18% Similarity=0.186 Sum_probs=80.3
Q ss_pred cccCccCceEEEEEEEcC-CcEEEEEEecCCCC---------------------------CHH----H----------HH
Q 048517 167 HKLGQGGFGSVYKGQLHT-GRLIAVKMMENSKF---------------------------SAE----E----------FI 204 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~-g~~VAVK~l~~~~~---------------------------~~~----~----------~i 204 (453)
+.||.|++|.||+|++++ |+.||||++..... ... + +.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 469999999999999887 99999999875310 001 1 11
Q ss_pred HH------Hhccccc-------------CcceEEEEEecCCCChhhhhhhccCC--CCCCCchhHHHHHHHHHHHHHHhH
Q 048517 205 NE------LLGLCSE-------------GFKRALVYEYMPNGSLDRHIFSKENK--GQTFGLEKPHEIALGTARGIEYLH 263 (453)
Q Consensus 205 ~e------l~g~~~~-------------~~~~~lv~E~~~~gsL~~~l~~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH 263 (453)
.| +...+.+ .....|||||++|+.+.+.-...... ...+....+..++.|+ +
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 11 2222222 12346999999999997642111100 0112222222233333 3
Q ss_pred cCCCCceeecccCCcceEEcCCC----ceEEEecCCccccCC
Q 048517 264 NGCDVCILHFDIKPHNILLDHNF----IPKVSDFGLAKFHPK 301 (453)
Q Consensus 264 ~~~~~~ivH~Dikp~NILl~~~~----~~kl~DFGla~~~~~ 301 (453)
.. +++|+|+||.||+++.++ .+++.|||+......
T Consensus 278 ~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34 999999999999999887 999999999876643
No 439
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.06 E-value=3e-10 Score=116.12 Aligned_cols=236 Identities=22% Similarity=0.202 Sum_probs=159.2
Q ss_pred HHHhhhhhcccCc--cCceEEEEEEE---cCCcEEEEEEecC--C-----CCCHHHH-----------HHHHhcccccCc
Q 048517 159 IAVTNHFTHKLGQ--GGFGSVYKGQL---HTGRLIAVKMMEN--S-----KFSAEEF-----------INELLGLCSEGF 215 (453)
Q Consensus 159 ~~~~~~~~~~LG~--G~fG~Vy~g~~---~~g~~VAVK~l~~--~-----~~~~~~~-----------i~el~g~~~~~~ 215 (453)
...+..+.+.+|. |.+|.||.+.. .+++.+|+|.-+. + .....++ ..........++
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 3344455678999 99999999986 3688999997322 1 1111111 111233445666
Q ss_pred ceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHH----HHHHhHcCCCCceeecccCCcceEEcCC-CceEE
Q 048517 216 KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTAR----GIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKV 290 (453)
Q Consensus 216 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~Dikp~NILl~~~-~~~kl 290 (453)
..++-+|.+ +.+|..+.+.. ...+.-..++.+..+..+ ||.++|+. .++|-|+||.||++..+ ...++
T Consensus 192 ~lfiqtE~~-~~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 192 ILFIQTELC-GESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred cceeeeccc-cchhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeec
Confidence 778888888 47777766432 234566667777777777 99999998 99999999999999999 88999
Q ss_pred EecCCccccCCCC---CceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchH
Q 048517 291 SDFGLAKFHPKEN---DFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS 367 (453)
Q Consensus 291 ~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 367 (453)
.|||+........ .........|...|++||...+ .++.+.|+|++|.+.+|-..+-...... +...
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g-------~~~~ 334 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVG-------KNSS 334 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCC-------CCCC
Confidence 9999998775443 1111223367788999999874 6888999999999999998876544322 1122
Q ss_pred HHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 048517 368 WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 418 (453)
Q Consensus 368 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 418 (453)
|. ++.++. +. .+.-......+..+...+++.+|-.|++.+.+..
T Consensus 335 W~--~~r~~~-ip----~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 335 WS--QLRQGY-IP----LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cc--cccccc-Cc----hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 21 122211 10 1111122334555888999999999998877765
No 440
>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.
Probab=98.95 E-value=5.1e-09 Score=95.48 Aligned_cols=125 Identities=14% Similarity=0.117 Sum_probs=83.2
Q ss_pred cccCccCceEEEEEEEcC-------CcEEEEEEecCCCC---CH-------------------HHHH-----HH------
Q 048517 167 HKLGQGGFGSVYKGQLHT-------GRLIAVKMMENSKF---SA-------------------EEFI-----NE------ 206 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~-------g~~VAVK~l~~~~~---~~-------------------~~~i-----~e------ 206 (453)
..||.|-=+.||.|.-.+ +..+|||+.+.+.. .. ...+ .|
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 57999998753210 00 1011 11
Q ss_pred Hh--cccc----cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHh-HcCCCCceeecccCCcc
Q 048517 207 LL--GLCS----EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYL-HNGCDVCILHFDIKPHN 279 (453)
Q Consensus 207 l~--g~~~----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dikp~N 279 (453)
+. |.-. .-...+|||||+.++.+..... ....++..+...+..+++.+|..| |+. +|+|+|+++.|
T Consensus 83 l~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~L----kd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKL----KDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEecCCEEEEEEcCCCCccchhh----hccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence 11 1110 1134579999997654422111 112344456678889999999999 776 99999999999
Q ss_pred eEEcCCCceEEEecCCcccc
Q 048517 280 ILLDHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 280 ILl~~~~~~kl~DFGla~~~ 299 (453)
||++ ++.+.|+|||.+...
T Consensus 156 IL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred EEEE-CCcEEEEECCCceeC
Confidence 9997 467999999988643
No 441
>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins. This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain
Probab=98.88 E-value=1.6e-08 Score=93.93 Aligned_cols=127 Identities=21% Similarity=0.261 Sum_probs=91.4
Q ss_pred cccCccCceEEEEEEEcCCcEEEEEEecCCCC--CHHHHHHH----------------HhcccccC---cceEEEEEecC
Q 048517 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF--SAEEFINE----------------LLGLCSEG---FKRALVYEYMP 225 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~--~~~~~i~e----------------l~g~~~~~---~~~~lv~E~~~ 225 (453)
+.||.|..+.||++...+|+.+++|+...... ...++..| ++.+.... ...++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999987778999999765332 12222222 22333332 24589999999
Q ss_pred CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCC---------------------------------------
Q 048517 226 NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC--------------------------------------- 266 (453)
Q Consensus 226 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------- 266 (453)
+.++.+.+.. ..++..++..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9988765421 24667777888888888888888531
Q ss_pred --------------CCceeecccCCcceEEcC--CCceEEEecCCccc
Q 048517 267 --------------DVCILHFDIKPHNILLDH--NFIPKVSDFGLAKF 298 (453)
Q Consensus 267 --------------~~~ivH~Dikp~NILl~~--~~~~kl~DFGla~~ 298 (453)
...++|+|++|.||+++. +..+.|.||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 56789999998764
No 442
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=98.81 E-value=1.8e-09 Score=110.59 Aligned_cols=227 Identities=19% Similarity=0.261 Sum_probs=151.2
Q ss_pred hhhcccCccCceEEEEEEEc--CCcEEEEEEecCCCCCH--------HHHHHHHhccc----------ccCcceEEEEEe
Q 048517 164 HFTHKLGQGGFGSVYKGQLH--TGRLIAVKMMENSKFSA--------EEFINELLGLC----------SEGFKRALVYEY 223 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~~--~g~~VAVK~l~~~~~~~--------~~~i~el~g~~----------~~~~~~~lv~E~ 223 (453)
++..+||.|.|+.|++...+ ++..+++|.+.+..... +-++...++.+ ......++=-||
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~ 347 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF 347 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence 44578999999999998744 68889999876633221 11222222322 233445688899
Q ss_pred cCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC-CceEEEecCCccccCCC
Q 048517 224 MPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFGla~~~~~~ 302 (453)
++++++...+ .....+....++.+..+++.++.++|+. .++|+|+||+||++..+ +..+++|||.+....-.
T Consensus 348 ~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 348 CEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred hcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccccee
Confidence 9999987765 2335678888899999999999999987 99999999999999886 88899999998642211
Q ss_pred CCceeecccCCCCCcc-ChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccc
Q 048517 303 NDFVSISDTRGTIGYL-APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 381 (453)
Q Consensus 303 ~~~~~~~~~~gt~~y~-aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 381 (453)
. ....++-++. .+|.+... ..+-.+.|++|||.-+.|.+++..-..... .|. .+..+....
T Consensus 421 ~-----~~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---------~~~--~i~~~~~p~- 482 (524)
T KOG0601|consen 421 S-----GVFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGV---------QSL--TIRSGDTPN- 482 (524)
T ss_pred c-----ccccccccccccchhhccc-cccccccccccccccccccccCcccCcccc---------cce--eeecccccC-
Confidence 1 1122333444 25555443 367789999999999999998864322111 010 111111111
Q ss_pred cchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517 382 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421 (453)
Q Consensus 382 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le 421 (453)
.+. ....+..++.-++..++..||++.+...+.+
T Consensus 483 -----~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 483 -----LPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred -----CCc-hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 111 1145666777888999999999888766544
No 443
>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]
Probab=98.80 E-value=1.9e-07 Score=92.03 Aligned_cols=249 Identities=15% Similarity=0.121 Sum_probs=149.0
Q ss_pred hhcccCccCceEEEEEE-EcCCcEEEEEEecCCCCC-HHHHHHH--------------------HhcccccCcceEEEEE
Q 048517 165 FTHKLGQGGFGSVYKGQ-LHTGRLIAVKMMENSKFS-AEEFINE--------------------LLGLCSEGFKRALVYE 222 (453)
Q Consensus 165 ~~~~LG~G~fG~Vy~g~-~~~g~~VAVK~l~~~~~~-~~~~i~e--------------------l~g~~~~~~~~~lv~E 222 (453)
....||+|+-+.+|--- ..+ .|| |+...-.-. ..+...+ |+|- ..+...-++|.
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d--~VA-KIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGflmP 90 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRD--QVA-KIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIGFLMP 90 (637)
T ss_pred CCccccCCccceeeecchhhc--hhh-eeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCC-CccceeEEecc
Confidence 35679999999999542 322 243 666542211 1121222 2221 12222456666
Q ss_pred ecCCCChhhhhhhc---cCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517 223 YMPNGSLDRHIFSK---ENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 223 ~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 299 (453)
.+.+..=-..+++. +..-....|+.++..+..+|.+.+-||.. +.+-+|++++|+|+.+++.+.|.|=..-.+.
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence 66554222222222 22335689999999999999999999998 9999999999999999999999974433333
Q ss_pred CCCCCceeecccCCCCCccChhhhc-ccC--CCCCccchHHHHHHHHHHHHcC-CCCCCCCccccc-----cccchHHHH
Q 048517 300 PKENDFVSISDTRGTIGYLAPELIS-RNF--GTVSCKSDVYGFGMVLLEMAGG-RRNSNMNATRSS-----KAYFPSWVY 370 (453)
Q Consensus 300 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~--~~~s~k~DV~S~Gvvl~elltg-~~p~~~~~~~~~-----~~~~~~~~~ 370 (453)
..+.. .....|...|.+||.-. ..+ -.-+...|-|.+|+++++++.| ++||...-..+. +..+....+
T Consensus 168 ~ng~~---~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 168 ANGTL---HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred cCCce---EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 22222 23467889999999654 111 1446789999999999998876 889865433221 111111111
Q ss_pred HHhhhCCCccccchhh-hHHHHHHHHHHHHHHhccc--CCCCCCCHHHHHHHHhCC
Q 048517 371 DQLNKGGDLELRNVTE-IESMIARKLCMIGLWCIQV--KAADRPSMTKVLEMLEGS 423 (453)
Q Consensus 371 ~~l~~~~~~~~~~~~~-~~~~~~~~l~~l~~~Cl~~--~p~~RPs~~evl~~Le~~ 423 (453)
....+.+........+ --..+...+..+..+|+.. ++.-|||.+..+..|...
T Consensus 245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 1111111111111111 1233445666777788865 366899999888776543
No 444
>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]
Probab=98.70 E-value=1.9e-07 Score=82.97 Aligned_cols=116 Identities=23% Similarity=0.282 Sum_probs=83.2
Q ss_pred ccCccCceEEEEEEEcCCcEEEEEEecCCCCC---------HHHHHHH--------Hhccc------ccCcceEEEEEec
Q 048517 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS---------AEEFINE--------LLGLC------SEGFKRALVYEYM 224 (453)
Q Consensus 168 ~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~---------~~~~i~e--------l~g~~------~~~~~~~lv~E~~ 224 (453)
.+++|+=+.+|.+.+. |.++.+|.-...... .++-.+| -.|.+ .+.....++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999765 445777743322111 1112222 22333 2444567999999
Q ss_pred CCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517 225 PNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 299 (453)
++-.|.+.+... ...++..+-.-+.-||.. +|+|+|+.++||++..+. +.+.||||+...
T Consensus 82 ~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999998888322 366788888889999998 999999999999997764 999999999743
No 445
>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]
Probab=98.62 E-value=5.1e-07 Score=80.03 Aligned_cols=127 Identities=24% Similarity=0.336 Sum_probs=86.4
Q ss_pred cccCccCceEEEEEEEcCCcEEEEEEecCCCC---------CHHHHHHH--------Hhccc------ccCcceEEEEEe
Q 048517 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF---------SAEEFINE--------LLGLC------SEGFKRALVYEY 223 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~---------~~~~~i~e--------l~g~~------~~~~~~~lv~E~ 223 (453)
..|-||+=+.|+++... |+...||.-..... ...+-.+| ..|.+ .+...-.|+|||
T Consensus 13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 45788999999999877 77777774322111 11222222 22333 233345699999
Q ss_pred cCC-CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC---ceEEEecCCcccc
Q 048517 224 MPN-GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF---IPKVSDFGLAKFH 299 (453)
Q Consensus 224 ~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~---~~kl~DFGla~~~ 299 (453)
+++ -++.+++.+.-. ....-+.....+..|-+.+.-||.+ .|+|+||..+||+|..++ .+.+.|||++...
T Consensus 92 ~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 92 IDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred ccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 976 478888754322 2222333378899999999999998 999999999999996543 4689999998754
No 446
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=98.61 E-value=3.2e-08 Score=106.79 Aligned_cols=181 Identities=18% Similarity=0.199 Sum_probs=126.5
Q ss_pred cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEe
Q 048517 213 EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSD 292 (453)
Q Consensus 213 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~D 292 (453)
......|+++|..+++|...|+.. ...+.+-.......+..+++|||+. .+.|+|++|.|+|...++..+++|
T Consensus 875 ~rsP~~L~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~ 947 (1205)
T KOG0606|consen 875 CRSPLPLVGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTD 947 (1205)
T ss_pred CCCCcchhhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCc
Confidence 455678999999999998877533 2455555566667788899999997 699999999999999999999999
Q ss_pred cCCccccCC---------------------CCC---c-----eeecccCCCCCccChhhhcccCCCCCccchHHHHHHHH
Q 048517 293 FGLAKFHPK---------------------END---F-----VSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVL 343 (453)
Q Consensus 293 FGla~~~~~---------------------~~~---~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl 343 (453)
||......- ... . .......||+.|.+||...+. .-...+|+|+.|+.+
T Consensus 948 ~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~--~hgs~ad~~~~g~~l 1025 (1205)
T KOG0606|consen 948 FGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR--RHGSAADWWSSGVCL 1025 (1205)
T ss_pred cccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc--cCCCcchhhhhhhhh
Confidence 984322110 000 0 011234689999999998875 566789999999999
Q ss_pred HHHHcCCCCCCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHH
Q 048517 344 LEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMT 414 (453)
Q Consensus 344 ~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ 414 (453)
+|.++|.+||+...... +.+.+..+..... ..+.+.+.....++...+..+|.+|-.|.
T Consensus 1026 ~e~l~g~pp~na~tpq~--------~f~ni~~~~~~~p----~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1026 FEVLTGIPPFNAETPQQ--------IFENILNRDIPWP----EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhcCCCCCCCcchhh--------hhhccccCCCCCC----CCccccChhhhhhhhhhhccCchhccCcc
Confidence 99999999997654322 2233332222111 12233344566677777778888887765
No 447
>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.
Probab=98.61 E-value=4.6e-07 Score=82.32 Aligned_cols=73 Identities=30% Similarity=0.377 Sum_probs=50.0
Q ss_pred eEEEEEecC--CCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHH-hHcCCCCceeecccCCcceEEcCCCceEEEec
Q 048517 217 RALVYEYMP--NGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY-LHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 293 (453)
Q Consensus 217 ~~lv~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivH~Dikp~NILl~~~~~~kl~DF 293 (453)
..|||||++ +..+.. +.. ..++.+....++.+++..+.. +|.. +|+|+|+.+.|||++++ .+.+.||
T Consensus 81 ~~ivME~I~~~G~~~~~-l~~-----~~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 81 NVIVMEYIGEDGVPLPR-LKD-----VDLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp TEEEEE--EETTEEGGC-HHH-----CGGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--G
T ss_pred CEEEEEecCCCccchhh-HHh-----ccccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEec
Confidence 469999998 544433 311 122256677888888886666 4676 99999999999999988 9999999
Q ss_pred CCcccc
Q 048517 294 GLAKFH 299 (453)
Q Consensus 294 Gla~~~ 299 (453)
|.+...
T Consensus 151 ~qav~~ 156 (188)
T PF01163_consen 151 GQAVDS 156 (188)
T ss_dssp TTEEET
T ss_pred Ccceec
Confidence 988643
No 448
>KOG2137 consensus Protein kinase [Signal transduction mechanisms]
Probab=98.51 E-value=3.3e-08 Score=102.89 Aligned_cols=152 Identities=18% Similarity=0.241 Sum_probs=101.4
Q ss_pred HHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCcee-ec------ccCCCCCccChhhhc
Q 048517 252 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-IS------DTRGTIGYLAPELIS 324 (453)
Q Consensus 252 ~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~~------~~~gt~~y~aPE~~~ 324 (453)
+.+++.|+.|+|.. ..+||++|.|++|.+++++..||+.|+.+........+.. .. -......|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 44566999999987 5899999999999999999999999998765443221110 01 112455799999997
Q ss_pred ccCCCCCccchHHHHHHHHHHHHcCCCC-CCCCccccccccchHHHHHHhhhCCCccccchhhhHHHHHHHHHHHHHHhc
Q 048517 325 RNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCI 403 (453)
Q Consensus 325 ~~~~~~s~k~DV~S~Gvvl~elltg~~p-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 403 (453)
.. ..+.++|+||+|++++.+..|+++ +....... ....... ..+... ......+..++.+=+.+.+
T Consensus 183 ~~--~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~---------~~~~~~~-~~~~~~-~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GT--TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL---------SYSFSRN-LLNAGA-FGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cc--cccccccceeeeeEEEEEecCCcchhhccCCcc---------hhhhhhc-cccccc-ccccccCcHHHHHHHHHHh
Confidence 64 678899999999999999954443 33222110 0001110 001000 0122445567777888899
Q ss_pred ccCCCCCCCHHHHHH
Q 048517 404 QVKAADRPSMTKVLE 418 (453)
Q Consensus 404 ~~~p~~RPs~~evl~ 418 (453)
..++..||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998876654
No 449
>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional
Probab=98.50 E-value=1.1e-06 Score=84.41 Aligned_cols=78 Identities=17% Similarity=0.081 Sum_probs=62.7
Q ss_pred ceEEEEEecCCC-ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC-------CCc
Q 048517 216 KRALVYEYMPNG-SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-------NFI 287 (453)
Q Consensus 216 ~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~-------~~~ 287 (453)
.-+||+|++++- +|.+++.... ....+......++.+++..+.-||.. +|+|+|++++|||++. +..
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 467999999876 7888763211 12344566778999999999999998 9999999999999975 468
Q ss_pred eEEEecCCccc
Q 048517 288 PKVSDFGLAKF 298 (453)
Q Consensus 288 ~kl~DFGla~~ 298 (453)
+.++||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 89999998853
No 450
>KOG1243 consensus Protein kinase [General function prediction only]
Probab=98.49 E-value=7.1e-07 Score=92.81 Aligned_cols=151 Identities=17% Similarity=0.182 Sum_probs=103.0
Q ss_pred EcCCcEEEEEEecCCCCC---------------HHHHHHHHhcccccCcceEEEEEecCCCChhhhhhhccCCCCCCCch
Q 048517 182 LHTGRLIAVKMMENSKFS---------------AEEFINELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLE 246 (453)
Q Consensus 182 ~~~g~~VAVK~l~~~~~~---------------~~~~i~el~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~ 246 (453)
..++.+|.|...+.+... ++..|..++.........|||+|-+.- |..++. .++-.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk-------~l~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLK-------ELGKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHH-------HhHHH
Confidence 446677777766654331 122333456666677789999998743 444441 23345
Q ss_pred hHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhccc
Q 048517 247 KPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRN 326 (453)
Q Consensus 247 ~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 326 (453)
...-.+.||+.||.+||..| +++|++|....|++++.|..||++|.++.....-.. .......--.|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 55667889999999999764 899999999999999999999999988764432211 01111222346777765432
Q ss_pred CCCCCccchHHHHHHHHHHHHcC
Q 048517 327 FGTVSCKSDVYGFGMVLLEMAGG 349 (453)
Q Consensus 327 ~~~~s~k~DV~S~Gvvl~elltg 349 (453)
....|.|-||++++|++.|
T Consensus 181 ----~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 ----EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ----ccchhhhhHHHHHHHHhCc
Confidence 1457999999999999998
No 451
>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]
Probab=98.44 E-value=1.3e-06 Score=82.32 Aligned_cols=122 Identities=25% Similarity=0.235 Sum_probs=83.0
Q ss_pred hhhcccCccCceEEEEEEEcCCcEEEEEEecCCCC-------CH----------------------HHHHHHHhcc--cc
Q 048517 164 HFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF-------SA----------------------EEFINELLGL--CS 212 (453)
Q Consensus 164 ~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~-------~~----------------------~~~i~el~g~--~~ 212 (453)
.+..+||-|.=+.||.|..+.|.++|||.=..... .. -+++..|+.. -.
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 45689999999999999999999999995332100 00 0112223333 11
Q ss_pred ----cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCce
Q 048517 213 ----EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIP 288 (453)
Q Consensus 213 ----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~ 288 (453)
..++.++||||.++--|.+. +++.+..-.|+..|+.-+.-+-.. +|||+|+.+-||++++|+.+
T Consensus 174 P~P~~~nRHaVvMe~ieG~eL~~~---------r~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 174 PKPIAWNRHAVVMEYIEGVELYRL---------RLDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred CCccccccceeeeehcccceeecc---------cCcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCCE
Confidence 23456899999988666431 123444445555555555555455 99999999999999999999
Q ss_pred EEEecCCcc
Q 048517 289 KVSDFGLAK 297 (453)
Q Consensus 289 kl~DFGla~ 297 (453)
.+.||--+.
T Consensus 242 ~vIDwPQ~v 250 (304)
T COG0478 242 VVIDWPQAV 250 (304)
T ss_pred EEEeCcccc
Confidence 999996554
No 452
>COG0661 AarF Predicted unusual protein kinase [General function prediction only]
Probab=98.27 E-value=4e-06 Score=87.35 Aligned_cols=135 Identities=20% Similarity=0.223 Sum_probs=88.3
Q ss_pred HHHHhhhhh-cccCccCceEEEEEEEcCCcEEEEEEecCCCCC---------------------------HHHHHHH---
Q 048517 158 IIAVTNHFT-HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS---------------------------AEEFINE--- 206 (453)
Q Consensus 158 ~~~~~~~~~-~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~---------------------------~~~~i~e--- 206 (453)
+.+.-.+|. +-|+.++-|.||+|++++|+.||||+....-.. ..+.+.|
T Consensus 121 iee~F~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 121 IEELFSEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred HHHHHHHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 333444555 469999999999999999999999998653111 0111111
Q ss_pred -----------------Hhcc-------------cccCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHH
Q 048517 207 -----------------LLGL-------------CSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTA 256 (453)
Q Consensus 207 -----------------l~g~-------------~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia 256 (453)
+-.. .+-.....|+|||++|-.+.+...... ..++ +..++..++
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d---~k~ia~~~~ 274 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGID---RKELAELLV 274 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCC---HHHHHHHHH
Confidence 1001 112345679999999999988753222 2333 333444444
Q ss_pred HH-HHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517 257 RG-IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 301 (453)
Q Consensus 257 ~g-L~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 301 (453)
++ +..+-.. +++|.|..|.||+++.++...+.|||+......
T Consensus 275 ~~f~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 275 RAFLRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 33 2222223 899999999999999999999999999876543
No 453
>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]
Probab=98.20 E-value=0.00013 Score=74.18 Aligned_cols=155 Identities=18% Similarity=0.276 Sum_probs=109.9
Q ss_pred eEEEEEE-EcCCcEEEEEEecCCCCC--------HHHHHH----------HHhc-ccccCcceEEEEEecCC-CChhhhh
Q 048517 175 GSVYKGQ-LHTGRLIAVKMMENSKFS--------AEEFIN----------ELLG-LCSEGFKRALVYEYMPN-GSLDRHI 233 (453)
Q Consensus 175 G~Vy~g~-~~~g~~VAVK~l~~~~~~--------~~~~i~----------el~g-~~~~~~~~~lv~E~~~~-gsL~~~l 233 (453)
.+.|++. ..||..+..|+++..+.. .+.+.+ +++. .--.....++||+|.++ ++|.+..
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 5779998 458999999999542211 122211 1221 22234567899999986 6777765
Q ss_pred hhccC-----------CCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCC
Q 048517 234 FSKEN-----------KGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 302 (453)
Q Consensus 234 ~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 302 (453)
+.... .+...++..+|.++.|+..||.++|+. ++.-+-+.+++||++.+..++|+..|...+...+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 53221 123566788999999999999999998 9999999999999999999999999887765443
Q ss_pred CCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCC
Q 048517 303 NDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS 353 (453)
Q Consensus 303 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~ 353 (453)
. .+| +.. --+-|.=.||.+++.|.+|..+.
T Consensus 447 ~--------------~~~--le~-----~Qq~D~~~lG~ll~aLAt~~~ns 476 (655)
T KOG3741|consen 447 P--------------TEP--LES-----QQQNDLRDLGLLLLALATGTENS 476 (655)
T ss_pred C--------------Ccc--hhH-----HhhhhHHHHHHHHHHHhhccccc
Confidence 2 011 111 11468889999999999997653
No 454
>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]
Probab=98.10 E-value=2.8e-05 Score=80.89 Aligned_cols=130 Identities=18% Similarity=0.191 Sum_probs=84.1
Q ss_pred hhhh-cccCccCceEEEEEEEcCCcEEEEEEecCCCCCH--H------------------------------------HH
Q 048517 163 NHFT-HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA--E------------------------------------EF 203 (453)
Q Consensus 163 ~~~~-~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~--~------------------------------------~~ 203 (453)
..|. +.||.-+.|.||+|++++|+.||||+.+..-... . +|
T Consensus 162 ~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF 241 (538)
T KOG1235|consen 162 SEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDF 241 (538)
T ss_pred HhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcch
Confidence 3444 4699999999999999999999999976532111 0 01
Q ss_pred HHH------Hhc----------------ccccCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHH
Q 048517 204 INE------LLG----------------LCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEY 261 (453)
Q Consensus 204 i~e------l~g----------------~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~y 261 (453)
.+| ... +.+-...+.|+||||+|..+.+.-.-.+ ..++.. .|+..+.++...
T Consensus 242 ~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~---~gi~~~---~i~~~l~~~~~~ 315 (538)
T KOG1235|consen 242 TKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK---RGISPH---DILNKLVEAYLE 315 (538)
T ss_pred HHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH---cCCCHH---HHHHHHHHHHHH
Confidence 111 000 0112235789999999998877643332 234443 344444443222
Q ss_pred hHcCCCCceeecccCCcceEEc----CCCceEEEecCCccccC
Q 048517 262 LHNGCDVCILHFDIKPHNILLD----HNFIPKVSDFGLAKFHP 300 (453)
Q Consensus 262 LH~~~~~~ivH~Dikp~NILl~----~~~~~kl~DFGla~~~~ 300 (453)
+= ...+++|.|-.|.||+++ .++.+.+.|||+.....
T Consensus 316 qI--f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 316 QI--FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HH--HhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 11 123899999999999998 36789999999987553
No 455
>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane
Probab=98.09 E-value=8.2e-06 Score=75.49 Aligned_cols=77 Identities=27% Similarity=0.351 Sum_probs=63.9
Q ss_pred ceEEEEEecCCC-ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCC---ceEEE
Q 048517 216 KRALVYEYMPNG-SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF---IPKVS 291 (453)
Q Consensus 216 ~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~---~~kl~ 291 (453)
.-++|+|++++- +|.+++.... .++......++.++++.+.-||.. +|+|+|++++|||++.+. .+.+.
T Consensus 91 ~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lI 163 (206)
T PF06293_consen 91 RSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLI 163 (206)
T ss_pred eEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEE
Confidence 347999999874 7888774321 255667789999999999999998 999999999999998876 89999
Q ss_pred ecCCcccc
Q 048517 292 DFGLAKFH 299 (453)
Q Consensus 292 DFGla~~~ 299 (453)
||+-++..
T Consensus 164 Dld~~~~~ 171 (206)
T PF06293_consen 164 DLDRMRFR 171 (206)
T ss_pred cchhceeC
Confidence 99987754
No 456
>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]
Probab=98.06 E-value=5.8e-05 Score=70.52 Aligned_cols=126 Identities=21% Similarity=0.231 Sum_probs=84.0
Q ss_pred cccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHH----------H---------------------HHHHhcccc--c
Q 048517 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEE----------F---------------------INELLGLCS--E 213 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~----------~---------------------i~el~g~~~--~ 213 (453)
..|.+|.-..||+|.-.++..||||+...+....+. | +..++.... .
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 357888889999999888999999998764332221 1 001221111 1
Q ss_pred ----CcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceE
Q 048517 214 ----GFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPK 289 (453)
Q Consensus 214 ----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~k 289 (453)
.....|||||+...... ...-+...+.......+..++++.+.-|-.. .++||+||..-|||+. ++.+.
T Consensus 134 ~Pi~~~~nVLvMEfIg~~g~p----AP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 134 EPIAFRNNVLVMEFIGDDGLP----APRLKDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred CceeecCCeEEEEeccCCCCC----CCCcccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CCeEE
Confidence 12346999999654210 0111112333335677788888888888873 2999999999999999 88999
Q ss_pred EEecCCcccc
Q 048517 290 VSDFGLAKFH 299 (453)
Q Consensus 290 l~DFGla~~~ 299 (453)
++|||-|...
T Consensus 207 iID~~QaV~~ 216 (268)
T COG1718 207 IIDVSQAVTI 216 (268)
T ss_pred EEECcccccc
Confidence 9999988643
No 457
>PRK09902 hypothetical protein; Provisional
Probab=97.93 E-value=0.00017 Score=66.40 Aligned_cols=124 Identities=15% Similarity=0.121 Sum_probs=87.5
Q ss_pred cCccCceEEEEEEEcCCcEEEEEEecCC-------CCCHHHHHHHHh---------------ccccc-----CcceEEEE
Q 048517 169 LGQGGFGSVYKGQLHTGRLIAVKMMENS-------KFSAEEFINELL---------------GLCSE-----GFKRALVY 221 (453)
Q Consensus 169 LG~G~fG~Vy~g~~~~g~~VAVK~l~~~-------~~~~~~~i~el~---------------g~~~~-----~~~~~lv~ 221 (453)
-|+||-+.|+.-.+. |+.+-+|.-.+. .....-|..|+. .++.. ..+.+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467999999997776 457999987631 223344555511 12211 12357899
Q ss_pred EecCC-CChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc--eEEEecCCccc
Q 048517 222 EYMPN-GSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI--PKVSDFGLAKF 298 (453)
Q Consensus 222 E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~--~kl~DFGla~~ 298 (453)
|-+.+ -+|.+++... .-...+...+..+..++++.+.-||+. ++.|+|+.++|||++.++. +++.||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97753 6787776321 123456667789999999999999998 9999999999999986666 99999987663
No 458
>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY). The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process
Probab=97.90 E-value=8.7e-05 Score=68.53 Aligned_cols=124 Identities=17% Similarity=0.164 Sum_probs=79.3
Q ss_pred HHHHHhhhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH----------------H--hcccc------
Q 048517 157 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE----------------L--LGLCS------ 212 (453)
Q Consensus 157 ~~~~~~~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e----------------l--~g~~~------ 212 (453)
++....+...+.+-......|.+-..+ |+...+|.........++++.. + .|+-.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 444444444455655555556555555 6788888876643333333221 0 11111
Q ss_pred --------cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcC
Q 048517 213 --------EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDH 284 (453)
Q Consensus 213 --------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~ 284 (453)
-....+++|||++|..|.+.. .++. .++..+..++.-||+. +++|+|..|.|++++.
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~--------~i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIE--------DIDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccch--------hcCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEEC
Confidence 112235899999998886543 1121 3556778889999998 9999999999999986
Q ss_pred CCceEEEecCCcc
Q 048517 285 NFIPKVSDFGLAK 297 (453)
Q Consensus 285 ~~~~kl~DFGla~ 297 (453)
++ +++.||+..+
T Consensus 171 ~~-i~iID~~~k~ 182 (229)
T PF06176_consen 171 NG-IRIIDTQGKR 182 (229)
T ss_pred Cc-EEEEECcccc
Confidence 55 8999997665
No 459
>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172. This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.
Probab=97.64 E-value=0.00057 Score=64.14 Aligned_cols=30 Identities=20% Similarity=0.144 Sum_probs=26.3
Q ss_pred CceeecccCCcceEEcCCCceEEEecCCccc
Q 048517 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298 (453)
Q Consensus 268 ~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 298 (453)
..++|+|+.|.||++++++ +.|.||+.+..
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 4678999999999999887 99999988753
No 460
>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily.; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....
Probab=97.34 E-value=0.0012 Score=61.30 Aligned_cols=129 Identities=21% Similarity=0.168 Sum_probs=69.1
Q ss_pred cccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH----------------Hhccc---ccCcceEEEEEecCCC
Q 048517 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE----------------LLGLC---SEGFKRALVYEYMPNG 227 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e----------------l~g~~---~~~~~~~lv~E~~~~g 227 (453)
+.|+.|..+.||+....+ +.+++|..... ....+...| ++..+ ......+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 468889999999999887 68999997654 111111111 12211 1122357899999998
Q ss_pred Chhh----------------h---hhhccCCCCCCCchh---------HHHH------------HHHHHH-HHHHhHc--
Q 048517 228 SLDR----------------H---IFSKENKGQTFGLEK---------PHEI------------ALGTAR-GIEYLHN-- 264 (453)
Q Consensus 228 sL~~----------------~---l~~~~~~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~-- 264 (453)
++.. . ++........+.+.. .... ...+.+ .+..+++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 8776 1 111111111111110 0000 111222 2333332
Q ss_pred --CCCCceeecccCCcceEEc-CCCceEEEecCCcc
Q 048517 265 --GCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAK 297 (453)
Q Consensus 265 --~~~~~ivH~Dikp~NILl~-~~~~~kl~DFGla~ 297 (453)
.....++|+|+.|+|||++ +++.+-|.||+.+.
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2345799999999999999 56666899998765
No 461
>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH). The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio
Probab=97.28 E-value=0.0023 Score=60.52 Aligned_cols=30 Identities=23% Similarity=0.253 Sum_probs=26.8
Q ss_pred CceeecccCCcceEEcCCCceEEEecCCcc
Q 048517 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAK 297 (453)
Q Consensus 268 ~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 297 (453)
+.++|+|+.|.|||++++..+.|.||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 469999999999999998778899998775
No 462
>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C). Proteins in this uncharacterised family are described as transmembrane proteins.
Probab=97.27 E-value=0.00078 Score=61.31 Aligned_cols=91 Identities=25% Similarity=0.226 Sum_probs=69.6
Q ss_pred HHHHhcccccCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc
Q 048517 204 INELLGLCSEGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD 283 (453)
Q Consensus 204 i~el~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~ 283 (453)
+.+++|.|- .+.+.||...+++.... ..-..-..-+|..+.+||.++++.+.+|++.....+.-.|++++|+-++
T Consensus 22 ~pk~lG~CG----~~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~ 96 (188)
T PF12260_consen 22 FPKLLGSCG----RFYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVN 96 (188)
T ss_pred CCCeeeECC----CEEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEe
Confidence 334677773 47899999887664210 0001113468999999999999999999996555688889999999999
Q ss_pred CCCceEEEecCCcccc
Q 048517 284 HNFIPKVSDFGLAKFH 299 (453)
Q Consensus 284 ~~~~~kl~DFGla~~~ 299 (453)
+++.+|+.|...+...
T Consensus 97 ~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 97 DDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCCcEEEEechhcchh
Confidence 9999999999877544
No 463
>PRK10593 hypothetical protein; Provisional
Probab=96.93 E-value=0.0098 Score=58.25 Aligned_cols=61 Identities=11% Similarity=0.077 Sum_probs=39.3
Q ss_pred cccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHH-----------------Hhccccc---CcceEEEEEecCC
Q 048517 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINE-----------------LLGLCSE---GFKRALVYEYMPN 226 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~e-----------------l~g~~~~---~~~~~lv~E~~~~ 226 (453)
+.||.|..+.||+-...+++ +.+|..+. ......+..| +++.|.. .+..++|||++++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~-~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGN-PMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCCC-EEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 46999999999998876664 66676443 1112222222 3444432 3557999999998
Q ss_pred CCh
Q 048517 227 GSL 229 (453)
Q Consensus 227 gsL 229 (453)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 765
No 464
>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members. The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista
Probab=96.87 E-value=0.012 Score=55.31 Aligned_cols=31 Identities=29% Similarity=0.457 Sum_probs=26.5
Q ss_pred CceeecccCCcceEEcCCCceEEEecCCccc
Q 048517 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298 (453)
Q Consensus 268 ~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 298 (453)
..++|+|+.+.||+++++...-|.||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 4599999999999999776677999998753
No 465
>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo
Probab=96.80 E-value=0.01 Score=55.59 Aligned_cols=31 Identities=23% Similarity=0.306 Sum_probs=27.0
Q ss_pred CCceeecccCCcceEEcC-CCceEEEecCCcc
Q 048517 267 DVCILHFDIKPHNILLDH-NFIPKVSDFGLAK 297 (453)
Q Consensus 267 ~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~ 297 (453)
+..++|+|+.+.|||++. +..+.+.||..|.
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 357999999999999998 5789999998775
No 466
>PLN02876 acyl-CoA dehydrogenase
Probab=96.76 E-value=0.016 Score=64.95 Aligned_cols=44 Identities=18% Similarity=0.307 Sum_probs=31.3
Q ss_pred HHHHHHhHcCCC--------CceeecccCCcceEEcC-CC-ceEEEecCCcccc
Q 048517 256 ARGIEYLHNGCD--------VCILHFDIKPHNILLDH-NF-IPKVSDFGLAKFH 299 (453)
Q Consensus 256 a~gL~yLH~~~~--------~~ivH~Dikp~NILl~~-~~-~~kl~DFGla~~~ 299 (453)
.+.+.+|..+.+ +.++|+|+++.|||++. +. ..-|.||+++..-
T Consensus 205 ~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 205 LELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred HHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 344667754322 35999999999999985 33 3578999988653
No 467
>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]
Probab=96.75 E-value=0.013 Score=52.19 Aligned_cols=119 Identities=20% Similarity=0.227 Sum_probs=71.8
Q ss_pred hhcccCccCceEEEEEEEcCCcEEEEEEecCCCCC----HH-HHHHHHhcccccC-----cceEEEEEecCCCChhhhhh
Q 048517 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS----AE-EFINELLGLCSEG-----FKRALVYEYMPNGSLDRHIF 234 (453)
Q Consensus 165 ~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~----~~-~~i~el~g~~~~~-----~~~~lv~E~~~~gsL~~~l~ 234 (453)
..+.||+|.+|.||+|.+. |..+|+|+-..+... .+ +++..+-+..... +...+.|||..|-.|.+.-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~~L~~~~~ 104 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGRPLGKLEI 104 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCcchhhhhh
Confidence 4567999999999999987 668999987653221 11 2222232222211 11235699998878765431
Q ss_pred hccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCC--cceEEcCCCceEEEecCCcccc
Q 048517 235 SKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKP--HNILLDHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 235 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp--~NILl~~~~~~kl~DFGla~~~ 299 (453)
. .+- +-...++..---|-. .+|-|+.|.- +||++.. ..+.|.||..|+..
T Consensus 105 ~-------~~r----k~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~k 156 (201)
T COG2112 105 G-------GDR----KHLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVND-RDVYIIDFDSATFK 156 (201)
T ss_pred c-------ccH----HHHHHHHHHHHHHHH---hccchhhhcCCceeEEecC-CcEEEEEccchhhc
Confidence 1 122 223334444333333 3899999974 4666654 48999999988743
No 468
>PRK09550 mtnK methylthioribose kinase; Reviewed
Probab=96.40 E-value=0.046 Score=55.58 Aligned_cols=32 Identities=25% Similarity=0.312 Sum_probs=26.9
Q ss_pred CCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 267 ~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 299 (453)
...++|||+.+.||++..+ .+++.||-.+...
T Consensus 222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~~G 253 (401)
T PRK09550 222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAFYG 253 (401)
T ss_pred CCceeeccCCcccEEeeCC-CcEEEeccccccC
Confidence 3479999999999999776 5899999877643
No 469
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=96.38 E-value=0.00078 Score=70.38 Aligned_cols=170 Identities=19% Similarity=0.158 Sum_probs=109.6
Q ss_pred hcccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHHHHHHHhcccccC-------------cceEEEEEecCCC-Chhh
Q 048517 166 THKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEEFINELLGLCSEG-------------FKRALVYEYMPNG-SLDR 231 (453)
Q Consensus 166 ~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~~i~el~g~~~~~-------------~~~~lv~E~~~~g-sL~~ 231 (453)
-+..++|++++++|.+--..+...+|.+... .......||+.-|... ...++.++++..| +...
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~--l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~ 324 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSAL 324 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc--hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccc
Confidence 3457889999999987322233335554433 3334455555554433 3345666666555 2111
Q ss_pred hhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeeccc
Q 048517 232 HIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDT 311 (453)
Q Consensus 232 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 311 (453)
-. ......+...+...+...-.++++|||+. .=+|+| ||+..+ ...|.+||+......+.. .....
T Consensus 325 ~~---~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~ 390 (829)
T KOG0576|consen 325 EM---TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTA 390 (829)
T ss_pred cC---ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc---ccccC
Confidence 10 01112233344456667778899999986 558888 887765 678999999987665543 23456
Q ss_pred CCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCC
Q 048517 312 RGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS 353 (453)
Q Consensus 312 ~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~ 353 (453)
.+|+.|+|||+...+ .+..+.|+|+.|+--.++.-|-+|-
T Consensus 391 ~~~~~~~~pev~~~~--~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQEN--TIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCCchhhccc--ccccCCCccCCCcchhhcCCCCCCC
Confidence 799999999988764 8889999999998777777776554
No 470
>PF14380 WAK_assoc: Wall-associated receptor kinase C-terminal
Probab=96.26 E-value=0.015 Score=46.44 Aligned_cols=47 Identities=28% Similarity=0.391 Sum_probs=36.1
Q ss_pred CCCCCCceEEEEEeeecCCCC-CCCCHHHHHHHHhcCcceeee--cccCC
Q 048517 64 SDLPESCVFISKVPVVLNRSV-DNPSYEDLRKLLDSGFDFTWF--EECSS 110 (453)
Q Consensus 64 ~~~~~~c~~~~~~p~~~~~~~-~~~~~~~~~~~~~~g~~~~~~--~~~~~ 110 (453)
.++...|...+.|||+..... ...+..++.+.|++||+|+|. ...|.
T Consensus 19 ~~~~~~C~~~v~vPV~~~~~~~~~~~~~~~~~~L~~GF~L~w~~~~~~C~ 68 (94)
T PF14380_consen 19 SDLAGSCQKSVVVPVLGSAVDSIDGSSGNYEEVLKKGFELEWNADSGDCR 68 (94)
T ss_pred cccCCcCCEEEEEEECchhhhccccchhHHHHHHhcCcEEEEeCCCCcCc
Confidence 456789999999999774321 234788999999999999999 34554
No 471
>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]
Probab=96.25 E-value=0.015 Score=57.63 Aligned_cols=126 Identities=19% Similarity=0.326 Sum_probs=85.8
Q ss_pred hhcccCccCceEEEEEEEcCCcEEEEEEecCCCC---CHHHHHHH----Hhccccc-----------------------C
Q 048517 165 FTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKF---SAEEFINE----LLGLCSE-----------------------G 214 (453)
Q Consensus 165 ~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~---~~~~~i~e----l~g~~~~-----------------------~ 214 (453)
+...|..|-=..||.+.-.+|..+|||+.+.+-. .+++++.- -.|+|.. +
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 3457899999999999988999999998765321 11111110 0112211 1
Q ss_pred ---------cceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCC
Q 048517 215 ---------FKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN 285 (453)
Q Consensus 215 ---------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~ 285 (453)
....|||+|+....- - ...-+...++...+...-.+++.-+.-|.+.| .+||.||.--|+|+- +
T Consensus 228 IP~PePIlLk~hVLVM~FlGrdgw---~-aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 228 IPCPEPILLKNHVLVMEFLGRDGW---A-APKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-D 300 (520)
T ss_pred CCCCCceeeecceEeeeeccCCCC---c-CcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-C
Confidence 113589999953221 1 11123346777788888899999999999886 899999999999995 5
Q ss_pred CceEEEecCCcc
Q 048517 286 FIPKVSDFGLAK 297 (453)
Q Consensus 286 ~~~kl~DFGla~ 297 (453)
|.+.++|-+-+.
T Consensus 301 G~lyiIDVSQSV 312 (520)
T KOG2270|consen 301 GKLYIIDVSQSV 312 (520)
T ss_pred CEEEEEEccccc
Confidence 678899977664
No 472
>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2
Probab=96.25 E-value=0.025 Score=51.83 Aligned_cols=40 Identities=28% Similarity=0.265 Sum_probs=32.6
Q ss_pred HHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCc
Q 048517 249 HEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA 296 (453)
Q Consensus 249 ~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla 296 (453)
..-+.++.+-|..+|.. +|+-+|+|+.|.. .-||+|||.+
T Consensus 167 ~~~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 167 IRDIPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred hhHHHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 34556778888899998 9999999999987 3489999864
No 473
>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]
Probab=96.15 E-value=0.0058 Score=59.44 Aligned_cols=120 Identities=18% Similarity=0.179 Sum_probs=79.5
Q ss_pred hhhhcccCccCceEEEEEEEcCCcEEEEEEecCCCCC------HH-----------------------HHHHHHhc--cc
Q 048517 163 NHFTHKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS------AE-----------------------EFINELLG--LC 211 (453)
Q Consensus 163 ~~~~~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~------~~-----------------------~~i~el~g--~~ 211 (453)
+.+.++||-|.=+.||.+-..+|++.++|.-...... .. .|+..|+. |-
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 4567899999999999999999999999853211000 00 12222332 21
Q ss_pred c----cCcceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCc
Q 048517 212 S----EGFKRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI 287 (453)
Q Consensus 212 ~----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~ 287 (453)
. +..+.++|||++.+-.|...- ...+.++ +...+..-+.-|-.+ ++||+|..-=||+++++..
T Consensus 174 VPkpiD~~RH~Vvmelv~g~Pl~~v~-------~v~d~~~---ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 174 VPKPIDHNRHCVVMELVDGYPLRQVR-------HVEDPPT---LYDDLMGLIVRLANH---GLIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCCcccccceeeHHHhhcccceeeee-------ecCChHH---HHHHHHHHHHHHHHc---CceecccchheeEEecCCC
Confidence 1 234568999999888775422 1122233 333333444555555 9999999999999999999
Q ss_pred eEEEecCC
Q 048517 288 PKVSDFGL 295 (453)
Q Consensus 288 ~kl~DFGl 295 (453)
++++||--
T Consensus 241 i~vIDFPQ 248 (465)
T KOG2268|consen 241 IVVIDFPQ 248 (465)
T ss_pred EEEeechH
Confidence 99999954
No 474
>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]
Probab=96.09 E-value=0.1 Score=51.74 Aligned_cols=126 Identities=24% Similarity=0.399 Sum_probs=73.5
Q ss_pred cCccCceEEEEEEEcCCcEEEEEEecCCCCCHH--HH----HHHH------------------hcccccCcceEEEEEec
Q 048517 169 LGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAE--EF----INEL------------------LGLCSEGFKRALVYEYM 224 (453)
Q Consensus 169 LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~--~~----i~el------------------~g~~~~~~~~~lv~E~~ 224 (453)
|.+ .-..+|+.+..+|+. ++|+.... .... ++ +..| +.......+.+-+++|+
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l 110 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL 110 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence 444 457889998887877 88988875 3222 22 2221 11112223678899999
Q ss_pred CCCChhh-h--------------hhh--------ccCCCCCCCchh-------------HHHHHHHHHHHHHHhHcC---
Q 048517 225 PNGSLDR-H--------------IFS--------KENKGQTFGLEK-------------PHEIALGTARGIEYLHNG--- 265 (453)
Q Consensus 225 ~~gsL~~-~--------------l~~--------~~~~~~~l~~~~-------------~~~i~~~ia~gL~yLH~~--- 265 (453)
+|..+.. - ++. .........|.. ......++...+..+.+.
T Consensus 111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~ 190 (331)
T COG2334 111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA 190 (331)
T ss_pred CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence 9988872 1 111 111122345541 011233334444444432
Q ss_pred -CCCc---eeecccCCcceEEcCCCc-eEEEecCCcc
Q 048517 266 -CDVC---ILHFDIKPHNILLDHNFI-PKVSDFGLAK 297 (453)
Q Consensus 266 -~~~~---ivH~Dikp~NILl~~~~~-~kl~DFGla~ 297 (453)
-... +||+|+.|.||+++.+.. ..+.||+-+.
T Consensus 191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 2223 999999999999998874 8899998764
No 475
>TIGR02721 ycfN_thiK thiamine kinase. Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.
Probab=96.02 E-value=0.058 Score=51.36 Aligned_cols=30 Identities=23% Similarity=0.321 Sum_probs=26.0
Q ss_pred CceeecccCCcceEEcCCCceEEEecCCccc
Q 048517 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298 (453)
Q Consensus 268 ~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 298 (453)
..++|+|+.|.||++++++ +.|.||..+..
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 4689999999999999877 78999988753
No 476
>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes. The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer
Probab=95.91 E-value=0.058 Score=52.69 Aligned_cols=32 Identities=31% Similarity=0.297 Sum_probs=27.9
Q ss_pred CCCceeecccCCcceEEcCC----CceEEEecCCcc
Q 048517 266 CDVCILHFDIKPHNILLDHN----FIPKVSDFGLAK 297 (453)
Q Consensus 266 ~~~~ivH~Dikp~NILl~~~----~~~kl~DFGla~ 297 (453)
....++|+|+.+.|||++++ ..+++.||..|.
T Consensus 177 ~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 177 SPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 45679999999999999875 789999998875
No 477
>cd05153 HomoserineK_II Homoserine Kinase, type II. Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.
Probab=95.90 E-value=0.066 Score=52.07 Aligned_cols=130 Identities=18% Similarity=0.172 Sum_probs=72.3
Q ss_pred cccCccCceEEEEEEEcCCcEEEEEEecCCCCC----HHHHHHHHh--ccc--------------ccCcceEEEEEecCC
Q 048517 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFS----AEEFINELL--GLC--------------SEGFKRALVYEYMPN 226 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~----~~~~i~el~--g~~--------------~~~~~~~lv~E~~~~ 226 (453)
+.|..|.-..+|+....+ ..+++|+....... ..+++..|. |+- ...+..+++++|++|
T Consensus 20 ~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G 98 (296)
T cd05153 20 EGISAGIENTNYFVTTDS-GRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAG 98 (296)
T ss_pred ecccCccccceEEEEeCC-CcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCC
Confidence 357777778999987654 46888987642111 111222221 110 112345789999998
Q ss_pred CChhh----h----------hhhccC-------CCCCCCchhHH----------HHHHHHHHHHHHhHc----CCCCcee
Q 048517 227 GSLDR----H----------IFSKEN-------KGQTFGLEKPH----------EIALGTARGIEYLHN----GCDVCIL 271 (453)
Q Consensus 227 gsL~~----~----------l~~~~~-------~~~~l~~~~~~----------~i~~~ia~gL~yLH~----~~~~~iv 271 (453)
..+.. . +|.... ......|.... .....+...+.++.+ .....++
T Consensus 99 ~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 178 (296)
T cd05153 99 EHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVI 178 (296)
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCC
Confidence 77532 0 111000 00112332211 111223344555553 2234799
Q ss_pred ecccCCcceEEcCCCceEEEecCCcc
Q 048517 272 HFDIKPHNILLDHNFIPKVSDFGLAK 297 (453)
Q Consensus 272 H~Dikp~NILl~~~~~~kl~DFGla~ 297 (453)
|+|+.|.|||++++..+.|.||+.+.
T Consensus 179 HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 179 HADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred ccCcCcccEEEeCCceEEEeehhhhc
Confidence 99999999999998778899998775
No 478
>PRK05231 homoserine kinase; Provisional
Probab=95.90 E-value=0.08 Score=52.13 Aligned_cols=31 Identities=23% Similarity=0.340 Sum_probs=26.7
Q ss_pred CCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297 (453)
Q Consensus 267 ~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 297 (453)
..+++|+|+.|.|||++.+...-|.||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 4589999999999999977666899998875
No 479
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=95.85 E-value=0.035 Score=62.23 Aligned_cols=167 Identities=19% Similarity=0.175 Sum_probs=109.2
Q ss_pred EEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCc---ceEEcCCCceEEE--ecCC
Q 048517 221 YEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPH---NILLDHNFIPKVS--DFGL 295 (453)
Q Consensus 221 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~---NILl~~~~~~kl~--DFGl 295 (453)
-|++..-++...+ ......+..+.+.+..+...||.|+|+. ...|.-+..+ +-..+..+....+ ||+.
T Consensus 265 ~~~~s~~~~~~~~----q~v~~i~~~~~r~~~~~~~~GL~~~h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~s 337 (1351)
T KOG1035|consen 265 QEICSKVELRSLL----QSVGSIPLETLRILHQKLLEGLAYLHSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDS 337 (1351)
T ss_pred HhhcCccchHHHH----hhccccCHHHHHHHHHHHhhhHHHHHHh---ccceeEEecccccccccCccceeecchhhhcc
Confidence 4555555555544 2335678888889999999999999997 5555555444 4444566677777 8888
Q ss_pred ccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCCCCCccccccccchHHHHHHhhh
Q 048517 296 AKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 375 (453)
Q Consensus 296 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~l~~ 375 (453)
++..+..... ....-+..+.+||....+....+...|+|.+|..+..+..|..+....... ...+..
T Consensus 338 s~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~----------~~~l~~ 404 (1351)
T KOG1035|consen 338 SKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVP----------VSLLDV 404 (1351)
T ss_pred cccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccch----------hhhhcc
Confidence 8766543321 223345678889888765445556689999999999998876543221110 000000
Q ss_pred CCCccccchhhhHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 048517 376 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 421 (453)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~Le 421 (453)
. ....+......|+..++++|++..++++..-
T Consensus 405 ---------~-----~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 405 ---------L-----STSELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred ---------c-----cchhhhhhhhhhcchhhhhccchhhhhhchh
Confidence 0 0013566777899999999999999998653
No 480
>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP. PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].
Probab=95.57 E-value=0.13 Score=47.13 Aligned_cols=112 Identities=20% Similarity=0.276 Sum_probs=69.7
Q ss_pred cccCccCceEEEEEEEcCCcEEEEEEecCCC-----------------CCHHHHHHH--------------------Hhc
Q 048517 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSK-----------------FSAEEFINE--------------------LLG 209 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~-----------------~~~~~~i~e--------------------l~g 209 (453)
..||+|+.=.||.- ++.....||+..... ....++..| .+|
T Consensus 7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 46999999888874 445557888887654 112333333 345
Q ss_pred ccccCcceEEEEEecCC--C----ChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc
Q 048517 210 LCSEGFKRALVYEYMPN--G----SLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD 283 (453)
Q Consensus 210 ~~~~~~~~~lv~E~~~~--g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~ 283 (453)
+...+....+|+|.+.+ | +|.+++. ...++. ...+ .+-+-..||-+. .|+.+|++|+||++.
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~~---~L~~f~~~l~~~---~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELRQ---ALDEFKRYLLDH---HIVIRDLNPHNIVVQ 152 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHHH---HHHHHHHHHHHc---CCeecCCCcccEEEE
Confidence 55555566788888743 3 4566652 123443 3333 333445667666 899999999999995
Q ss_pred CC--C--ceEEEe
Q 048517 284 HN--F--IPKVSD 292 (453)
Q Consensus 284 ~~--~--~~kl~D 292 (453)
.+ + .+.|.|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 32 2 466776
No 481
>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]
Probab=95.54 E-value=0.0018 Score=73.74 Aligned_cols=134 Identities=13% Similarity=0.034 Sum_probs=95.0
Q ss_pred ceEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCC--CCceeecccCCcceEEcCCCceEEEec
Q 048517 216 KRALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGC--DVCILHFDIKPHNILLDHNFIPKVSDF 293 (453)
Q Consensus 216 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dikp~NILl~~~~~~kl~DF 293 (453)
..+..++|+..|.+.+.|.....+...+...-+...-.+......-.|+.. ..--+|+++|+-|.+|..+-.+|++++
T Consensus 1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence 345788899999999988665544445544444443344344445544432 224789999999999999999999999
Q ss_pred CCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccchHHHHHHHHHHHHcCCCCC
Q 048517 294 GLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS 353 (453)
Q Consensus 294 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DV~S~Gvvl~elltg~~p~ 353 (453)
|+.+........ .+...+++-|+.|+....- .++.++|+|..|+.+++..-|..++
T Consensus 1385 gLdKIknp~~sf--~Gl~l~sp~~v~qli~N~i--k~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1385 GLDKIKNPVLSF--FGLELCSPIYVLQLIKNEI--KFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred ccccccCchHhh--hhhhhCCHHHHHHHHHHHH--hhhhHHHHHHHHHHHHHHhcccHHH
Confidence 999943332221 2445678889999987654 6677799999999999998776554
No 482
>PLN02236 choline kinase
Probab=95.43 E-value=0.11 Score=51.97 Aligned_cols=32 Identities=22% Similarity=0.429 Sum_probs=27.2
Q ss_pred CCceeecccCCcceEEcC-CCceEEEecCCccc
Q 048517 267 DVCILHFDIKPHNILLDH-NFIPKVSDFGLAKF 298 (453)
Q Consensus 267 ~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~ 298 (453)
+..++|+|+++.|||+++ +..+.+.||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 457999999999999986 57899999988753
No 483
>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]
Probab=94.76 E-value=0.37 Score=47.42 Aligned_cols=43 Identities=26% Similarity=0.400 Sum_probs=33.9
Q ss_pred HHHhHcCC-----CCceeecccCCcceEEcCCCceEEEecCCccccCC
Q 048517 259 IEYLHNGC-----DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 301 (453)
Q Consensus 259 L~yLH~~~-----~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 301 (453)
..+|+++. .+.++|+|+.+.|++++.+.-+-|.||+++.+-..
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 45555442 25699999999999999888899999999986543
No 484
>PRK06148 hypothetical protein; Provisional
Probab=93.91 E-value=0.54 Score=53.91 Aligned_cols=33 Identities=30% Similarity=0.318 Sum_probs=26.9
Q ss_pred CCCceeecccCCcceEEcCCC--ceE-EEecCCccc
Q 048517 266 CDVCILHFDIKPHNILLDHNF--IPK-VSDFGLAKF 298 (453)
Q Consensus 266 ~~~~ivH~Dikp~NILl~~~~--~~k-l~DFGla~~ 298 (453)
...++||+|+.+.|||++.+. .+. |.|||-+..
T Consensus 201 Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 201 LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 345899999999999999875 454 999998753
No 485
>PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding
Probab=93.70 E-value=0.14 Score=41.75 Aligned_cols=23 Identities=35% Similarity=0.257 Sum_probs=21.0
Q ss_pred cccEEEEEEecCCcEEEEEecCC
Q 048517 2 TFQHYVKRISYDECTISVADVNL 24 (453)
Q Consensus 2 ~~~y~V~~I~Y~~~t~~v~d~~~ 24 (453)
.++|+|++|+|.+++++|.++..
T Consensus 46 ~~~~~V~~I~~~~~~i~v~~~~~ 68 (106)
T PF13947_consen 46 SGNYEVLSISYENGTIRVSDPIS 68 (106)
T ss_pred CCcEEEEEEecCCCEEEEEeccc
Confidence 47899999999999999999875
No 486
>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]
Probab=93.61 E-value=0.2 Score=50.58 Aligned_cols=60 Identities=20% Similarity=0.119 Sum_probs=41.2
Q ss_pred eEEEEEecCCCChhhhhhhccCCCCCCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEc
Q 048517 217 RALVYEYMPNGSLDRHIFSKENKGQTFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLD 283 (453)
Q Consensus 217 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~ 283 (453)
..|+-+|+.+.++..++... ..++....+++.--++||.-+--- .+.+|.|+.|.||++-
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~-----~~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK-----SQPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhcc-----cChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEE
Confidence 34677888898998888432 233345566666666665544332 2899999999999994
No 487
>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]
Probab=93.35 E-value=0.21 Score=49.61 Aligned_cols=55 Identities=18% Similarity=0.176 Sum_probs=49.2
Q ss_pred CCCchhHHHHHHHHHHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCcccc
Q 048517 242 TFGLEKPHEIALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 299 (453)
Q Consensus 242 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~ 299 (453)
.-.|++...|+.+.++.+.-+..+ .+.=|||+.-.||||+ +|++.|.||-++|+-
T Consensus 317 ~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 317 ADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred cccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeeecc
Confidence 457899999999999988888876 5889999999999999 999999999999954
No 488
>PRK11768 serine/threonine protein kinase; Provisional
Probab=93.06 E-value=1.6 Score=43.14 Aligned_cols=29 Identities=34% Similarity=0.421 Sum_probs=24.5
Q ss_pred CCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297 (453)
Q Consensus 267 ~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 297 (453)
..+++|+|+.+.|||++ + .+.|.||+-+.
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred CccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 44789999999999995 4 57899999775
No 489
>PLN02421 phosphotransferase, alcohol group as acceptor/kinase
Probab=92.71 E-value=0.8 Score=45.51 Aligned_cols=31 Identities=23% Similarity=0.330 Sum_probs=26.3
Q ss_pred CceeecccCCcceEEcC-CCceEEEecCCccc
Q 048517 268 VCILHFDIKPHNILLDH-NFIPKVSDFGLAKF 298 (453)
Q Consensus 268 ~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~ 298 (453)
.-++|+|+.+.|||+++ ++.+++.||..|..
T Consensus 182 ~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 182 VVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred eEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 35899999999999975 57899999988753
No 490
>TIGR00938 thrB_alt homoserine kinase, Neisseria type. Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.
Probab=92.61 E-value=0.18 Score=49.39 Aligned_cols=42 Identities=29% Similarity=0.506 Sum_probs=32.3
Q ss_pred HHHHHHhHc----CCCCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517 256 ARGIEYLHN----GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297 (453)
Q Consensus 256 a~gL~yLH~----~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 297 (453)
.+.++++.. ....+++|+|+++.||+++.+....|.||+.+.
T Consensus 171 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 171 DKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 344555542 234689999999999999988777899998774
No 491
>PHA03111 Ser/Thr kinase; Provisional
Probab=92.41 E-value=0.15 Score=50.05 Aligned_cols=37 Identities=35% Similarity=0.331 Sum_probs=27.0
Q ss_pred hhHHHHHHHHHHHHHHh-HcCCCCceeecccCCcceEE
Q 048517 246 EKPHEIALGTARGIEYL-HNGCDVCILHFDIKPHNILL 282 (453)
Q Consensus 246 ~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dikp~NILl 282 (453)
+-+..+..|||--.-.. .-.|....+|-||||+|||+
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILi 316 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILI 316 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEE
Confidence 34566778887655444 33445689999999999999
No 492
>PLN02756 S-methyl-5-thioribose kinase
Probab=91.48 E-value=2.8 Score=42.87 Aligned_cols=31 Identities=16% Similarity=0.295 Sum_probs=25.5
Q ss_pred CCceeecccCCcceEEcCCCceEEEecCCccc
Q 048517 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298 (453)
Q Consensus 267 ~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 298 (453)
.+.++|+|+.|.||+++.+. +++.|...+..
T Consensus 229 ~~~L~HGDl~~g~i~~~~~~-~~~id~ef~~~ 259 (418)
T PLN02756 229 AQALVHGDLHTGSVMVTPDS-TQVIDPEFAFY 259 (418)
T ss_pred ccceeecCCCCCcEEEcCCC-ceEecchhhcc
Confidence 36899999999999999875 88888765543
No 493
>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []. Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.
Probab=91.19 E-value=0.65 Score=45.20 Aligned_cols=60 Identities=18% Similarity=0.231 Sum_probs=31.6
Q ss_pred cccCccCceEEEEEEEcCCcEEEEEEecCCCCCH---H-HHHHH-----------HhcccccCcceEEEEEecCCC
Q 048517 167 HKLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSA---E-EFINE-----------LLGLCSEGFKRALVYEYMPNG 227 (453)
Q Consensus 167 ~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~---~-~~i~e-----------l~g~~~~~~~~~lv~E~~~~g 227 (453)
+.++.|.-..+|+.. .+++.+-||+-....... | +-++. .+++.......+|++||++.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 458888889999987 668889999877432211 1 11111 333333445568999999877
No 494
>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly. ; GO: 0004672 protein kinase activity, 0005524 ATP binding
Probab=90.83 E-value=0.25 Score=48.76 Aligned_cols=51 Identities=29% Similarity=0.427 Sum_probs=33.4
Q ss_pred HHHHHHHHHHHHHH--hHc-CCCCceeecccCCcceEEc------------------CCCceEEEecCCccccC
Q 048517 248 PHEIALGTARGIEY--LHN-GCDVCILHFDIKPHNILLD------------------HNFIPKVSDFGLAKFHP 300 (453)
Q Consensus 248 ~~~i~~~ia~gL~y--LH~-~~~~~ivH~Dikp~NILl~------------------~~~~~kl~DFGla~~~~ 300 (453)
+..+..|+| |.| .-+ .|....+|-||||+|||+= +.-.++|-||.+++...
T Consensus 277 vkfifLQia--LLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~ 348 (434)
T PF05445_consen 277 VKFIFLQIA--LLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN 348 (434)
T ss_pred HHHHHHHHH--HHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcc
Confidence 455666765 344 322 2456899999999999992 22246777887776543
No 495
>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.
Probab=89.87 E-value=0.088 Score=44.06 Aligned_cols=34 Identities=24% Similarity=0.432 Sum_probs=29.0
Q ss_pred hhhh-cccCccCceEEEEEEEcCCcEEEEEEecCC
Q 048517 163 NHFT-HKLGQGGFGSVYKGQLHTGRLIAVKMMENS 196 (453)
Q Consensus 163 ~~~~-~~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~ 196 (453)
..|. +-||.|+.|.||+|++++|+.||||+.+..
T Consensus 12 ~~fd~~PlasASiaQVh~a~l~~g~~VaVKV~rP~ 46 (119)
T PF03109_consen 12 DEFDPEPLASASIAQVHRARLKDGEEVAVKVQRPG 46 (119)
T ss_pred HHCCcchhhheehhhheeeeecccchhhhhhcchH
Confidence 3444 469999999999999999999999998763
No 496
>TIGR02906 spore_CotS spore coat protein, CotS family. Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.
Probab=89.70 E-value=0.7 Score=45.12 Aligned_cols=30 Identities=33% Similarity=0.253 Sum_probs=25.7
Q ss_pred CCceeecccCCcceEEcCCCceEEEecCCcc
Q 048517 267 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK 297 (453)
Q Consensus 267 ~~~ivH~Dikp~NILl~~~~~~kl~DFGla~ 297 (453)
..+++|+|+.++||+++. +.+.|.||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 358999999999999987 567899998764
No 497
>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length. The function of this family is unknown.
Probab=89.18 E-value=0.57 Score=43.57 Aligned_cols=76 Identities=20% Similarity=0.230 Sum_probs=55.3
Q ss_pred HHHHHHhHcCCCCceeecccCCcceEEcCCCceEEEecCCccccCCCCCceeecccCCCCCccChhhhcccCCCCCccch
Q 048517 256 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISDTRGTIGYLAPELISRNFGTVSCKSD 335 (453)
Q Consensus 256 a~gL~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~D 335 (453)
+++|.-.|+. ....+|+|-.|+||+-|..|.+||.|=+..- ..+..|.--| +...+.++.
T Consensus 151 i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--------------~~~V~~vN~~-----Y~~lT~~aE 210 (308)
T PF07387_consen 151 IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--------------ENQVNMVNIE-----YESLTQEAE 210 (308)
T ss_pred HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhh--------------hheeeEEeee-----ccccChHHH
Confidence 4667888864 4689999999999999999999999965432 1122233322 235678899
Q ss_pred HHHHHHHHHHHHcCCC
Q 048517 336 VYGFGMVLLEMAGGRR 351 (453)
Q Consensus 336 V~S~Gvvl~elltg~~ 351 (453)
+-+|=..+++++...+
T Consensus 211 ~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 211 VKVFVKSCLKLVEKQR 226 (308)
T ss_pred HHHHHHHHHHHHHHHh
Confidence 9999999999886543
No 498
>PRK10271 thiK thiamine kinase; Provisional
Probab=88.19 E-value=0.42 Score=43.31 Aligned_cols=30 Identities=20% Similarity=0.282 Sum_probs=26.1
Q ss_pred CceeecccCCcceEEcCCCceEEEecCCccc
Q 048517 268 VCILHFDIKPHNILLDHNFIPKVSDFGLAKF 298 (453)
Q Consensus 268 ~~ivH~Dikp~NILl~~~~~~kl~DFGla~~ 298 (453)
...+|+|+.|.|+++++++ ++|.||+.+..
T Consensus 77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 3579999999999998877 88999998863
No 499
>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []. Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process
Probab=88.04 E-value=2.6 Score=40.22 Aligned_cols=65 Identities=17% Similarity=0.109 Sum_probs=40.3
Q ss_pred ccCccCceEEEEEEEcCCcEEEEEEecCCCCCHHH-----HHHHHhcc------cccCcceEEEEEecC-CCChhhh
Q 048517 168 KLGQGGFGSVYKGQLHTGRLIAVKMMENSKFSAEE-----FINELLGL------CSEGFKRALVYEYMP-NGSLDRH 232 (453)
Q Consensus 168 ~LG~G~fG~Vy~g~~~~g~~VAVK~l~~~~~~~~~-----~i~el~g~------~~~~~~~~lv~E~~~-~gsL~~~ 232 (453)
.+-.|..+.|+.++..+|.++++|+........++ .+.-.-|. -.+.....+++|... +-+|.+.
T Consensus 9 ~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~~g~~~L~~w~G~GaVrll~~d~~~~AlLLErl~~g~~L~~~ 85 (253)
T PF04655_consen 9 PPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEARGEAALRWWNGRGAVRLLAADPERGALLLERLDPGRSLASL 85 (253)
T ss_pred CCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhhhHHhHhheeCCCCceeeeccccccchhhhhhccCCCchhhc
Confidence 45678889999999999999999998764433222 22211111 112234568888884 4455443
No 500
>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2.7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....
Probab=87.75 E-value=0.57 Score=43.08 Aligned_cols=30 Identities=33% Similarity=0.490 Sum_probs=21.5
Q ss_pred CceeecccCCcceEE-cCCCceEEEecCCcc
Q 048517 268 VCILHFDIKPHNILL-DHNFIPKVSDFGLAK 297 (453)
Q Consensus 268 ~~ivH~Dikp~NILl-~~~~~~kl~DFGla~ 297 (453)
.-+.|+|+.|.|||+ +.++.+++.||..|.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 468999999999999 888999999998875
Done!